100070 AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 1; AAA1
100600 ACANTHOSIS NIGRICANS
100820 ACHOO SYNDROME
101850 PALMOPLANTAR KERATODERMA, PUNCTATE TYPE III; PPKP3
102100 ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA
102150 ACROMEGALOID FACIAL APPEARANCE SYNDROME
102300 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1
102350 ACROMIAL DIMPLES
102510 ACROPECTOROVERTEBRAL DYSPLASIA; ACRPV
102800 ADENOSINE TRIPHOSPHATASE DEFICIENCY, ANEMIA DUE TO
103200 ADIPOSIS DOLOROSA
103300 HYPOGLOSSIA-HYPODACTYLIA
103420 ALACRIMA, CONGENITAL
104000 ALOPECIA AREATA 1
104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY
104530 AMELOGENESIS IMPERFECTA, HYPOPLASTIC TYPE
104570 AMELOONYCHOHYPOHIDROTIC SYNDROME
105600 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE III; CDAN3
105800 ANEURYSM, INTRACRANIAL BERRY, 1; ANIB1
106070 ANGIOMA, HEREDITARY NEUROCUTANEOUS
106700 TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1; TAPVR1
106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES
107000 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 6; NDNC6
107100 ANORECTAL ANOMALIES
107200 ANOSMIA, ISOLATED CONGENITAL; ANIC
107290 ANTIPYRINE METABOLISM
107600 APLASIA CUTIS CONGENITA, NONSYNDROMIC; ACC
107650 APNEA, OBSTRUCTIVE SLEEP
108390 ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY
108420 SPERMATOGENIC FAILURE 2; SPGF2
108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7
108725 ATHEROSCLEROSIS SUSCEPTIBILITY; ATHS
108760 ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTIVE DEAFNESS
108800 ATRIAL SEPTAL DEFECT 1; ASD1
108980 PR INTERVAL, VARIATION IN
109000 AURICULOOSTEODYSPLASIA
109160 AZOTEMIA, FAMILIAL
109200 ALOPECIA, ANDROGENETIC, 1; AGA1
109350 GASTROESOPHAGEAL REFLUX; GER
109500 BASILAR IMPRESSION, PRIMARY
109543 LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 2
109650 BEHCET SYNDROME
109660 BETA-AMINO ACIDS, RENAL TRANSPORT OF; AABT
109720 BILIARY CIRRHOSIS, PRIMARY, 1; PBC1
110350 BLOOD GROUP--AHONEN; AN
111130 BLOOD GROUP--LKE; LKE
111800 BLOOD GROUP--STOLTZFUS SYSTEM; Sf
112000 BLOOD GROUP--Ul SYSTEM; UL
112200 BLUE RUBBER BLEB NEVUS
112300 BOOK SYNDROME
112350 WEISMANN-NETTER SYNDROME; WNS
112410 HYPERTENSION WITH BRACHYDACTYLY
112440 BRACHYDACTYLY, COMBINED B AND E TYPES
112700 BRACHYDACTYLY, TYPE A3; BDA3
112800 BRACHYDACTYLY, TYPE A4; BDA4
113670 HYPERTROPHY OF THE BREAST, JUVENILE; JHB
113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT
114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET
114140 CALLOSITIES, HEREDITARY PAINFUL
114150 CAMPTOBRACHYDACTYLY
114200 CAMPTODACTYLY 1; CAMPD1
114580 CANDIDIASIS, FAMILIAL, 1; CANDF1
115650 CATARACT 32, MULTIPLE TYPES; CTRCT32
115660 CATARACT 7; CTRCT7
115665 CATARACT 8, MULTIPLE TYPES; CTRCT8
115800 CATARACT 29; CTRCT29
117100 CENTRALOPATHIC EPILEPSY
118420 CHIARI MALFORMATION TYPE I
118651 CHONDRODYSPLASIA PUNCTATA, TIBIA-METACARPAL TYPE
118830 CHYLOMICRONEMIA, FAMILIAL, DUE TO CIRCULATING INHIBITOR OF LIPOPROTEIN
118840 CHROMATE RESISTANCE; CHR
119100 SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1; SHFLD1
119530 OROFACIAL CLEFT 1; OFC1
119540 CLEFT PALATE, ISOLATED; CPI
119550 SYNGNATHIA
119580 BLEPHAROCHEILODONTIC SYNDROME; BCDS
119915 CLUSTER HEADACHE, FAMILIAL
120300 COLOBOMA OF MACULA
120450 COMEDONES, FAMILIAL DYSKERATOTIC
120502 BRANCHIOOTIC SYNDROME 2
121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1
121390 CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS
121400 CORNEA PLANA 1; CNA1
121700 CORNEAL ENDOTHELIAL DYSTROPHY 1, AUTOSOMAL DOMINANT; CHED1
122400 EPITHELIAL RECURRENT EROSION DYSTROPHY; ERED
122450 CORNEAL HYPESTHESIA, FAMILIAL
122460 HUMAN CORONAVIRUS SENSITIVITY; HCVS
122750 COXA VARA
123155 HYDROCEPHALUS, AUTOSOMAL DOMINANT; HDCPH1
123550 CRYOGLOBULINEMIA, FAMILIAL MIXED
123570 CRYPTOPHTHALMOS, UNILATERAL OR BILATERAL, ISOLATED
124300 DARWINIAN TUBERCLE OF PINNA
124480 DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT; DDOD
124700 DEAFNESS, MID-TONE NEURAL
125260 DEFECTIVE INTERFERING PARTICLE INDUCTION, CONTROL OF
125440 DENTIN DYSPLASIA WITH SCLEROTIC BONES
125480 MAJOR AFFECTIVE DISORDER 1; MAFD1
125520 CAYLER CARDIOFACIAL SYNDROME
125540 DERMAL RIDGES, PATTERNLESS
125550 DERMAL RIDGES-OFF-THE-END; ROES
125590 DERMATOGLYPHICS--FINGERPRINT PATTERN
126050 DIGITOTALAR DYSMORPHISM
126070 DILUTION, PIGMENTARY
126300 DISTICHIASIS
126550 DOUGHNUT LESIONS OF SKULL, FAMILIAL
126800 DUANE RETRACTION SYNDROME 1; DURS1
126850 DUODENAL ULCER, HYPERPEPSINOGENEMIC I
126900 DUPUYTREN CONTRACTURE
127500 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 1; DUH1
127600 DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID
128000 DYSTELEPHALANGY
128600 EAR MALFORMATION
128700 PREAURICULAR FISTULAE, CONGENITAL
128980 EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIAL
129150 ECHO VIRUS 11 SENSITIVITY; E11S
129200 ADERMATOGLYPHIA WITH CONGENITAL FACIAL MILIA AND ACRAL BLISTERS, DIGITAL
129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME
130080 EHLERS-DANLOS SYNDROME, TYPE VIII
130180 ELECTROENCEPHALOGRAM, LOW-VOLTAGE
130190 ELECTROENCEPHALOGRAPHIC PATTERN, BETA FREQUENCY, QUANTITATIVE TRAIT
130720 LATERAL MENINGOCELE SYNDROME
131200 ENDOMETRIOSIS, SUSCEPTIBILITY TO, 1
131400 EOSINOPHILIA, FAMILIAL
132100 PHOTOPAROXYSMAL RESPONSE 1; PPR1
133000 ERYTHEMA PALMARE HEREDITARIUM
133190 SPINOCEREBELLAR ATAXIA 34; SCA34
134200 FACIAL PALSY, FAMILIAL RECURRENT PERIPHERAL
134600 FANCONI RENOTUBULAR SYNDROME 1; FRTS1
135500 ZIMMERMANN-LABAND SYNDROME; ZLS
135550 FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS
135750 LAURIN-SANDROW SYNDROME
136300 FLYNN-AIRD SYNDROME
136500 FOCAL FACIAL DERMAL DYSPLASIA 1, BRAUER TYPE; FFDD1
136550 MACULAR DYSTROPHY, RETINAL, 1, NORTH CAROLINA TYPE; MCDR1
137100 IMMUNOGLOBULIN A DEFICIENCY 1; IGAD1
137360 GENOCHONDROMATOSIS
137575 GIGANTIFORM CEMENTOMA, FAMILIAL
137950 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1
139100 GRAYING OF HAIR, PRECOCIOUS
139450 HAIR MORPHOLOGY 2; HRM2
139600 HAIRY ELBOWS
139650 HAIRY PALMS AND SOLES
139900 HAND SKILL, RELATIVE; HSR
140300 HASHIMOTO THYROIDITIS
140400 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE II; PFHB2
141300 HEMIFACIAL ATROPHY, PROGRESSIVE; HFA
141350 HEMIFACIAL HYPERPLASIA WITH STRABISMUS
141400 HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS
142335 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 5; HBFQTL5
142340 DIAPHRAGMATIC HERNIA, CONGENITAL
142400 HERNIA, HIATUS
142470 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HBFQTL2
142669 HIP DYSPLASIA, BEUKES TYPE
142700 DEVELOPMENTAL DYSPLASIA OF THE HIP 1; DDH1
143000 HORNER SYNDROME, CONGENITAL
143400 MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD
143850 ORTHOSTATIC HYPOTENSIVE DISORDER, STREETEN TYPE
144110 HYPERHIDROSIS PALMARIS ET PLANTARIS; HYPRPP
144150 HYPERKERATOSIS LENTICULARIS PERSTANS; HLP
144755 HYPEROSTOSIS CRANIALIS INTERNA
145100 HYPERPIGMENTATION OF EYELIDS
145260 PSEUDOHYPOALDOSTERONISM, TYPE IIA; PHA2A
145400 HYPERTELORISM
145420 HYPERTELORISM, TEEBI TYPE
145700 HYPERTRICHOSIS UNIVERSALIS
145701 HYPERTRICHOSIS UNIVERSALIS CONGENITA, AMBRAS TYPE; HTC1
145800 HYPERTROPHIA MUSCULORUM VERA
146350 HYPOPHOSPHATEMIC BONE DISEASE; HBD
146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3
147061 IMMUNOGLOBULIN E CONCENTRATION, SERUM; IGES
147400 INCISORS, SHOVEL-SHAPED
147421 INCLUSION BODY MYOSITIS
147430 INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL DOMINANT
147770 JOHNSON NEUROECTODERMAL SYNDROME
147800 AASE-SMITH SYNDROME I
147900 JOINT LAXITY, FAMILIAL
148100 KELOID FORMATION
148200 KERATITIS FUGAX HEREDITARIA
148370 KERATOLYTIC WINTER ERYTHEMA
148730 KERATOSIS, FOCAL PALMOPLANTAR AND GINGIVAL
148840 KLEINE-LEVIN HIBERNATION SYNDROME
149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME
149300 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 2; NDNC2
150260 LARYNGEAL ABDUCTOR PARALYSIS
150270 LARYNGEAL ADDUCTOR PARALYSIS; LAP
151001 LENTIGINOSIS, INHERITED PATTERNED
151630 LIP, MEDIAN NODULE OF UPPER
151900 LIPOMATOSIS, MULTIPLE
152100 LIPOPROTEIN TYPES--Ld SYSTEM
152430 LONGEVITY 1
152800 LYMPHANGIECTASIA, INTESTINAL
153200 LYMPHEDEMA, HEREDITARY, II
153300 YELLOW NAIL SYNDROME
153600 MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1; WM1
153630 MACROGLOSSIA
153840 MACULAR DYSTROPHY, ATYPICAL VITELLIFORM; VMD1
153870 MACULAR DYSTROPHY, CONCENTRIC ANNULAR
153880 MACULAR EDEMA, CYSTOID
154275 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 2
154276 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 3
154570 MANNOSE 6-PHOSPHATE RECEPTOR RECOGNITION DEFECT, LEBANESE TYPE
155000 MAXILLOFACIAL DYSOSTOSIS
155050 MAXILLONASAL DYSPLASIA, BINDER TYPE
155145 CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA
155350 MEGALENCEPHALY, AUTOSOMAL DOMINANT
155600 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 1; CMM1
155800 MELANOSIS, UNIVERSAL
155900 MELKERSSON-ROSENTHAL SYNDROME
155950 MELORHEOSTOSIS, ISOLATED
155980 MEMBRANOUS CRANIAL OSSIFICATION, DELAYED
156230 MESOMELIC DWARFISM OF HYPOPLASTIC TIBIA AND RADIUS TYPE
156232 MESOMELIC DYSPLASIA, KANTAPUTRA TYPE; MMDK
156520 METATARSUS VARUS, TYPE I
156580 MICROCEPHALY, AUTOSOMAL DOMINANT
156600 MICROCORIA, CONGENITAL
156610 SKIN CREASES, MULTIPLE BENIGN RING-SHAPED, OF LIMBS
156850 MICROPHTHALMIA, ISOLATED, WITH CATARACT 1; MCOPCT1
157300 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1
157400 MILIA, MULTIPLE ERUPTIVE
157700 MITRAL VALVE PROLAPSE, FAMILIAL; MVP
157900 MOEBIUS SYNDROME; MBS
157950 PERMANENT MOLARS, SECONDARY RETENTION OF
158310 MUCOEPITHELIAL DYSPLASIA, HEREDITARY
158400 MUSCLE CRAMPS, FAMILIAL
158500 MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS
159050 MUSCULAR DYSTROPHY, PSEUDOHYPERTROPHIC, WITH INTERNALIZED CAPILLARIES
159300 MUSICAL PERFECT PITCH
159595 MYELOPROLIFERATIVE SYNDROME, TRANSIENT
159600 MYOCLONIC EPILEPSY, HARTUNG TYPE
160010 MYOGLOBINURIA, AUTOSOMAL DOMINANT
160300 MYOPATHY, DISTAL, WITH ONSET IN INFANCY
160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2
160750 MYOSITIS
161050 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 1; NDNC1
161500 NASAL GROOVE, FAMILIAL TRANSVERSE
161550 NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 2
161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1
161950 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1
162370 NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX
162700 NEUTROPENIA, CHRONIC FAMILIAL
162820 NEUTROPHIL MIGRATION; NM
163100 NEVUS FLAMMEUS OF NAPE OF NECK
163400 NIEVERGELT SYNDROME
163700 NIPPLES, SUPERNUMERARY
164100 NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2
164150 NYSTAGMUS, HEREDITARY VERTICAL
164170 NYSTAGMUS, VOLUNTARY
164210 HEMIFACIAL MICROSOMIA; HFM
164220 SCHILBACH-ROTT SYNDROME
164310 OCULOPHARYNGODISTAL MYOPATHY; OPDM
164745 OMODYSPLASIA 2; OMOD2
164800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 5; NDNC5
164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA
165000 OPHTHALMOPLEGIA, FAMILIAL STATIC
165660 OSLAM SYNDROME
165700 THIEMANN DISEASE
166000 ENCHONDROMATOSIS, MULTIPLE, OLLIER TYPE
166760 OTITIS MEDIA, SUSCEPTIBILITY TO
166800 OTOSCLEROSIS 1; OTSC1
167030 NEPHROLITHIASIS, CALCIUM OXALATE
167100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL DOMINANT; PHOAD
167500 PALATOPHARYNGEAL INCOMPETENCE
167730 PALPEBRAL COLOBOMA-LIPOMA SYNDROME
167870 PANIC DISORDER 1; PAND1
167900 PAPILLOMATOSIS, CONFLUENT AND RETICULATED; CARP
168860 PATELLA APLASIA-HYPOPLASIA; PTLAH
168900 PATELLA, CHONDROMALACIA OF
169000 PATELLA, FAMILIAL RECURRENT DISLOCATION OF
169545 PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA
171000 PEYRONIE DISEASE
171720 ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 1
172150 6-@PHOSPHOGLUCONOLACTONASE DEFICIENCY
172900 PIGMENTED PURPURIC ERUPTION
173800 POLAND SYNDROME
174400 POLYDACTYLY, PREAXIAL I
174600 POLYDACTYLY, PREAXIAL III
174770 ACTINIC PRURIGO
175020 POLYPOSIS, GASTRIC
175690 POLYSYNDACTYLY, CROSSED
175800 POROKERATOSIS 1, MIBELLI TYPE; POROK1
175850 POROKERATOSIS 2, PALMAR, PLANTAR, AND DISSEMINATED TYPE; POROK2
175860 PALMOPLANTAR KERATODERMA, PUNCTATE TYPE II; PPKP2
176700 PROGNATHISM, MANDIBULAR
176780 PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO
177050 PROTRUSIO ACETABULI
177750 PSEUDOMONILETHRIX
178110 ARTHROGRYPOSIS, DISTAL, TYPE 8; DA8
178200 PTERYGIUM, ANTECUBITAL
178300 PTOSIS, HEREDITARY CONGENITAL 1; PTOS1
178350 PUBIC BONE DYSPLASIA
179010 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 1; IHPS1
179200 RADIAL HEADS, POSTERIOR DISLOCATION OF
179600 RAYNAUD DISEASE
179650 RED CELL PERMEABILITY DEFECT
179700 RED CELL PHOSPHOLIPID DEFECT WITH HEMOLYSIS
180000 RETINAL ARTERIES, TORTUOSITY OF
180020 RETINAL CONE DYSTROPHY 1; RCD1
180600 RINGED HAIR
180950 SALIVARY SUBSTANCE, CLOSTRIDIUM BOTULINUM TYPE
181440 SCHEUERMANN DISEASE
181460 SCHISTOSOMA MANSONI INFECTION, SUSCEPTIBILITY/RESISTANCE TO
181510 SCHIZOPHRENIA 1; SCZD1
181515 SCHOLTE SYNDROME
181600 SCLEROTYLOSIS
181750 SCLERODERMA, FAMILIAL PROGRESSIVE
181800 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 1; IS1
182250 SINGLETON-MERTEN SYNDROME
182280 SMALL CELL CANCER OF THE LUNG
182410 SNEDDON SYNDROME
182950 SPINAL ARACHNOIDITIS
182960 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE I; HMN1
182970 SPINAL MUSCULAR ATROPHY, FACIOSCAPULOHUMERAL TYPE
183050 SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY
183840 SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2; SPDA2
184100 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT
184255 SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE
184400 SPRENGEL DEFORMITY
184450 STUTTERING, FAMILIAL PERSISTENT, 1; STUT1
184700 POLYCYSTIC OVARY SYNDROME 1; PCOS1
184850 STIFF-PERSON SYNDROME; SPS
185000 OVERHYDRATED HEREDITARY STOMATOCYTOSIS; OHS
185050 STORAGE POOL PLATELET DISEASE
185100 STRABISMUS, SUSCEPTIBILITY TO
185200 STRIAE DISTENSAE, FAMILIAL
185700 SYMPHALANGISM, DISTAL
186400 SYNOSTOSES, TARSAL, CARPAL, AND DIGITAL
186700 SYRINGOMYELIA, ISOLATED
186850 TARSAL COALITION
186890 TEAR PROTEIN, ANODAL
187000 TEETH, ODD SHAPES OF
187260 TELANGIECTASIA, HEREDITARY BENIGN
187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10
187650 THEOPHYLLINE BIOTRANSFORMATION
188470 THYROID CARCINOMA, FOLLICULAR; FTC
188770 TIBIA, HYPOPLASIA OF, WITH POLYDACTYLY
188800 TIBIAL TORSION, BILATERAL MEDIAL
189700 TORUS PALATINUS AND TORUS MANDIBULARIS
189800 PREECLAMPSIA/ECLAMPSIA 1; PEE1
190100 GENIOSPASM 1; GSM1
190310 TREMOR, NYSTAGMUS, AND DUODENAL ULCER
190340 DISCOID FIBROMAS, FAMILIAL MULTIPLE; FMDF
190600 TRIPHALANGEAL THUMB, NONOPPOSABLE
190680 TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY
191181 SUPPRESSOR OF TUMORIGENICITY 3; ST3
191200 TUNE DEAFNESS
191390 INFLAMMATORY BOWEL DISEASE 11; IBD11
191440 ULNAR HYPOPLASIA
191480 UNCOMBABLE HAIR SYNDROME
191500 UNDRITZ ANOMALY
191520 UPINGTON DISEASE
191530 URATE-BINDING GLOBULIN, DECREASE IN
191550 URETER, BIFID OR DOUBLE
192900 VERTEBRAL HYPOPLASIA WITH LUMBAR KYPHOSIS
193000 VESICOURETERAL REFLUX 1; VUR1
193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4
193007 VERTIGO, BENIGN RECURRENT; BRV
193090 TRANSCOBALAMIN I DEFICIENCY
193200 VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 6;
193250 VOLVULUS OF MIDGUT
194090 WILMS TUMOR 3; WT3
194470 ZINC, ELEVATED PLASMA
200110 ABLEPHARON-MACROSTOMIA SYNDROME
200400 ACHALASIA, FAMILIAL ESOPHAGEAL
201170 ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ
201550 ADDUCTED THUMBS SYNDROME
203330 PSEUDOHYPOPARATHYROIDISM, TYPE II; PHP2
203650 ALOPECIA-MENTAL RETARDATION SYNDROME 1; APMR1
203740 ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY
205200 AMYOTROPHIC LATERAL SCLEROSIS, JUVENILE, WITH DEMENTIA
206500 ANENCEPHALY
206570 ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT
206780 ANODONTIA OF PERMANENT DENTITION
207950 CHIARI MALFORMATION TYPE II
208060 ARTERIOSCLEROSIS, SEVERE JUVENILE
208100 ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN
208200 ARTHROGRYPOSIS-LIKE DISORDER
208500 SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1
208750 ATAXIA, DEAFNESS, AND CARDIOMYOPATHY
209700 ATROPHODERMA VERMICULATA; AVA
209850 AUTISM
209885 BARBER-SAY SYNDROME
210000 BEHR SYNDROME
210100 BETA-AMINOISOBUTYRIC ACID, URINARY EXCRETION OF
210500 BILIARY ATRESIA, EXTRAHEPATIC; EHBA
210730 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III
210745 BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE
211170 BORRONE DERMATOCARDIOSKELETAL SYNDROME
211350 KYPHOMELIC DYSPLASIA
211390 SABINAS BRITTLE HAIR SYNDROME
211890 CAMPOMELIA, CUMMING TYPE
211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMAL
212130 CARDIOMYOPATHY ASSOCIATED WITH MYOPATHY AND SUDDEN DEATH
212160 CARNITINE DEFICIENCY, MYOPATHIC
212200 CARNOSINEMIA
212500 CATARACT, CONGENITAL OR JUVENILE
212790 PREMATURE CENTROMERE DIVISION; PCD
212895 CEREBELLAR ATAXIA, EARLY-ONSET, WITH RETAINED TENDON REFLEXES; EOCA
213000 CEREBELLAR HYPOPLASIA
213100 CEREBELLOPARENCHYMAL DISORDER II; CPD2
213200 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2
214370 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,
214900 CHOLESTASIS-LYMPHEDEMA SYNDROME
215500 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 1; CACD1
215520 CILIARY DYSKINESIA WITH TRANSPOSITION OF CILIARY MICROTUBULES
216700 COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING; RPC
216950 COMPLEMENT COMPONENT C1r/C1s DEFICIENCY
217100 CONSTRICTING BANDS, CONGENITAL
217980 CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE
217990 CORPUS CALLOSUM, AGENESIS OF
218900 CROME SYNDROME
220200 DANDY-WALKER SYNDROME; DWS
221300 DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR
221350 DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA
221800 DERMOCHONDROCORNEAL DYSTROPHY
222100 DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM
222400 DIAPHRAGMATIC HERNIA 2; DIH2
222690 DIBASIC AMINO ACIDURIA I
223200 DISORGANIZATION, MOUSE, HOMOLOG OF
223370 DUBOWITZ SYNDROME
224300 DYSOSTEOSCLEROSIS
224400 DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE
224500 DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2
225000 ROSSELLI-GULIENETTI SYNDROME
226300 ENTEROPATHY, PROTEIN-LOSING
226960 EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS
227050 TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD; TEC
227090 ERYTHRODERMA, LETHAL CONGENITAL
227150 ETHANOLAMINOSIS
227330 FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE
228100 VISCERAL STEATOSIS, CONGENITAL
228250 FEMUR, UNILATERAL BIFID, WITH MONODACTYLOUS ECTRODACTYLY
229120 FOUNTAIN SYNDROME
229400 FRONTOFACIONASAL DYSPLASIA
229500 FRUCTOSE AND GALACTOSE INTOLERANCE
229850 FRYNS SYNDROME; FRNS
234100 HALLERMANN-STREIFF SYNDROME; HSS
235000 HEMIHYPERPLASIA, ISOLATED; IH
235255 MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL
235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT
235900 HISTIOCYTOSIS, FAMILIAL LIPOCHROME
236100 HOLOPROSENCEPHALY
236400 HUMERORADIAL SYNOSTOSIS
236795 3-@HYDROXYISOBUTYRIC ACIDURIA
236800 HYDROXYKYNURENINURIA
236900 HYDROXYLYSINURIA
237800 HYPERBILIRUBINEMIA, SHUNT, PRIMARY; PSHB
239800 HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME
240200 HYPOADRENOCORTICISM, FAMILIAL
241090 HYPERGONADOTROPIC HYPOGONADISM AND PARTIAL ALOPECIA
241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY
241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS
242670 CILIARY DYSKINESIA WITH DEFECTIVE RADIAL SPOKES
242700 IMMUNE DEFECT DUE TO ABSENCE OF THYMUS
243180 VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE
243600 JEJUNAL ATRESIA
243910 ARIMA SYNDROME
244300 KAPUR-TORIELLO SYNDROME
244450 KAUFMAN OCULOCEREBROFACIAL SYNDROME
245100 RICHARDS-RUNDLE SYNDROME; RRNS
246000 LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT
246400 LETTERER-SIWE DISEASE
247800 LYMPHOPENIC HYPERGAMMAGLOBULINEMIA, ANTIBODY DEFICIENCY, AUTOIMMUNE
248310 PLASMODIUM FALCIPARUM BLOOD INFECTION LEVEL
249310 MEGALOCORNEA-MENTAL RETARDATION SYNDROME
249620 OHDO SYNDROME
249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU
250215 METAPHYSEAL ACROSCYPHODYSPLASIA
250220 SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE
250900 METHIONINE MALABSORPTION SYNDROME
251230 MICROCEPHALY-MICROMELIA SYNDROME
251300 MICROCEPHALY, HIATAL HERNIA, AND NEPHROTIC SYNDROME
251600 MICROPHTHALMIA, ISOLATED 1; MCOP1
251800 MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS
252100 MOHR SYNDROME
252350 MOYAMOYA DISEASE 1; MYMY1
253240 MUCUS INSPISSATION OF RESPIRATORY TRACT
253900 MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS
254150 MUSK, INABILITY TO SMELL
255160 MYOPATHY, HYALINE BODY, AUTOSOMAL RECESSIVE
255300 MYOPATHY, CONGENITAL
255500 MYOPIA 18, AUTOSOMAL RECESSIVE; MYP18
255980 NASODIGITOACOUSTIC SYNDROME
256855 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH EXCESSIVE MYELIN FOLDING
257150 NEUTROPHIL ACTIN DYSFUNCTION; NAD
257550 OCULAR MOTOR APRAXIA
257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY
257800 OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION
257910 OCULOPALATOCEREBRAL SYNDROME
257970 OCULORENOCEREBELLAR SYNDROME
258150 SPERMATOGENIC FAILURE 1; SPGF1
258300 OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE
258360 ONYCHOTRICHODYSPLASIA AND NEUTROPENIA
258500 OPTIC ATROPHY 6; OPA6
258700 OPTICOCOCHLEODENTATE DEGENERATION
258850 OROFACIODIGITAL SYNDROME III; OFD3
258865 OROFACIODIGITAL SYNDROME IX; OFD9
259250 OSTEODYSPLASIA, FAMILIAL, ANDERSON TYPE
259780 OTOONYCHOPERONEAL SYNDROME
260565 PEHO SYNDROME
261650 PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, MITOCHONDRIAL
261800 PIERRE ROBIN SYNDROME
263000 INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP
263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,
263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5
263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION
264090 PROGEROID SYNDROME, NEONATAL
264270 PSEUDOHERMAPHRODITISM, FEMALE, WITH SKELETAL ANOMALIES
265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL
265850 PYGMY
265900 PYLE DISEASE
265950 PYLORIC ATRESIA
266350 RED SKIN PIGMENT ANOMALY OF NEW GUINEA
267700 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1; FHL1
268080 RETINOSCHISIS OF FOVEA
268700 SACCHAROPINURIA
268850 RICHIERI-COSTA/GUION-ALMEIDA SYNDROME
269200 AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II; APS2
269860 SHORT-RIB THORACIC DYSPLASIA 12; SRTD12
270150 SJOGREN SYNDROME
270600 SPASTIC DIPLEGIA, INFANTILE TYPE
270710 FITZSIMMONS-GUILBERT SYNDROME
270750 SPASTIC PARAPLEGIA 23; SPG23
271250 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3
271510 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE
271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE
271550 SPONDYLOENCHONDRODYSPLASIA; SPENCD
271600 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE
271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE
271650 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE; SEMDIT
272370 SUSCEPTIBILITY TO LYSIS BY ALLOREACTIVE NATURAL KILLER CELLS; EC1
272440 SYNDACTYLY, TYPE I, WITH MICROCEPHALY AND MENTAL RETARDATION
273250 TESTICULAR REGRESSION SYNDROME; TRS
273900 THROMBOCYTOPENIA 3; THC3
275000 GRAVES DISEASE
275120 THYROTROPIN-RELEASING HORMONE DEFICIENCY
275250 TONGUE, PIGMENTED FUNGIFORM PAPILLAE OF
275370 TRICARBOXYLIC ACID CYCLE, DEFECT OF
275400 TRICHOMEGALY WITH MENTAL RETARDATION, DWARFISM, AND PIGMENTARY DEGENERATION
275550 TRICHORRHEXIS NODOSA SYNDROME
276100 TRYPTOPHANURIA WITH DWARFISM
276400 TWINNING, DIZYGOTIC
277000 MAYER-ROKITANSKY-KUSTER-HAUSER SYNDROME
277100 VALINEMIA
277150 VAN BOGAERT-HOZAY SYNDROME
277170 OROFACIODIGITAL SYNDROME VI; OFD6
277320 VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA
277350 HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL RECESSIVE
277720 WHISTLING FACE SYNDROME, RECESSIVE FORM
277730 WERNICKE-KORSAKOFF SYNDROME
279000 YOUNG SYNDROME
300001 ICHTHYOSIS, X-LINKED, WITHOUT STEROID SULFATASE DEFICIENCY
300030 DEAFNESS, X-LINKED 3; DFNX3
300046 MENTAL RETARDATION, X-LINKED 23; MRX23
300047 MENTAL RETARDATION, X-LINKED 20; MRX20
300062 MENTAL RETARDATION, X-LINKED 14; MRX14
300076 IMMUNONEUROLOGIC DISORDER, X-LINKED
300082 COGNITIVE FUNCTION 1, SOCIAL; CGF1
300085 CONE-ROD DYSTROPHY, X-LINKED, 2; CORDX2
300114 MENTAL RETARDATION, X-LINKED 49; MRX49
300115 MENTAL RETARDATION, X-LINKED 50; MRX50
300125 MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2
300136 DIABETES MELLITUS, INSULIN-DEPENDENT, X-LINKED, SUSCEPTIBILITY TO
300147 PROSTATE CANCER, HEREDITARY, X-LINKED 1; HPCX1
300148 MENTAL RETARDATION, EPILEPTIC SEIZURES, HYPOGONADISM AND HYPOGENITALISM,
300155 RETINITIS PIGMENTOSA 24; RP24
300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX
300179 X INACTIVATION, FAMILIAL SKEWED, 2; SXI2
300211 EPISODIC MUSCLE WEAKNESS, X-LINKED; EMWX
300218 MENTAL RETARDATION, X-LINKED, SYNDROMIC 7; MRXS7
300221 HODGKIN DISEASE, X-LINKED PSEUDOAUTOSOMAL
300228 TESTICULAR GERM CELL TUMOR 1; TGCT1
300238 MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11
300245 PTOSIS, HEREDITARY CONGENITAL 2
300258 ROIFMAN SYNDROME
300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA
300262 ABIDI X-LINKED MENTAL RETARDATION SYNDROME; MRXSAB
300266 SPASTIC PARAPLEGIA 16, X-LINKED; SPG16
300273 GOITER, MULTINODULAR 2; MNG2
300306 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 11; BMIQ11
300310 AGAMMAGLOBULINEMIA, X-LINKED, TYPE 2; AGMX2
300324 MENTAL RETARDATION, X-LINKED 53; MRX53
300331 THROMBOCYTHEMIA, X-LINKED; THCYTX
300345 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 1; MCOPCB1
300351 GRAVES DISEASE, SUSCEPTIBILITY TO, X-LINKED 1
300355 MENTAL RETARDATION, X-LINKED 73; MRX73
300360 MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE
300372 MENTAL RETARDATION, X-LINKED 42; MRX42
300378 RADIAL RAY DEFICIENCY, X-LINKED
300388 POLYMICROGYRIA, BILATERAL PERISYLVIAN, X-LINKED; BPPX
300406 FG SYNDROME 3; FGS3
300421 WITTWER SYNDROME
300428 MENTAL RETARDATION, X-LINKED 2; MRX2
300433 MENTAL RETARDATION, X-LINKED 81; MRX81
300454 MENTAL RETARDATION, X-LINKED 77; MRX77
300464 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 3
300471 CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES
300484 OROFACIODIGITAL SYNDROME VIII; OFD8
300488 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENOQ1
300504 MENTAL RETARDATION, X-LINKED 52; MRX52
300505 MENTAL RETARDATION, X-LINKED 84; MRX84
300509 DYSLEXIA, SUSCEPTIBILITY TO, 9; DYX9
300518 MENTAL RETARDATION, X-LINKED 82; MRX82
300536 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 4; BMND4
300551 MENTAL RETARDATION, X-LINKED 78; MRX78
300557 PARKINSON DISEASE 12; PARK12
300580 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX
300581 FG SYNDROME 5; FGS5
300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5
300591 STATURE QUANTITATIVE TRAIT LOCUS 6; STQTL6
300605 RETINITIS PIGMENTOSA 34; RP34
300612 BROOKS-WISNIEWSKI-BROWN SYNDROME
300613 MYOPIA 13, X-LINKED; MYP13
300614 DEAFNESS, X-LINKED 5; DFNX5
300619 CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION
300652 ANGIOMA SERPIGINOSUM, X-LINKED
300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD
300700 ALBINISM-DEAFNESS SYNDROME; ADFN
300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5
300704 PROSTATE CANCER, HEREDITARY, X-LINKED 2; HPCX2
300709 MENTAL RETARDATION, X-LINKED, SYNDROMIC 9; MRXS9
300710 ALOPECIA, ANDROGENETIC, 2; AGA2
300711 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 4; IHPS4
300712 CRANIOFACIOSKELETAL SYNDROME
300716 MENTAL RETARDATION, X-LINKED 95; MRX95
300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES
300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34
300756 ALZHEIMER DISEASE 16; AD16
300778 CORNEAL DYSTROPHY, LISCH EPITHELIAL; LECD
300779 CORNEAL DYSTROPHY, ENDOTHELIAL, X-LINKED; XECD
300809 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 15; SLEB15
300829 CARDIOMYOPATHY, FATAL FETAL, DUE TO MYOCARDIAL CALCIFICATION
300843 BORNHOLM EYE DISEASE; BED
300848 MENTAL RETARDATION, X-LINKED 89; MRX89
300851 MENTAL RETARDATION, X-LINKED 92; MRX92
300852 MENTAL RETARDATION, X-LINKED 88; MRX88
300856 HYPOSPADIAS 4, X-LINKED, SUSCEPTIBILITY TO; HYSP4
300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17
300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS
300870 ANEURYSM, INTRACRANIAL BERRY, 5; ANIB5
300881 BARATELA-SCOTT SYNDROME
301201 AMELOGENESIS IMPERFECTA, HYPOPLASTIC/HYPOMATURATION, X-LINKED 2
301220 PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS; PDR
301590 MICROPHTHALMIA, SYNDROMIC 4; MCOPS4
301845 BAZEX SYNDROME; BZX
302000 BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE
302380 CATEL-MANZKE SYNDROME
302801 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2; CMTX2
302802 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3
304050 AICARDI SYNDROME; AIC
304730 DERMOIDS OF CORNEA; CND
305200 EHLERS-DANLOS SYNDROME, TYPE V
305435 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HBFQTL3
306960 HHHH SYNDROME
307700 HYPOPARATHYROIDISM, X-LINKED; HYPX
308250 IMMUNOGLOBULIN M, LEVEL OF
308280 IMPACTED TEETH, MULTIPLE
308905 LEBER OPTIC ATROPHY, SUSCEPTIBILITY TO
309100 MACULAR DYSTROPHY, X-LINKED
309200 MAJOR AFFECTIVE DISORDER 2; MAFD2
309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12
309555 MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES
309560 MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS
309605 MILES-CARPENTER X-LINKED MENTAL RETARDATION SYNDROME; MCS
309610 PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS
309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD
310440 MYOPATHY, X-LINKED, WITH EXCESSIVE AUTOPHAGY; MEAX
310460 MYOPIA 1, X-LINKED; MYP1
311000 OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA; OPEM
311050 OPTIC ATROPHY 2; OPA2
311510 PARKINSONISM, EARLY-ONSET, WITH MENTAL RETARDATION
312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED
312500 RETICULOENDOTHELIOSIS, X-LINKED
312612 RETINITIS PIGMENTOSA 6; RP6
313000 SPATIAL VISUALIZATION, APTITUDE FOR
313350 SPLIT-HAND/FOOT MALFORMATION 2; SHFM2
313850 THORACOABDOMINAL SYNDROME; THAS
314300 TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR
314380 UNIQUE GREEN PHENOMENON
314705 XG REGULATOR; XGR
314900 XM SYSTEM
400004 RETINITIS PIGMENTOSA, Y-LINKED; RPY
400021 HODGKIN DISEASE, Y-LINKED PSEUDOAUTOSOMAL
400043 DEAFNESS, Y-LINKED 1; DFNY1
424500 GONADOBLASTOMA; GBY
475000 GROWTH CONTROL, Y-CHROMOSOME INFLUENCED; GCY
600048 BREAST CANCER, 11-22 TRANSLOCATION-ASSOCIATED; BRCATA
600057 EXSTROPHY OF BLADDER
600082 PROSTATIC HYPERPLASIA, BENIGN; BPH
600131 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1
600156 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 5; HSCR5
600165 NANOPHTHALMOS 1; NNO1
600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS
600193 WAARDENBURG SYNDROME, TYPE 2B; WS2B
600202 DYSLEXIA, SUSCEPTIBILITY TO, 2; DYX2
600209 EXOSTOSES, MULTIPLE, TYPE III; EXT3
600223 SPINOCEREBELLAR ATAXIA 4; SCA4
600268 OCULOECTODERMAL SYNDROME; OES
600318 DIABETES MELLITUS, INSULIN-DEPENDENT, 3; IDDM3
600319 DIABETES MELLITUS, INSULIN-DEPENDENT, 4; IDDM4
600321 DIABETES MELLITUS, INSULIN-DEPENDENT, 7; IDDM7
600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA
600332 RIPPLING MUSCLE DISEASE 1; RMD1
600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP
600360 APLASIA CUTIS CONGENITA OF LIMBS, AUTOSOMAL RECESSIVE
600361 HEREDITARY MOTOR AND SENSORY NEUROPATHY V
600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSAL
600467 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 4
600510 GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1
600511 SCHIZOPHRENIA 3; SCZD3
600593 CRANIOSYNOSTOSIS, ADELAIDE TYPE; CRSA
600624 CONE-ROD DYSTROPHY 1; CORD1
600631 ENURESIS, NOCTURNAL, 1; ENUR1
600668 CHONDROCALCINOSIS 1; CCAL1
600669 EPILEPSY, IDIOPATHIC GENERALIZED; EIG
600674 MICROTIA-ANOTIA
600757 OROFACIAL CLEFT 3; OFC3
600771 DWARFISM, FAMILIAL, WITH MUSCLE SPASMS
600785 VITAMIN D-DEPENDENT RICKETS, TYPE 2B, WITH NORMAL VITAMIN D RECEPTOR;
600790 CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL
600792 DEAFNESS, AUTOSOMAL RECESSIVE 5; DFNB5
600808 ENURESIS, NOCTURNAL, 2; ENUR2
600883 DIABETES MELLITUS, INSULIN-DEPENDENT, 8; IDDM8
600884 CARDIOMYOPATHY, DILATED, 1B; CMD1B
600975 GLAUCOMA 3, PRIMARY INFANTILE, B; GLC3B
601068 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1
601076 MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACIC
601086 LATERALITY DEFECTS, AUTOSOMAL DOMINANT
601101 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 3; HHT3
601162 SPASTIC PARAPLEGIA 9, AUTOSOMAL DOMINANT; SPG9
601163 DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS
601202 CATARACT 24; CTRCT24
601208 DIABETES MELLITUS, INSULIN-DEPENDENT, 11; IDDM11
601308 MYELOID TUMOR SUPPRESSOR
601318 DIABETES MELLITUS, INSULIN-DEPENDENT, 13; IDDM13
601346 MARTINEZ-FRIAS SYNDROME
601349 MICROPHTHALMIA, SYNDROMIC 8; MCOPS8
601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE
601357 BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH
601362 DIGEORGE SYNDROME/VELOCARDIOFACIAL SYNDROME COMPLEX 2
601363 WILMS TUMOR 4
601407 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 2; NIDDM2
601412 DEAFNESS, AUTOSOMAL DOMINANT 7; DFNA7
601452 OCULOAURICULOFRONTONASAL SYNDROME; OAFNS
601454 PSORIASIS SUSCEPTIBILITY 3; PSORS3
601458 INFLAMMATORY BOWEL DISEASE 2; IBD2
601471 FACIAL PARESIS, HEREDITARY CONGENITAL, 1; HCFP1
601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2
601537 MICROCEPHALY, RETINITIS PIGMENTOSA, AND SUTURAL CATARACT
601549 ALACRIMA, CONGENITAL, AUTOSOMAL RECESSIVE
601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;
601616 IRIS PIGMENT EPITHELIUM ANOMALIES
601666 DIABETES MELLITUS, INSULIN-DEPENDENT, 15; IDDM15
601676 ACUTE INSULIN RESPONSE
601682 GLAUCOMA 1, PRIMARY OPEN ANGLE, C; GLC1C
601694 LEPTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; LEPQTL1
601700 SEBACEOUS GLAND HYPERPLASIA, FAMILIAL PRESENILE
601764 SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1
601794 COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME
601846 VACUOLAR NEUROMYOPATHY
601888 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 6
601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES
601941 DIABETES MELLITUS, INSULIN-DEPENDENT, 6; IDDM6
601992 FRIEDREICH ATAXIA 2; FRDA2
602071 BROAD TERMINAL PHALANGES, FAMILIAL
602082 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II; CDB2
602085 POLYDACTYLY, POSTAXIAL, TYPE A2; PAPA2
602086 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 3; ARVD3
602087 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 4; ARVD4
602096 ALZHEIMER DISEASE 5
602097 USHER SYNDROME, TYPE IE; USH1E
602099 AMYOTROPHIC LATERAL SCLEROSIS 5; ALS5
602124 DYSTONIA 7, TORSION; DYT7
602134 TREMOR, HEREDITARY ESSENTIAL, 2; ETM2
602196 PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES
602199 MEDIUM CHAIN 3-KETOACYL-CoA THIOLASE DEFICIENCY
602200 VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY
602247 XANTHOMATOSIS, SUSCEPTIBILITY TO
602248 MALIGNANT ATROPHIC PAPULOSIS
602342 PLANTAR LIPOMATOSIS, UNUSUAL FACIES, AND DEVELOPMENTAL DELAY
602401 ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE; ECTD8
602404 PARKINSON DISEASE 3, AUTOSOMAL DOMINANT; PARK3
602429 GLAUCOMA 1, OPEN ANGLE, D; GLC1D
602440 AMYOTROPHY, MONOMELIC
602475 OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL
602477 FEBRILE SEIZURES, FAMILIAL, 2; FEB2
602499 MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM
602594 RETINITIS PIGMENTOSA 22; RP22
602639 TOOTH AGENESIS, SELECTIVE, 2; STHAG2
602685 MENTAL RETARDATION, SEVERE, WITH SPASTICITY AND PIGMENTARY TAPETORETINAL
602759 PROSTATE CANCER, HEREDITARY, 8
602966 OROFACIAL CLEFT 2; OFC2
603003 BILE DUCT CYSTS
603010 DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17
603013 SCHIZOPHRENIA 6; SCZD6
603040 TUMOR SUPPRESSOR GENE ON CHROMOSOME 11
603047 ASTIGMATISM
603098 DEAFNESS, AUTOSOMAL RECESSIVE 13; DFNB13
603116 CDAGS SYNDROME
603165 DERMATITIS, ATOPIC
603175 SCHIZOPHRENIA 5; SCZD5
603176 SCHIZOPHRENIA 7; SCZD7
603188 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 8; BMIQ8
603204 EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2
603206 SCHIZOPHRENIA 8; SCZD8
603221 MYOPIA 3, AUTOSOMAL DOMINANT; MYP3
603266 DIABETES MELLITUS, INSULIN-DEPENDENT, 17; IDDM17
603342 SCHIZOPHRENIA 2; SCZD2
603386 THYROID CARCINOMA, NONMEDULLARY, WITH OR WITHOUT CELL OXYPHILIA
603388 GRAVES DISEASE, SUSCEPTIBILITY TO, 2
603663 MENTAL HEALTH WELLNESS 1
603671 ACROMELIC FRONTONASAL DYSOSTOSIS
603678 DEAFNESS, AUTOSOMAL RECESSIVE 14; DFNB14
603694 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 3
603783 INTELLIGENCE QUANTITATIVE TRAIT LOCUS 1
603802 MICROCEPHALY WITH SIMPLIFIED GYRAL PATTERN
603855 CYSTIC FIBROSIS, MODIFIER OF, 1; CFM1
603918 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 1
603935 PSORIASIS SUSCEPTIBILITY 4; PSORS4
603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16
604060 DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20
604185 FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2
604201 HEPATIC FIBROSIS, SEVERE, SUSCEPTIBILITY TO, DUE TO SCHISTOSOMA MANSONI
604254 DYSLEXIA, SUSCEPTIBILITY TO, 3; DYX3
604288 CARDIOMYOPATHY, DILATED, 1H; CMD1H
604314 BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION
604316 PSORIASIS SUSCEPTIBILITY 5; PSORS5
604329 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 2
604401 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 6; ARVD6
604431 POLYNEUROPATHY, LETHAL NEONATAL, AXONAL SENSORIMOTOR, AUTOSOMAL RECESSIVE
604499 HYPERLIPIDEMIA, COMBINED, 2
604519 INFLAMMATORY BOWEL DISEASE 3; IBD3
604547 VAN DER WOUDE SYNDROME 1, MODIFIER OF
604595 CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 1
604801 MUSCULAR DYSTROPHY, CONGENITAL, 1B; MDC1B
604802 HUNTINGTON DISEASE-LIKE 3; HDL3
604809 PANBRONCHIOLITIS, DIFFUSE
604827 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 7; EIG7
605055 ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND
605201 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
605225 INFLAMMATORY BOWEL DISEASE 7; IBD7
605229 SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE; SPG14
605233 DIANZANI AUTOIMMUNE LYMPHOPROLIFERATIVE DISEASE
605244 CARNEY COMPLEX, TYPE 2; CNC2
605293 OPTIC ATROPHY 4; OPA4
605364 PSORIASIS SUSCEPTIBILITY 6; PSORS6
605365 BREAST CANCER 3; BRCA3
605388 CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE
605419 SCHIZOPHRENIA 10; SCZD10
605428 DEAFNESS, AUTOSOMAL RECESSIVE 26; DFNB26
605429 DEAFNESS, NONSYNDROMIC, MODIFIER 1; DFNM1
605462 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1
605480 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 3; SLEB3
605526 ALZHEIMER DISEASE 6
605544 FIBROMATOSIS, GINGIVAL, 2; GINGF2
605549 CONE-ROD DYSTROPHY 8; CORD8
605552 ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1
605572 ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2
605582 CARDIOMYOPATHY, DILATED, 1K; CMD1K
605598 DIABETES MELLITUS, INSULIN-DEPENDENT, 18; IDDM18
605606 PSORIASIS SUSCEPTIBILITY 7; PSORS7
605627 CEREBROOCULONASAL SYNDROME
605635 HYPERALDOSTERONISM, FAMILIAL, TYPE II
605642 THYROID CARCINOMA, PAPILLARY, WITH PAPILLARY RENAL NEOPLASIA
605726 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 2; DSMA2
605727 OTOSCLEROSIS 2; OTSC2
605728 CATARACT 25; CTRCT25
605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12
605738 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 2; MCOPCB2
605746 ANISOMASTIA
605749 CATARACT 26, MULTIPLE TYPES; CTRCT26
605750 EXUDATIVE VITREORETINOPATHY 3; EVR3
605779 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 7; NDNC7
605804 DERMATITIS, ATOPIC, 3; ATOD3
605805 DERMATITIS, ATOPIC, 4; ATOD4
605809 MYASTHENIA, FAMILIAL INFANTILE, 1
605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27
605827 BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT;
605833 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 2; BMND2
605841 NARCOLEPSY 2, SUSCEPTIBILITY TO; NRCLP2
605844 DERMATITIS, ATOPIC, 5; ATOD5
605845 DERMATITIS, ATOPIC, 6; ATOD6
605856 SHORT STATURE, MENTAL RETARDATION, CALLOSAL AGENESIS, HEMINASAL HYPOPLASIA,
605913 BLEEDING DISORDER, EAST TEXAS TYPE
605934 HOLOPROSENCEPHALY 6; HPE6
605946 METAPHYSEAL DYSPLASIA, BRAUN-TINSCHERT TYPE
605967 ACROPECTORAL SYNDROME; ACRPS
606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18
606035 FASTING INSULIN LEVEL QUANTITATIVE TRAIT LOCUS 1; FIQTL1
606049 ACROMEGALOID FEATURES, OVERGROWTH, CLEFT PALATE, AND HERNIA
606053 AUTISM, SUSCEPTIBILITY TO, 5; AUTS5
606082 GOITER, MULTINODULAR 3; MNG3
606129 DIAMOND-BLACKFAN ANEMIA 2; DBA2
606164 DIAMOND-BLACKFAN ANEMIA WITH MICROTIA AND CLEFT PALATE
606187 ALZHEIMER DISEASE 7
606215 ATRIOVENTRICULAR SEPTAL DEFECT; AVSD
606240 THYROID CARCINOMA, NONMEDULLARY, SUSCEPTIBILITY TO, 1
606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,
606255 STATURE AS A QUANTITATIVE TRAIT
606256 STATURE QUANTITATIVE TRAIT LOCUS 2; STQTL2
606257 STATURE QUANTITATIVE TRAIT LOCUS 3; STQTL3
606258 STATURE QUANTITATIVE TRAIT LOCUS 4; STQTL4
606263 PAGET DISEASE OF BONE 4; PDB4
606282 DEAFNESS, AUTOSOMAL DOMINANT 24; DFNA24
606325 HETEROTAXY, VISCERAL, 3, AUTOSOMAL; HTX3
606348 INFLAMMATORY BOWEL DISEASE 5; IBD5
606451 DEAFNESS, AUTOSOMAL DOMINANT 30; DFNA30
606460 LONGEVITY 2
606483 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA
606552 EPISODIC ATAXIA, TYPE 4; EA4
606554 EPISODIC ATAXIA, TYPE 3; EA3
606613 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
606616 DYSLEXIA, SUSCEPTIBILITY TO, 6; DYX6
606640 AMYOTROPHIC LATERAL SCLEROSIS 3; ALS3
606641 BODY MASS INDEX; BMI
606643 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 2; BMIQ2
606656 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 2; IBGC2
606660 MELANOMA, UVEAL, SUSCEPTIBILITY TO, 1
606661 MELANOMA, UVEAL, SUSCEPTIBILITY TO, 2
606662 WAARDENBURG SYNDROME, TYPE 2C; WS2C
606668 INFLAMMATORY BOWEL DISEASE 8; IBD8
606674 INFLAMMATORY BOWEL DISEASE 6; IBD6
606675 INFLAMMATORY BOWEL DISEASE 4; IBD4
606689 GLAUCOMA 1, OPEN ANGLE, B; GLC1B
606708 SPLIT-HAND/FOOT MALFORMATION 5; SHFM5
606711 SPECIFIC LANGUAGE IMPAIRMENT 1; SLI1
606712 SPECIFIC LANGUAGE IMPAIRMENT 2; SLI2
606770 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 2; ADIPQTL2
606771 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 3; ADIPQTL3
606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKIN
606787 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1
606788 ANOREXIA NERVOSA, SUSCEPTIBILITY TO, 1; ANON1
606789 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 4; HBFQTL4
606799 STROKE, SUSCEPTIBILITY TO, 1
606840 PARASOMNIA, SLEEP BRUXISM TYPE; PSMNSB
606842 CARDIONEUROMYOPATHY WITH HYALINE MASSES AND NEMALINE RODS
606852 PARKINSON DISEASE 10; PARK10
606874 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 6; HSCR6
606875 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 7; HSCR7
606896 DYSLEXIA, SUSCEPTIBILITY TO, 5; DYX5
606928 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 3; BMND3
606960 INSULINOMA TUMOR SUPPRESSOR GENE LOCUS
606963 PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD
606972 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 2; EIG2
606984 HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 2
606995 SENIOR-LOKEN SYNDROME 3; SLSN3
607004 BRACHYDACTYLY, TYPE A1, B; BDA1B
607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21
607053 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
607085 MYASTHENIA GRAVIS WITH THYMUS HYPERPLASIA
607086 AORTIC ANEURYSM, FAMILIAL THORACIC 1; AAT1
607087 AORTIC ANEURYSM, FAMILIAL THORACIC 2; AAT2
607088 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 3; DSMA3
607107 NASOPHARYNGEAL CARCINOMA
607116 ALZHEIMER DISEASE 8
607131 MACROCEPHALY WITH MULTIPLE EPIPHYSEAL DYSPLASIA AND DISTINCTIVE FACIES
607134 SPECIFIC LANGUAGE IMPAIRMENT 3; SLI3
607135 CREATININE CLEARANCE QUANTITATIVE TRAIT LOCUS
607152 SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT; SPG19
607202 CELIAC DISEASE, SUSCEPTIBILITY TO, 5; CELIAC5
607221 EPILEPSY, PARTIAL, WITH PERICENTRAL SPIKES; PEPS
607239 DEAFNESS, AUTOSOMAL RECESSIVE 33; DFNB33
607248 GLIOMA SUSCEPTIBILITY 4; GLM4
607258 HYPERCALCIURIA, ABSORPTIVE, 1
607279 SYSTEMIC LUPUS ERYTHEMATOSUS WITH HEMOLYTIC ANEMIA, SUSCEPTIBILITY
607304 CATARACT 27; CTRCT27
607308 MAMMOGRAPHIC DENSITY
607317 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4
607324 POLYDACTYLY, POSTAXIAL, TYPE A3
607329 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 3
607339 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 1
607354 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 2; IS2
607373 AUTISM, SUSCEPTIBILITY TO, 8; AUTS8
607411 PATENT DUCTUS ARTERIOSUS
607446 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 3; BMIQ3
607454 SPINOCEREBELLAR ATAXIA 21; SCA21
607458 SPINOCEREBELLAR ATAXIA 18; SCA18
607488 DYSTONIA 15, MYOCLONIC; DYT15
607498 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3
607499 BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1; BULN1
607501 MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4
607508 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5
607516 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6
607539 CAMPTOSYNPOLYDACTYLY, COMPLEX
607572 LEPROSY, SUSCEPTIBILITY TO, 2; LPRS2
607584 SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE; SPG24
607592 PROSTATE CANCER AGGRESSIVENESS QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
607600 EPIDERMOLYSIS BULLOSA SIMPLEX SUPERFICIALIS; EBSS
607644 CANDIDIASIS, FAMILIAL, 3; CANDF3
607656 CURLY HAIR-ACRAL KERATODERMA-CARIES SYNDROME
607658 HYPOTRICHOSIS-OSTEOLYSIS-PERIODONTITIS-PALMOPLANTAR KERATODERMA SYNDROME
607671 DYSTONIA 13, TORSION, AUTOSOMAL DOMINANT; DYT13
607674 CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY
607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52
607687 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
607728 POROKERATOSIS 4, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK4
607829 MITRAL VALVE PROLAPSE, MYXOMATOUS 2; MMVP2
607834 ANXIETY
607853 PANIC DISORDER 2
607857 PSORIASIS SUSCEPTIBILITY 9; PSORS9
607876 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 2; FAME2
607893 OVARIAN CANCER, SUSCEPTIBILITY TO, 1; OVCAS1
607949 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 1
607965 SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 1;
607966 SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 2;
607967 SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS, SUSCEPTIBILITY TO, 3;
608026 HYPERTENSIVE NEPHROPATHY; HNP1
608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3
608029 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6; SCAR6
608031 AMYOTROPHIC LATERAL SCLEROSIS 7; ALS7
608035 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 4; CMM4
608036 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 4
608045 REPRESSOR OF TELOMERASE EXPRESSION 1
608049 AUTISM, SUSCEPTIBILITY TO, 3; AUTS3
608068 NEUTROPHILIC DERMATOSIS, ACUTE FEBRILE
608078 SCHIZOPHRENIA 11
608088 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND
608096 EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2
608098 HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5p ANOMALIES
608105 EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND
608154 LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT
608158 CoQ-RESPONSIVE OXPHOS DEFICIENCY
608173 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 1
608174 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 2
608176 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 4
608207 KALA-AZAR, SUSCEPTIBILITY TO, 1; KAZA1
608217 SEIZURES, BENIGN FAMILIAL NEONATAL, 3; BFNS3
608219 DEAFNESS, AUTOSOMAL RECESSIVE 38; DFNB38
608220 SPASTIC PARAPLEGIA 25, AUTOSOMAL RECESSIVE; SPG25
608244 OTOSCLEROSIS 3; OTSC3
608251 PHOBIA, SPECIFIC
608264 DEAFNESS, AUTOSOMAL RECESSIVE 40; DFNB40
608290 LELIS SYNDROME
608316 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 2
608318 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 4
608345 NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3
608367 MYOPIA 17, AUTOSOMAL DOMINANT; MYP17
608371 OROFACIAL CLEFT 4; OFC4
608372 DEAFNESS, AUTOSOMAL DOMINANT 49; DFNA49
608391 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 2; AIS2
608392 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 3; AIS3
608394 DEAFNESS, AUTOSOMAL DOMINANT 43; DFNA43
608410 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 7; BMIQ7
608437 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 4; SLEB4
608445 SPEECH-SOUND DISORDER
608447 CAROTID INTIMAL MEDIAL THICKNESS 2
608448 INFLAMMATORY BOWEL DISEASE 9; IBD9
608462 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 8; HSCR8
608474 MYOPIA 5, AUTOSOMAL DOMINANT; MYP5
608520 MAJOR DEPRESSIVE DISORDER 1
608526 PERIODONTITIS, AGGRESSIVE, 2
608542 ANEURYSM, INTRACRANIAL BERRY, 2; ANIB2
608543 SCHIZOPHRENIA 12
608545 LARSEN-LIKE SYNDROME
608557 MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO, 2
608558 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 5; BMIQ5
608559 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 6; BMIQ6
608562 POLYDACTYLY, POSTAXIAL, TYPE A4
608572 BURN-MCKEOWN SYNDROME
608578 CEREBROFRONTOFACIAL SYNDROME
608583 ATRIAL FIBRILLATION, FAMILIAL, 1; ATFB1
608585 BRACHIAL PALSY, FAMILIAL CONGENITAL
608586 KERATOCONUS 3; KTCN3
608591 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2G; CMT2G
608600 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1; FPLD1
608631 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2
608638 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1
608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31
608646 CILIARY DYSKINESIA, PRIMARY, 4; CILD4
608652 DEAFNESS, AUTOSOMAL DOMINANT 47; DFNA47
608653 DEAFNESS, AUTOSOMAL RECESSIVE 32; DFNB32
608656 PROSTATE CANCER, HEREDITARY, 3
608658 PROSTATE CANCER, HEREDITARY, 4
608664 SECKEL SYNDROME 3; SCKL3
608691 MAJOR DEPRESSIVE DISORDER 2
608695 GLAUCOMA 1, OPEN ANGLE, J; GLC1J
608696 GLAUCOMA 1, OPEN ANGLE, K; GLC1K
608703 SPINOCEREBELLAR ATAXIA 25; SCA25
608710 WEGENER GRANULOMATOSIS
608742 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 4
608762 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3
608781 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 3; ASPG3
608787 OTOSCLEROSIS 5; OTSC5
608796 MOYAMOYA DISEASE 3; MYMY3
608816 MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 3; EJM3
608831 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 2; RLS2
608850 MACULAR DYSTROPHY, RETINAL, 3
608852 PULMONARY FUNCTION
608875 GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
608878 GENE EXPRESSION, VARIATION IN, QUANTITATIVE TRAIT LOCUS ON CHROMOSOME
608903 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 1
608904 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 2
608905 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 3
608906 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 4
608907 ALZHEIMER DISEASE 9
608911 CHOANAL ATRESIA, POSTERIOR; PCA
608932 KERATOCONUS 2; KTCN2
608935 LUNG CANCER SUSCEPTIBILITY 1; LNCR1
608970 MACULAR DYSTROPHY, BUTTERFLY-SHAPED PIGMENTARY, 2
608982 STATURE QUANTITATIVE TRAIT LOCUS 5; STQTL5
608988 ATRIAL FIBRILLATION, FAMILIAL, 2; ATFB2
608995 DYSLEXIA, SUSCEPTIBILITY TO, 8; DYX8
609021 PERIPHERAL CONE DYSTROPHY
609026 CATARACT 28; CTRCT28
609039 NARCOLEPSY 3; NRCLP3
609041 SPASTIC PARAPLEGIA 27, AUTOSOMAL RECESSIVE; SPG27
609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4
609055 CEROID LIPOFUSCINOSIS, NEURONAL, 9; CLN9
609070 HEMOGLOBIN, HIGH OXYGEN SATURATION OF
609113 TELOMERE LENGTH, MEAN LEUKOCYTE
609115 LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G
609116 RESPIRATORY RHYTHMICITY IN SLEEP
609122 ANEURYSM, INTRACRANIAL BERRY, 3; ANIB3
609128 ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4
609143 TIBIA, BOWING OF, WITH PSEUDARTHROSIS AND PECTUS EXCAVATUM
609153 PSEUDOHYPERKALEMIA, FAMILIAL, 2, DUE TO RED CELL LEAK
609164 UMBILICUS, FAMILIAL FLAT
609166 BRANCHIOGENIC-DEAFNESS SYNDROME
609179 MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 7
609197 GLUCOCORTICOID DEFICIENCY 3; GCCD3
609222 DANDY-WALKER MALFORMATION WITH OCCIPITAL CEPHALOCELE, AUTOSOMAL DOMINANT;
609223 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGER
609253 FEBRILE SEIZURES, FAMILIAL, 6; FEB6
609255 FEBRILE SEIZURES, FAMILIAL, 5; FEB5
609256 MYOPIA 7; MYP7
609257 MYOPIA 8; MYP8
609258 MYOPIA 9; MYP9
609259 MYOPIA 10; MYP10
609261 STUTTERING, FAMILIAL PERSISTENT, 2; STUT2
609266 LI-FRAUMENI SYNDROME 3; LFS3
609271 KERATOCONUS 4; KTCN4
609296 B-CELL IMMUNODEFICIENCY, DISTAL LIMB ANOMALIES, AND UROGENITAL MALFORMATIONS
609299 PROSTATE CANCER, HEREDITARY, 5
609319 HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HCHGQ1
609320 HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 2; HCHGQ2
609324 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA
609325 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MINIEPIPHYSES
609354 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 5; BMND5
609376 CATARACT 35; CTRCT35
609378 AUTISM, SUSCEPTIBILITY TO, 6; AUTS6
609384 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3C; CFEOM3C
609400 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 4; AIS4
609402 PREECLAMPSIA/ECLAMPSIA 2; PEE2
609403 PREECLAMPSIA/ECLAMPSIA 3; PEE3
609408 HOLOPROSENCEPHALY 8; HPE8
609428 TUKEL SYNDROME
609432 SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION; MSSD
609454 SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2
609456 MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE
609469 NEPHROPATHY, PROGRESSIVE, WITH DEAFNESS
609470 LEFT VENTRICULAR NONCOMPACTION 2; LVNC2
609500 MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET
609541 SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN
609558 PROSTATE CANCER, HEREDITARY, 6
609566 PARIETAL FORAMINA 3; PFM3
609570 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 8
609572 PHOTOPAROXYSMAL RESPONSE 2; PPR2
609573 PHOTOPAROXYSMAL RESPONSE 3; PPR3
609578 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 2; RCM2
609629 VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL DOMINANT
609630 LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 1
609633 MAJOR AFFECTIVE DISORDER 3; MAFD3
609636 ALZHEIMER DISEASE 10
609643 NGUYEN SYNDROME
609647 DEAFNESS, AUTOSOMAL RECESSIVE 46; DFNB46
609649 TRICHILEMMAL CYST 1; TRICY1
609656 BONE SIZE QUANTITATIVE TRAIT LOCUS 1
609657 BONE SIZE QUANTITATIVE TRAIT LOCUS 2
609670 MIGRAINE WITH AURA, SUSCEPTIBILITY TO, 9
609727 SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT; SPG29
609745 GLAUCOMA 1, OPEN ANGLE, I; GLC1I
609750 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 4; EIG4
609754 CELIAC DISEASE, SUSCEPTIBILITY TO, 2; CELIAC2
609782 AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 2; AAA2
609790 ALZHEIMER DISEASE 11
609800 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4
609815 ZYGODACTYLY 1
609817 VASCULITIS, LYMPHOCYTIC, CUTANEOUS SMALL VESSEL
609822 STATURE QUANTITATIVE TRAIT LOCUS 7; STQTL7
609876 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 6; BMND6
609888 LEPROSY, SUSCEPTIBILITY TO, 1; LPRS1
609893 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 3; CHNG3
609903 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 5; SLEB5
609913 RETINITIS PIGMENTOSA 32; RP32
609915 CARDIOMYOPATHY, DILATED, 1Q; CMD1Q
609918 GALLBLADDER DISEASE 2; GBD2
609919 GALLBLADDER DISEASE 3; GBD3
609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6
609941 DEAFNESS, AUTOSOMAL RECESSIVE 51; DFNB51
609946 DEAFNESS, AUTOSOMAL RECESSIVE 47; DFNB47
609952 DEAFNESS, AUTOSOMAL RECESSIVE 55; DFNB55
609954 ASPERGER SYNDROME, SUSCEPTIBILITY TO, 4; ASPG4
609955 FIBROMATOSIS, GINGIVAL, 3; GINGF3
609958 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 3
609965 DEAFNESS, AUTOSOMAL DOMINANT 53; DFNA53
609985 PANIC DISORDER 3
609989 METAPHYSEAL CHONDRODYSPLASIA WITH CONE-SHAPED EPIPHYSES, NORMAL HAIR,
609990 TRICHOSCYPHODYSPLASIA
609993 OSTEOSCLEROSIS WITH ICHTHYOSIS AND PREMATURE OVARIAN FAILURE
609994 MYOPIA 11, AUTOSOMAL DOMINANT; MYP11
609995 MYOPIA 12, AUTOSOMAL DOMINANT; MYP12
610064 OPIOID DEPENDENCE, SUSCEPTIBILITY TO, 1
610065 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 7; SLEB7
610066 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 8; SLEB8
610071 HYPERPARATHYROIDISM 3; HRPT3
610099 MYOPATHY, DISTAL, 3; MPD3
610114 STATURE QUANTITATIVE TRAIT LOCUS 8; STQTL8
610141 QT INTERVAL, VARIATION IN
610143 DEAFNESS, AUTOSOMAL RECESSIVE 62; DFNB62
610155 DIABETES MELLITUS, INSULIN-DEPENDENT, 19; IDDM19
610158 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 2; FECD2
610208 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10
610209 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11
610212 DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66
610213 ANEURYSM, INTRACRANIAL BERRY, 4; ANIB4
610234 SYNPOLYDACTYLY 3; SPD3
610239 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
610247 ESOPHAGITIS, EOSINOPHILIC, 1; EOE1
610260 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 2; IHPS2
610261 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 5
610262 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 6
610279 PACHYGYRIA, FRONTOTEMPORAL
610294 INTELLIGENCE QUANTITATIVE TRAIT LOCUS 2
610295 INTELLIGENCE QUANTITATIVE TRAIT LOCUS 3
610320 MYOPIA 14; MYP14
610321 PROSTATE CANCER, HEREDITARY, 7; HPC7
610332 OCULOOTOFACIAL DYSPLASIA
610361 OROFACIAL CLEFT 9; OFC9
610382 PROSOPAGNOSIA, HEREDITARY
610419 DEAFNESS, AUTOSOMAL RECESSIVE 68; DFNB68
610420 PREAURICULAR TAG, ISOLATED, AUTOSOMAL DOMINANT, 1
610422 ALOPECIA-MENTAL RETARDATION SYNDROME 2; APMR2
610430 MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 2; WM2
610438 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 3; RLS3
610439 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 4; RLS4
610441 TESTICULAR MICROLITHIASIS
610452 MUTAGEN SENSITIVITY
610483 AGAMMAGLOBULINEMIA, MICROCEPHALY, AND SEVERE DERMATITIS
610535 GLAUCOMA 1, OPEN ANGLE, M; GLC1M
610649 BONE SIZE QUANTITATIVE TRAIT LOCUS 3
610655 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4
610676 AUTISM, SUSCEPTIBILITY TO, 7; AUTS7
610685 SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 2; SHFLD2
610707 PSORIASIS SUSCEPTIBILITY 8; PSORS8
610708 OPTIC ATROPHY 5; OPA5
610744 IRIS PATTERN
610753 ALOPECIA AREATA 2
610760 CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS 2
610761 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
610836 AUTISM, SUSCEPTIBILITY TO, 11; AUTS11
610838 AUTISM, SUSCEPTIBILITY TO, 12; AUTS12
610839 OSTEOARTHRITIS SUSCEPTIBILITY 4; OS4
610840 MITRAL VALVE PROLAPSE, MYXOMATOUS 3; MMVP3
610873 MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 1; MENAQ1
610898 SUPRANUCLEAR PALSY, PROGRESSIVE, 3; PSNP3
610906 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 4
610908 AUTISM, SUSCEPTIBILITY TO, 13; AUTS13
610910 PULMONARY ALVEOLAR PROTEINOSIS, ACQUIRED
610926 TOOTH AGENESIS, SELECTIVE, 5; STHAG5
610948 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 7
610997 PROSTATE CANCER, HEREDITARY, 9
611003 SMOKING AS A QUANTITATIVE TRAIT LOCUS 1; SQTL1
611004 SMOKING AS A QUANTITATIVE TRAIT LOCUS 2; SQTL2
611010 FIBROMATOSIS, GINGIVAL, 4; GINGF4
611014 HYPERTENSION, ESSENTIAL, SUSCEPTIBILITY TO, 8; HYT8
611015 AUTISM, SUSCEPTIBILITY TO, 9; AUTS9
611016 AUTISM, SUSCEPTIBILITY TO, 10; AUTS10
611031 EPISODIC KINESIGENIC DYSKINESIA 2; EKD2
611046 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 2
611073 ALZHEIMER DISEASE 12
611094 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 8; MRT8
611095 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9
611096 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10; MRT10
611097 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 11; MRT11
611100 PROSTATE CANCER, HEREDITARY, 10; HPC10
611107 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4; MRT4
611109 CINNAMON ODOR, PLEASANTNESS OF
611139 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 8; CHDS8
611147 PAROXYSMAL NONKINESIGENIC DYSKINESIA 2; PNKD2
611152 ALZHEIMER DISEASE 13; AD13
611154 ALZHEIMER DISEASE 14; AD14
611155 ALZHEIMER DISEASE 15; AD15
611185 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 6; RLS6
611222 MICROPHTHALMIA, SYNDROMIC 10; MCOPS10
611242 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 5; RLS5
611247 MAJOR AFFECTIVE DISORDER 4; MAFD4
611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32
611274 GLAUCOMA 1, OPEN ANGLE, N; GLC1N
611276 GLAUCOMA 1, OPEN ANGLE, H; GLC1H
611284 DYSTONIA, FOCAL, TASK-SPECIFIC; FTSD
611308 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL DOMINANT
611311 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE
611364 MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4
611376 MUNGAN SYNDROME; MGS
611381 KALA-AZAR, SUSCEPTIBILITY TO, 2; KAZA2
611382 KALA-AZAR, SUSCEPTIBILITY TO, 3; KAZA3
611384 PLASMODIUM FALCIPARUM FEVER EPISODES QUANTITATIVE TRAIT LOCUS 1
611403 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 6
611456 TREMOR, HEREDITARY ESSENTIAL, 3; ETM3
611469 COLORECTAL CANCER, SUSCEPTIBILITY TO, 2; CRCS2
611494 ATRIAL FIBRILLATION, FAMILIAL, 5; ATFB5
611515 FEBRILE SEIZURES, FAMILIAL, 7; FEB7
611522 INTRAOCULAR PRESSURE QUANTITATIVE TRAIT LOCUS; IOPQTL
611535 MAJOR AFFECTIVE DISORDER 5; MAFD5
611536 MAJOR AFFECTIVE DISORDER 6; MAFD6
611543 CAVITARY OPTIC DISC ANOMALIES
611547 STATURE QUANTITATIVE TRAIT LOCUS 9; STQTL9
611571 OTOSCLEROSIS 4; OTSC4
611572 OTOSCLEROSIS 7; OTSC7
611598 CELIAC DISEASE, SUSCEPTIBILITY TO, 6; CELIAC6
611630 EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3
611631 EPILEPSY, FAMILIAL TEMPORAL LOBE, 4; ETL4
611634 FEBRILE SEIZURES, FAMILIAL, 9; FEB9
611637 PRIMARY LATERAL SCLEROSIS, ADULT, 1; PLSA1
611644 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 9; HSCR9
611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA
611706 MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12
611717 SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH
611724 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 8; SHEP8
611738 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 7; BMND7
611739 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 8; BMND8
611816 TEMPLE-BARAITSER SYNDROME
611863 MICROTIA WITH NASOLACRIMAL DUCT IMPERFORATION AND EYE COLOBOMA
611891 AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 3; AAA3
611892 ANEURYSM, INTRACRANIAL BERRY, 6; ANIB6
611897 NANOPHTHALMOS 3; NNO3
611907 EPISODIC ATAXIA, TYPE 7; EA7
611920 C-REACTIVE PROTEIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; CRPQTL1
611926 IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS
611929 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III
611934 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 5; EIG5
611944 LYMPHEDEMA, HEREDITARY, IB
611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37
611955 PROSTATE CANCER, HEREDITARY, 11; HPC11
611958 PROSTATE CANCER, HEREDITARY, 14; HPC14
611959 PROSTATE CANCER, HEREDITARY, 15; HPC15
611962 HUNTER-MACDONALD SYNDROME
612005 CELIAC DISEASE, SUSCEPTIBILITY TO, 7; CELIAC7
612006 CELIAC DISEASE, SUSCEPTIBILITY TO, 8; CELIAC8
612007 CELIAC DISEASE, SUSCEPTIBILITY TO, 9; CELIAC9
612008 CELIAC DISEASE, SUSCEPTIBILITY TO, 10; CELIAC10
612009 CELIAC DISEASE, SUSCEPTIBILITY TO, 11; CELIAC11
612010 CELIAC DISEASE, SUSCEPTIBILITY TO, 12; CELIAC12
612011 CELIAC DISEASE, SUSCEPTIBILITY TO, 13; CELIAC13
612017 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 3; IHPS3
612030 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 9; CHDS9
612083 MUSCLE STRENGTH QUANTITATIVE TRAIT LOCUS 1
612089 HYPOPHOSPHATEMIC RICKETS AND HYPERPARATHYROIDISM
612096 OTOSCLEROSIS 8; OTSC8
612097 DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS
612099 TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 2
612108 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 1; FGQTL1
612110 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 9; BMND9
612113 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 10; BMND10
612114 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 11; BMND11
612119 TREHALASE DEFICIENCY
612161 ANEURYSM, INTRACRANIAL BERRY, 7; ANIB7
612162 ANEURYSM, INTRACRANIAL BERRY, 8; ANIB8
612165 RETINITIS PIGMENTOSA 29; RP29
612198 DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA
612221 STATURE QUANTITATIVE TRAIT LOCUS 10; STQTL10
612223 STATURE QUANTITATIVE TRAIT LOCUS 11; STQTL11
612224 STATURE QUANTITATIVE TRAIT LOCUS 12; STQTL12
612226 STATURE QUANTITATIVE TRAIT LOCUS 13; STQTL13
612228 STATURE QUANTITATIVE TRAIT LOCUS 14; STQTL14
612230 COLORECTAL CANCER, SUSCEPTIBILITY TO, 5; CRCS5
612231 COLORECTAL CANCER, SUSCEPTIBILITY TO, 6; CRCS6
612232 COLORECTAL CANCER, SUSCEPTIBILITY TO, 7; CRCS7
612238 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 4; IS4
612239 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 5; IS5
612241 INFLAMMATORY BOWEL DISEASE 12; IBD12
612254 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 12; SLEB12
612255 INFLAMMATORY BOWEL DISEASE 15; IBD15
612259 INFLAMMATORY BOWEL DISEASE 16; IBD16
612262 INFLAMMATORY BOWEL DISEASE 18; IBD18
612263 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 7; CMM7
612274 CILIARY DYSKINESIA, PRIMARY, 8; CILD8
612279 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 6; GEFSP6
612288 INFLAMMATORY BOWEL DISEASE 20; IBD20
612293 POROKERATOSIS 5, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK5
612306 THYROID-STIMULATING HORMONE LEVEL QUANTITATIVE TRAIT LOCUS 1; TSHQTL1
612311 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 5
612312 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 6
612335 SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38
612343 MUSICAL APTITUDE QUANTITATIVE TRAIT LOCUS
612348 THROMBOPHILIA, FAMILIAL, DUE TO DECREASED RELEASE OF TISSUE PLASMINOGEN
612353 POROKERATOSIS 6, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK6
612354 INFLAMMATORY BOWEL DISEASE 21; IBD21
612357 MAJOR AFFECTIVE DISORDER 8; MAFD8
612361 SCHIZOPHRENIA 14
612363 ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS
612364 ALANINE AMINOTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS
612365 GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS
612366 GAMMA GLUTAMYLTRANSFERASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS
612367 ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 2
612368 ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 3
612369 ALKALINE PHOSPHATASE, PLASMA LEVEL OF, QUANTITATIVE TRAIT LOCUS 4
612372 MAJOR AFFECTIVE DISORDER 9; MAFD9
612378 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 13; SLEB13
612380 INFLAMMATORY BOWEL DISEASE 22; IBD22
612381 INFLAMMATORY BOWEL DISEASE 23; IBD23
612388 SARCOIDOSIS, SUSCEPTIBILITY TO, 3; SS3
612401 OSTEOARTHRITIS SUSCEPTIBILITY 6; OS6
612406 DYSTONIA 17, TORSION, AUTOSOMAL RECESSIVE; DYT17
612410 PSORIASIS SUSCEPTIBILITY 10; PSORS10
612417 NARCOLEPSY 4, SUSCEPTIBILITY TO; NRCLP4
612421 ALOPECIA, ANDROGENETIC, 3; AGA3
612431 DEAFNESS, AUTOSOMAL DOMINANT 27; DFNA27
612433 DEAFNESS, AUTOSOMAL RECESSIVE 45; DFNB45
612448 AGE-RELATED HEARING IMPAIRMENT 1; ARHI1
612459 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 13; BMIQ13
612460 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 14; BMIQ14
612514 SPECIFIC LANGUAGE IMPAIRMENT 4; SLI4
612521 DIABETES MELLITUS, INSULIN-DEPENDENT, 21; IDDM21
612525 PYLORIC STENOSIS, INFANTILE HYPERTROPHIC, 5; IHPS5
612554 MYOPIA 16, AUTOSOMAL DOMINANT; MYP16
612557 LEUKEMIA, CHRONIC LYMPHOCYTIC, SUSCEPTIBILITY TO, 3
612558 LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 4
612559 LEUKEMIA, CHRONIC LYMPHOCYTIC SUSCEPTIBILITY TO, 5
612566 INFLAMMATORY BOWEL DISEASE 24; IBD24
612571 LUNG CANCER SUSCEPTIBILITY 3; LNCR3
612573 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 1; MPVQTL1
612574 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 2; MPVQTL2
612575 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 3; MPVQTL3
612578 STATURE QUANTITATIVE TRAIT LOCUS 15; STQTL15
612579 STATURE QUANTITATIVE TRAIT LOCUS 16; STQTL16
612586 ANEURYSM, INTRACRANIAL BERRY, 9; ANIB9
612587 ANEURYSM, INTRACRANIAL BERRY, 10; ANIB10
612589 COLORECTAL CANCER, SUSCEPTIBILITY TO, 8; CRCS8
612590 COLORECTAL CANCER, SUSCEPTIBILITY TO, 9; CRCS9
612592 COLORECTAL CANCER, SUSCEPTIBILITY TO, 11; CRCS11
612593 LUNG CANCER SUSCEPTIBILITY 4; LNCR4
612594 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 2; MS2
612595 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 3; MS3
612596 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 4; MS4
612599 PSORIASIS SUSCEPTIBILITY 11; PSORS11
612622 DIABETES MELLITUS, INSULIN-DEPENDENT, 23; IDDM23
612627 SEIZURES, BENIGN FAMILIAL INFANTILE, 4; BFIS4
612632 USHER SYNDROME, TYPE IH; USH1H
612637 FEBRILE SEIZURES, FAMILIAL, 10; FEB10
612639 INFLAMMATORY BOWEL DISEASE 26; IBD26
612642 DEAFNESS, AUTOSOMAL DOMINANT 59; DFNA59
612691 POLYMICROGYRIA, BILATERAL OCCIPITAL
612715 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 2; DUH2
612717 MYOPIA 15, AUTOSOMAL DOMINANT; MYP15
612726 HARDIKAR SYNDROME
612727 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 13; BMND13
612728 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 14; BMND14
612729 LEAN BODY MASS QUANTITATIVE TRAIT LOCUS 1; LBMQTL1
612731 FACIOCARDIOMELIC SYNDROME
612737 STATURE QUANTITATIVE TRAIT LOCUS 17; STQTL17
612759 SYNESTHESIA
612776 HYPOGLOSSIA WITH SITUS INVERSUS
612795 POLYUNSATURATED FATTY ACIDS PLASMA LEVEL QUANTITATIVE TRAIT LOCUS
612796 INFLAMMATORY BOWEL DISEASE 27; IBD27
612841 HYPOTRICHOSIS 5; HYPT5
612843 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD
612851 NARCOLEPSY 5, SUSCEPTIBILITY TO; NRCLP5
612853 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 7; RLS7
612858 OROFACIAL CLEFT 12; OFC12
612862 PULMONARY HYPERTENSION, CHRONIC THROMBOEMBOLIC, WITHOUT DEEP VEIN
612868 CORNEAL DYSTROPHY, POSTERIOR AMORPHOUS; PACD
612876 SPINOCEREBELLAR ATAXIA 9; SCA9
612881 HETEROTOPIA, PERIVENTRICULAR, ASSOCIATED WITH CHROMOSOME 5q DELETION
612882 MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENAQ2
612883 MENARCHE, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENAQ3
612884 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 2; MENOQ2
612885 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 3; MENOQ3
612886 MENOPAUSE, NATURAL, AGE AT, QUANTITATIVE TRAIT LOCUS 4; MENOQ4
612892 STATURE QUANTITATIVE TRAIT LOCUS 18; STQTL18
612893 STATURE QUANTITATIVE TRAIT LOCUS 19; STQTL19
612894 STATURE QUANTITATIVE TRAIT LOCUS 20; STQTL20
612913 OROFACIODIGITAL SYNDROME XI; OFD11
612929 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, 3
612946 HADZISELIMOVIC SYNDROME
612950 PSORIASIS SUSCEPTIBILITY 12; PSORS12
612957 VITAMIN B6 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B6QTL1
612967 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 15; BMIQ15
612968 CATARACT 34, MULTIPLE TYPES; CTRCT34
612976 AGE-RELATED HEARING IMPAIRMENT 2; ARHI2
613001 ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL
613006 DIABETES MELLITUS, INSULIN-DEPENDENT, 24; IDDM24
613007 BILIARY CIRRHOSIS, PRIMARY, 2; PBC2
613008 BILIARY CIRRHOSIS, PRIMARY, 3; PBC3
613015 NEUROBLASTOMA, SUSCEPTIBILITY TO, 4; NBLST4
613016 NEUROBLASTOMA, SUSCEPTIBILITY TO, 5; NBLST5
613017 NEUROBLASTOMA, SUSCEPTIBILITY TO, 6; NBLST6
613024 FOLLICULAR LYMPHOMA, SUSCEPTIBILITY TO, 1; FL1
613025 SCHIZOPHRENIA 13; SCZD13
613030 GLIOMA SUSCEPTIBILITY 5; GLM5
613031 GLIOMA SUSCEPTIBILITY 6; GLM6
613032 GLIOMA SUSCEPTIBILITY 7; GLM7
613033 GLIOMA SUSCEPTIBILITY 8; GLM8
613035 HEARING LOSS, NOISE-INDUCED, SUSCEPTIBILITY TO; NIHL
613055 ATRIAL FIBRILLATION, FAMILIAL, 8; ATFB8
613058 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 2; BCC2
613059 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 3; BCC3
613061 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 4; BCC4
613062 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 5; BCC5
613063 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 6; BCC6
613064 DERMATITIS, ATOPIC, 7; ATOD7
613065 LEUKEMIA, ACUTE LYMPHOBLASTIC; ALL
613067 LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 2; ALL2
613088 PELVIC ORGAN PROLAPSE, SUSCEPTIBILITY TO, 2
613096 SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36
613106 VERTIGO, BENIGN RECURRENT, 2; BRV2
613144 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 3; CACD3
613145 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 14; SLEB14
613164 PARKINSON DISEASE 16; PARK16
613207 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 8; ASRT8
613219 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 2; FGQTL2
613233 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 3; FGQTL3
613238 SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 3; SPDA3
613267 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 3; FECD3
613269 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 5; FECD5
613271 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 7; FECD7
613280 HYPERMANGANESEMIA WITH DYSTONIA, POLYCYTHEMIA, AND CIRRHOSIS; HMDPC
613282 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 1; NAFLD1
613284 HEMATOCRIT/HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 3; HCHGQ3
613290 HEARING LOSS, CISPLATIN-INDUCED, SUSCEPTIBILITY TO; CIHL
613318 MIYOSHI MUSCULAR DYSTROPHY 2; MMD2
613339 EPILEPSY, HOT WATER, 1; HWE1
613340 EPILEPSY, HOT WATER, 2; HWE2
613343 HANDIGODU JOINT DISEASE
613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41
613371 SPINOCEREBELLAR ATAXIA 30; SCA30
613387 FATTY LIVER DISEASE, NONALCOHOLIC, SUSCEPTIBILITY TO, 2; NAFLD2
613392 DEAFNESS, AUTOSOMAL RECESSIVE 85; DFNB85
613407 LEPROSY, SUSCEPTIBILITY TO, 6; LPRS6
613412 ESOPHAGITIS, EOSINOPHILIC, 2; EOE2
613440 STATURE QUANTITATIVE TRAIT LOCUS 21; STQTL21
613459 BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 2; BWQTL2
613460 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 6; FGQTL6
613462 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 4; FGQTL4
613498 SEX HORMONE-BINDING GLOBULIN CIRCULATING LEVEL QUANTITATIVE TRAIT
613518 DERMATITIS, ATOPIC, 8; ATOD8
613519 DERMATITIS, ATOPIC, 9; ATOD9
613530 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1H; LGMD1H
613545 MACROSTOMIA, ISOLATED
613547 STATURE QUANTITATIVE TRAIT LOCUS 22; STQTL22
613548 STATURE QUANTITATIVE TRAIT LOCUS 23; STQTL23
613549 STATURE QUANTITATIVE TRAIT LOCUS 24; STQTL24
613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2
613606 FORSYTHE-WAKELING SYNDROME; FWS
613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3
613628 ODONTOID HYPOPLASIA
613636 TUBERCULIN SKIN TEST REACTIVITY, ABSENCE OF
613637 TUBERCULIN SKIN TEST REACTIVITY QUANTITATIVE TRAIT LOCUS
613658 RAJAB SYNDROME
613678 BRACHYOLMIA TYPE 2
613685 DEAFNESS, AUTOSOMAL RECESSIVE 83; DFNB83
613689 MAMMARY-DIGITAL-NAIL SYNDROME; MDNS
613806 CHOLANGITIS, PRIMARY SCLEROSING; PSC
613828 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 8; GEFSP8
613836 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 5; ADIPQTL5
613857 OROFACIAL CLEFT 13; OFC13
613913 LIPODYSTROPHY, PARTIAL, ACQUIRED, WITH LOW COMPLEMENT COMPONENT C3,
613930 ALOPECIA-MENTAL RETARDATION SYNDROME 3; APMR3
613933 ACETYL-CoA CARBOXYLASE DEFICIENCY; ACACAD
613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSW
613944 IgA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2
613969 MYOPIA 19, AUTOSOMAL DOMINANT; MYP19
614021 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 3; CPVT3
614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE
614101 PLASMA FIBRONECTIN DEFICIENCY
614103 LIPEDEMA
614149 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 9; NDNC9
614164 GLUTATHIONE PEROXIDASE DEFICIENCY; GPXD
614166 MYOPIA 20, AUTOSOMAL DOMINANT; MYP20
614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD
614200 BLEEDING DISORDER, PLATELET-TYPE, 9; BDPLT9
614208 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16; MRT16
614210 LUNG CANCER SUSCEPTIBILITY 5; LNCR5
614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33
614220 BILIARY CIRRHOSIS, PRIMARY, 4; PBC4
614221 BILIARY CIRRHOSIS, PRIMARY, 5; PBC5
614223 NARCOLEPSY 6, SUSCEPTIBILITY TO; NRCLP6
614227 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 3; HNFJ3
614233 HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 1; FPH1
614237 HYPOTRICHOSIS 9; HYPT9
614238 HYPOTRICHOSIS 10; HYPT10
614252 ANEURYSM, INTRACRANIAL BERRY, 11; ANIB11
614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9
614317 VESICOURETERAL REFLUX 4; VUR4
614318 VESICOURETERAL REFLUX 5; VUR5
614319 VESICOURETERAL REFLUX 6; VUR6
614323 NEVOID HYPERMELANOSIS, LINEAR AND WHORLED; LWNH
614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31
614333 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29; MRT29
614338 PANCREATIC LIPASE DEFICIENCY; PNLIPD
614339 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 32; MRT32
614341 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33; MRT33
614342 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30; MRT30
614343 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19; MRT19
614344 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23; MRT23
614345 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24; MRT24
614346 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25; MRT25
614347 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28; MRT28
614375 AORTIC ANEURYSM, FAMILIAL ABDOMINAL, 4; AAA4
614407 MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT
614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96
614422 CATARACT 37; CTRCT37
614494 RETINITIS PIGMENTOSA 63; RP63
614561 LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS; LCC
614569 MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE
614575 CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME;
614588 DYSTONIA 21; DYT21
614590 PODOCONIOSIS, SUSCEPTIBILITY TO; PDCOS
614622 KERATOCONUS 5; KTCN5
614623 KERATOCONUS 6; KTCN6
614628 KERATOCONUS 8; KTCN8
614629 KERATOCONUS 7; KTCN7
614644 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 4; MPVQTL4
614645 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 5; MPVQTL5
614646 MEAN PLATELET VOLUME QUANTITATIVE TRAIT LOCUS 6; MPVQTL6
614655 STUTTERING, FAMILIAL PERSISTENT, 3; STUT3
614668 STUTTERING, FAMILIAL PERSISTENT, 4; STUT4
614670 PERIPARTUM CARDIOMYOPATHY, SUSCEPTIBILITY TO
614676 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 21; CMH21
614684 HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL
614692 MEMBRANOUS NEPHROPATHY, SUSCEPTIBILITY TO; MBNP
614714 POROKERATOSIS 7, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK7
614746 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 5; UAQTL5
614747 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 6; UAQTL6
614826 NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7
614834 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 3; TTPP3
614836 HUMAN HERPESVIRUS 8, SUSCEPTIBILITY TO; HHV8S
614860 DYSTONIA 23; DYT23
614875 METAPHYSEAL ENCHONDROMATOSIS WITH D-2-HYDROXYGLUTARIC ACIDURIA
614927 ECTODERMAL DYSPLASIA 5, HAIR/NAIL TYPE; ECTD5
614928 ECTODERMAL DYSPLASIA 6, HAIR/NAIL TYPE; ECTD6
614936 PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IB; PPKP1B
614954 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3
614969 PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7
614973 FOCAL FACIAL DERMAL DYSPLASIA 2, BRAUER-SETLEIS TYPE; FFDD2
614979 SPLENOMEGALY, CYTOPENIA, AND VISION LOSS
614990 USHER SYNDROME, TYPE IK; USH1K
615022 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 7; ARCI7
615048 SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ
615080 ALZHEIMER DISEASE 17; AD17
615102 TYSHCHENKO SYNDROME
615118 CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD
615121 STOMATIN-LIKE PROTEIN-2, HYPERPHOSPHORYLATION OF
615127 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4
615155 STEEL SYNDROME; STLS
615162 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35; MRT35
615163 CONE-ROD DYSTROPHY 17; CORD17
615170 WAHAB SYNDROME
615192 BIRTH WEIGHT QUANTITATIVE TRAIT LOCUS 4; BWQTL4
615197 RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 8; RLS8
615198 OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA; OSMD
615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5
615390 VESICOURETERAL REFLUX 7; VUR7
615612 DEVELOPMENTAL DYSPLASIA OF THE HIP 2; DDH2
615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54
615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58
615674 DOWLING-DEGOS DISEASE 3; DDD3
615697 EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6
100100 ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY AND
100300 ADAMS-OLIVER SYNDROME 1; AOS1
100800 ACHONDROPLASIA; ACH
101000 NEUROFIBROMATOSIS, TYPE II; NF2
101200 APERT SYNDROME
101400 SAETHRE-CHOTZEN SYNDROME; SCS
101600 PFEIFFER SYNDROME
101800 ACRODYSOSTOSIS 1 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1
101900 ACROKERATOSIS VERRUCIFORMIS; AKV
102200 PITUITARY ADENOMA, GROWTH HORMONE-SECRETING
102370 ACROMICRIC DYSPLASIA; ACMICD
102500 HAJDU-CHENEY SYNDROME; HJCYS
102530 SPERMATOGENIC FAILURE 6; SPGF6
102700 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,
102900 ADENOSINE TRIPHOSPHATE, ELEVATED, OF ERYTHROCYTES
103050 ADENYLOSUCCINASE DEFICIENCY
103100 ADIE PUPIL
103285 ADULT SYNDROME
103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS
103500 TIETZ SYNDROME
103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A
103780 ALCOHOL DEPENDENCE
103900 GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; GRA
104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT
104290 ALTERNATING HEMIPLEGIA OF CHILDHOOD 1; AHC1
104300 ALZHEIMER DISEASE; AD
104310 ALZHEIMER DISEASE 2
104500 AMELOGENESIS IMPERFECTA, TYPE IB; AI1B
104510 AMELOGENESIS IMPERFECTA, TYPE IV; AI4
105120 AMYLOIDOSIS, FINNISH TYPE
105150 CEREBRAL AMYLOID ANGIOPATHY, CST3-RELATED
105200 AMYLOIDOSIS, FAMILIAL VISCERAL
105210 AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED
105250 AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 1; PLCA1
105400 AMYOTROPHIC LATERAL SCLEROSIS 1; ALS1
105500 AMYOTROPHIC LATERAL SCLEROSIS-PARKINSONISM/DEMENTIA COMPLEX 1
105550 FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS; FTDALS
105650 DIAMOND-BLACKFAN ANEMIA 1; DBA1
105830 ANGELMAN SYNDROME; AS
106100 ANGIOEDEMA, HEREDITARY, TYPE I; HAE1
106210 ANIRIDIA; AN
106260 ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE
106300 SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1; SPDA1
106600 TOOTH AGENESIS, SELECTIVE, 1; STHAG1
107250 ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS; ASMD
107480 TOWNES-BROCKS SYNDROME; TBS
107750 ARBITRARY RESTRICTION POLYMORPHISM 1
107970 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 1; ARVD1
108010 ARTERIOVENOUS MALFORMATIONS OF THE BRAIN
108120 ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A
108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5
108300 STICKLER SYNDROME, TYPE I; STL1
108340 ARYL HYDROCARBON HYDROXYLASE INDUCIBILITY
108500 EPISODIC ATAXIA, TYPE 2; EA2
108600 SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1
108720 ATELOSTEOGENESIS, TYPE I; AO1
108721 ATELOSTEOGENESIS, TYPE III; AO3
108770 ATRIAL STANDSTILL 1; ATRST1
108900 ATRIAL SEPTAL DEFECT 7 WITH OR WITHOUT ATRIOVENTRICULAR CONDUCTION
108985 SVEINSSON CHORIORETINAL ATROPHY; SCRA
109100 AUTOIMMUNE DISEASE
109150 MACHADO-JOSEPH DISEASE; MJD
109400 BASAL CELL NEVUS SYNDROME; BCNS
109730 AORTIC VALVE DISEASE 1; AOVD1
109800 BLADDER CANCER
110100 BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS; BPES
110450 BLOOD GROUP--COLTON; CO
110500 BLOOD GROUP--DIEGO SYSTEM; DI
110700 BLOOD GROUP, DUFFY SYSTEM; FY
110800 BLOOD GROUP, I SYSTEM; Ii
110900 BLOOD GROUP--KELL SYSTEM; KEL
111000 BLOOD GROUP--KIDD SYSTEM; JK
111150 BLOOD GROUP--LUTHERAN INHIBITOR; INLU
111200 BLOOD GROUP--LUTHERAN SYSTEM; LU
111250 BLOOD GROUP SYSTEM, LANDSTEINER-WIENER; LW
111380 BLOOD GROUP--OK; OK
111400 BLOOD GROUP, P1PK SYSTEM
111500 BLOOD GROUP--PRIVATE SYSTEMS
111600 BLOOD GROUP, LANGEREIS SYSTEM; LAN
111620 RADIN BLOOD GROUP ANTIGEN; RD
111690 BLOOD GROUP--RHESUS SYSTEM E POLYPEPTIDE; RHE
111750 BLOOD GROUP--SCIANNA SYSTEM; SC
112010 BLOOD GROUP--WALDNER TYPE; WD
112050 BLOOD GROUP--WRIGHT ANTIGEN; WR
112100 YT BLOOD GROUP ANTIGEN
112250 DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA;
112310 BOOMERANG DYSPLASIA
112500 BRACHYDACTYLY, TYPE A1; BDA1
112600 BRACHYDACTYLY, TYPE A2; BDA2
113000 BRACHYDACTYLY, TYPE B1; BDB1
113100 BRACHYDACTYLY, TYPE C; BDC
113200 BRACHYDACTYLY, TYPE D; BDD
113300 BRACHYDACTYLY, TYPE E1; BDE1
113500 BRACHYOLMIA TYPE 3
113620 BRANCHIOOCULOFACIAL SYNDROME; BOFS
113650 BRANCHIOOTORENAL SYNDROME 1; BOR1
113750 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 4; SHEP4
113800 EPIDERMOLYTIC HYPERKERATOSIS; EHK
113900 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA; PFHB1A
113970 BURKITT LYMPHOMA; BL
114000 CAFFEY DISEASE
114290 CAMPOMELIC DYSPLASIA
114300 ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3
114480 BREAST CANCER
114500 COLORECTAL CANCER; CRC
114550 HEPATOCELLULAR CARCINOMA
114900 CARCINOID TUMORS, INTESTINAL
115080 CARDIAC CONDUCTION DEFECT
115150 CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1
115195 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 2; CMH2
115196 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 3; CMH3
115197 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4; CMH4
115200 CARDIOMYOPATHY, DILATED, 1A; CMD1A
115210 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 1; RCM1
115300 HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT
115310 PARAGANGLIOMAS 4; PGL4
115430 CARPAL TUNNEL SYNDROME; CTS1
115470 CAT EYE SYNDROME; CES
115700 CATARACT 4, MULTIPLE TYPES; CTRCT4
116100 CATARACT 20, MULTIPLE TYPES; CTRCT20
116200 CATARACT 1, MULTIPLE TYPES; CTRCT1
116300 CATARACT 30; CTRCT30
116600 CATARACT 6, MULTIPLE TYPES; CTRCT6
116800 CATARACT 5, MULTIPLE TYPES; CTRCT5
116860 CEREBRAL CAVERNOUS MALFORMATIONS; CCM
116920 LEUKOCYTE ADHESION DEFICIENCY, TYPE I; LAD
117000 CENTRAL CORE DISEASE OF MUSCLE
117210 SPINOCEREBELLAR ATAXIA 31; SCA31
117300 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 2
117360 SPINOCEREBELLAR ATAXIA 29; SCA29
117550 SOTOS SYNDROME 1; SOTOS1
117800 APOCRINE GLAND SECRETION, VARIATION IN
118100 KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1
118200 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B
118210 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A1; CMT2A1
118220 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A; CMT1A
118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS
118400 CHERUBISM
118450 ALAGILLE SYNDROME 1; ALGS1
118600 CHONDROCALCINOSIS 2; CCAL2
118700 CHOREA, BENIGN HEREDITARY; BHC
118800 PAROXYSMAL NONKINESIGENIC DYSKINESIA 1; PNKD1
119300 VAN DER WOUDE SYNDROME 1; VWS1
119500 POPLITEAL PTERYGIUM SYNDROME; PPS
119600 CLEIDOCRANIAL DYSPLASIA; CCD
119800 CLUBFOOT, CONGENITAL, WITH OR WITHOUT DEFICIENCY OF LONG BONES AND/OR
119900 DIGITAL CLUBBING, ISOLATED CONGENITAL
120080 COLCHICINE RESISTANCE
120100 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1; FCAS1
120200 COLOBOMA, OCULAR
120330 PAPILLORENAL SYNDROME; PAPRS
120430 COLOBOMA OF OPTIC NERVE
120433 COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE,
120435 LYNCH SYNDROME I
120790 COMPLEMENT COMPONENT 4, PARTIAL DEFICIENCY OF
120970 CONE-ROD DYSTROPHY 2; CORD2
121050 ARTHROGRYPOSIS, DISTAL, TYPE 9; DA9
121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1
121201 SEIZURES, BENIGN FAMILIAL NEONATAL, 2; BFNS2
121300 COPROPORPHYRIA, HEREDITARY; HCP
121800 SCHNYDER CORNEAL DYSTROPHY; SCCD
121820 CORNEAL DYSTROPHY, EPITHELIAL BASEMENT MEMBRANE; EBMD
121850 CORNEAL DYSTROPHY, FLECK
121900 CORNEAL DYSTROPHY, GROENOUW TYPE I; CDGG1
122000 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1; PPCD1
122100 CORNEAL DYSTROPHY, MEESMANN; MECD
122200 CORNEAL DYSTROPHY, LATTICE TYPE I; LCD1
122470 CORNELIA DE LANGE SYNDROME 1; CDLS1
122600 SPONDYLOCOSTAL DYSOSTOSIS 5, AUTOSOMAL DOMINANT; SCDO5
122700 COUMARIN RESISTANCE
122860 CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD
122880 CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS
123000 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CMDD
123100 CRANIOSYNOSTOSIS 1; CRS1
123150 JACKSON-WEISS SYNDROME; JWS
123320 CREATINE PHOSPHOKINASE, ELEVATED SERUM
123400 CREUTZFELDT-JAKOB DISEASE; CJD
123450 CRI-DU-CHAT SYNDROME
123500 CROUZON SYNDROME
123700 CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1
123790 BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS
124000 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1; MC3DN1
124200 DARIER-WHITE DISEASE; DAR
124500 DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OF
124900 DEAFNESS, AUTOSOMAL DOMINANT 1; DFNA1
125250 OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY,
125310 CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS
125350 FAILURE OF TOOTH ERUPTION, PRIMARY; PFE
125370 DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY; DRPLA
125400 DENTIN DYSPLASIA, TYPE I; DTDP1
125420 DENTIN DYSPLASIA, TYPE II
125490 DENTINOGENESIS IMPERFECTA 1; DGI1
125500 DENTINOGENESIS IMPERFECTA, SHIELDS TYPE III
125595 DERMATOPATHIA PIGMENTOSA RETICULARIS; DPR
125700 DIABETES INSIPIDUS, NEUROHYPOPHYSEAL
125800 DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL
125850 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 1; MODY1
125851 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 2; MODY2
125852 DIABETES MELLITUS, INSULIN-DEPENDENT, 2
125853 DIABETES MELLITUS, NONINSULIN-DEPENDENT; NIDDM
126200 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO; MS
126600 DOYNE HONEYCOMB RETINAL DYSTROPHY; DHRD
126700 BASAL LAMINAR DRUSEN
127000 KENNY-CAFFEY SYNDROME, TYPE 2; KCS2
127300 LERI-WEILL DYSCHONDROSTEOSIS; LWD
127400 DYSCHROMATOSIS SYMMETRICA HEREDITARIA; DSH
127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1
127700 DYSLEXIA, SUSCEPTIBILITY TO, 1; DYX1
127750 DEMENTIA, LEWY BODY; DLB
128100 DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT; DYT1
128101 DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4
128200 EPISODIC KINESIGENIC DYSKINESIA 1; EKD1
128230 DYSTONIA, DOPA-RESPONSIVE; DRD
128235 DYSTONIA 12; DYT12
129400 RAPP-HODGKIN SYNDROME; RHS
129490 ECTODERMAL DYSPLASIA 10A, HYPOHIDROTIC/HAIR/NAIL TYPE, AUTOSOMAL DOMINANT;
129500 CLOUSTON SYNDROME
129600 ECTOPIA LENTIS 1, ISOLATED, AUTOSOMAL DOMINANT; ECTOL1
129850 EDINBURGH MALFORMATION SYNDROME
130000 EHLERS-DANLOS SYNDROME, TYPE I
130010 EHLERS-DANLOS SYNDROME, TYPE II
130020 EHLERS-DANLOS SYNDROME, TYPE III
130050 EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT
130060 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL DOMINANT
130070 EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 1; EDSP1
130600 ELLIPTOCYTOSIS 2; EL2
130650 BECKWITH-WIEDEMANN SYNDROME; BWS
130900 AMELOGENESIS IMPERFECTA, TYPE III; AI3
131100 MULTIPLE ENDOCRINE NEOPLASIA, TYPE I; MEN1
131300 CAMURATI-ENGELMANN DISEASE; CAEND
131440 MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
131705 TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN; TBDN
131750 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL DOMINANT; DDEB
131760 EPIDERMOLYSIS BULLOSA SIMPLEX, DOWLING-MEARA TYPE
131800 EPIDERMOLYSIS BULLOSA SIMPLEX, LOCALIZED
131850 EPIDERMOLYSIS BULLOSA DYSTROPHICA, PRETIBIAL
131900 EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED
131950 EPIDERMOLYSIS BULLOSA SIMPLEX, OGNA TYPE
131960 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MOTTLED PIGMENTATION; EBS-MP
132000 EPIDERMOLYSIS BULLOSA WITH CONGENITAL LOCALIZED ABSENCE OF SKIN AND
132400 EPIPHYSEAL DYSPLASIA, MULTIPLE, 1; EDM1
132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;
132600 PILOMATRIXOMA
132700 CYLINDROMATOSIS, FAMILIAL
132800 MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA, SUSCEPTIBILITY TO; MSSE
132900 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
133020 ERYTHERMALGIA, PRIMARY
133100 ERYTHROCYTOSIS, FAMILIAL, 1; ECYT1
133200 ERYTHROKERATODERMIA VARIABILIS ET PROGRESSIVA; EKVP
133239 ESOPHAGEAL CANCER
133540 COCKAYNE SYNDROME B; CSB
133700 EXOSTOSES, MULTIPLE, TYPE I
133701 EXOSTOSES, MULTIPLE, TYPE II
133780 EXUDATIVE VITREORETINOPATHY 1; EVR1
134610 FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT
135100 FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP
135150 BIRT-HOGG-DUBE SYNDROME; BHD
135290 DESMOID DISEASE, HEREDITARY
135300 FIBROMATOSIS, GINGIVAL, 1; GINGF1
135400 HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA;
135700 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1
135900 COFFIN-SIRIS SYNDROME; CSS
136000 ADERMATOGLYPHIA; ADERM
136120 FISH-EYE DISEASE; FED
136140 FLOATING-HARBOR SYNDROME; FLHS
136520 FOVEAL HYPOPLASIA 1; FVH1
136540 FRAGILE SITE 10q23
136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KB
136580 FRAGILE SITE 16q22; FRA16A
136610 FRAGILE SITE 2q11
136620 FRAGILE SITE 10q25; FRA10B
136630 MENTAL RETARDATION, FRA12A TYPE
136640 FRAGILE SITE 9q32
136660 FRAGILE SITE 17p12
136680 FRASIER SYNDROME
136760 FRONTONASAL DYSPLASIA 1; FND1
136800 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 1; FECD1
136880 FUNDUS ALBIPUNCTATUS
136900 FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, OF SORSBY; SFD
137200 NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE; NMAN
137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC
137440 GERSTMANN-STRAUSSLER DISEASE; GSD
137550 MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS
137580 GILLES DE LA TOURETTE SYNDROME; GTS
137600 IRIDOGONIODYSGENESIS, TYPE 2; IRID2
137750 GLAUCOMA 1, OPEN ANGLE, A; GLC1A
137760 GLAUCOMA, PRIMARY OPEN ANGLE; POAG
137800 GLIOMA SUSCEPTIBILITY 1; GLM1
137920 RENAL CYSTS AND DIABETES SYNDROME; RCAD
138000 GLOMUVENOUS MALFORMATIONS; GVM
138500 HYPERGLYCINURIA
138800 GOITER, MULTINODULAR 1, WITH OR WITHOUT SERTOLI-LEYDIG CELL TUMORS;
138900 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 1; UAQTL1
139090 GRAY PLATELET SYNDROME; GPS
139210 MYHRE SYNDROME; MYHRS
139300 AROMATASE EXCESS SYNDROME; AEXS
139393 GUILLAIN-BARRE SYNDROME, FAMILIAL; GBS
140000 HAND-FOOT-GENITAL SYNDROME; HFG
140350 HAWKINSINURIA
140600 OSTEOARTHRITIS SUSCEPTIBILITY 2; OS2
140700 HEINZ BODY ANEMIAS
141200 HEMATURIA, BENIGN FAMILIAL; BFH
141500 MIGRAINE, FAMILIAL HEMIPLEGIC, 1; FHM1
141749 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1; HBFQTL1
141750 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED
142309 HEMOGLOBIN--VARIANTS FOR WHICH THE CHAIN CARRYING THE MUTATION IS
142330 HEPATIC ADENOMAS, FAMILIAL
142395 HEPATITIS B VACCINE, RESPONSE TO
142623 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1
142680 PERIODIC FEVER, FAMILIAL, AUTOSOMAL DOMINANT
142690 ACNE INVERSA, FAMILIAL, 1; ACNINV1
142900 HOLT-ORAM SYNDROME; HOS
142945 HOLOPROSENCEPHALY 3; HPE3
142946 HOLOPROSENCEPHALY 4; HPE4
143095 SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS
143100 HUNTINGTON DISEASE; HD
143200 WAGNER VITREORETINOPATHY; WGVRP
143465 ATTENTION DEFICIT-HYPERACTIVITY DISORDER; ADHD
143470 HYPERALPHALIPOPROTEINEMIA 1; HALP1
143500 GILBERT SYNDROME
143860 HYPERCHLORHIDROSIS, ISOLATED
143870 HYPERCALCIURIA, ABSORPTIVE, 2; HCA2
143880 HYPERCALCEMIA, INFANTILE
143890 HYPERCHOLESTEROLEMIA, FAMILIAL
144010 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, TYPE B
144200 PALMOPLANTAR KERATODERMA, EPIDERMOLYTIC; EPPK
144250 HYPERLIPIDEMIA, FAMILIAL COMBINED; FCHL
144650 HYPERLIPOPROTEINEMIA, TYPE V
144700 RENAL CELL CARCINOMA, NONPAPILLARY; RCC
144750 HYPEROSTOSIS CORTICALIS GENERALISATA, BENIGN FORM OF WORTH, WITH TORUS
145000 HYPERPARATHYROIDISM 1; HRPT1
145001 HYPERPARATHYROIDISM 2; HRPT2
145250 HYPERPIGMENTATION, FAMILIAL PROGRESSIVE, 2; FPH2
145410 OPITZ GBBB SYNDROME, AUTOSOMAL DOMINANT
145500 HYPERTENSION, ESSENTIAL
145600 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1; MHS1
145650 THYROID HORMONE RESISTANCE, SELECTIVE PITUITARY; PRTH
145680 DYSTRANSTHYRETINEMIC EUTHYROIDAL HYPERTHYROXINEMIA
145750 HYPERTRIGLYCERIDEMIA, FAMILIAL
145900 HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS
145980 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1
145981 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II; HHC2
146000 HYPOCHONDROPLASIA; HCH
146110 HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7
146200 HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH
146255 HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE; HDR
146300 HYPOPHOSPHATASIA, ADULT
146390 CHROMOSOME 18p DELETION SYNDROME
146500 MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1
146510 PALLISTER-HALL SYNDROME 1; PHS1
146520 HYPOTRICHOSIS 2; HYPT2
146550 HYPOTRICHOSIS 4; HYPT4
146590 ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE; IHCM
146700 ICHTHYOSIS VULGARIS
146800 ICHTHYOSIS, BULLOUS TYPE
147050 IgE RESPONSIVENESS, ATOPIC; IGER
147060 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT
147250 SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI
147480 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1
147750 IVIC SYNDROME
147791 JACOBSEN SYNDROME; JBS
147891 SMALL PATELLA SYNDROME; SPS
147920 KABUKI SYNDROME 1; KABUK1
147950 HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA; HH2
148000 KAPOSI SARCOMA, SUSCEPTIBILITY TO
148050 KBG SYNDROME; KBGS
148190 KERATITIS, HEREDITARY
148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT
148300 KERATOCONUS 1; KTCN1
148350 KERATODERMA, PALMOPLANTAR, WITH DEAFNESS
148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC
148600 PALMOPLANTAR KERATODERMA, PUNCTATE TYPE IA; PPKP1A
148700 PALMOPLANTAR KERATODERMA I, STRIATE, FOCAL, OR DIFFUSE; PPKS1
148820 WAARDENBURG SYNDROME, TYPE 3; WS3
149100 KNUCKLE PADS
149200 KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS
149400 HYPEREKPLEXIA, HEREDITARY 1; HKPX1
149730 LACRIMOAURICULODENTODIGITAL SYNDROME; LADD
150230 TRICHORHINOPHALANGEAL SYNDROME, TYPE II; TRPS2
150250 LARSEN SYNDROME; LRS
150400 TOOTH AGENESIS, SELECTIVE, 4; STHAG4
150600 LEGG-CALVE-PERTHES DISEASE; LCPD
150699 LEIOMYOMA, UTERINE; UL
150800 HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC
151050 LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM; LMHD
151100 LEOPARD SYNDROME 1
151200 CHROMOSOME 8q22.1 DUPLICATION SYNDROME
151210 PLATYSPONDYLIC LETHAL SKELETAL DYSPLASIA, TORRANCE TYPE; PLSDT
151400 LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL
151600 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 3; NDNC3
151623 LI-FRAUMENI SYNDROME 1; LFS1
151660 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2; FPLD2
152700 SYSTEMIC LUPUS ERYTHEMATOSUS; SLE
152950 MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL
153100 LYMPHEDEMA, HEREDITARY, IA
153400 LYMPHEDEMA-DISTICHIASIS SYNDROME
153480 BANNAYAN-RILEY-RUVALCABA SYNDROME; BRRS
153550 CHROMOSOME 5q DELETION SYNDROME
153640 FECHTNER SYNDROME; FTNS
153650 EPSTEIN SYNDROME
153670 BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2
153700 MACULAR DYSTROPHY, VITELLIFORM; VMD
153800 MACULAR DEGENERATION, AGE-RELATED, 2; ARMD2
154020 HYPOMAGNESEMIA 2, RENAL; HOMG2
154230 46,XY SEX REVERSAL 4; SRXY4
154400 ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1
154500 TREACHER COLLINS SYNDROME 1; TCS1
154700 MARFAN SYNDROME; MFS
154780 MARSHALL SYNDROME; MRSHS
155100 MAY-HEGGLIN ANOMALY; MHA
155240 THYROID CARCINOMA, FAMILIAL MEDULLARY; MTC
155255 MEDULLOBLASTOMA; MDB
155310 VISCERAL MYOPATHY; VSCM
155601 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2; CMM2
155720 MELANOMA, UVEAL
155755 MELANOMA-ASTROCYTOMA SYNDROME
156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1
156240 MESOTHELIOMA, MALIGNANT; MESOM
156250 METACHONDROMATOSIS; METCDS
156400 METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE
156500 METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE; MCDS
156510 METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA WITH OR WITHOUT BRACHYDACTYLY;
156530 METATROPIC DYSPLASIA
156550 KNIEST DYSPLASIA
157170 HOLOPROSENCEPHALY 2; HPE2
157600 MIRROR MOVEMENTS 1; MRMV1
157640 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
158000 MONILETHRIX; MNLIX
158170 CHROMOSOME 9p DELETION SYNDROME
158300 ARTHROGRYPOSIS, DISTAL, TYPE 7; DA7
158320 MUIR-TORRE SYNDROME; MRTES
158330 MULLERIAN APLASIA AND HYPERANDROGENISM
158350 COWDEN SYNDROME 1; CWS1
158580 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIA; HMN7A
158590 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIA; HMN2A
158600 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL
158810 BETHLEM MYOPATHY
158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1
158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2
159000 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1A; LGMD1A
159001 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B; LGMD1B
159900 MYOCLONIC DYSTONIA
159950 SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY; SMAPME
160120 EPISODIC ATAXIA, TYPE 1; EA1
160150 MYOPATHY, CENTRONUCLEAR, 1; CNM1
160500 MYOPATHY, DISTAL, 1; MPD1
160565 MYOPATHY, TUBULAR AGGREGATE, 1; TAM1
160800 MYOTONIA CONGENITA, AUTOSOMAL DOMINANT
160900 MYOTONIC DYSTROPHY 1; DM1
160980 CARNEY COMPLEX, TYPE 1; CNC1
161000 NAEGELI SYNDROME
161200 NAIL-PATELLA SYNDROME; NPS
161400 NARCOLEPSY 1; NRCLP1
161800 NEMALINE MYOPATHY 3; NEM3
162000 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1
162091 SCHWANNOMATOSIS 1; SWNTS1
162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA
162200 NEUROFIBROMATOSIS, TYPE I; NF1
162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL
162300 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B
162350 CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B
162400 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A
162500 NEUROPATHY, HEREDITARY, WITH LIABILITY TO PRESSURE PALSIES; HNPP
162800 CYCLIC NEUTROPENIA
162830 NEUTROPHILIA, HEREDITARY
162900 NEVUS, EPIDERMAL
163000 CAPILLARY MALFORMATIONS, CONGENITAL; CMC
163200 SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM
163500 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 2; CSNBAD2
163800 SICK SINUS SYNDROME 2, AUTOSOMAL DOMINANT; SSS2
163950 NOONAN SYNDROME 1; NS1
164200 OCULODENTODIGITAL DYSPLASIA; ODDD
164230 OBSESSIVE-COMPULSIVE DISORDER; OCD
164280 FEINGOLD SYNDROME 1; FGLDS1
164300 OCULOPHARYNGEAL MUSCULAR DYSTROPHY; OPMD
164400 SPINOCEREBELLAR ATAXIA 1; SCA1
164500 SPINOCEREBELLAR ATAXIA 7; SCA7
164750 OMPHALOCELE, AUTOSOMAL
165300 OPTIC ATROPHY 3, AUTOSOMAL DOMINANT
165500 OPTIC ATROPHY 1; OPA1
165550 OPTIC NERVE HYPOPLASIA, BILATERAL
165720 OSTEOARTHRITIS SUSCEPTIBILITY 1; OS1
165800 OSTEOCHONDRITIS DISSECANS, SHORT STATURE, AND EARLY-ONSET OSTEOARTHRITIS;
166200 OSTEOGENESIS IMPERFECTA, TYPE I
166210 OSTEOGENESIS IMPERFECTA, TYPE II
166220 OSTEOGENESIS IMPERFECTA, TYPE IV
166250 OSTEOGLOPHONIC DYSPLASIA; OGD
166260 GNATHODIAPHYSEAL DYSPLASIA; GDD
166300 MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO
166350 OSSEOUS HETEROPLASIA, PROGRESSIVE; POH
166600 OSTEOPETROSIS, AUTOSOMAL DOMINANT 2; OPTA2
166700 BUSCHKE-OLLENDORFF SYNDROME; BOS
166710 OSTEOPOROSIS
166750 OTODENTAL DYSPLASIA
166780 OTOFACIOCERVICAL SYNDROME 1; OFC1
167000 OVARIAN CANCER
167200 PACHYONYCHIA CONGENITA 1; PC1
167210 PACHYONYCHIA CONGENITA 2; PC2
167320 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT
167400 PAROXYSMAL EXTREME PAIN DISORDER
167800 PANCREATITIS, HEREDITARY; PCTT
168000 PARAGANGLIOMAS 1; PGL1
168300 PARAMYOTONIA CONGENITA OF VON EULENBURG; PMC
168400 PARASTREMMATIC DWARFISM
168500 PARIETAL FORAMINA; PFM
168550 PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA; PFMCCD
168600 PARKINSON DISEASE, LATE-ONSET; PD
168601 PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1
168605 PERRY SYNDROME
169100 CHAR SYNDROME
169150 PATTERNED DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
169400 PELGER-HUET ANOMALY; PHA
169500 LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD
169600 BENIGN CHRONIC PEMPHIGUS; BCPM
170100 PROLIDASE DEFICIENCY
170390 ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS
170400 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 1; HOKPP1
170500 HYPERKALEMIC PERIODIC PARALYSIS; HYPP
170650 PERIODONTITIS, AGGRESSIVE, 1
171200 THIOUREA TASTING
171300 PHEOCHROMOCYTOMA
171400 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A
172700 PICK DISEASE OF BRAIN
172800 PIEBALD TRAIT; PBT
172870 PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY; PPCRA
173100 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE II; IGHD2
173200 PITYRIASIS RUBRA PILARIS; PRP
173600 PNEUMOTHORAX, PRIMARY SPONTANEOUS
173650 KINDLER SYNDROME
173900 POLYCYSTIC KIDNEY DISEASE 1; PKD1
174000 MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1
174050 POLYCYSTIC LIVER DISEASE; PCLD
174200 POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1
174300 OROFACIODIGITAL SYNDROME V; OFD5
174500 POLYDACTYLY, PREAXIAL II; PPD2
174700 POLYDACTYLY, PREAXIAL IV
174800 MCCUNE-ALBRIGHT SYNDROME; MAS
174810 FAMILIAL EXPANSILE OSTEOLYSIS; FEO
174900 JUVENILE POLYPOSIS SYNDROME; JPS
175050 JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME;
175100 FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1
175200 PEUTZ-JEGHERS SYNDROME; PJS
175700 GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; GCPS
175780 PORENCEPHALY 1; POREN1
175900 POROKERATOSIS 3, DISSEMINATED SUPERFICIAL ACTINIC TYPE; POROK3
176000 PORPHYRIA, ACUTE INTERMITTENT
176100 PORPHYRIA CUTANEA TARDA
176200 PORPHYRIA VARIEGATA
176270 PRADER-WILLI SYNDROME; PWS
176305 PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS
176400 PRECOCIOUS PUBERTY, CENTRAL, 1; CPPB1
176410 PRECOCIOUS PUBERTY, MALE-LIMITED
176430 PREMATURE CHROMATID SEPARATION TRAIT; PCS
176450 CURRARINO SYNDROME
176500 CEREBRAL AMYLOID ANGIOPATHY, ITM2B-RELATED, 1
176670 HUTCHINSON-GILFORD PROGERIA SYNDROME; HGPS
176807 PROSTATE CANCER
176860 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL DOMINANT; THPH3
176920 PROTEUS SYNDROME
177000 PROTOPORPHYRIA, ERYTHROPOIETIC; EPP
177170 PSEUDOACHONDROPLASIA; PSACH
177200 LIDDLE SYNDROME
177650 EXFOLIATION SYNDROME; XFS
177700 GLAUCOMA 1, OPEN ANGLE, P; GLC1P
177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A
177820 PSEUDO-VON WILLEBRAND DISEASE; VWDP
177850 PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE
177900 PSORIASIS SUSCEPTIBILITY 1; PSORS1
177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES
178500 PULMONARY FIBROSIS, IDIOPATHIC; IPF
178600 PULMONARY HYPERTENSION, PRIMARY, 1; PPH1
179613 RECOMBINANT CHROMOSOME 8 SYNDROME
179620 RAPH BLOOD GROUP SYSTEM
179800 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL DOMINANT
179850 DOWLING-DEGOS DISEASE 1; DDD1
180100 RETINITIS PIGMENTOSA 1; RP1
180104 RETINITIS PIGMENTOSA 9; RP9
180105 RETINITIS PIGMENTOSA 10; RP10
180200 RETINOBLASTOMA; RB1
180295 RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2
180300 RHEUMATOID ARTHRITIS; RA
180500 AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1
180550 RING DERMOID OF CORNEA; RDC
180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS
180750 ROBINOW-SORAUF SYNDROME
180800 ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA
180849 RUBINSTEIN-TAYBI SYNDROME 1; RSTS1
180860 SILVER-RUSSELL SYNDROME; SRS
180920 APLASIA OF LACRIMAL AND SALIVARY GLANDS; ALSG
181000 SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1
181030 SALIVARY GLAND ADENOMA, PLEOMORPHIC
181270 SCALP-EAR-NIPPLE SYNDROME; SENS
181350 EMERY-DREIFUSS MUSCULAR DYSTROPHY 2, AUTOSOMAL DOMINANT; EDMD2
181400 SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE; SCPNK
181405 SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA
181430 SCAPULOPERONEAL MYOPATHY, MYH7-RELATED; SPMM
181450 ULNAR-MAMMARY SYNDROME; UMS
181500 SCHIZOPHRENIA; SCZD
182000 KERATOSIS, SEBORRHEIC
182212 SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS
182230 SEPTOOPTIC DYSPLASIA
182290 SMITH-MAGENIS SYNDROME; SMS
182600 SPASTIC PARAPLEGIA 3, AUTOSOMAL DOMINANT; SPG3A
182601 SPASTIC PARAPLEGIA 4, AUTOSOMAL DOMINANT; SPG4
182900 SPHEROCYTOSIS, TYPE 1; SPH1
182920 MYOPATHY, SPHEROID BODY
182940 NEURAL TUBE DEFECTS
182980 SPINAL MUSCULAR ATROPHY, LATE-ONSET, FINKEL TYPE; SMAFK
183086 SPINOCEREBELLAR ATAXIA 6; SCA6
183090 SPINOCEREBELLAR ATAXIA 2; SCA2
183600 SPLIT-HAND/FOOT MALFORMATION 1; SHFM1
183900 SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; SEDC
184095 SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK
184252 SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES
184500 STEATOCYSTOMA MULTIPLEX
184840 STICKLER SYNDROME, TYPE III; STL3
184900 STIFF SKIN SYNDROME; SSKS
185070 STORMORKEN SYNDROME; STRMK
185300 STURGE-WEBER SYNDROME; SWS
185500 SUPRAVALVULAR AORTIC STENOSIS; SVAS
185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A
185900 CHROMOSOME 2q35 DUPLICATION SYNDROME
186000 SYNPOLYDACTYLY 1; SPD1
186100 SYNDACTYLY, TYPE III
186200 SYNDACTYLY, TYPE IV
186300 SYNDACTYLY, TYPE V
186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1
186550 LIEBENBERG SYNDROME; LBNBG
186570 TARSAL-CARPAL COALITION SYNDROME; TCC
186580 BLAU SYNDROME
187300 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, OF RENDU, OSLER, AND WEBER;
187500 TETRALOGY OF FALLOT; TOF
187600 THANATOPHORIC DYSPLASIA, TYPE I; TD1
187601 THANATOPHORIC DYSPLASIA, TYPE II; TD2
187800 BLEEDING DISORDER, PLATELET-TYPE, 16; BDPLT16
187900 BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17
187950 THROMBOCYTHEMIA 1; THCYT1
188000 THROMBOCYTOPENIA 2; THC2
188025 THROMBOCYTOPENIA, PARIS-TROUSSEAU TYPE; TCPT
188050 THROMBOPHILIA DUE TO THROMBIN DEFECT; THPH1
188055 THROMBOPHILIA DUE TO ACTIVATED PROTEIN C RESISTANCE; THPH2
188400 DIGEORGE SYNDROME; DGS
188550 THYROID CARCINOMA, PAPILLARY
188570 THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT; GRTH
188580 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1
188890 TOBACCO ADDICTION, SUSCEPTIBILITY TO
189500 WITKOP SYNDROME
190300 TREMOR, HEREDITARY ESSENTIAL, 1; ETM1
190320 TRICHODENTOOSSEOUS SYNDROME; TDO
190350 TRICHORHINOPHALANGEAL SYNDROME, TYPE I; TRPS1
190351 TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3
190440 TRIGONOCEPHALY 1; TRIGNO1
190685 DOWN SYNDROME
190900 TRITANOPIA
191100 TUBEROUS SCLEROSIS 1; TSC1
191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1
191900 MUCKLE-WELLS SYNDROME; MWS
192315 VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL
192350 VATER ASSOCIATION
192430 VELOCARDIOFACIAL SYNDROME
192500 LONG QT SYNDROME 1; LQT1
192600 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1; CMH1
192605 VENTRICULAR TACHYCARDIA, FAMILIAL
192950 VERTICAL TALUS, CONGENITAL; CVT
193100 HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT; ADHR
193220 VITREORETINOCHOROIDOPATHY; VRCP
193230 VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD
193235 VITREORETINOPATHY, NEOVASCULAR INFLAMMATORY; VRNI
193300 VON HIPPEL-LINDAU SYNDROME; VHL
193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1
193500 WAARDENBURG SYNDROME, TYPE 1; WS1
193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A
193520 WATSON SYNDROME
193530 WEYERS ACROFACIAL DYSOSTOSIS; WAD
193670 WHIM SYNDROME
193700 ARTHROGRYPOSIS, DISTAL, TYPE 2A; DA2A
193900 WHITE SPONGE NEVUS 1; WSN1
194050 WILLIAMS-BEUREN SYNDROME; WBS
194070 WILMS TUMOR 1; WT1
194071 WILMS TUMOR 2; WT2
194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATION
194080 DENYS-DRASH SYNDROME; DDS
194190 WOLF-HIRSCHHORN SYNDROME; WHS
194200 WOLFF-PARKINSON-WHITE SYNDROME
194300 WOOLLY HAIR, AUTOSOMAL DOMINANT; ADWH
194380 DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH OR WITHOUT PSEUDOHYPERKALEMIA
200100 ABETALIPOPROTEINEMIA; ABL
200150 CHOREOACANTHOCYTOSIS; CHAC
200500 ACHEIROPODY
200600 ACHONDROGENESIS, TYPE IA; ACG1A
200610 ACHONDROGENESIS, TYPE II; ACG2
200700 CHONDRODYSPLASIA, GREBE TYPE
200990 ACROCALLOSAL SYNDROME; ACLS
201000 CARPENTER SYNDROME 1; CRPT1
201100 ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE; AEZ
201250 ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE
201300 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIA; HSAN2A
201400 ACTH DEFICIENCY, ISOLATED; IAD
201450 ACYL-CoA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF; ACADMD
201470 ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF; ACADSD
201475 ACYL-CoA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF; ACADVLD
201710 LIPOID CONGENITAL ADRENAL HYPERPLASIA; LCAH
201750 ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS;
201810 3-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II, DEFICIENCY OF
201910 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY
202010 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASE
202110 ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY
202200 GLUCOCORTICOID DEFICIENCY 1; GCCD1
202300 ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC
202370 PEROXISOME BIOGENESIS DISORDER 2B; PBD2B
202400 AFIBRINOGENEMIA, CONGENITAL
202650 AGNATHIA-OTOCEPHALY COMPLEX; AGOTC
202700 NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1
203100 ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A
203200 ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2
203290 ALBINISM, OCULOCUTANEOUS, TYPE III; OCA3
203300 HERMANSKY-PUDLAK SYNDROME 1; HPS1
203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY
203450 ALEXANDER DISEASE
203500 ALKAPTONURIA; AKU
203655 ALOPECIA UNIVERSALIS CONGENITA; ALUNC
203700 MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE); MTDPS4A
203750 ALPHA-METHYLACETOACETIC ACIDURIA
203780 ALPORT SYNDROME, AUTOSOMAL RECESSIVE
203800 ALSTROM SYNDROME; ALMS
204000 LEBER CONGENITAL AMAUROSIS 1; LCA1
204100 LEBER CONGENITAL AMAUROSIS 2; LCA2
204200 CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3
204300 CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE; CLN4A
204500 CEROID LIPOFUSCINOSIS, NEURONAL, 2; CLN2
204650 AMELOGENESIS IMPERFECTA, TYPE IC; AI1C
204690 AMELOGENESIS IMPERFECTA, TYPE IG; AI1G
204700 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA1; AI2A1
204750 2-@AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD
204870 CORNEAL DYSTROPHY, GELATINOUS DROP-LIKE; GDLD
205100 AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2
205400 TANGIER DISEASE; TGD
205950 ANEMIA, SIDEROBLASTIC, PYRIDOXINE-REFRACTORY, AUTOSOMAL RECESSIVE
206100 ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1
206200 IRON-REFRACTORY IRON DEFICIENCY ANEMIA; IRIDA
206700 ANIRIDIA, CEREBELLAR ATAXIA, AND MENTAL RETARDATION
206800 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 4; NDNC4
206900 MICROPHTHALMIA, SYNDROMIC 3; MCOPS3
206920 MICROPHTHALMIA WITH LIMB ANOMALIES
207410 ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS;
207750 APOLIPOPROTEIN C-II DEFICIENCY
207800 ARGININEMIA
207900 ARGININOSUCCINIC ACIDURIA
208000 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1
208050 ARTERIAL TORTUOSITY SYNDROME; ATS
208085 ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1; ARCS1
208150 FETAL AKINESIA DEFORMATION SEQUENCE; FADS
208230 ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD; PPAC
208250 CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME; CACP
208400 ASPARTYLGLUCOSAMINURIA; AGU
208530 RIGHT ATRIAL ISOMERISM; RAI
208540 RENAL-HEPATIC-PANCREATIC DYSPLASIA 1; RHPD1
208550 ASTHMA, NASAL POLYPS, AND ASPIRIN INTOLERANCE
208900 ATAXIA-TELANGIECTASIA; AT
208920 ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA;
209300 ATRANSFERRINEMIA
209500 ATRICHIA WITH PAPULAR LESIONS; APL
209880 CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS
209900 BARDET-BIEDL SYNDROME; BBS
209920 BARE LYMPHOCYTE SYNDROME, TYPE II
209950 ATYPICAL MYCOBACTERIOSIS, FAMILIAL
210200 3-@METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY
210210 3-@METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY
210250 SITOSTEROLEMIA
210370 BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY
210600 SECKEL SYNDROME 1; SCKL1
210710 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I; MOPD1
210720 MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2
210750 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6; SHEP6
210900 BLOOM SYNDROME; BLM
211180 BOWEN-CONRADI SYNDROME; BWCNS
211400 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 1; BESC1
211500 FAZIO-LONDE DISEASE
211530 BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1
211600 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 1; PFIC1
211750 C SYNDROME
211800 CALCIFICATION OF JOINTS AND ARTERIES; CALJA
211900 TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL; HFTC
211980 LUNG CANCER
212050 CANDIDIASIS, FAMILIAL, 2; CANDF2
212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
212066 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A
212070 CARBOXYPEPTIDASE N DEFICIENCY
212112 CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM
212138 CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY; CACTD
212140 CARNITINE DEFICIENCY, SYSTEMIC PRIMARY; CDSP
212350 SENGERS SYNDROME
212550 MICROPHTHALMIA, ISOLATED, WITH CATARACT 2; MCOPCT2
212720 MARTSOLF SYNDROME
212750 CELIAC DISEASE; CD
212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS
212840 GORDON HOLMES SYNDROME; GDHS
213300 JOUBERT SYNDROME 1; JBTS1
213600 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1
213700 CEREBROTENDINOUS XANTHOMATOSIS; CTX
213980 CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION
214100 PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER); PBD1A
214110 PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A
214150 CEREBROOCULOFACIOSKELETAL SYNDROME 1; COFS1
214300 KLIPPEL-FEIL SYNDROME 2, AUTOSOMAL RECESSIVE; KFS2
214400 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A
214450 GRISCELLI SYNDROME, TYPE 1; GS1
214500 CHEDIAK-HIGASHI SYNDROME; CHS
214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1
214800 CHARGE SYNDROME
214950 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 4; CBAS4
215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD
215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1
215140 GREENBERG DYSPLASIA; GRBGD
215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED
215300 CHONDROSARCOMA
215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM
215470 BOUCHER-NEUHAUSER SYNDROME; BNHS
215600 CIRRHOSIS, FAMILIAL
215700 CITRULLINEMIA, CLASSIC
216340 YUNIS-VARON SYNDROME; YVS
216360 COACH SYNDROME
216400 COCKAYNE SYNDROME A; CSA
216550 COHEN SYNDROME; COH1
216900 ACHROMATOPSIA 2; ACHM2
217000 COMPLEMENT COMPONENT 2 DEFICIENCY; C2D
217080 JALILI SYNDROME
217090 PLASMINOGEN DEFICIENCY, TYPE I
217095 CONOTRUNCAL HEART MALFORMATIONS; CTHM
217300 CORNEA PLANA 2; CNA2
217400 CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS; CDPD
217700 CORNEAL ENDOTHELIAL DYSTROPHY 2, AUTOSOMAL RECESSIVE; CHED2
217800 MACULAR DYSTROPHY, CORNEAL, 1; MCDC1
218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN
218030 APPARENT MINERALOCORTICOID EXCESS; AME
218040 COSTELLO SYNDROME
218330 CRANIOECTODERMAL DYSPLASIA 1; CED1
218340 TEMTAMY SYNDROME; TEMTYS
218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR
218600 BALLER-GEROLD SYNDROME; BGS
218700 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2; CHNG2
218800 CRIGLER-NAJJAR SYNDROME, TYPE I
219000 FRASER SYNDROME
219050 CRYPTORCHIDISM, UNILATERAL OR BILATERAL
219080 ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH
219090 PITUITARY ADENOMA, ACTH-SECRETING
219100 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IA; ARCL1A
219150 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA; ARCL3A
219200 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A
219500 CYSTATHIONINURIA
219700 CYSTIC FIBROSIS; CF
219750 CYSTINOSIS, ADULT NONNEPHROPATHIC
219800 CYSTINOSIS, NEPHROPATHIC; CTNS
219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE
220100 CYSTINURIA
220110 MITOCHONDRIAL COMPLEX IV DEFICIENCY
220111 LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC
220120 D-GLYCERIC ACIDURIA
220150 HYPOURICEMIA, RENAL, 1; RHUC1
220210 RITSCHER-SCHINZEL SYNDROME; RTSC
220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1A
220400 JERVELL AND LANGE-NIELSEN SYNDROME 1; JLNS1
220500 DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND
220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS, AUTOSOMAL
221200 DEAFNESS AND MYOPIA; DFNMYP
221750 PITUITARY HORMONE DEFICIENCY, COMBINED, 3; CPHD3
221770 POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY;
221820 LEUKOENCEPHALOPATHY, DIFFUSE HEREDITARY, WITH SPHEROIDS; HDLS
221900 RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC
222300 WOLFRAM SYNDROME 1; WFS1
222448 DONNAI-BARROW SYNDROME
222470 TRICHOHEPATOENTERIC SYNDROME 1; THES1
222600 DIASTROPHIC DYSPLASIA
222700 LYSINURIC PROTEIN INTOLERANCE; LPI
222748 DIHYDROPYRIMIDINASE DEFICIENCY
222765 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2; RCDP2
222800 BISPHOSPHOGLYCERATE MUTASE DEFICIENCY
222900 SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL; CSID
223000 LACTASE DEFICIENCY, CONGENITAL
223100 LACTOSE INTOLERANCE, ADULT TYPE
223360 DOPAMINE BETA-HYDROXYLASE DEFICIENCY, CONGENITAL
223800 DYGGVE-MELCHIOR-CLAUSEN DISEASE; DMC
223900 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III; HSAN3
224050 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME
224100 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE II; CDAN2
224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A
224230 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 1; DKCB1
224410 DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH
224690 MEIER-GORLIN SYNDROME 1; MGORS1
224750 SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS
224900 ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL
225060 CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1
225100 ECTOPIA LENTIS 2, ISOLATED, AUTOSOMAL RECESSIVE; ECTOL2
225200 ECTOPIA LENTIS ET PUPILLAE
225250 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 5; CHNG5
225280 EEM SYNDROME
225300 SPLIT-HAND/FOOT MALFORMATION 6; SHFM6
225320 EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM
225400 EHLERS-DANLOS SYNDROME, TYPE VI; EDS6
225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE
225500 ELLIS-VAN CREVELD SYNDROME; EVC
225750 AICARDI-GOUTIERES SYNDROME 1; AGS1
225753 PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4
225790 PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME;
226200 ENTEROKINASE DEFICIENCY
226400 EPIDERMODYSPLASIA VERRUCIFORMIS; EV
226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB
226650 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE
226670 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY
226700 EPIDERMOLYSIS BULLOSA, JUNCTIONAL, HERLITZ TYPE
226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA
226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS
226900 EPIPHYSEAL DYSPLASIA, MULTIPLE, 4; EDM4
226980 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS
227220 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1; SHEP1
227240 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5; SHEP5
227260 FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE; FFDD3
227300 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 1; F5F8D1
227400 FACTOR V DEFICIENCY
227500 FACTOR VII DEFICIENCY
227600 FACTOR X DEFICIENCY
227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC
227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2
227650 FANCONI ANEMIA, COMPLEMENTATION GROUP A; FANCA
227810 FANCONI-BICKEL SYNDROME; FBS
228000 FARBER LIPOGRANULOMATOSIS
228300 FERTILE EUNUCH SYNDROME
228520 FIBROCHONDROGENESIS 1; FBCG1
228550 MYOFIBROMATOSIS, INFANTILE, 1; IMF1
228600 HYALINE FIBROMATOSIS SYNDROME; HFS
228900 FIBULAR HYPOPLASIA AND COMPLEX BRACHYDACTYLY
228930 FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND
228960 HIGH MOLECULAR WEIGHT KININOGEN DEFICIENCY
228980 FLECK RETINA, FAMILIAL BENIGN; FRFB
229050 FOLATE MALABSORPTION, HEREDITARY
229070 FOLLICLE-STIMULATING HORMONE DEFICIENCY, ISOLATED
229100 FORMIMINOTRANSFERASE DEFICIENCY
229200 BRITTLE CORNEA SYNDROME 1; BCS1
229300 FRIEDREICH ATAXIA 1; FRDA
229600 FRUCTOSE INTOLERANCE, HEREDITARY
229700 FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY
229800 FRUCTOSURIA, ESSENTIAL
230000 FUCOSIDOSIS
230200 GALACTOKINASE DEFICIENCY
230350 GALACTOSE EPIMERASE DEFICIENCY
230400 GALACTOSEMIA
230450 GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUE
230500 GM1-GANGLIOSIDOSIS, TYPE I
230600 GM1-GANGLIOSIDOSIS, TYPE II
230650 GM1-GANGLIOSIDOSIS, TYPE III
230740 GAPO SYNDROME
230800 GAUCHER DISEASE, TYPE I
230900 GAUCHER DISEASE, TYPE II
231000 GAUCHER DISEASE, TYPE III
231005 GAUCHER DISEASE, TYPE IIIC
231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1
231070 GERODERMA OSTEODYSPLASTICUM; GO
231090 HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1
231095 GHOSAL HEMATODIAPHYSEAL DYSPLASIA; GHDD
231200 BERNARD-SOULIER SYNDROME; BSS
231300 GLAUCOMA 3, PRIMARY CONGENITAL, A; GLC3A
231530 3-@HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS
231670 GLUTARIC ACIDEMIA I
231680 MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD
231690 GLUTARIC ACIDURIA III
231900 GLUTATHIONE SYNTHETASE DEFICIENCY OF ERYTHROCYTES, HEMOLYTIC ANEMIA
232200 GLYCOGEN STORAGE DISEASE Ia; GSD1A
232220 GLYCOGEN STORAGE DISEASE Ib; GSD1B
232240 GLYCOGEN STORAGE DISEASE Ic
232300 GLYCOGEN STORAGE DISEASE II; GSD2
232400 GLYCOGEN STORAGE DISEASE III; GSD3
232500 GLYCOGEN STORAGE DISEASE IV; GSD4
232600 GLYCOGEN STORAGE DISEASE V; GSD5
232700 GLYCOGEN STORAGE DISEASE VI; GSD6
232800 GLYCOGEN STORAGE DISEASE VII; GSD7
233100 RENAL GLUCOSURIA; GLYS1
233300 OVARIAN DYSGENESIS 1; ODG1
233400 PERRAULT SYNDROME 1; PRLTS1
233420 46,XY SEX REVERSAL 7; SRXY7
233650 COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS; CCHIDG
233690 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-NEGATIVE
233700 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
233710 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
233910 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B
234000 FACTOR XII DEFICIENCY
234050 TRICHOTHIODYSTROPHY, NONPHOTOSENSITIVE 1; TTDN1
234200 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1
234500 HARTNUP DISORDER; HND
234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2
235200 HEMOCHROMATOSIS, TYPE 1; HFE1
235400 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 1; AHUS1
235510 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME
235550 HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY; VODI
235555 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 2; CBAS2
235700 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO HEXOKINASE DEFICIENCY
235730 MOWAT-WILSON SYNDROME; MOWS
235800 HISTIDINEMIA
236000 LYMPHOMA, HODGKIN
236200 HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY
236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE
236270 HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblE COMPLEMENTATION TYPE; HMAE
236600 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 1; HYC1
236670 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
236680 HYDROLETHALUS SYNDROME 1; HLS1
236700 MCKUSICK-KAUFMAN SYNDROME; MKKS
236730 UROFACIAL SYNDROME 1; UFS1
236750 HYDROPS FETALIS, NONIMMUNE; NIHF
236792 L-2-HYDROXYGLUTARIC ACIDURIA
237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO
237310 N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY
237450 HYPERBILIRUBINEMIA, ROTOR TYPE; HBLRR
237500 DUBIN-JOHNSON SYNDROME; DJS
237900 HYPERBILIRUBINEMIA, TRANSIENT FAMILIAL NEONATAL; HBLRTFN
238320 LEYDIG CELL HYPOPLASIA, TYPE I
238600 HYPERLIPOPROTEINEMIA, TYPE I
238700 HYPERLYSINEMIA, TYPE I
238970 HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME
239000 PAGET DISEASE, JUVENILE
239100 HYPEROSTOSIS CORTICALIS GENERALISATA
239200 HYPERPARATHYROIDISM, NEONATAL SEVERE; NSHPT
239300 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 1; HPMRS1
239500 HYPERPROLINEMIA, TYPE I; HPI
239510 HYPERPROLINEMIA, TYPE II; HPII
239850 CANTU SYNDROME
240300 AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE
240500 IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2
240600 GLYCOGEN STORAGE DISEASE 0, LIVER; GSD0A
240800 HYPOGLYCEMIA, LEUCINE-INDUCED; LIH
240900 HYPOINSULINEMIC HYPOGLYCEMIA WITH HEMIHYPERTROPHY; HIHGHH
241080 WOODHOUSE-SAKATI SYNDROME
241200 BARTTER SYNDROME, ANTENATAL, TYPE 2
241410 HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME; HRD
241500 HYPOPHOSPHATASIA, INFANTILE
241510 HYPOPHOSPHATASIA, CHILDHOOD
241520 HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 1; ARHR1
241530 HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY; HHRH
241550 HYPOPLASTIC LEFT HEART SYNDROME 1; HLHS1
241600 HYPOPROTEINEMIA, HYPERCATABOLIC
241850 HYPOTHYROIDISM, ATHYROIDAL, WITH SPIKY HAIR AND CLEFT PALATE
242100 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2; ARCI2
242300 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1
242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B
242600 IMINOGLYCINURIA
242840 VICI SYNDROME; VICIS
242860 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
242900 IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE
243000 INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE
243060 SPERMATOGENIC FAILURE 5; SPGF5
243150 INTESTINAL ATRESIA, MULTIPLE; MINAT
243300 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 1; BRIC1
243310 BARAITSER-WINTER SYNDROME 1; BRWS1
243400 ACETYLATION, SLOW
243500 ISOVALERIC ACIDEMIA; IVA
243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE
243800 JOHANSON-BLIZZARD SYNDROME; JBS
244200 HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3
244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1
244460 KENNY-CAFFEY SYNDROME, TYPE 1; KCS1
245000 PAPILLON-LEFEVRE SYNDROME; PALS
245010 HAIM-MUNK SYNDROME; HMS
245050 SUCCINYL-CoA:3-OXOACID CoA TRANSFERASE DEFICIENCY
245150 KEUTEL SYNDROME
245200 KRABBE DISEASE
245300 KURU, SUSCEPTIBILITY TO
245340 ERYTHROCYTE LACTATE TRANSPORTER DEFECT
245348 PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD
245349 PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY; PDHXD
245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITH
245480 SPECIFIC GRANULE DEFICIENCY; SGD
245570 EPILEPSY, FOCAL, WITH SPEECH DISORDER AND WITH OR WITHOUT MENTAL RETARDATION;
245590 GROWTH HORMONE INSENSITIVITY WITH IMMUNODEFICIENCY
245600 MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, CRANIOFACIAL DYSMORPHISM,
245660 LARYNGOONYCHOCUTANEOUS SYNDROME; LOCS
245900 LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY
246200 DONOHUE SYNDROME
246300 LEPROSY, SUSCEPTIBILITY TO, 3; LPRS3
246450 3-@HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD
246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3
246650 LIPASE DEFICIENCY, COMBINED
246700 CHYLOMICRON RETENTION DISEASE; CMRD
246900 DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY; DLDD
247100 LIPOID PROTEINOSIS OF URBACH AND WIETHE
247200 MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS
247420 LUTHERAN NULL
248000 MEGALENCEPHALY, AUTOSOMAL RECESSIVE; MGCPH
248190 HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5
248200 STARGARDT DISEASE 1; STGD1
248250 HYPOMAGNESEMIA 3, RENAL; HOMG3
248300 MAL DE MELEDA; MDM
248360 MALONYL-CoA DECARBOXYLASE DEFICIENCY
248370 MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA
248390 TREACHER COLLINS SYNDROME 3; TCS3
248450 MANITOBA OCULOTRICHOANAL SYNDROME; MOTA
248500 MANNOSIDOSIS, ALPHA B, LYSOSOMAL; MANSA
248510 MANNOSIDOSIS, BETA A, LYSOSOMAL; MANSB
248600 MAPLE SYRUP URINE DISEASE; MSUD
248700 MARDEN-WALKER SYNDROME; MWKS
248800 MARINESCO-SJOGREN SYNDROME; MSS
248900 MAST SYNDROME
249000 MECKEL SYNDROME, TYPE 1; MKS1
249100 FAMILIAL MEDITERRANEAN FEVER; FMF
249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA
249400 MELANOSIS, NEUROCUTANEOUS; NCMS
249420 FRANK-TER HAAR SYNDROME; FTHS
249500 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1; MRT1
249700 LANGER MESOMELIC DYSPLASIA; LMD
249900 METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY
250100 METACHROMATIC LEUKODYSTROPHY
250250 CARTILAGE-HAIR HYPOPLASIA; CHH
250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS
250620 BETA-HYDROXYISOBUTYRYL CoA DEACYLASE DEFICIENCY
250790 METHEMOGLOBINEMIA TYPE IV
250800 METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE
250850 METHIONINE ADENOSYLTRANSFERASE DEFICIENCY
250940 HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblG COMPLEMENTATION TYPE; HMAG
250950 3-@METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1
251000 METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY
251100 METHYLMALONIC ACIDURIA, cblA TYPE
251110 METHYLMALONIC ACIDURIA, cblB TYPE
251120 METHYLMALONYL-CoA EPIMERASE DEFICIENCY
251200 MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1
251255 JAWAD SYNDROME; JWDS
251260 NIJMEGEN BREAKAGE SYNDROME
251270 MICROCEPHALY AND CHORIORETINOPATHY WITH OR WITHOUT MENTAL RETARDATION,
251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;
251450 DESBUQUOIS DYSPLASIA 1; DBQD1
251750 MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH
251850 DIARRHEA 2, WITH MICROVILLUS ATROPHY; DIAR2
251880 MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE); MTDPS3
252010 MITOCHONDRIAL COMPLEX I DEFICIENCY
252011 MITOCHONDRIAL COMPLEX II DEFICIENCY
252150 MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA
252160 MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB
252270 MONOSOMY 7 OF BONE MARROW
252500 MUCOLIPIDOSIS II ALPHA/BETA
252600 MUCOLIPIDOSIS III ALPHA/BETA
252605 MUCOLIPIDOSIS III GAMMA
252650 MUCOLIPIDOSIS IV
252700 MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES
252900 MUCOPOLYSACCHARIDOSIS, TYPE IIIA; MPS3A
252920 MUCOPOLYSACCHARIDOSIS, TYPE IIIB; MPS3B
252930 MUCOPOLYSACCHARIDOSIS, TYPE IIIC; MPS3C
252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D
253000 MUCOPOLYSACCHARIDOSIS, TYPE IVA; MPS4A
253010 MUCOPOLYSACCHARIDOSIS TYPE IVB
253200 MUCOPOLYSACCHARIDOSIS TYPE VI; MPS6
253220 MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7
253250 MULIBREY NANISM
253260 BIOTINIDASE DEFICIENCY
253270 HOLOCARBOXYLASE SYNTHETASE DEFICIENCY
253280 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS
253300 SPINAL MUSCULAR ATROPHY, TYPE I; SMA1
253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1
253400 SPINAL MUSCULAR ATROPHY, TYPE III; SMA3
253550 SPINAL MUSCULAR ATROPHY, TYPE II; SMA2
253600 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A
253601 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B
253700 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2C; LGMD2C
253800 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
254090 ULLRICH CONGENITAL MUSCULAR DYSTROPHY; UCMD
254110 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H; LGMD2H
254130 MIYOSHI MUSCULAR DYSTROPHY 1; MMD1
254210 MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH EPISODIC APNEA
254300 MYASTHENIA, LIMB-GIRDLE, FAMILIAL
254450 MYELOFIBROSIS
254500 MYELOMA, MULTIPLE
254600 MYELOPEROXIDASE DEFICIENCY; MPOD
254770 EPILEPSY, MYOCLONIC JUVENILE; EJM
254780 MYOCLONIC EPILEPSY OF LAFORA
254800 MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG
254900 EPILEPSY, PROGRESSIVE MYOCLONIC 4, WITH OR WITHOUT RENAL FAILURE;
255110 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LATE-ONSET
255120 CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY
255125 MYOPATHY WITH LACTIC ACIDOSIS, HEREDITARY; HML
255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2
255310 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD
255320 MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA
255600 MYOSCLEROSIS, AUTOSOMAL RECESSIVE
255700 MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE
255800 SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1
255960 MYXOMA, INTRACARDIAC
255995 NATIVE AMERICAN MYOPATHY; NAM
256000 LEIGH SYNDROME; LS
256030 NEMALINE MYOPATHY 2; NEM2
256040 AUTOINFLAMMATION, LIPODYSTROPHY, AND DERMATOSIS SYNDROME; ALDD
256050 ATELOSTEOGENESIS, TYPE II; AO2
256100 NEPHRONOPHTHISIS 1; NPHP1
256300 NEPHROTIC SYNDROME, TYPE 1; NPHS1
256370 NEPHROTIC SYNDROME, TYPE 4; NPHS4
256450 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 1; HHF1
256500 NETHERTON SYNDROME; NETH
256520 NEU-LAXOVA SYNDROME; NLS
256540 GALACTOSIALIDOSIS; GSL
256550 NEURAMINIDASE DEFICIENCY
256600 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A; NBIA2A
256700 NEUROBLASTOMA, SUSCEPTIBILITY TO
256710 ELEJALDE DISEASE
256730 CEROID LIPOFUSCINOSIS, NEURONAL, 1; CLN1
256731 CEROID LIPOFUSCINOSIS, NEURONAL, 5; CLN5
256800 INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA
256810 MITOCHONDRIAL DNA DEPLETION SYNDROME 6 (HEPATOCEREBRAL TYPE); MTDPS6
256840 NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL
256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1
257200 NIEMANN-PICK DISEASE, TYPE A
257220 NIEMANN-PICK DISEASE, TYPE C1; NPC1
257270 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B; CSNB1B
257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1
257320 LISSENCEPHALY 2; LIS2
257850 OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE
257920 3MC SYNDROME 1; 3MC1
257980 ODONTOONYCHODERMAL DYSPLASIA; OODD
258100 OGUCHI DISEASE 1
258315 OMODYSPLASIA 1; OMOD1
258450 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
258480 OPSISMODYSPLASIA; OPSMD
258501 3-@METHYLGLUTACONIC ACIDURIA, TYPE III; MGCA3
258660 NONARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY, SUSCEPTIBILITY TO
258860 OROFACIODIGITAL SYNDROME IV; OFD4
258870 GYRATE ATROPHY OF CHOROID AND RETINA; GACR
258900 OROTIC ACIDURIA
259100 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1
259420 OSTEOGENESIS IMPERFECTA, TYPE III
259440 OSTEOGENESIS IMPERFECTA, TYPE IX; OI9
259450 BRUCK SYNDROME 1; BRKS1
259500 OSTEOGENIC SARCOMA
259600 MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA
259700 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1
259710 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 2; OPTB2
259720 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5
259730 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3
259770 OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME; OPPG
259775 RAINE SYNDROME; RNS
259900 HYPEROXALURIA, PRIMARY, TYPE I; HP1
260000 HYPEROXALURIA, PRIMARY, TYPE II; HP2
260005 5-@OXOPROLINASE DEFICIENCY; OPLAHD
260300 PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK15
260350 PANCREATIC CANCER
260370 PANCREATIC AGENESIS, CONGENITAL; PAGEN
260400 SHWACHMAN-DIAMOND SYNDROME; SDS
260500 PAPILLOMA OF CHOROID PLEXUS; CPP
260540 PARKINSON-DEMENTIA SYNDROME
260600 LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3
260660 COUSIN SYNDROME
260800 PENTOSURIA; PNTSU
260920 HYPER-IgD SYNDROME; HIDS
261000 INTRINSIC FACTOR DEFICIENCY; IFD
261100 MEGALOBLASTIC ANEMIA 1
261500 EOSINOPHIL PEROXIDASE DEFICIENCY; EPXD
261515 D-BIFUNCTIONAL PROTEIN DEFICIENCY
261540 PETERS-PLUS SYNDROME
261550 PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II; PMDS
261600 PHENYLKETONURIA; PKU
261630 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C
261640 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A
261670 GLYCOGEN STORAGE DISEASE X; GSD10
261740 GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL
261750 GLYCOGEN STORAGE DISEASE IXb; GSD9B
262000 BJORNSTAD SYNDROME; BJS
262190 PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC
262300 ACHROMATOPSIA 3; ACHM3
262400 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IA; IGHD1A
262500 LARON SYNDROME
262600 PITUITARY HORMONE DEFICIENCY, COMBINED, 2; CPHD2
262650 KOWARSKI SYNDROME
262700 PITUITARY HORMONE DEFICIENCY, COMBINED, 4; CPHD4
262850 ALPHA-2-PLASMIN INHIBITOR DEFICIENCY
262890 SCOTT SYNDROME; SCTS
263200 POLYCYSTIC KIDNEY DISEASE, AUTOSOMAL RECESSIVE; ARPKD
263300 POLYCYTHEMIA VERA; PV
263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2
263520 SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6
263570 POLYGLUCOSAN BODY DISEASE, ADULT FORM; APBD
263650 POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE
263700 PORPHYRIA, CONGENITAL ERYTHROPOIETIC
263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS
263800 GITELMAN SYNDROME
264070 HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D; HPABH4D
264300 17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY
264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B
264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY
264600 PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH
264700 VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A; VDDR1A
264800 PSEUDOXANTHOMA ELASTICUM; PXE
265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS
265050 3MC SYNDROME 2; 3MC2
265100 PULMONARY ALVEOLAR MICROLITHIASIS
265120 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1
265380 ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS;
265450 PULMONARY VENOOCCLUSIVE DISEASE 1, AUTOSOMAL DOMINANT; PVOD1
265800 PYCNODYSOSTOSIS
266100 EPILEPSY, PYRIDOXINE-DEPENDENT; EPD
266120 URIDINE 5-PRIME MONOPHOSPHATE HYDROLASE DEFICIENCY, HEMOLYTIC ANEMIA
266130 GLUTATHIONE SYNTHETASE DEFICIENCY; GSSD
266140 PYROPOIKILOCYTOSIS, HEREDITARY; HPP
266150 PYRUVATE CARBOXYLASE DEFICIENCY
266200 PYRUVATE KINASE DEFICIENCY OF RED CELLS
266265 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C
266280 RAPADILINO SYNDROME
266300 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 2; SHEP2
266500 REFSUM DISEASE, CLASSIC
266510 PEROXISOME BIOGENESIS DISORDER 3B; PBD3B
266600 INFLAMMATORY BOWEL DISEASE 1; IBD1
266900 SENIOR-LOKEN SYNDROME 1; SLSN1
266920 SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9
267000 PERLMAN SYNDROME; PRLMNS
267010 MECKEL SYNDROME, TYPE 7; MKS7
267300 RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS
267430 RENAL TUBULAR DYSGENESIS; RTD
267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS
267500 RETICULAR DYSGENESIS
267750 KNOBLOCH SYNDROME 1; KNO1
268000 RETINITIS PIGMENTOSA; RP
268100 ENHANCED S-CONE SYNDROME; ESCS
268130 REVESZ SYNDROME
268150 RH-NULL, REGULATOR TYPE; RHN
268200 MYOGLOBINURIA, ACUTE RECURRENT, AUTOSOMAL RECESSIVE
268210 RHABDOMYOSARCOMA, EMBRYONAL, 1; RMSE1
268220 RHABDOMYOSARCOMA 2; RMS2
268300 ROBERTS SYNDROME; RBS
268305 ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES
268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS
268400 ROTHMUND-THOMSON SYNDROME; RTS
268800 SANDHOFF DISEASE
268900 SARCOSINEMIA; SARCOS
269000 SC PHOCOMELIA SYNDROME
269150 SCHINZEL-GIEDION MIDFACE RETRACTION SYNDROME
269160 SCHIZENCEPHALY
269250 SCHNECKENBECKEN DYSPLASIA
269500 SCLEROSTEOSIS 1; SOST1
269600 SEA-BLUE HISTIOCYTE DISEASE
269700 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2; CGL2
269840 SELECTIVE T-CELL DEFECT; STCD
269880 SHORT SYNDROME
269920 INFANTILE SIALIC ACID STORAGE DISEASE; ISSD
269921 SIALURIA
270100 HETEROTAXY, VISCERAL, 5, AUTOSOMAL; HTX5
270200 SJOGREN-LARSSON SYNDROME; SLS
270300 PEELING SKIN SYNDROME
270400 SMITH-LEMLI-OPITZ SYNDROME; SLOS
270420 DIARRHEA 3, SECRETORY SODIUM, CONGENITAL; DIAR3
270450 INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO
270550 SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE; SACS
270685 SPASTIC PARAPLEGIA 17, AUTOSOMAL DOMINANT; SPG17
270700 SPASTIC PARAPLEGIA 15, AUTOSOMAL RECESSIVE; SPG15
270800 SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A
270960 SPERMATOGENIC FAILURE 4; SPGF4
270970 SPHEROCYTOSIS, TYPE 3; SPH3
271150 SPINAL MUSCULAR ATROPHY, TYPE IV; SMA4
271245 MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE); MTDPS7
271400 ASPLENIA, ISOLATED CONGENITAL; ICAS
271640 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR
271665 SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE
271700 SPONDYLOPERIPHERAL DYSPLASIA
271900 CANAVAN DISEASE
271930 STRIATONIGRAL DEGENERATION, INFANTILE; SNDI
271980 SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; SSADHD
272120 SUDDEN INFANT DEATH SYNDROME
272200 MULTIPLE SULFATASE DEFICIENCY; MSD
272300 SULFOCYSTEINURIA
272430 COLD-INDUCED SWEATING SYNDROME 1; CISS1
272460 SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT
272750 GM2-GANGLIOSIDOSIS, AB VARIANT
272800 TAY-SACHS DISEASE; TSD
273300 TESTICULAR GERM CELL TUMOR; TGCT
273395 TETRAAMELIA, AUTOSOMAL RECESSIVE
273750 THREE M SYNDROME 1; 3M1
273800 GLANZMANN THROMBASTHENIA; GT
274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR
274150 THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL; TTP
274270 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY
274300 THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE; GRTH
274400 THYROID DYSHORMONOGENESIS 1; TDH1
274500 THYROID DYSHORMONOGENESIS 2A; TDH2A
274600 PENDRED SYNDROME; PDS
274700 THYROID DYSHORMONOGENESIS 3; TDH3
274800 THYROID DYSHORMONOGENESIS 4; TDH4
274900 THYROID DYSHORMONOGENESIS 5; TDH5
275100 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4; CHNG4
275200 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 1; CHNG1
275210 RESTRICTIVE DERMOPATHY, LETHAL
275350 TRANSCOBALAMIN II DEFICIENCY
275355 SQUAMOUS CELL CARCINOMA, HEAD AND NECK; HNSCC
275630 CHANARIN-DORFMAN SYNDROME; CDS
275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20
276300 MISMATCH REPAIR CANCER SYNDROME; MMRCS
276600 TYROSINEMIA, TYPE II; TYRSN2
276700 TYROSINEMIA, TYPE I; TYRSN1
276710 TYROSINEMIA, TYPE III; TYRSN3
276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY
276880 UROCANASE DEFICIENCY
276900 USHER SYNDROME, TYPE I; USH1
276901 USHER SYNDROME, TYPE IIA; USH2A
276902 USHER SYNDROME, TYPE IIIA; USH3A
276904 USHER SYNDROME, TYPE IC; USH1C
276950 VACTERL ASSOCIATION WITH HYDROCEPHALUS
277180 VAS DEFERENS, CONGENITAL BILATERAL APLASIA OF; CBAVD
277300 SPONDYLOCOSTAL DYSOSTOSIS 1, AUTOSOMAL RECESSIVE; SCDO1
277380 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblF TYPE
277400 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE
277410 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE
277440 VITAMIN D-DEPENDENT RICKETS, TYPE 2A; VDDR2A
277450 VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1
277460 VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF; VED
277470 PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A
277480 VON WILLEBRAND DISEASE, TYPE 3; VWD3
277580 WAARDENBURG SYNDROME, TYPE 4A; WS4A
277590 WEAVER SYNDROME; WVS
277600 WEILL-MARCHESANI SYNDROME 1; WMS1
277610 WEISSENBACHER-ZWEYMULLER SYNDROME; WZS
277700 WERNER SYNDROME; WRN
277900 WILSON DISEASE
277950 WINCHESTER SYNDROME; WNCHRS
278000 LYSOSOMAL ACID LIPASE DEFICIENCY
278150 HYPOTRICHOSIS 8; HYPT8
278250 WRINKLY SKIN SYNDROME; WSS
278300 XANTHINURIA, TYPE I
278700 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA
278720 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC
278730 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD
278740 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E
278750 XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV
278760 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF
278780 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG
278800 DE SANCTIS-CACCHIONE SYNDROME
278850 46,XX SEX REVERSAL 2; SRXX2
280000 COLOBOMA, CONGENITAL HEART DISEASE, ICHTHYOSIFORM DERMATOSIS, MENTAL
300000 OPITZ GBBB SYNDROME, X-LINKED
300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA
300009 DENT DISEASE 1
300018 46,XY SEX REVERSAL 2; SRXY2
300029 RETINITIS PIGMENTOSA 3; RP3
300048 INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED
300049 HETEROTOPIA, PERIVENTRICULAR, X-LINKED DOMINANT
300055 MENTAL RETARDATION, X-LINKED, SYNDROMIC 13; MRXS13
300066 DEAFNESS, X-LINKED 4; DFNX4
300067 LISSENCEPHALY, X-LINKED, 1; LISX1
300068 ANDROGEN INSENSITIVITY SYNDROME; AIS
300071 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A; CSNB2A
300087 X INACTIVATION, FAMILIAL SKEWED, 1; SXI1
300088 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9
300100 ADRENOLEUKODYSTROPHY; ALD
300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISM
300143 MENTAL RETARDATION, X-LINKED 21; MRX21
300166 MICROPHTHALMIA, SYNDROMIC 2; MCOPS2
300194 AMME COMPLEX
300200 ADRENAL HYPOPLASIA, CONGENITAL; AHC
300209 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2
300210 MENTAL RETARDATION, X-LINKED 58; MRX58
300215 LISSENCEPHALY, X-LINKED, 2; LISX2
300219 MYOTUBULAR MYOPATHY WITH ABNORMAL GENITAL DEVELOPMENT
300220 MENTAL RETARDATION, X-LINKED, SYNDROMIC 10; MRXS10
300243 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE; MRXSCH
300244 TERMINAL OSSEOUS DYSPLASIA; TOD
300257 DANON DISEASE
300260 LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL
300263 SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD
300271 MENTAL RETARDATION, X-LINKED 72; MRX72
300291 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH IMMUNE DEFICIENCY
300299 NEUTROPENIA, SEVERE CONGENITAL, X-LINKED; SCNX
300301 ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH IMMUNODEFICIENCY, OSTEOPETROSIS,
300321 FG SYNDROME 2; FGS2
300322 LESCH-NYHAN SYNDROME; LNS
300323 KELLEY-SEEGMILLER SYNDROME
300337 HYPOMELANOSIS OF ITO; HMI
300352 CEREBRAL CREATINE DEFICIENCY SYNDROME 1; CCDS1
300354 MENTAL RETARDATION, X-LINKED, WITH SHORT STATURE, HYPOGONADISM, AND
300367 THROMBOCYTOPENIA, X-LINKED, WITH OR WITHOUT DYSERYTHROPOIETIC ANEMIA;
300373 OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS; OSCS
300376 MUSCULAR DYSTROPHY, BECKER TYPE; BMD
300387 MENTAL RETARDATION, X-LINKED 63; MRX63
300400 SEVERE COMBINED IMMUNODEFICIENCY, X-LINKED; SCIDX1
300419 MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED;
300422 FG SYNDROME 4; FGS4
300423 MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH
300424 RETINITIS PIGMENTOSA 23; RP23
300425 AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1
300434 STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME
300436 MENTAL RETARDATION, X-LINKED 46; MRX46
300438 17-@BETA-HYDROXYSTEROID DEHYDROGENASE X DEFICIENCY
300448 ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS
300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITH
300472 CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,
300475 DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH
300476 CONE-ROD DYSTROPHY, X-LINKED, 3; CORDX3
300486 MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE
300489 SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3; SMAX3
300491 EPILEPSY, X-LINKED, WITH VARIABLE LEARNING DISABILITIES AND BEHAVIOR
300494 ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1
300495 AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2
300496 AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3
300497 ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2
300498 MENTAL RETARDATION, X-LINKED 45; MRX45
300500 ALBINISM, OCULAR, TYPE I; OA1
300510 OVARIAN DYSGENESIS 2; ODG2
300511 PREMATURE OVARIAN FAILURE 2A; POF2A
300514 FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB
300519 MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE; MRXSMP
300523 ALLAN-HERNDON-DUDLEY SYNDROME; AHDS
300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ
300537 HETEROTOPIA, PERIVENTRICULAR, EHLERS-DANLOS VARIANT
300539 NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD
300554 HYPOPHOSPHATEMIC RICKETS, X-LINKED RECESSIVE
300555 DENT DISEASE 2
300558 MENTAL RETARDATION, X-LINKED 30; MRX30
300559 GLYCOGEN STORAGE DISEASE, TYPE IXd; GSD9D
300577 MENTAL RETARDATION, X-LINKED 91; MRX91
300578 CHROMOSOME Xp11.3 DELETION SYNDROME
300582 SHORT STATURE, IDIOPATHIC, X-LINKED; ISS
300584 IMMUNODEFICIENCY WITHOUT ANHIDROTIC ECTODERMAL DYSPLASIA
300590 CORNELIA DE LANGE SYNDROME 2; CDLS2
300600 ALAND ISLAND EYE DISEASE; AIED
300604 PREMATURE OVARIAN FAILURE 2B; POF2B
300607 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 8; EIEE8
300615 BRUNNER SYNDROME
300622 TN POLYAGGLUTINATION SYNDROME; TNPS
300623 FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS
300624 FRAGILE X MENTAL RETARDATION SYNDROME
300633 HYPOSPADIAS 1, X-LINKED; HYSP1
300635 LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2
300636 ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 1; AMCBX1
300640 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 2; IPD2
300643 ROLANDIC EPILEPSY, MENTAL RETARDATION, AND SPEECH DYSPRAXIA, X-LINKED;
300645 ATYPICAL MYCOBACTERIOSIS, FAMILIAL, X-LINKED 2; AMCBX2
300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY
300659 MENTAL RETARDATION, X-LINKED 93; MRX93
300661 PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY
300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2
300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS
300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14
300679 CHROMOSOME Xp21 DELETION SYNDROME
300695 SCAPULOPERONEAL MYOPATHY, X-LINKED DOMINANT; SPM
300696 MYOPATHY, X-LINKED, WITH POSTURAL MUSCLE ATROPHY; XMPMA
300699 MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW
300705 MENTAL RETARDATION, X-LINKED 17; MRX17
300706 MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST
300707 TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS;
300717 MYOPATHY, REDUCING BODY, X-LINKED, EARLY-ONSET, SEVERE
300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET
300749 MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA;
300751 ANEMIA, SIDEROBLASTIC, X-LINKED; XLSA
300752 PROTOPORPHYRIA, ERYTHROPOIETIC, X-LINKED; XLEPP
300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA
300758 HYPOSPADIAS 2, X-LINKED; HYSP2
300770 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 4; SMDP4
300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR
300801 CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME
300802 MENTAL RETARDATION, X-LINKED 96; MRX96
300803 MENTAL RETARDATION, X-LINKED 97; MRX97
300804 JOUBERT SYNDROME 10; JBTS10
300807 THROMBOPHILIA, X-LINKED, DUE TO FACTOR IX DEFECT; THPH8
300814 NYSTAGMUS 6, CONGENITAL, X-LINKED; NYS6
300815 CHROMOSOME Xq28 DUPLICATION SYNDROME
300816 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6
300818 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 1; PNH1
300830 CHROMOSOME Xp22 DELETION SYNDROME
300831 CK SYNDROME
300833 46,XX SEX REVERSAL 3; SRXX3
300834 MACULAR DEGENERATION, X-LINKED ATROPHIC
300835 ANEMIA, X-LINKED, WITH OR WITHOUT NEUTROPENIA AND/OR PLATELET ABNORMALITIES;
300842 MCLEOD SYNDROME; MCLDS
300844 MENTAL RETARDATION, X-LINKED 19; MRX19
300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,
300847 AUTISM, SUSCEPTIBILITY TO, X-LINKED 5; AUTSX5
300849 MENTAL RETARDATION, X-LINKED 41; MRX41
300850 MENTAL RETARDATION, X-LINKED 90; MRX90
300853 IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUS
300854 RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1
300855 OGDEN SYNDROME; OGDNS
300857 AMYOTROPHIC LATERAL SCLEROSIS 15, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;
300860 MENTAL RETARDATION, X-LINKED, SYNDROMIC, NASCIMENTO TYPE; MRXSN
300863 CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY,
300867 KABUKI SYNDROME 2; KABUK2
300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2
300869 CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME
300872 EPSILON-TRIMETHYLLYSINE HYDROXYLASE DEFICIENCY; TMLHED
300882 CORNELIA DE LANGE SYNDROME 5; CDLS5
300884 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Is; CDG1S
300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32
300887 APLASIA CUTIS CONGENITA, RETICULOLINEAR, WITH MICROCEPHALY, FACIAL
300888 HYPOTHYROIDISM, CENTRAL, AND TESTICULAR ENLARGEMENT; CHTE
300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5
300895 OHDO SYNDROME, X-LINKED; OHDOX
300896 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M
300905 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6
300908 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, DUE TO G6PD DEFICIENCY
300909 ANGIOEDEMA INDUCED BY ACE INHIBITORS, SUSCEPTIBILITY TO; AEACEI
300910 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 18; BMND18
300911 PARKINSONISM WITH SPASTICITY, X-LINKED; XPDS
300912 MENTAL RETARDATION, X-LINKED 98; MRX98
300915 MICROPHTHALMIA, SYNDROMIC 13; MCOPS13
300918 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC
300919 MENTAL RETARDATION, X-LINKED 99; MRX99
301000 WISKOTT-ALDRICH SYNDROME; WAS
301040 ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX
301050 ALPORT SYNDROME, X-LINKED; ATS
301200 AMELOGENESIS IMPERFECTA, TYPE IE; AI1E
301310 ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA; ASAT
301500 FABRY DISEASE
301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2
301835 ARTS SYNDROME; ARTS
301900 BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS
302045 CARDIOMYOPATHY, DILATED, 3B; CMD3B
302060 BARTH SYNDROME; BTHS
302200 CATARACT 40; CTRCT40
302350 NANCE-HORAN SYNDROME; NHS
302500 SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1
302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1
302905 ABRUZZO-ERICKSON SYNDROME; ABERS
302950 CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE; CDPX1
302960 CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2
303100 CHOROIDEREMIA; CHM
303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION
303350 MASA SYNDROME
303400 CLEFT PALATE WITH OR WITHOUT ANKYLOGLOSSIA, X-LINKED; CPX
303600 COFFIN-LOWRY SYNDROME; CLS
303700 BLUE CONE MONOCHROMACY; BCM
303800 COLORBLINDNESS, PARTIAL, DEUTAN SERIES; CBD
303900 COLORBLINDNESS, PARTIAL, PROTAN SERIES; CBP
304020 CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1
304100 CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED
304110 CRANIOFRONTONASAL SYNDROME; CFNS
304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2
304150 OCCIPITAL HORN SYNDROME; OHS
304340 MENTAL RETARDATION, X-LINKED, SYNDROMIC 5; MRXS5
304400 DEAFNESS, X-LINKED 2; DFNX2
304500 DEAFNESS, X-LINKED 1; DFNX1
304700 MOHR-TRANEBJAERG SYNDROME; MTS
304790 IMMUNODYSREGULATION, POLYENDOCRINOPATHY, AND ENTEROPATHY, X-LINKED;
304800 DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED
305000 DYSKERATOSIS CONGENITA, X-LINKED; DKCX
305100 ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED
305390 EXUDATIVE VITREORETINOPATHY 2, X-LINKED; EVR2
305400 AARSKOG-SCOTT SYNDROME; AAS
305450 OPITZ-KAVEGGIA SYNDROME; OKS
305600 FOCAL DERMAL HYPOPLASIA; FDH
305620 FRONTOMETAPHYSEAL DYSPLASIA; FMD
306000 GLYCOGEN STORAGE DISEASE IXa1; GSD9A1
306400 GRANULOMATOUS DISEASE, CHRONIC, X-LINKED; CGD
306700 HEMOPHILIA A; HEMA
306900 HEMOPHILIA B; HEMB
306955 HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1
307000 HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS; HSAS
307030 GLYCEROL KINASE DEFICIENCY
307150 HYPERTRICHOSIS, CONGENITAL GENERALIZED; HTC2
307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3
307800 HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; XLHR
308050 CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB
308100 ICHTHYOSIS, X-LINKED; XLI
308205 IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME
308230 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1; HIGM1
308240 LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1
308300 INCONTINENTIA PIGMENTI; IP
308350 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1
308700 HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1
308800 KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX
308930 LEIGH SYNDROME, X-LINKED
308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS
308990 PROTEINURIA, LOW MOLECULAR WEIGHT, WITH HYPERCALCIURIA AND NEPHROCALCINOSIS
309000 LOWE OCULOCEREBRORENAL SYNDROME; OCRL
309300 MEGALOCORNEA; MGC1
309350 MELNICK-NEEDLES SYNDROME; MNS
309400 MENKES DISEASE
309500 RENPENNING SYNDROME 1; RENS1
309510 PARTINGTON X-LINKED MENTAL RETARDATION SYNDROME; PRTS
309520 LUJAN-FRYNS SYNDROME
309530 MENTAL RETARDATION, X-LINKED 1; MRX1
309541 METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, cblX TYPE
309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE
309549 MENTAL RETARDATION, X-LINKED 9; MRX9
309580 MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1
309583 MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE; MRXSSR
309585 WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS
309630 METACARPAL 4-5 FUSION; MF4
309800 MICROPHTHALMIA, SYNDROMIC 1; MCOPS1
309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7
309900 MUCOPOLYSACCHARIDOSIS, TYPE II; MPS2
310200 MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD
310300 EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1
310400 MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX
310468 NEPHROLITHIASIS, X-LINKED RECESSIVE, WITH RENAL FAILURE; XRN
310490 COWCHOCK SYNDROME; COWCK
310500 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1A; CSNB1A
310600 NORRIE DISEASE; ND
310700 NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1
311070 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5; CMTX5
311150 OPTICOACOUSTIC NERVE ATROPHY WITH DEMENTIA
311200 OROFACIODIGITAL SYNDROME I; OFD1
311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO
311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1
311360 PREMATURE OVARIAN FAILURE 1; POF1
311900 TARP SYNDROME; TARPS
312000 PANHYPOPITUITARISM, X-LINKED; PHPX
312060 PROPERDIN DEFICIENCY, X-LINKED; CFPD
312080 PELIZAEUS-MERZBACHER DISEASE; PMD
312170 PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD
312300 ANDROGEN INSENSITIVITY, PARTIAL; PAIS
312600 RETINITIS PIGMENTOSA 2; RP2
312700 RETINOSCHISIS 1, X-LINKED, JUVENILE; RS1
312750 RETT SYNDROME; RTT
312863 COMBINED IMMUNODEFICIENCY, X-LINKED; CIDX
312870 SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1; SGBS1
312920 SPASTIC PARAPLEGIA 2, X-LINKED; SPG2
313200 SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1; SMAX1
313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT
313500 TOOTH AGENESIS, SELECTIVE, X-LINKED, 1; STHAGX1
313900 THROMBOCYTOPENIA 1; THC1
314050 THROMBOCYTOPENIA WITH BETA-THALASSEMIA, X-LINKED; XLTT
314250 DYSTONIA 3, TORSION, X-LINKED; DYT3
314390 VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX
314400 CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1
314580 WIEACKER-WOLFF SYNDROME; WRWF
400042 SPERMATOGENIC FAILURE, Y-LINKED, 1; SPGFY1
400044 46,XY SEX REVERSAL 1; SRXY1
400045 46,XX SEX REVERSAL 1; SRXX1
415000 SPERMATOGENIC FAILURE, Y-LINKED, 2; SPGFY2
500000 CARDIOMYOPATHY, INFANTILE HISTIOCYTOID
500001 LEBER OPTIC ATROPHY AND DYSTONIA
500002 MITOCHONDRIAL MYOPATHY WITH DIABETES
500003 STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL
500004 RETINITIS PIGMENTOSA-DEAFNESS SYNDROME
500005 HYPOMAGNESEMIA, HYPERTENSION, AND HYPERCHOLESTEROLEMIA, MITOCHONDRIAL
500007 CYCLIC VOMITING SYNDROME; CVS
500008 DEAFNESS, NONSYNDROMIC SENSORINEURAL, MITOCHONDRIAL
500009 MITOCHONDRIAL MYOPATHY, INFANTILE, TRANSIENT; MMIT
502000 AGING
502500 ALZHEIMER DISEASE, SUSCEPTIBILITY TO, MITOCHONDRIAL
515000 CHLORAMPHENICOL TOXICITY
520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD
520100 DIARRHEA, CHRONIC, WITH VILLOUS ATROPHY
530000 KEARNS-SAYRE SYNDROME; KSS
535000 LEBER OPTIC ATROPHY
540000 MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE
545000 MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS; MERRF
550500 MYOGLOBINURIA, RECURRENT
551000 MITOCHONDRIAL MYOPATHY, LETHAL, INFANTILE; LIMM
551200 NEPHROPATHY, CHRONIC TUBULOINTERSTITIAL
551500 NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA
553000 ONCOCYTOMA
556500 PARKINSON DISEASE, MITOCHONDRIAL
557000 PEARSON MARROW-PANCREAS SYNDROME
560000 RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA
580000 DEAFNESS, AMINOGLYCOSIDE-INDUCED
598500 WOLFRAM SYNDROME, MITOCHONDRIAL FORM
600001 PANCREATIC AGENESIS AND CONGENITAL HEART DEFECTS; PACHD
600002 EIKEN SKELETAL DYSPLASIA
600059 RETINITIS PIGMENTOSA 13; RP13
600060 DEAFNESS, AUTOSOMAL RECESSIVE 2; DFNB2
600072 FATAL FAMILIAL INSOMNIA; FFI
600081 VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B; VDDR1B
600101 DEAFNESS, AUTOSOMAL DOMINANT 2A; DFNA2A
600105 RETINITIS PIGMENTOSA 12; RP12
600110 STARGARDT DISEASE 3; STGD3
600116 PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE; PARK2
600118 WARBURG MICRO SYNDROME 1; WARBM1
600121 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 3; RCDP3
600132 RETINITIS PIGMENTOSA 14; RP14
600138 RETINITIS PIGMENTOSA 11; RP11
600142 CEREBRAL AUTOSOMAL RECESSIVE ARTERIOPATHY WITH SUBCORTICAL INFARCTS
600143 CEROID LIPOFUSCINOSIS, NEURONAL, 8; CLN8
600145 SACRAL DEFECT WITH ANTERIOR MENINGOCELE
600155 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 2; HSCR2
600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE
600195 VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL; VMCM
600204 EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2
600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS
600224 SPINOCEREBELLAR ATAXIA 5; SCA5
600231 PALMOPLANTAR KERATODERMA, BOTHNIAN TYPE; PPKB
600251 FACIAL CLEFTING, OBLIQUE, 1; OBLFC1
600257 CHROMOSOME 8q12.1-q21.2 DELETION SYNDROME
600263 HELICOBACTER PYLORI INFECTION, SUSCEPTIBILITY TO
600273 POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS;
600274 FRONTOTEMPORAL DEMENTIA; FTD
600309 ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3
600316 DEAFNESS, AUTOSOMAL RECESSIVE 3; DFNB3
600320 DIABETES MELLITUS, INSULIN-DEPENDENT, 5; IDDM5
600334 TIBIAL MUSCULAR DYSTROPHY, TARDIVE
600363 SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT; SPG6
600376 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2
600383 MESOMELIA-SYNOSTOSES SYNDROME
600430 BRACHYDACTYLY-MENTAL RETARDATION SYNDROME; BDMR
600462 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1
600496 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 3; MODY3
600501 ABCD SYNDROME; ABCDS
600512 EPILEPSY, FAMILIAL TEMPORAL LOBE, 1; ETL1
600513 EPILEPSY, NOCTURNAL FRONTAL LOBE, 1; ENFL1
600625 OROFACIAL CLEFT 11; OFC11
600630 UV-SENSITIVE SYNDROME 1; UVSS1
600634 PITUITARY ADENOMA, PROLACTIN-SECRETING
600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULAR
600649 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE
600651 FRAGILE SITE 11B; FRA11B
600652 DEAFNESS, AUTOSOMAL DOMINANT 4A; DFNA4A
600721 D-2-@HYDROXYGLUTARIC ACIDURIA 1
600737 INCLUSION BODY MYOPATHY 2, AUTOSOMAL RECESSIVE; IBM2
600740 HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III; HHC3
600775 CRANIOSYNOSTOSIS 4; CRS4
600791 DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT;
600794 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VA; HMN5A
600795 FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3
600802 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,
600803 GALLBLADDER DISEASE 1; GBD1
600807 ASTHMA, SUSCEPTIBILITY TO
600850 SCHIZOPHRENIA 4; SCZD4
600852 RETINITIS PIGMENTOSA 17; RP17
600858 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 6; CMH6
600880 BUDD-CHIARI SYNDROME; BDCHS
600881 CATARACT 10, MULTIPLE TYPES; CTRCT10
600882 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B
600886 HYPERFERRITINEMIA WITH OR WITHOUT CATARACT
600901 FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE
600919 CARDIAC ARRHYTHMIA, ANKYRIN-B-RELATED
600920 VAN DEN ENDE-GUPTA SYNDROME; VDEGS
600955 PROPROTEIN CONVERTASE 1/3 DEFICIENCY
600962 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC; NEPPK
600965 DEAFNESS, AUTOSOMAL DOMINANT 6; DFNA6
600969 EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3
600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6
600972 ACHONDROGENESIS, TYPE IB; ACG1B
600974 DEAFNESS, AUTOSOMAL RECESSIVE 7; DFNB7
600977 CONE-ROD DYSTROPHY 5; CORD5
600994 DEAFNESS, AUTOSOMAL DOMINANT 5; DFNA5
600995 NEPHROTIC SYNDROME, TYPE 2; NPHS2
600996 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2; ARVD2
601001 EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 1; EBSB1
601003 BRODY MYOPATHY
601005 TIMOTHY SYNDROME; TS
601042 DYSTONIA 9; DYT9
601067 USHER SYNDROME, TYPE ID; USH1D
601071 DEAFNESS, AUTOSOMAL RECESSIVE 9; DFNB9
601072 DEAFNESS, AUTOSOMAL RECESSIVE 8; DFNB8
601098 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1C; CMT1C
601104 SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1
601110 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D
601144 BRUGADA SYNDROME 1; BRGDA1
601152 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VI; HSMN6
601154 CARDIOMYOPATHY, DILATED, 1E; CMD1E
601186 MICROPHTHALMIA, SYNDROMIC 9; MCOPS9
601198 HYPOCALCEMIA, AUTOSOMAL DOMINANT 1; HYPOC1
601200 PLEUROPULMONARY BLASTOMA; PPB
601214 NAXOS DISEASE
601224 POTOCKI-SHAFFER SYNDROME
601228 POLYPOSIS SYNDROME, HEREDITARY MIXED, 1; HMPS1
601238 CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY
601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A
601283 DIABETES MELLITUS, NONINSULIN-DEPENDENT, 1; NIDDM1
601287 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F; LGMD2F
601316 DEAFNESS, AUTOSOMAL DOMINANT 10; DFNA10
601317 DEAFNESS, AUTOSOMAL DOMINANT 11; DFNA11
601321 NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS
601331 RENAL DYSPLASIA, CYSTIC, SUSCEPTIBILITY TO; CYSRD
601358 NICOLAIDES-BARAITSER SYNDROME; NCBRS
601367 STROKE, ISCHEMIC
601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9
601382 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1
601386 DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12
601388 DIABETES MELLITUS, INSULIN-DEPENDENT, 12; IDDM12
601390 VAN MALDERGEM SYNDROME 1; VMLDS1
601399 PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY; FPDMM
601410 DIABETES MELLITUS, TRANSIENT NEONATAL, 1
601414 RETINITIS PIGMENTOSA 18; RP18
601419 MYOPATHY, MYOFIBRILLAR, 1; MFM1
601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D
601457 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,
601462 MYASTHENIC SYNDROME, CONGENITAL, SLOW-CHANNEL; SCCMS
601472 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2D; CMT2D
601492 MUCOPOLYSACCHARIDOSIS, TYPE IX; MPS9
601493 CARDIOMYOPATHY, DILATED, 1C; CMD1C
601494 CARDIOMYOPATHY, DILATED, 1D; CMD1D
601495 AGAMMAGLOBULINEMIA 1, AUTOSOMAL RECESSIVE; AGM1
601518 PROSTATE CANCER, HEREDITARY, 1; HPC1
601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS
601539 PEROXISOME BIOGENESIS DISORDER 1B; PBD1B
601543 DEAFNESS, AUTOSOMAL DOMINANT 12; DFNA12
601544 DEAFNESS, AUTOSOMAL DOMINANT 3A; DFNA3A
601547 CATARACT 3, MULTIPLE TYPES; CTRCT3
601550 BLOOD GROUP--SWANN SYSTEM; SW
601551 BLOOD GROUP--FROESE
601552 FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES,
601553 HYPOTRICHOSIS, CONGENITAL, WITH JUVENILE MACULAR DYSTROPHY; HJMD
601559 STUVE-WIEDEMANN SYNDROME
601583 WILMS TUMOR 5; WT5
601596 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C
601606 TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1
601626 LEUKEMIA, ACUTE MYELOID; AML
601631 IRIDOGONIODYSGENESIS, TYPE 1; IRID1
601634 NEURAL TUBE DEFECTS, FOLATE-SENSITIVE
601650 PARAGANGLIOMAS 2; PGL2
601665 OBESITY
601675 TRICHOTHIODYSTROPHY, PHOTOSENSITIVE; TTDP
601678 BARTTER SYNDROME, ANTENATAL, TYPE 1
601680 ARTHROGRYPOSIS, DISTAL, TYPE 2B; DA2B
601705 T-CELL IMMUNODEFICIENCY, CONGENITAL ALOPECIA, AND NAIL DYSTROPHY
601709 QUEBEC PLATELET DISORDER; QPD
601718 RETINITIS PIGMENTOSA 19; RP19
601744 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 1; SLEB1
601776 EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 1; EDSMC1
601777 CONE-ROD DYSTROPHY 6; CORD6
601780 CEROID LIPOFUSCINOSIS, NEURONAL, 6; CLN6
601800 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 3; SHEP3
601803 PALLISTER-KILLIAN SYNDROME; PKS
601808 CHROMOSOME 18q DELETION SYNDROME
601813 EXUDATIVE VITREORETINOPATHY 4; EVR4
601815 PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY
601816 BILIRUBIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; BILIQTL1
601820 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 2; HHF2
601847 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 2; PFIC2
601859 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; ALPS
601868 DEAFNESS, AUTOSOMAL DOMINANT 13; DFNA13
601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15
601884 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1; BMND1
601885 CATARACT 14, MULTIPLE TYPES; CTRCT14
601887 MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 5
601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2
601942 DIABETES MELLITUS, INSULIN-DEPENDENT, 10; IDDM10
601952 KERATOSIS LINEARIS WITH ICHTHYOSIS CONGENITA AND SCLEROSING KERATODERMA
601954 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G; LGMD2G
601977 THROMBOCYTHEMIA 2; THCYT2
602014 HYPOMAGNESEMIA 1, INTESTINAL; HOMG1
602025 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 9; BMIQ9
602032 ECTODERMAL DYSPLASIA 4, HAIR/NAIL TYPE; ECTD4
602066 CONVULSIONS, FAMILIAL INFANTILE, WITH PAROXYSMAL CHOREOATHETOSIS;
602078 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2
602079 TRIMETHYLAMINURIA; TMAU
602080 PAGET DISEASE OF BONE; PDB
602081 SPEECH-LANGUAGE DISORDER 1; SPCH1
602083 USHER SYNDROME, TYPE IF; USH1F
602088 NEPHRONOPHTHISIS 2; NPHP2
602089 HEMANGIOMA, CAPILLARY INFANTILE
602092 DEAFNESS, AUTOSOMAL RECESSIVE 18A; DFNB18A
602093 CONE DYSTROPHY 3; COD3
602111 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MISSOURI TYPE
602347 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 3; PFIC3
602361 GRACILE BONE DYSPLASIA; GCLEB
602390 HEMOCHROMATOSIS, TYPE 2A; HFE2A
602398 DESMOSTEROLOSIS
602400 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11
602433 AMYOTROPHIC LATERAL SCLEROSIS 4, JUVENILE; ALS4
602450 SEVERE COMBINED IMMUNODEFICIENCY WITH SENSITIVITY TO IONIZING RADIATION
602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15
602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, AND
602473 ENCEPHALOPATHY, ETHYLMALONIC; EE
602481 MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2
602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3
602483 AURICULOCONDYLAR SYNDROME 1; ARCND1
602485 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3
602491 HYPERLIPIDEMIA, COMBINED, 1
602501 MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME; MCAP
602522 BARTTER SYNDROME, TYPE 4A
602535 MARSHALL-SMITH SYNDROME; MRSHSS
602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS
602541 MUSCULAR DYSTROPHY, CONGENITAL, MEGACONIAL TYPE; MDCMC
602579 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B
602588 BRANCHIOOTIC SYNDROME 1; BOS1
602629 DYSTONIA 6, TORSION; DYT6
602668 MYOTONIC DYSTROPHY 2; DM2
602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR
602723 PSORIASIS SUSCEPTIBILITY 2; PSORS2
602771 RIGID SPINE MUSCULAR DYSTROPHY 1; RSMD1
602772 RETINITIS PIGMENTOSA 25; RP25
602782 HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME
602849 MUENKE SYNDROME; MNKES
602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDM
603034 ENDPLATE ACETYLCHOLINESTERASE DEFICIENCY; EAD
603041 MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1
603075 MACULAR DEGENERATION, AGE-RELATED, 1; ARMD1
603147 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C
603194 MECKEL SYNDROME, TYPE 2; MKS2
603218 HUNTINGTON DISEASE-LIKE 1; HDL1
603233 PSEUDOHYPOPARATHYROIDISM, TYPE IB; PHP1B
603278 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1; FSGS1
603284 CEREBRAL CAVERNOUS MALFORMATIONS 2; CCM2
603285 CEREBRAL CAVERNOUS MALFORMATIONS 3; CCM3
603358 GRACILE SYNDROME
603373 HYPERTHYROIDISM, FAMILIAL GESTATIONAL
603383 GLAUCOMA 1, OPEN ANGLE, F; GLC1F
603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;
603467 FANCONI ANEMIA, COMPLEMENTATION GROUP F; FANCF
603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2
603511 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E; LGMD1E
603513 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 1; CPSQ1
603516 SPINOCEREBELLAR ATAXIA 10; SCA10
603543 LIMB-MAMMARY SYNDROME; LMS
603546 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY TYPE 2; SEMDJL2
603552 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4; FHL4
603553 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2; FHL2
603554 OMENN SYNDROME
603563 SPASTIC PARAPLEGIA 8, AUTOSOMAL DOMINANT; SPG8
603585 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F
603596 POLYDACTYLY
603622 DEAFNESS, AUTOSOMAL DOMINANT 17; DFNA17
603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21
603649 CONE-ROD DYSTROPHY 7; CORD7
603688 PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY
603689 HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE; HMERF
603720 DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16
603736 OHDO SYNDROME, SBBYS VARIANT; SBBYSS
603776 HYPERCHOLESTEROLEMIA, AUTOSOMAL DOMINANT, 3; HCHOLA3
603786 STARGARDT DISEASE 4; STGD4
603813 HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH
603829 VENTRICULAR FIBRILLATION DURING MYOCARDIAL INFARCTION, SUSCEPTIBILITY
603830 LONG QT SYNDROME 3; LQT3
603860 MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2
603896 LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM
603902 BETA-THALASSEMIA, DOMINANT INCLUSION BODY TYPE
603903 SICKLE CELL ANEMIA
603909 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IIA; ALPS2A
603932 INTERVERTEBRAL DISC DISEASE; IDD
603933 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 1; MVCD1
603956 CERVICAL CANCER
603965 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2
604004 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 1; MLC1
604091 HYPOALPHALIPOPROTEINEMIA, PRIMARY
604116 CONE-ROD DYSTROPHY 3; CORD3
604117 VOHWINKEL SYNDROME, VARIANT FORM
604121 CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN
604129 EPIDERMOLYSIS BULLOSA PRURIGINOSA
604131 ALPHA-THALASSEMIA
604145 CARDIOMYOPATHY, DILATED, 1G; CMD1G
604168 CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY
604169 LEFT VENTRICULAR NONCOMPACTION 1; LVNC1
604173 POIKILODERMA WITH NEUTROPENIA; PN
604187 SPASTIC PARAPLEGIA 10, AUTOSOMAL DOMINANT; SPG10
604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS
604218 ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB
604219 CATARACT 9, MULTIPLE TYPES; CTRCT9
604229 PETERS ANOMALY
604232 LEBER CONGENITAL AMAUROSIS 3; LCA3
604233 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 1; GEFSP1
604250 HEMOCHROMATOSIS, TYPE 3; HFE3
604271 SHORT STATURE, IDIOPATHIC, AUTOSOMAL
604273 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1;
604278 RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTAL
604286 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2E; LGMD2E
604290 ACERULOPLASMINEMIA
604292 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME
604302 RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE
604307 CATARACT 2, MULTIPLE TYPES; CTRCT2
604308 MASS SYNDROME
604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICAL
604320 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1
604321 MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4
604326 SPINOCEREBELLAR ATAXIA 12; SCA12
604348 ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1
604352 FEBRILE SEIZURES, FAMILIAL, 4; FEB4
604356 DUANE RETRACTION SYNDROME 2; DURS2
604360 SPASTIC PARAPLEGIA 11, AUTOSOMAL RECESSIVE; SPG11
604364 EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI; FFEVF
604367 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 3; FPLD3
604369 SALLA DISEASE; SD
604370 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1
604377 CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE
604379 HYPOTRICHOSIS 7; HYPT7
604387 NEPHRONOPHTHISIS 3; NPHP3
604391 ATAXIA-TELANGIECTASIA-LIKE DISORDER; ATLD
604393 LEBER CONGENITAL AMAUROSIS 4; LCA4
604400 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 5; ARVD5
604403 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 2; GEFSP2
604416 PYOGENIC STERILE ARTHRITIS, PYODERMA GANGRENOSUM, AND ACNE
604432 SPINOCEREBELLAR ATAXIA 11; SCA11
604454 WELANDER DISTAL MYOPATHY; WDM
604484 HEREDITARY MOTOR AND SENSORY NEUROPATHY, PROXIMAL TYPE; HMSNP
604498 AMEGAKARYOCYTIC THROMBOCYTOPENIA, CONGENITAL; CAMT
604536 ECTODERMAL DYSPLASIA/SKIN FRAGILITY SYNDROME
604537 LEBER CONGENITAL AMAUROSIS 5; LCA5
604559 PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IB; PFHB1B
604563 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2
604571 BARE LYMPHOCYTE SYNDROME, TYPE I
604625 TOOTH AGENESIS, SELECTIVE, 3; STHAG3
604715 ORTHOSTATIC INTOLERANCE
604717 DEAFNESS, AUTOSOMAL DOMINANT 20; DFNA20
604757 CRANIOSYNOSTOSIS 2; CRS2
604765 CARDIOMYOPATHY, DILATED, 1I; CMD1I
604772 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR
604777 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 5; ARCI5
604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3
604805 SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT; SPG12
604841 STICKLER SYNDROME, TYPE II; STL2
604864 OSTEOARTHRITIS WITH MILD CHONDRODYSPLASIA
604901 NORTH AMERICAN INDIAN CHILDHOOD CIRRHOSIS; NAIC
604906 SCHIZOPHRENIA 9; SCZD9
604928 WOLFRAM SYNDROME 2; WFS2
604931 CORTISONE REDUCTASE DEFICIENCY 1; CORTRD1
604966 PROTOCADHERIN-ALPHA GENE CLUSTER; PCDHA@
604967 PROTOCADHERIN-BETA GENE CLUSTER; PCDHB@
604968 PROTOCADHERIN-GAMMA GENE CLUSTER; PCDHG@
605013 MICROHYDRANENCEPHALY; MHAC
605019 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 2; FHBL2
605021 MYOCLONIC EPILEPSY, FAMILIAL INFANTILE; FIME
605027 LYMPHOMA, NON-HODGKIN, FAMILIAL
605039 BOHRING-OPITZ SYNDROME; BOPS
605041 BROOKE-SPIEGLER SYNDROME; BRSS
605074 RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1
605115 HYPERTENSION, EARLY-ONSET, AUTOSOMAL DOMINANT, WITH SEVERE EXACERBATION
605130 HAIRY ELBOWS, SHORT STATURE, FACIAL DYSMORPHISM, AND DEVELOPMENTAL
605192 DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23
605218 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 2; SLEB2
605249 SEBASTIAN SYNDROME; SBS
605253 NEUROPATHY, CONGENITAL HYPOMYELINATING OR AMYELINATING, AUTOSOMAL
605258 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 2; HIGM2
605259 SPINOCEREBELLAR ATAXIA 13; SCA13
605280 SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT; SPG13
605282 TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME; TPBS
605285 NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR
605289 SPLIT-HAND/FOOT MALFORMATION 4; SHFM4
605309 MACROCEPHALY/AUTISM SYNDROME
605355 NEMALINE MYOPATHY 5; NEM5
605361 SPINOCEREBELLAR ATAXIA 14; SCA14
605362 CARDIOMYOPATHY, DILATED, 1J; CMD1J
605373 PARAGANGLIOMAS 3; PGL3
605375 EPILEPSY, NOCTURNAL FRONTAL LOBE, 3; ENFL3
605376 HETEROTAXY, VISCERAL, 2, AUTOSOMAL; HTX2
605387 CATARACT 31, MULTIPLE TYPES; CTRCT31
605389 HYPOTRICHOSIS 1; HYPT1
605407 SEGAWA SYNDROME, AUTOSOMAL RECESSIVE
605432 RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA; RUSAT
605472 USHER SYNDROME, TYPE IIC; USH2C
605479 CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC, 2; BRIC2
605543 PARKINSON DISEASE 4, AUTOSOMAL DOMINANT; PARK4
605583 DEAFNESS, AUTOSOMAL DOMINANT 25; DFNA25
605588 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1
605589 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B2; CMT2B2
605594 DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1
605637 INCLUSION BODY MYOPATHY 3, AUTOSOMAL DOMINANT; IBM3
605670 LATE-ONSET RETINAL DEGENERATION; LORD
605676 CARDIOMYOPATHY, DILATED, WITH WOOLLY HAIR AND KERATODERMA; DCWHK
605711 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1
605714 CEREBRAL AMYLOID ANGIOPATHY, APP-RELATED
605724 FANCONI ANEMIA, COMPLEMENTATION GROUP D1; FANCD1
605751 SEIZURES, BENIGN FAMILIAL INFANTILE, 2; BFIS2
605803 DERMATITIS, ATOPIC, 2; ATOD2
605814 CITRULLINEMIA, TYPE II, NEONATAL-ONSET
605820 NONAKA MYOPATHY; NM
605850 DIMETHYLGLYCINE DEHYDROGENASE DEFICIENCY; DMGDHD
605899 GLYCINE ENCEPHALOPATHY; GCE
605909 PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK6
605911 3-@HYDROXY-3-METHYLGLUTARYL-CoA SYNTHASE 2 DEFICIENCY
605990 NEPHROLITHIASIS, URIC ACID, SUSCEPTIBILITY TO
606002 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1
606003 TRANSALDOLASE DEFICIENCY
606054 PROPIONIC ACIDEMIA
606056 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb; CDG2B
606068 RETINITIS PIGMENTOSA 28; RP28
606069 HEMOCHROMATOSIS, TYPE 4; HFE4
606070 AMYOTROPHIC LATERAL SCLEROSIS 21; ALS21
606071 HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C
606072 RIPPLING MUSCLE DISEASE; RMD
606159 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3
606170 GENITOPATELLAR SYNDROME; GTPTS
606176 DIABETES MELLITUS, PERMANENT NEONATAL; PNDM
606217 ATRIOVENTRICULAR SEPTAL DEFECT, SUSCEPTIBILITY TO, 2; AVSD2
606232 PHELAN-MCDERMID SYNDROME
606243 ALVEOLAR SOFT PART SARCOMA; ASPS
606324 PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET; PARK7
606346 DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22
606353 PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ
606367 INTERLEUKIN 2 RECEPTOR, ALPHA, DEFICIENCY OF
606391 MATURITY-ONSET DIABETES OF THE YOUNG; MODY
606392 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 4; MODY4
606394 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 6; MODY6
606407 HYPOTONIA-CYSTINURIA SYNDROME
606408 EHLERS-DANLOS-LIKE SYNDROME DUE TO TENASCIN-X DEFICIENCY
606438 HUNTINGTON DISEASE-LIKE 2; HDL2
606445 PERSISTENT POLYCLONAL B-CELL LYMPHOCYTOSIS; PPBL
606482 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE B; CMTDIB
606528 HOMOZYGOUS 11p15-p14 DELETION SYNDROME
606545 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 3; ARCI3
606574 ALBINISM, OCULOCUTANEOUS, TYPE IV; OCA4
606579 VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1;
606581 POLYSUBSTANCE ABUSE, SUSCEPTIBILITY TO; PSAB
606593 LIG4 SYNDROME
606595 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F
606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUT
606657 GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO
606658 SPINOCEREBELLAR ATAXIA 15; SCA15
606664 GLYCINE N-METHYLTRANSFERASE DEFICIENCY
606685 CARDIOMYOPATHY, DILATED, 1L; CMD1L
606688 SPONGIFORM ENCEPHALOPATHY WITH NEUROPSYCHIATRIC FEATURES
606690 LYMPHANGIOLEIOMYOMATOSIS; LAM
606693 KUFOR-RAKEB SYNDROME; KRS
606703 DYSKINESIA, FAMILIAL, WITH FACIAL MYOKYMIA; FDFM
606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36
606713 VAN DER WOUDE SYNDROME 2; VWS2
606719 MELANOMA-PANCREATIC CANCER SYNDROME
606721 PARTIAL LIPODYSTROPHY, CONGENITAL CATARACTS, AND NEURODEGENERATION
606744 SECKEL SYNDROME 2; SCKL2
606762 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6
606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2
606764 GASTROINTESTINAL STROMAL TUMOR; GIST
606766 SPERMATOGENIC FAILURE 3; SPGF3
606768 MYOPATHY, DISTAL, WITH ANTERIOR TIBIAL ONSET; DMAT
606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1
606785 CRIGLER-NAJJAR SYNDROME, TYPE II
606798 BLEPHAROSPASM, BENIGN ESSENTIAL
606812 FUMARASE DEFICIENCY
606824 GLUCOSE/GALACTOSE MALABSORPTION; GGM
606835 DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
606843 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 3; HIGM3
606854 POLYMICROGYRIA, BILATERAL FRONTOPARIETAL; BFPP
606856 PANCREATIC CANCER, SUSCEPTIBILITY TO, 1
606864 PARAGANGLIOMA AND GASTRIC STROMAL SARCOMA
606889 ALZHEIMER DISEASE 4
606937 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 5; SCAR5
606943 USHER SYNDROME, TYPE IG; USH1G
606952 ALBINISM, OCULOCUTANEOUS, TYPE IB; OCA1B
606966 NEPHRONOPHTHISIS 4; NPHP4
606996 SENIOR-LOKEN SYNDROME 4; SLSN4
607014 HURLER SYNDROME
607015 HURLER-SCHEIE SYNDROME
607016 SCHEIE SYNDROME
607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22
607060 PARKINSON DISEASE 8, AUTOSOMAL DOMINANT; PARK8
607078 EPIPHYSEAL DYSPLASIA, MULTIPLE, 5; EDM5
607080 46,XY GONADAL DYSGENESIS, PARTIAL, WITH MINIFASCICULAR NEUROPATHY
607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31
607091 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IId; CDG2D
607095 ANAUXETIC DYSPLASIA
607101 DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30
607115 CINCA SYNDROME; CINCA
607136 SPINOCEREBELLAR ATAXIA 17; SCA17
607140 ANGIOID STREAKS
607143 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G
607151 MOYAMOYA DISEASE 2; MYMY2
607154 ALLERGIC RHINITIS
607155 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5
607174 MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO
607196 MICROCEPHALY, AMISH TYPE; MCPHA
607200 THYROID DYSHORMONOGENESIS 6; TDH6
607208 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6
607225 SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP
607236 HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,
607250 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY;
607259 SPASTIC PARAPLEGIA 7, AUTOSOMAL RECESSIVE; SPG7
607271 CASPASE 8 DEFICIENCY
607276 RESTING HEART RATE, VARIATION IN
607277 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 1
607313 GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS; HGPPS
607323 DUANE-RADIAL RAY SYNDROME; DRRS
607326 SMITH-MCCORT DYSPLASIA 1; SMC1
607330 LATHOSTEROLOSIS
607341 FOCAL CORTICAL DYSPLASIA OF TAYLOR; FCDT
607346 SPINOCEREBELLAR ATAXIA 19; SCA19
607361 MECKEL SYNDROME, TYPE 3; MKS3
607364 BARTTER SYNDROME, TYPE 3
607371 DYSTONIA, JUVENILE-ONSET
607398 GLUCOCORTICOID DEFICIENCY 2; GCCD2
607417 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2
607426 COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1
607432 LISSENCEPHALY 1; LIS1
607447 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 4; BMIQ4
607450 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 8; ARVD8
607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44
607457 GIL BLOOD GROUP
607459 SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO
607464 THYROID CARCINOMA, HURTHLE CELL
607473 VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 2; VKCFD2
607475 BOTHNIA RETINAL DYSTROPHY
607476 NEWFOUNDLAND ROD-CONE DYSTROPHY; NFRCD
607482 CARDIOMYOPATHY, DILATED, 1M; CMD1M
607483 THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE
607485 FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED
607486 KNOPS BLOOD GROUP SYSTEM; KN
607487 CARDIOMYOPATHY, DILATED, 1N; CMD1N
607507 PSORIATIC ARTHRITIS, SUSCEPTIBILITY TO
607514 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 10; BMIQ10
607523 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 8; NDNC8
607541 CORNEAL DYSTROPHY, AVELLINO TYPE; CDA
607554 ATRIAL FIBRILLATION, FAMILIAL, 3; ATFB3
607594 IMMUNODEFICIENCY, COMMON VARIABLE, 1; CVID1
607595 BRAIN SMALL VESSEL DISEASE WITH HEMORRHAGE
607596 PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A
607598 LETHAL CONGENITAL CONTRACTURE SYNDROME 2; LCCS2
607602 ICHTHYOSIS, CYCLIC, WITH EPIDERMOLYTIC HYPERKERATOSIS
607616 NIEMANN-PICK DISEASE, TYPE B
607624 GRISCELLI SYNDROME, TYPE 2; GS2
607625 NIEMANN-PICK DISEASE, TYPE C2; NPC2
607626 ICHTHYOSIS, LEUKOCYTE VACUOLES, ALOPECIA, AND SCLEROSING CHOLANGITIS
607628 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 11; EIG11
607631 EPILEPSY, JUVENILE ABSENCE, SUSCEPTIBILITY TO, 1; EJA1
607634 OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1
607636 VAN BUCHEM DISEASE, TYPE 2
607641 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VIIB; HMN7B
607654 KERATOSIS PALMOPLANTARIS STRIATA III; PPKS3
607655 SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS
607676 IRAK4 DEFICIENCY
607677 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I; CMT2I
607678 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D
607681 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 2; ECA2
607682 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 9; EIG9
607684 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E
607685 HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC; HES
607688 PARKINSON DISEASE 11, AUTOSOMAL DOMINANT; PARK11
607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/OR
607706 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, WITH VOCAL CORD PARESIS, AUTOSOMAL
607721 NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR; NSLH
607734 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F
607736 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J
607745 SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3
607748 HYPERCHOLANEMIA, FAMILIAL; FHCA
607765 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 1; CBAS1
607778 ACROCAPITOFEMORAL DYSPLASIA; ACFD
607785 JUVENILE MYELOMONOCYTIC LEUKEMIA; JMML
607791 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE D; CMTDID
607801 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1C; LGMD1C
607812 CRANIOLENTICULOSUTURAL DYSPLASIA; CLSD
607821 DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37
607822 ALZHEIMER DISEASE 3
607823 HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS
607831 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K
607832 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 3, SUSCEPTIBILITY TO; FSGS3
607836 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 1; AIS1
607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48
607842 AURAL ATRESIA, CONGENITAL; CAA
607847 NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS
607850 OSTEOARTHRITIS SUSCEPTIBILITY 3; OS3
607855 MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A
607864 CAUDAL DUPLICATION ANOMALY
607872 CHROMOSOME 1p36 DELETION SYNDROME
607903 HYPOTRICHOSIS 6; HYPT6
607906 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I
607907 DERMATOFIBROSARCOMA PROTUBERANS; DFSP
607921 RETINITIS PIGMENTOSA 30; RP30
607932 MICROPHTHALMIA, SYNDROMIC 6; MCOPS6
607936 EXFOLIATIVE ICHTHYOSIS, AUTOSOMAL RECESSIVE, ICHTHYOSIS BULLOSA OF
607941 ATRIAL SEPTAL DEFECT 2; ASD2
607944 SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI
607948 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO
608013 GAUCHER DISEASE, PERINATAL LETHAL
608022 DIAPHANOSPONDYLODYSOSTOSIS
608030 AMYOTROPHIC LATERAL SCLEROSIS 6, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;
608033 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 3; IIAE3
608051 MACULAR DYSTROPHY, RETINAL, 2; MCDR2
608089 ENDOMETRIAL CANCER
608091 JOUBERT SYNDROME 2; JBTS2
608093 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J
608097 PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE;
608099 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2D; LGMD2D
608104 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H
608106 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 5; HIGM5
608115 OVARIAN HYPERSTIMULATION SYNDROME
608118 ZINC DEFICIENCY, TRANSIENT NEONATAL; TNZD
608133 RETINITIS PIGMENTOSA 7; RP7
608149 UNIPARENTAL DISOMY, PATERNAL, CHROMOSOME 14
608156 NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS
608161 MACULAR DYSTROPHY, VITELLIFORM, ADULT-ONSET
608175 AUTOIMMUNE THYROID DISEASE, SUSCEPTIBILITY TO, 3; AITD3
608180 SYNPOLYDACTYLY 2; SPD2
608189 TROPICAL CALCIFIC PANCREATITIS
608194 CONE-ROD DYSTROPHY 13; CORD13
608203 NEUTROPHIL IMMUNODEFICIENCY SYNDROME
608224 DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41
608232 LEUKEMIA, CHRONIC MYELOID; CML
608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2
608236 SLOWED NERVE CONDUCTION VELOCITY, AUTOSOMAL DOMINANT
608265 DEAFNESS, AUTOSOMAL RECESSIVE 39; DFNB39
608266 PARATHYROID CARCINOMA
608320 CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1
608323 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC
608328 WEILL-MARCHESANI SYNDROME 2; WMS2
608340 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE A; CMTRIA
608354 CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM
608355 PARKES WEBER SYNDROME
608358 MYOPATHY, MYOSIN STORAGE
608361 SPONDYLOEPIPHYSEAL DYSPLASIA, KIMBERLEY TYPE
608363 CHROMOSOME 22q11.2 DUPLICATION SYNDROME
608380 RETINITIS PIGMENTOSA 26; RP26
608389 BRANCHIOOTIC SYNDROME 3; BOS3
608390 MYOTONIA, POTASSIUM-AGGRAVATED
608393 MICROCEPHALY 6, PRIMARY, AUTOSOMAL RECESSIVE; MCPH6
608404 PLATELET GLYCOPROTEIN IV DEFICIENCY
608415 PROLONGED ELECTRORETINAL RESPONSE SUPPRESSION; PERRS
608423 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1F; LGMD1F
608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3
608446 MYOCARDIAL INFARCTION, SUSCEPTIBILITY TO
608456 FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2
608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1
608471 CORNEAL DYSTROPHY, LATTICE TYPE IIIA; CDL3A
608516 MAJOR DEPRESSIVE DISORDER; MDD
608540 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K
608553 LEBER CONGENITAL AMAUROSIS 9; LCA9
608556 LEGIONNAIRE DISEASE, SUSCEPTIBILITY TO
608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35
608567 SICK SINUS SYNDROME 1, AUTOSOMAL RECESSIVE; SSS1
608569 CARDIOMYOPATHY, DILATED, 1O; CMD1O
608579 SEVERE CUTANEOUS ADVERSE REACTION, SUSCEPTIBILITY TO
608584 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 2
608594 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1
608611 RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY
608612 MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB
608615 OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS
608622 HYPERTENSION, DIASTOLIC, RESISTANCE TO
608627 AMYOTROPHIC LATERAL SCLEROSIS 8; ALS8
608629 JOUBERT SYNDROME 3; JBTS3
608634 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B
608636 CHROMOSOME 15q11-q13 DUPLICATION SYNDROME
608641 DEAFNESS, AUTOSOMAL DOMINANT 28; DFNA28
608643 AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY
608644 CILIARY DYSKINESIA, PRIMARY, 3; CILD3
608647 CILIARY DYSKINESIA, PRIMARY, 5; CILD5
608649 ICHTHYOSIS PREMATURITY SYNDROME; IPS
608654 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE V; HSAN5
608673 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2L; CMT2L
608681 SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2
608687 SPINOCEREBELLAR ATAXIA 20; SCA20
608688 AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY
608709 LIPODYSTROPHY, PARTIAL, ACQUIRED, SUSCEPTIBILITY TO; APLD
608716 MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE; MCPH5
608728 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 RELATED
608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY
608751 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 8; CMH8
608758 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 10; CMH10
608765 SCOLIOSIS, IDIOPATHIC, SUSCEPTIBILITY TO, 3; IS3
608768 SPINOCEREBELLAR ATAXIA 8; SCA8
608776 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L
608779 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E
608782 PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY; PDHPD
608799 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ie; CDG1E
608800 SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME; SIDDT
608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2
608805 AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY
608807 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2J; LGMD2J
608808 TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 1; DTGA1
608810 MYOPATHY, MYOFIBRILLAR, 2; MFM2
608812 COLORECTAL CANCER, SUSCEPTIBILITY TO, 1; CRCS1
608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL
608837 CARNEY COMPLEX VARIANT
608840 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),
608864 OROFACIAL CLEFT 6, SUSCEPTIBILITY TO; OFC6
608874 OROFACIAL CLEFT 5; OFC5
608890 WAARDENBURG SYNDROME, TYPE 2D; WS2D
608895 MACULAR DEGENERATION, AGE-RELATED, 3; ARMD3
608898 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 3; FHL3
608901 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 5
608902 DRUG METABOLISM, POOR, CYP2D6-RELATED
608908 MYOPIA 6; MYP6
608930 MYASTHENIC SYNDROME, CONGENITAL, FAST-CHANNEL
608931 MYASTHENIC SYNDROME, CONGENITAL, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR
608940 SPONDYLOMETAPHYSEAL DYSPLASIA WITH CONE-ROD DYSTROPHY; SMDCRD
608957 CD8 DEFICIENCY, FAMILIAL
608971 SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE,
608978 MEACHAM SYNDROME
608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR
608984 ATAXIA, SENSORY, 1, AUTOSOMAL DOMINANT; SNAX1
608996 PREMATURE OVARIAN FAILURE 3; POF3
609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;
609015 TRIFUNCTIONAL PROTEIN DEFICIENCY
609016 LONG-CHAIN 3-HYDROXYACYL-CoA DEHYDROGENASE DEFICIENCY
609027 BLOOD GROUP, INDIAN SYSTEM; IN
609029 EMANUEL SYNDROME
609033 POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1
609040 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 9; ARVD9
609048 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3; CMM3
609049 PIERSON SYNDROME
609053 FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI
609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ
609056 AMISH INFANTILE EPILEPSY SYNDROME
609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS
609060 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 1; COXPD1
609069 PANCREATIC AND CEREBELLAR AGENESIS; PACA
609129 AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1; AUNA1
609135 APLASTIC ANEMIA
609136 PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG
609140 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 2; PPCD2
609141 CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 3; PPCD3
609148 MALARIA, MILD, SUSCEPTIBILITY TO
609152 HYPERTHYROIDISM, NONAUTOIMMUNE
609161 STRIATAL DEGENERATION, AUTOSOMAL DOMINANT; ADSD
609162 CZECH DYSPLASIA
609165 ERYTHRODERMA, ICHTHYOSIFORM, CONGENITAL RETICULAR; CRIE
609180 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE If; CDG1F
609192 LOEYS-DIETZ SYNDROME 1; LDS1
609195 SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26
609200 MYOPATHY, MYOFIBRILLAR, 3; MFM3
609218 FOVEAL HYPOPLASIA 2; FVH2
609220 BRUCK SYNDROME 2; BRKS2
609227 GRISCELLI SYNDROME, TYPE 3; GS3
609241 SCHINDLER DISEASE, TYPE I
609242 KANZAKI DISEASE
609254 SENIOR-LOKEN SYNDROME 5; SLSN5
609260 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2
609265 LI-FRAUMENI SYNDROME 2; LFS2
609270 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 7; SCAR7
609273 NEMALINE MYOPATHY 6; NEM6
609283 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
609284 NEMALINE MYOPATHY 1; NEM1
609285 NEMALINE MYOPATHY 4; NEM4
609286 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
609304 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 3; EIEE3
609306 SPINOCEREBELLAR ATAXIA 26; SCA26
609307 SPINOCEREBELLAR ATAXIA 27; SCA27
609308 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 1; MDDGC1
609310 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2
609311 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H
609313 MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY,
609322 RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1
609334 CHROMOSOME 18 PERICENTRIC INVERSION
609338 CAROTID INTIMAL MEDIAL THICKNESS 1
609340 SPASTIC PARAPLEGIA 28, AUTOSOMAL RECESSIVE; SPG28
609352 EPIDERMOLYSIS BULLOSA SIMPLEX WITH MIGRATORY CIRCINATE ERYTHEMA
609404 PREECLAMPSIA/ECLAMPSIA 4; PEE4
609423 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
609425 CHROMOSOME 3q29 DELETION SYNDROME
609439 DEAFNESS, AUTOSOMAL RECESSIVE 48; DFNB48
609441 CHONDRODYSPLASIA, ACROMESOMELIC, WITH GENITAL ANOMALIES
609446 GENERALIZED EPILEPSY AND PAROXYSMAL DYSKINESIA; GEPD
609452 MYOPATHY, MYOFIBRILLAR, 4; MFM4
609460 GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME; GOSHS
609464 SARCOIDOSIS, EARLY-ONSET
609508 STICKLER SYNDROME, TYPE I, NONSYNDROMIC OCULAR
609524 MYOPATHY, MYOFIBRILLAR, 5; MFM5
609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMA
609529 IMMUNOGLOBULIN A DEFICIENCY 2; IGAD2
609532 HEPATITIS C VIRUS, SUSCEPTIBILITY TO
609533 DEAFNESS, AUTOSOMAL RECESSIVE 23; DFNB23
609535 DRUG METABOLISM, POOR, CYP2C19-RELATED
609536 COMPLEMENT COMPONENT 5 DEFICIENCY; C5D
609549 NANOPHTHALMOS 2; NNO2
609560 MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE); MTDPS2
609579 SCAPHOCEPHALY, MAXILLARY RETRUSION, AND MENTAL RETARDATION
609583 JOUBERT SYNDROME 4; JBTS4
609597 PARIETAL FORAMINA 2; PFM2
609620 SHORT QT SYNDROME 1; SQT1
609621 SHORT QT SYNDROME 2; SQT2
609622 SHORT QT SYNDROME 3; SQT3
609625 CHROMOSOME 10q26 DELETION SYNDROME
609628 MAJEED SYNDROME
609634 MIGRAINE, FAMILIAL HEMIPLEGIC, 3; FHM3
609637 HOLOPROSENCEPHALY 5; HPE5
609638 EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC
609640 FRIAS SYNDROME
609646 DEAFNESS, AUTOSOMAL RECESSIVE 42; DFNB42
609698 THYROID HORMONE METABOLISM, ABNORMAL
609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53
609734 PROOPIOMELANOCORTIN DEFICIENCY
609741 CATARACT 22; CTRCT22
609753 CELIAC DISEASE, SUSCEPTIBILITY TO, 4; CELIAC4
609755 CELIAC DISEASE, SUSCEPTIBILITY TO, 3; CELIAC3
609757 WILLIAMS-BEUREN REGION DUPLICATION SYNDROME
609796 PEELING SKIN SYNDROME, ACRAL TYPE
609812 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 8, WITH EXOCRINE DYSFUNCTION;
609813 SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3
609814 COMPLEMENT FACTOR H DEFICIENCY; CFHD
609820 ERYTHROCYTOSIS, FAMILIAL, 3; ECYT3
609821 BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8
609823 DEAFNESS, AUTOSOMAL RECESSIVE 28; DFNB28
609886 GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA
609887 GLAUCOMA 1, OPEN ANGLE, G; GLC1G
609889 ALPHA/BETA T-CELL LYMPHOPENIA WITH GAMMA/DELTA T-CELL EXPANSION, SEVERE
609909 CARDIOMYOPATHY, DILATED, 1P; CMD1P
609923 RETINITIS PIGMENTOSA 31; RP31
609924 AMINOACYLASE 1 DEFICIENCY
609942 NOONAN SYNDROME 3; NS3
609968 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5
609975 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4
609981 NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR
610003 CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT
610006 2-@METHYLBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
610015 GLUTAMINE DEFICIENCY, CONGENITAL
610017 MULTIPLE SYNOSTOSES SYNDROME 2; SYNS2
610019 CATARACT 18; CTRCT18
610021 HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7
610024 RETINAL CONE DYSTROPHY 3A; RCD3A
610031 POLYMICROGYRIA, SYMMETRIC OR ASYMMETRIC; PMGYSA
610042 CORTICAL DYSPLASIA-FOCAL EPILEPSY SYNDROME
610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD
610069 POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2
610090 PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY
610092 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3
610093 MICROPHTHALMIA, ISOLATED 2; MCOP2
610100 GIANT AXONAL NEUROPATHY 2, AUTOSOMAL DOMINANT; GAN2
610102 COMPLEMENT COMPONENT 7 DEFICIENCY; C7D
610125 MICROPHTHALMIA, SYNDROMIC 5; MCOPS5
610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10
610131 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
610140 HEART-HAND SYNDROME, SLOVENIAN TYPE
610149 MACULAR DEGENERATION, AGE-RELATED, 7; ARMD7
610153 DEAFNESS, AUTOSOMAL RECESSIVE 49; DFNB49
610154 DEAFNESS, AUTOSOMAL RECESSIVE 44; DFNB44
610156 MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS
610163 IMMUNODEFICIENCY DUE TO DEFECT IN CD3-ZETA
610168 LOEYS-DIETZ SYNDROME 2; LDS2
610181 AICARDI-GOUTIERES SYNDROME 2; AGS2
610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME
610187 DIAPHRAGMATIC HERNIA 3
610188 JOUBERT SYNDROME 5; JBTS5
610189 SENIOR-LOKEN SYNDROME 6; SLSN6
610193 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 10; ARVD10
610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5
610199 DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM
610202 CATARACT 21, MULTIPLE TYPES; CTRCT21
610205 ALAGILLE SYNDROME 2; ALGS2
610217 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B
610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59
610227 SEBORRHEA-LIKE DERMATITIS WITH PSORIASIFORM ELEMENTS
610244 SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT; SPG33
610245 SPINOCEREBELLAR ATAXIA 23; SCA23
610246 SPINOCEREBELLAR ATAXIA 28; SCA28
610250 SPASTIC PARAPLEGIA 31, AUTOSOMAL DOMINANT; SPG31
610251 ALCOHOL SENSITIVITY, ACUTE
610253 KLEEFSTRA SYNDROME
610256 APHAKIA, CONGENITAL PRIMARY
610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67
610269 BULIMIA NERVOSA, SUSCEPTIBILITY TO, 2; BULN2
610282 RETINITIS PIGMENTOSA 35; RP35
610283 CONE-ROD DYSTROPHY 10; CORD10
610293 GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY
610297 PARKINSON DISEASE 13, AUTOSOMAL DOMINANT, SUSCEPTIBILITY TO; PARK13
610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2
610329 AICARDI-GOUTIERES SYNDROME 3; AGS3
610333 AICARDI-GOUTIERES SYNDROME 4; AGS4
610353 EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4
610356 RETINAL CONE DYSTROPHY 3B; RCD3B
610357 SPASTIC PARAPLEGIA 30, AUTOSOMAL RECESSIVE; SPG30
610359 RETINITIS PIGMENTOSA 33; RP33
610370 DIARRHEA 4, MALABSORPTIVE, CONGENITAL; DIAR4
610374 DIABETES MELLITUS, TRANSIENT NEONATAL, 2
610377 MEVALONIC ACIDURIA; MEVA
610379 WEST NILE VIRUS, SUSCEPTIBILITY TO
610381 CONE-ROD DYSTROPHY 11; CORD11
610424 HEPATITIS B VIRUS, SUSCEPTIBILITY TO
610425 CATARACT 23; CTRCT23
610427 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B; CSNB2B
610443 KOOLEN-DE VRIES SYNDROME; KDVS
610444 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 3; CSNBAD3
610445 NIGHT BLINDNESS, CONGENITAL STATIONARY, AUTOSOMAL DOMINANT 1; CSNBAD1
610446 BURULI ULCER, SUSCEPTIBILITY TO
610448 CHILBLAIN LUPUS 1; CHBL1
610455 TUMORAL CALCINOSIS, NORMOPHOSPHATEMIC, FAMILIAL; NFTC
610460 THIOPURINE S-METHYLTRANSFERASE DEFICIENCY
610474 CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME
610475 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2; PPNAD2
610476 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 11; ARVD11
610478 RETINAL CONE DYSTROPHY 4; RCD4
610489 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1; PPNAD1
610498 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2
610504 PRETERM PREMATURE RUPTURE OF THE MEMBRANES; PPROM
610505 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3; COXPD3
610508 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 7; MODY7
610532 LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5
610536 MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA
610539 GAUCHER DISEASE, ATYPICAL, DUE TO SAPOSIN C DEFICIENCY
610542 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 1; CMSTA1
610543 CHROMOSOME 16p13.3 DELETION SYNDROME, PROXIMAL
610549 DIABETES MELLITUS, INSULIN-RESISTANT, WITH ACANTHOSIS NIGRICANS
610551 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 1
610582 DIABETES MELLITUS, TRANSIENT NEONATAL, 3
610599 RETINITIS PIGMENTOSA 36; RP36
610600 CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY
610612 LEBER CONGENITAL AMAUROSIS 12; LCA12
610618 ANGIOEDEMA, HEREDITARY, TYPE III; HAE3
610623 CATARACT 11, MULTIPLE TYPES; CTRCT11
610628 HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4
610629 DIAMOND-BLACKFAN ANEMIA 3; DBA3
610644 PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND
610651 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B; XPB
610678 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4
610682 OSTEOGENESIS IMPERFECTA, TYPE VII; OI7
610687 NEMALINE MYOPATHY 7; NEM7
610688 JOUBERT SYNDROME 6; JBTS6
610698 MACULAR DEGENERATION, AGE-RELATED, 4; ARMD4
610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA
610713 BRACHYDACTYLY-SYNDACTYLY SYNDROME
610717 NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM
610725 NEPHROTIC SYNDROME, TYPE 3; NPHS3
610733 NOONAN SYNDROME 4; NS4
610738 NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3
610743 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8
610755 MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4
610756 CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2
610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4
610759 CORNELIA DE LANGE SYNDROME 3; CDLS3
610762 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
610768 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Im; CDG1M
610773 MITOCHONDRIAL PHOSPHATE CARRIER DEFICIENCY
610798 IMMUNODEFICIENCY DUE TO DEFECT IN MAPBP-INTERACTING PROTEIN
610799 INVASIVE PNEUMOCOCCAL DISEASE, RECURRENT ISOLATED, 1; IPD1
610805 CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT, SUSCEPTIBILITY TO;
610828 HOLOPROSENCEPHALY 7; HPE7
610829 HOLOPROSENCEPHALY 9; HPE9
610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN
610842 PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR
610852 CILIARY DYSKINESIA, PRIMARY, 6; CILD6
610878 VESICOURETERAL REFLUX 2; VUR2
610883 POTOCKI-LUPSKI SYNDROME; PTLS
610896 BRANCHIOOTORENAL SYNDROME 2; BOR2
610913 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 2; SMDP2
610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8
610921 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 3; SMDP3
610927 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9; SLEB9
610938 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 7; CHDS7
610947 CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2
610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7
610954 PITT-HOPKINS SYNDROME; PTHS
610965 XFE PROGEROID SYNDROME
610967 OSTEOGENESIS IMPERFECTA, TYPE V; OI5
610968 OSTEOGENESIS IMPERFECTA, TYPE XI; OI11
610978 CHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM WITH OR WITHOUT PULMONARY
610984 COMPLEMENT FACTOR I DEFICIENCY; CFID
610988 LEPROSY, SUSCEPTIBILITY TO, 4; LPRS4
610992 PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY
611022 DEAFNESS, AUTOSOMAL RECESSIVE 24; DFNB24
611038 MICROPHTHALMIA, ISOLATED 3; MCOP3
611040 MICROPHTHALMIA, ISOLATED 5; MCOP5
611064 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 5
611067 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4; DSMA4
611081 INFLAMMATORY BOWEL DISEASE 10; IBD10
611087 POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE
611090 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 12; MRT12
611091 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5; MRT5
611092 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6
611093 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 7; MRT7
611102 DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY
611105 LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND
611126 ACYL-CoA DEHYDROGENASE FAMILY, MEMBER 9, DEFICIENCY OF
611131 RETINITIS PIGMENTOSA 37; RP37
611134 MECKEL SYNDROME, TYPE 4; MKS4
611136 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 13; EIG13
611162 MALARIA, SUSCEPTIBILITY TO
611174 HAMAMY SYNDROME; HMMS
611182 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIh; CDG2H
611209 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G
611225 SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18
611228 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J; CMT4J
611263 SHORT-RIB THORACIC DYSPLASIA 2 WITH OR WITHOUT POLYDACTYLY; SRTD2
611277 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 3; GEFSP3
611283 ISOBUTYRYL-CoA DEHYDROGENASE DEFICIENCY
611291 SEVERE COMBINED IMMUNODEFICIENCY WITH MICROCEPHALY, GROWTH RETARDATION,
611302 SPASTIC ATAXIA 2, AUTOSOMAL RECESSIVE; SPAX2
611307 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2L; LGMD2L
611363 ATRIAL SEPTAL DEFECT 4; ASD4
611369 LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3
611377 BRACHYDACTYLY, TYPE B2; BDB2
611378 MACULAR DEGENERATION, AGE-RELATED, 9; ARMD9
611383 USHER SYNDROME, TYPE IID; USH2D
611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3
611391 CATARACT 33; CTRCT33
611407 CARDIOMYOPATHY, DILATED, 1W; CMD1W
611431 LEGIUS SYNDROME
611451 DEAFNESS, AUTOSOMAL RECESSIVE 63; DFNB63
611465 GALLBLADDER DISEASE 4; GBD4
611488 MACULAR DEGENERATION, AGE-RELATED, 10; ARMD10
611489 CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY
611490 OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4
611493 ATRIAL FIBRILLATION, FAMILIAL, 4; ATFB4
611497 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 6; OPTB6
611498 NEPHRONOPHTHISIS 7; NPHP7
611521 TYROSINE KINASE 2 DEFICIENCY
611523 PONTOCEREBELLAR HYPOPLASIA, TYPE 6; PCH6
611528 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 12; ARVD12
611544 CATARACT 17, MULTIPLE TYPES; CTRCT17
611548 PREMATURE OVARIAN FAILURE 5; POF5
611553 NOONAN SYNDROME 5; NS5
611554 LEOPARD SYNDROME 2
611556 GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B
611560 JOUBERT SYNDROME 7; JBTS7
611561 MECKEL SYNDROME, TYPE 5; MKS5
611584 WAARDENBURG SYNDROME, TYPE 2E; WS2E
611588 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4
611590 RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA
611597 CATARACT 12, MULTIPLE TYPES; CTRCT12
611603 LISSENCEPHALY 3; LIS3
611615 CARDIOMYOPATHY, DILATED, 1X; CMD1X
611638 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 5; MCOPCB5
611664 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 7; SHEP7
611705 MYOPATHY, EARLY-ONSET, WITH FATAL CARDIOMYOPATHY
611718 HYPOMAGNESEMIA 4, RENAL; HOMG4
611719 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5
611721 COMBINED SAPOSIN DEFICIENCY
611722 KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY
611726 EPILEPSY, PROGRESSIVE MYOCLONIC 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS;
611742 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 9; SHEP9
611755 LEBER CONGENITAL AMAUROSIS 10; LCA10
611762 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2
611771 LIPOPROTEIN GLOMERULOPATHY; LPG
611773 ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS;
611775 KAWASAKI DISEASE
611777 BRUGADA SYNDROME 2; BRGDA2
611783 ERYTHROCYTOSIS, FAMILIAL, 4; ECYT4
611788 AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
611804 ELLIPTOCYTOSIS 1; EL1
611809 BESTROPHINOPATHY, AUTOSOMAL RECESSIVE; ARB
611812 46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS;
611818 LONG QT SYNDROME 9; LQT9
611819 LONG QT SYNDROME 10; LQT10
611820 LONG QT SYNDROME 11; LQT11
611862 WHITE BLOOD CELL COUNT QUANTITATIVE TRAIT LOCUS 1; WBCQ1
611867 CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL
611868 PROSTATE CANCER, HEREDITARY, 12; HPC12
611875 BRUGADA SYNDROME 3; BRGDA3
611876 BRUGADA SYNDROME 4; BRGDA4
611878 CARDIOMYOPATHY, DILATED, 1Y; CMD1Y
611879 CARDIOMYOPATHY, DILATED, 1Z; CMD1Z
611880 CARDIOMYOPATHY, DILATED, 2A; CMD2A
611881 GLYCOGEN STORAGE DISEASE XII; GSD12
611884 CILIARY DYSKINESIA, PRIMARY, 7; CILD7
611890 LETHAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; LAAHD
611895 AMYOTROPHIC LATERAL SCLEROSIS 9; ALS9
611913 CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB
611928 PROSTATE CANCER, HEREDITARY, 13; HPC13
611936 CHROMOSOME 3q29 DUPLICATION SYNDROME
611938 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2
611942 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6; ECA6
611943 RIDDLE SYNDROME
611953 MACULAR DEGENERATION, AGE-RELATED, 11; ARMD11
611960 ASTHMA-RELATED TRAITS, SUSCEPTIBILITY TO, 7; ASRT7
612001 CHROMOSOME 15q13.3 DELETION SYNDROME
612004 THROMBOCYTOPENIA 4; THC4
612015 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE In; CDG1N
612016 COENZYME Q10 DEFICIENCY, PRIMARY, 4; COQ10D4
612018 CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA; CJMG
612020 SPASTIC PARAPLEGIA 39, AUTOSOMAL RECESSIVE; SPG39
612042 RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
612052 SMOKING AS A QUANTITATIVE TRAIT LOCUS 3; SQTL3
612067 DYSTONIA 16; DYT16
612069 AMYOTROPHIC LATERAL SCLEROSIS 10, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;
612073 MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR
612075 MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH
612076 HYPOURICEMIA, RENAL, 2; RHUC2
612079 ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME
612095 RETINITIS PIGMENTOSA 41; RP41
612098 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 11; CMH11
612100 AUTISM, SUSCEPTIBILITY TO, 15; AUTS15
612109 OCULOAURICULAR SYNDROME
612124 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 12; CMH12
612126 GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2
612132 ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH T-CELL IMMUNODEFICIENCY, AUTOSOMAL
612138 EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA
612158 CARDIOMYOPATHY, DILATED, 1AA; CMD1AA
612160 HISTIOCYTOMA, ANGIOMATOID FIBROUS
612164 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4; EIEE4
612199 CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS; CRMCC
612201 ATRIAL FIBRILLATION, FAMILIAL, 6; ATFB6
612219 EWING SARCOMA; ES
612225 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 9; MODY9
612227 DIABETES MELLITUS, KETOSIS-PRONE; KPD
612229 COLORECTAL CANCER, SUSCEPTIBILITY TO, 3; CRCS3
612233 LEUKODYSTROPHY, HYPOMYELINATING, 4; HLD4
612237 CHONDROSARCOMA, EXTRASKELETAL MYXOID
612240 ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7
612242 CHROMOSOME 10q23 DELETION SYNDROME
612244 INFLAMMATORY BOWEL DISEASE 13; IBD13
612245 INFLAMMATORY BOWEL DISEASE 14; IBD14
612247 CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS; CAN
612251 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 10; SLEB10
612253 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 11; SLEB11
612260 MYD88 DEFICIENCY; MYD88D
612261 INFLAMMATORY BOWEL DISEASE 17; IBD17
612267 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 10; SHEP10
612269 EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 5; ECA5
612271 SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 11; SHEP11
612278 INFLAMMATORY BOWEL DISEASE 19; IBD19
612281 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 6; ARCI6
612284 MECKEL SYNDROME, TYPE 6; MKS6
612285 JOUBERT SYNDROME 9; JBTS9
612286 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 1; NPHLOP1
612287 NEPHROLITHIASIS/OSTEOPOROSIS, HYPOPHOSPHATEMIC, 2; NPHLOP2
612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATE
612291 JOUBERT SYNDROME 8; JBTS8
612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME
612300 HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY;
612301 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7
612304 THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4
612310 PREMATURE OVARIAN FAILURE 6; POF6
612313 GLASS SYNDROME
612318 PSEUDOFOLLICULITIS BARBAE
612319 SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE; SPG35
612336 THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL DOMINANT; THPH5
612337 MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22
612345 CHROMOSOME 2q31.2 DELETION SYNDROME
612347 JERVELL AND LANGE-NIELSEN SYNDROME 2; JLNS2
612350 SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE
612356 HEPARIN COFACTOR II DEFICIENCY
612359 COWDEN SYNDROME 2; CWS2
612362 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 12; BMIQ12
612370 HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA; HH5
612371 MAJOR AFFECTIVE DISORDER 7; MAFD7
612376 ACUTE PROMYELOCYTIC LEUKEMIA; APL
612379 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iq; CDG1Q
612387 SARCOIDOSIS, SUSCEPTIBILITY TO, 2; SS2
612389 PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B
612390 PONTOCEREBELLAR HYPOPLASIA, TYPE 2C; PCH2C
612394 BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS
612400 OSTEOARTHRITIS SUSCEPTIBILITY 5; OS5
612416 FACTOR XI DEFICIENCY
612422 CARDIOMYOPATHY, FAMILIAL RESTRICTIVE, 3; RCM3
612423 PREKALLIKREIN DEFICIENCY
612437 EPILEPSY, PROGRESSIVE MYOCLONIC 1B; EPM1B
612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6
612444 CILIARY DYSKINESIA, PRIMARY, 9; CILD9
612446 COMPLEMENT COMPONENT 6 DEFICIENCY; C6D
612447 SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION
612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C
612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP
612469 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, MENTAL RETARDATION,
612474 CHROMOSOME 1q21.1 DELETION SYNDROME, 1.35-MB
612475 CHROMOSOME 1q21.1 DUPLICATION SYNDROME
612513 CHROMOSOME 2p16.1-p15 DELETION SYNDROME
612518 CILIARY DYSKINESIA, PRIMARY, 10; CILD10
612520 DIABETES MELLITUS, INSULIN-DEPENDENT, 20; IDDM20
612522 DIABETES MELLITUS, INSULIN-DEPENDENT, 22; IDDM22
612526 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3
612527 DIAMOND-BLACKFAN ANEMIA 4; DBA4
612528 DIAMOND-BLACKFAN ANEMIA 5; DBA5
612529 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA2; AI2A2
612530 CHROMOSOME 1q41-q42 DELETION SYNDROME
612539 SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42
612540 MYOPATHY, CONGENITAL, COMPTON-NORTH; MYPCN
612541 NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4
612542 VITAMIN B12 PLASMA LEVEL QUANTITATIVE TRAIT LOCUS 1; B12QTL1
612551 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO; FSGS4
612555 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2
612556 ADIPONECTIN, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS 1; ADIPQTL1
612560 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 12; BMND12
612561 DIAMOND-BLACKFAN ANEMIA 6; DBA6
612562 DIAMOND-BLACKFAN ANEMIA 7; DBA7
612563 DIAMOND-BLACKFAN ANEMIA 8; DBA8
612567 INFLAMMATORY BOWEL DISEASE 25, AUTOSOMAL RECESSIVE; IBD25
612572 RETINITIS PIGMENTOSA 46; RP46
612576 CHROMOSOME 17p13.3, TELOMERIC, DUPLICATION SYNDROME
612577 AMYOTROPHIC LATERAL SCLEROSIS 11; ALS11
612580 MENTAL RETARDATION, AUTOSOMAL DOMINANT 3; MRD3
612581 MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4
612582 CHROMOSOME 6pter-p24 DELETION SYNDROME
612591 COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10
612621 MENTAL RETARDATION, AUTOSOMAL DOMINANT 5; MRD5
612623 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 2; MVCD2
612624 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3; MVCD3
612626 CHROMOSOME 15q26-qter DELETION SYNDROME
612628 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 4; MVCD4
612630 HAIR MORPHOLOGY 1; HRM1
612631 ADENYLATE KINASE DEFICIENCY, HEMOLYTIC ANEMIA DUE TO
612633 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 5; MVCD5
612634 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 6; MVCD6
612635 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 7; MVCD7
612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B
612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B
612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B
612649 CILIARY DYSKINESIA, PRIMARY, 11; CILD11
612650 CILIARY DYSKINESIA, PRIMARY, 12; CILD12
612651 ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO
612653 SPHEROCYTOSIS, TYPE 4; SPH4
612656 EPISODIC ATAXIA, TYPE 6; EA6
612657 CONE-ROD DYSTROPHY 12; CORD12
612671 URIC ACID CONCENTRATION, SERUM, QUANTITATIVE TRAIT LOCUS 4; UAQTL4
612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;
612690 SPHEROCYTOSIS, TYPE 5; SPH5
612692 AGAMMAGLOBULINEMIA 6, AUTOSOMAL RECESSIVE; AGM6
612702 HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6
612703 MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE; MCPH7
612712 LEBER CONGENITAL AMAUROSIS 13; LCA13
612713 KAHRIZI SYNDROME; KHRZ
612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIAL
612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY
612718 CEREBRAL CREATINE DEFICIENCY SYNDROME 3; CCDS3
612736 CEREBRAL CREATINE DEFICIENCY SYNDROME 2; CCDS2
612740 PORPHYRIA, ACUTE HEPATIC
612775 CONE-ROD DYSTROPHY 9; CORD9
612780 SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND
612781 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE IB; IGHD1B
612782 IMMUNODEFICIENCY 9; IMD9
612783 IMMUNODEFICIENCY 10; IMD10
612794 ATRIAL SEPTAL DEFECT 5; ASD5
612797 HIGH DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
612798 QUESTION MARK EARS, ISOLATED; QME
612813 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE
612838 BRUGADA SYNDROME 5; BRGDA5
612840 LEUKOCYTE ADHESION DEFICIENCY, TYPE III; LAD3
612847 BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES
612852 OSTEOMYELITIS, STERILE MULTIFOCAL, WITH PERIOSTITIS AND PUSTULOSIS;
612863 CHROMOSOME 6q24-q25 DELETION SYNDROME
612874 ERYTHROCYTE AMP DEAMINASE DEFICIENCY
612877 CARDIOMYOPATHY, DILATED, 1BB; CMD1BB
612899 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 8; EIG8
612900 CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 2; CPSQ2
612908 KERATOSIS PALMOPLANTARIS STRIATA II; PPKS2
612918 CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL
612921 THREE M SYNDROME 2; 3M2
612922 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 2; AHUS2
612923 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 3; AHUS3
612924 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 4; AHUS4
612925 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 5; AHUS5
612926 HEMOLYTIC UREMIC SYNDROME, ATYPICAL, SUSCEPTIBILITY TO, 6; AHUS6
612932 GLYCOGEN STORAGE DISEASE XIII; GSD13
612933 GLYCOGEN STORAGE DISEASE XI; GSD11
612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50
612937 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Io; CDG1O
612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLY
612940 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B
612943 RETINITIS PIGMENTOSA 42; RP42
612949 HYPOMYELINATION, GLOBAL CEREBRAL
612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY
612952 AICARDI-GOUTIERES SYNDROME 5; AGS5
612953 PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14
612954 MYOPATHY, MYOFIBRILLAR, 6; MFM6
612955 LONG QT SYNDROME 12; LQT12
612956 VENTRICULAR FIBRILLATION, PAROXYSMAL FAMILIAL, 2; VF2
612961 MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3
612964 PREMATURE OVARIAN FAILURE 7; POF7
612965 46,XY SEX REVERSAL 3; SRXY3
612975 SHORT SLEEPER
612989 OPTIC ATROPHY 7; OPA7
612997 SPERMATOGENIC FAILURE 7; SPGF7
612998 EMERY-DREIFUSS MUSCULAR DYSTROPHY 4, AUTOSOMAL DOMINANT; EDMD4
612999 EMERY-DREIFUSS MUSCULAR DYSTROPHY 5, AUTOSOMAL DOMINANT; EDMD5
613000 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL; FNEPPK
613002 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 2
613003 ATTENTION DEFICIT-HYPERACTIVITY DISORDER, SUSCEPTIBILITY TO, 7
613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1
613013 NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2
613014 NEUROBLASTOMA, SUSCEPTIBILITY TO, 3; NBLST3
613021 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 2; BESC2
613026 CHROMOSOME 19q13.11 DELETION SYNDROME
613027 GLYCOGEN STORAGE DISEASE IXc; GSD9C
613028 GLIOMA SUSCEPTIBILITY 2; GLM2
613029 GLIOMA SUSCEPTIBILITY 3; GLM3
613038 PITUITARY HORMONE DEFICIENCY, COMBINED, 1; CPHD1
613060 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 10; EIG10
613068 NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY
613070 LIVER FAILURE, INFANTILE, TRANSIENT; LFIT
613071 BRONCHIECTASIS WITH OR WITHOUT ELEVATED SWEAT CHLORIDE 3; BESC3
613073 METAPHYSEAL ANADYSPLASIA 2; MANDP2
613074 DEAFNESS, AUTOSOMAL DOMINANT 50; DFNA50
613075 MACS SYNDROME
613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARING
613077 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
613078 NIJMEGEN BREAKAGE SYNDROME-LIKE DISORDER; NBSLD
613079 DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77
613080 46,XY SEX REVERSAL 5; SRXY5
613086 GLAUCOMA 3, PRIMARY CONGENITAL, D; GLC3D
613090 BARTTER SYNDROME, TYPE 4B
613091 SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3
613092 HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 2; HNFJ2
613093 CONE DYSTROPHY 4; COD4
613094 MICROPHTHALMIA, ISOLATED 4; MCOP4
613095 POLYCYSTIC KIDNEY DISEASE 2; PKD2
613097 TOOTH AGENESIS, SELECTIVE, 6; STHAG6
613098 INCREASED ANALGESIA FROM KAPPA-OPIOID RECEPTOR AGONIST, FEMALE-SPECIFIC
613099 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 5; CMM5
613100 GLAUCOMA 1, OPEN ANGLE, O; GLC1O
613101 HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 5; FHL5
613102 HYPOTRICHOSIS AND RECURRENT SKIN VESICLES
613105 CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2
613107 NEUTROPENIA, SEVERE CONGENITAL, 2, AUTOSOMAL DOMINANT; SCN2
613108 CANDIDIASIS, FAMILIAL, 4; CANDF4
613112 MACROTHROMBOCYTOPENIA, AUTOSOMAL DOMINANT, TUBB1-RELATED
613115 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B
613116 THROMBOPHILIA DUE TO HISTIDINE-RICH GLYCOPROTEIN DEFICIENCY; THPH11
613118 ANTITHROMBIN III DEFICIENCY; AT3D
613119 BRUGADA SYNDROME 6; BRGDA6
613120 BRUGADA SYNDROME 7; BRGDA7
613122 CARDIOMYOPATHY, DILATED, 1CC; CMD1CC
613123 BRUGADA SYNDROME 8; BRGDA8
613135 PARKINSONISM-DYSTONIA, INFANTILE; PKDYS
613148 INFLAMMATORY BOWEL DISEASE 28, AUTOSOMAL RECESSIVE; IBD28
613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),
613152 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION),
613153 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
613155 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),
613156 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),
613157 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 3; MDDGC3
613158 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 2; MDDGC2
613159 NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1; NPHPL1
613161 BETA-UREIDOPROPIONASE DEFICIENCY
613162 SPASTIC PARAPLEGIA 45, AUTOSOMAL RECESSIVE; SPG45
613163 GABA-TRANSAMINASE DEFICIENCY
613172 CARDIOMYOPATHY, DILATED, 1DD; CMD1DD
613174 CHROMOSOME 5p13 DUPLICATION SYNDROME
613177 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C
613179 PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY
613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA
613192 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13
613193 CILIARY DYSKINESIA, PRIMARY, 13; CILD13
613194 RETINITIS PIGMENTOSA 50; RP50
613195 WEILL-MARCHESANI-LIKE SYNDROME
613204 MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY
613205 MUSCULAR DYSTROPHY, CONGENITAL, LMNA-RELATED
613206 SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44
613211 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA3; AI2A3
613215 CHROMOSOME 17p13.3, CENTROMERIC, DUPLICATION SYNDROME
613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C
613217 DIARRHEA 5, WITH TUFTING ENTEROPATHY, CONGENITAL; DIAR5
613223 LEPROSY, SUSCEPTIBILITY TO, 5; LPRS5
613224 NOONAN SYNDROME 6; NS6
613225 FACTOR XIII, A SUBUNIT, DEFICIENCY OF
613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME
613229 TRICHOTILLOMANIA; TTM
613235 FACTOR XIII, B SUBUNIT, DEFICIENCY OF
613237 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 5; FSGS5
613239 THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2
613243 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 13; CMH13
613244 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8
613251 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 14; CMH14
613252 CARDIOMYOPATHY, DILATED, 1EE; CMD1EE
613254 TUBEROUS SCLEROSIS 2; TSC2
613255 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15; CMH15
613265 WAARDENBURG SYNDROME, TYPE 4B; WS4B
613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C
613268 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 4; FECD4
613270 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 6; FECD6
613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25
613286 CARDIOMYOPATHY, DILATED, 1FF; CMD1FF
613287 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N; CMT2N
613291 BILE ACID MALABSORPTION, PRIMARY; PBAM
613307 DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79
613308 DIAMOND-BLACKFAN ANEMIA 9; DBA9
613309 DIAMOND-BLACKFAN ANEMIA 10; DBA10
613310 EXUDATIVE VITREORETINOPATHY 5; EVR5
613312 HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE, 2; ARHR2
613313 HEMOCHROMATOSIS, TYPE 2B; HFE2B
613319 MIYOSHI MUSCULAR DYSTROPHY 3; MMD3
613325 RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2
613327 LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4
613329 PLASMINOGEN ACTIVATOR INHIBITOR-1 DEFICIENCY
613330 SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD
613341 LEBER CONGENITAL AMAUROSIS 14; LCA14
613345 HYPOKALEMIC PERIODIC PARALYSIS, TYPE 2; HOKPP2
613347 PANCREATIC CANCER, SUSCEPTIBILITY TO, 2
613348 PANCREATIC CANCER, SUSCEPTIBILITY TO, 3
613353 MONONEUROPATHY OF THE MEDIAN NERVE, MILD; MNMN
613355 CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME
613370 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 10; MODY10
613375 MATURITY-ONSET DIABETES OF THE YOUNG, TYPE 11; MODY11
613376 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIC; HMN2C
613382 BRACHYDACTYLY, TYPE E2; BDE2
613385 AUTOIMMUNE DISEASE, SYNDROMIC MULTISYSTEM
613388 FANCONI RENOTUBULAR SYNDROME 2; FRTS2
613390 FANCONI ANEMIA, COMPLEMENTATION GROUP O; FANCO
613391 DEAFNESS, AUTOSOMAL RECESSIVE 84A; DFNB84A
613393 BIRBECK GRANULE DEFICIENCY
613398 WARSAW BREAKAGE SYNDROME; WABS
613399 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 3; BROVCA3
613402 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 10; EIEE10
613404 ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2; ARCS2
613406 CHROMOSOME 15q24 DELETION SYNDROME
613410 AUTISM, SUSCEPTIBILITY TO, 16; AUTS16
613411 OGUCHI DISEASE 2
613418 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 15; BMND15
613424 CARDIOMYOPATHY, DILATED, 1R; CMD1R
613426 CARDIOMYOPATHY, DILATED, 1S; CMD1S
613428 RETINITIS PIGMENTOSA 54; RP54
613435 AMYOTROPHIC LATERAL SCLEROSIS 12; ALS12
613436 AUTISM, SUSCEPTIBILITY TO, 17; AUTS17
613443 MENTAL RETARDATION, AUTOSOMAL DOMINANT 20; MRD20
613444 CHROMOSOME 16p11.2 DELETION SYNDROME, 220-KB
613451 FRONTONASAL DYSPLASIA 2; FND2
613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91
613454 RETT SYNDROME, CONGENITAL VARIANT
613456 FRONTONASAL DYSPLASIA 3; FND3
613457 CHROMOSOME 14q11-q22 DELETION SYNDROME
613458 CHROMOSOME 16p13.3 DUPLICATION SYNDROME
613463 FASTING PLASMA GLUCOSE LEVEL QUANTITATIVE TRAIT LOCUS 5; FGQTL5
613464 RETINITIS PIGMENTOSA 51; RP51
613470 HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE
613471 REYNOLDS SYNDROME
613477 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5; EIEE5
613480 LYMPHEDEMA, HEREDITARY, IC
613485 LONG QT SYNDROME 13; LQT13
613488 MYXOID LIPOSARCOMA
613489 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J
613490 ALPHA-1-ANTITRYPSIN DEFICIENCY
613493 IMMUNODEFICIENCY, COMMON VARIABLE, 3; CVID3
613494 IMMUNODEFICIENCY, COMMON VARIABLE, 4; CVID4
613495 IMMUNODEFICIENCY, COMMON VARIABLE, 5; CVID5
613496 IMMUNODEFICIENCY, COMMON VARIABLE, 6; CVID6
613500 AGAMMAGLOBULINEMIA 2, AUTOSOMAL RECESSIVE; AGM2
613501 AGAMMAGLOBULINEMIA 3, AUTOSOMAL RECESSIVE; AGM3
613502 AGAMMAGLOBULINEMIA 4, AUTOSOMAL RECESSIVE; AGM4
613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5
613507 GLYCOGEN STORAGE DISEASE XV; GSD15
613508 SODIUM SERUM LEVEL QUANTITATIVE TRAIT LOCUS 1; SSQTL1
613509 CHROMOSOME 4q21 DELETION SYNDROME
613517 MICROPHTHALMIA, ISOLATED 6; MCOP6
613523 CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
613533 CHROMOSOME 17q21.31 DUPLICATION SYNDROME
613544 CHROMOSOME 6q11-q14 DELETION SYNDROME
613546 AROMATASE DEFICIENCY
613550 NEPHRONOPHTHISIS 11; NPHP11
613551 AUTOIMMUNE DISEASE, SUSCEPTIBILITY TO, 6; AIS6
613554 VON WILLEBRAND DISEASE, TYPE 2; VWD2
613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51
613559 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7
613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2
613563 NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC
613564 CHROMOSOME 2p12-p11.2 DELETION SYNDROME
613566 FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 6; HBFQTL6
613571 DISORDERED STEROIDOGENESIS DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY
613573 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1; EDSS1
613575 RETINITIS PIGMENTOSA 55; RP55
613581 RETINITIS PIGMENTOSA 56; RP56
613582 RETINITIS PIGMENTOSA 57; RP57
613587 OCCULT MACULAR DYSTROPHY; OCMD
613589 LOW DENSITY LIPOPROTEIN CHOLESTEROL LEVEL QUANTITATIVE TRAIT LOCUS
613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME
613604 CHROMOSOME 16p12.2-p11.2 DELETION SYNDROME, 7.1- TO 8.7-MB
613610 CRANIOECTODERMAL DYSPLASIA 2; CED2
613611 CHOANAL ATRESIA AND LYMPHEDEMA
613612 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIi; CDG2I
613615 SENIOR-LOKEN SYNDROME 7; SLSN7
613616 HYPEROXALURIA, PRIMARY, TYPE III; HP3
613617 RETINITIS PIGMENTOSA 58; RP58
613618 CHROMOSOME 17q23.1-q23.2 DUPLICATION SYNDROME
613625 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, 2; F5F8D2
613630 COCOON SYNDROME
613638 CHROMOSOME 19p13.13 DELETION SYNDROME
613640 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C
613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB
613642 CARDIOMYOPATHY, DILATED, 1GG; CMD1GG
613643 PARKINSON DISEASE 5, AUTOSOMAL DOMINANT; PARK5
613646 METHYLMALONIC ACIDURIA DUE TO TRANSCOBALAMIN RECEPTOR DEFECT
613647 SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48
613652 C1q DEFICIENCY; C1QD
613656 MIGRAINE, WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 13; MGR13
613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2
613659 GASTRIC CANCER
613660 CONE-ROD DYSTROPHY 15; CORD15
613661 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P
613662 MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B
613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY
613670 MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND AUTISTIC FEATURES
613671 MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS;
613672 SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4
613673 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE IV; CDAN4
613674 VESICOURETERAL REFLUX 3; VUR3
613675 CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB
613676 SECKEL SYNDROME 4; SCKL4
613677 HYPERALDOSTERONISM, FAMILIAL, TYPE III
613679 PROTHROMBIN DEFICIENCY, CONGENITAL
613680 BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS
613681 CHROMOSOME 2q31.1 DUPLICATION SYNDROME
613684 RUBINSTEIN-TAYBI SYNDROME 2; RSTS2
613686 SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4
613688 LONG QT SYNDROME 2; LQT2
613690 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7
613693 LONG QT SYNDROME 6; LQT6
613694 CARDIOMYOPATHY, DILATED, 1U; CMD1U
613695 LONG QT SYNDROME 5; LQT5
613697 CARDIOMYOPATHY, DILATED, 1V; CMD1V
613700 SUPERNUMERARY DER(22)t(8;22) SYNDROME
613702 KLIPPEL-FEIL SYNDROME 3, AUTOSOMAL DOMINANT; KFS3
613703 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6; MCOPCB6
613704 MICROPHTHALMIA, ISOLATED 7; MCOP7
613705 OROFACIAL CLEFT 10; OFC10
613706 NOONAN SYNDROME 7; NS7
613707 LEOPARD SYNDROME 3
613708 NEUROPATHY, HEREDITARY SENSORY, TYPE ID; HSN1D
613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATION
613711 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 3; HSCR3
613712 HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 4; HSCR4
613717 TREACHER COLLINS SYNDROME 2; TCS2
613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74
613720 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7; EIEE7
613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11
613722 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 12; EIEE12
613723 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Q; LGMD2Q
613724 LEUKOENCEPHALOPATHY WITH DYSTONIA AND MOTOR NEUROPATHY
613728 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 10; SCAR10
613729 CHROMOSOME 7q11.23 DELETION SYNDROME, DISTAL, 1.2-MB
613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,
613731 RETINITIS PIGMENTOSA 4; RP4
613735 CHROMOSOME 1p32-p31 DELETION SYNDROME
613736 ACNE INVERSA, FAMILIAL, 2; ACNINV2
613737 ACNE INVERSA, FAMILIAL, 3; ACNINV3
613740 CARDIOMYOPATHY, DILATED, 1T; CMD1T
613743 ADRENAL INSUFFICIENCY, CONGENITAL, WITH 46,XY SEX REVERSAL, PARTIAL
613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51
613750 RETINITIS PIGMENTOSA 27; RP27
613751 HETEROTAXY, VISCERAL, 4, AUTOSOMAL; HTX4
613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY
613756 RETINITIS PIGMENTOSA 49; RP49
613757 MACULAR DEGENERATION, AGE-RELATED, 6; ARMD6
613758 RETINITIS PIGMENTOSA 47; RP47
613759 INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND
613761 MACULAR DEGENERATION, AGE-RELATED, 5; ARMD5
613762 46,XY SEX REVERSAL 6; SRXY6
613763 CATARACT 16, MULTIPLE TYPES; CTRCT16
613765 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 9; CMH9
613767 RETINITIS PIGMENTOSA 45; RP45
613769 RETINITIS PIGMENTOSA 44; RP44
613776 CHROMOSOME 17p13.1 DELETION SYNDROME
613778 MACULAR DEGENERATION, AGE-RELATED, 8; ARMD8
613779 COMPLEMENT COMPONENT 3 DEFICIENCY, AUTOSOMAL RECESSIVE; C3D
613780 AORTIC ANEURYSM, FAMILIAL THORACIC 7; AAT7
613783 COMPLEMENT COMPONENT C1s DEFICIENCY; C1SD
613784 MACULAR DEGENERATION, AGE-RELATED, 12; ARMD12
613789 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE II; C8D2
613790 COMPLEMENT COMPONENT 8 DEFICIENCY, TYPE I; C8D1
613791 MASP2 DEFICIENCY
613792 CHROMOSOME 3pter-p25 DELETION SYNDROME
613793 BLOOD GROUP, CROMER SYSTEM; CROM
613794 RETINITIS PIGMENTOSA 20; RP20
613795 LOEYS-DIETZ SYNDROME 3; LDS3
613796 MYCOBACTERIAL AND VIRAL INFECTIONS, SUSCEPTIBILITY TO, AUTOSOMAL RECESSIVE
613800 MEIER-GORLIN SYNDROME 2; MGORS2
613801 RETINITIS PIGMENTOSA 40; RP40
613803 MEIER-GORLIN SYNDROME 3; MGORS3
613804 MEIER-GORLIN SYNDROME 4; MGORS4
613805 MEIER-GORLIN SYNDROME 5; MGORS5
613807 CILIARY DYSKINESIA, PRIMARY, 14; CILD14
613808 CILIARY DYSKINESIA, PRIMARY, 15; CILD15
613809 RETINITIS PIGMENTOSA 39; RP39
613810 RETINITIS PIGMENTOSA 43; RP43
613811 PONTOCEREBELLAR HYPOPLASIA, TYPE 2D; PCH2D
613812 BILE ACID SYNTHESIS DEFECT, CONGENITAL, 3; CBAS3
613818 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9
613819 SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4
613820 NEPHRONOPHTHISIS 12; NPHP12
613823 SECKEL SYNDROME 5; SCKL5
613824 NEPHRONOPHTHISIS 9; NPHP9
613825 COMPLEMENT COMPONENT 9 DEFICIENCY; C9D
613826 LEBER CONGENITAL AMAUROSIS 6; LCA6
613827 RETINITIS PIGMENTOSA 48; RP48
613829 LEBER CONGENITAL AMAUROSIS 7; LCA7
613830 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1D; CSNB1D
613832 EPILEPSY, PROGRESSIVE MYOCLONIC 5; EPM5
613834 MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME
613835 LEBER CONGENITAL AMAUROSIS 8; LCA8
613837 LEBER CONGENITAL AMAUROSIS 11; LCA11
613838 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 16; CMH16
613839 MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY
613843 LEBER CONGENITAL AMAUROSIS 15; LCA15
613845 HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS
613848 OSTEOGENESIS IMPERFECTA, TYPE X
613849 OSTEOGENESIS IMPERFECTA, TYPE XII; OI12
613850 INOSINE TRIPHOSPHATASE DEFICIENCY
613852 FUCOSYLTRANSFERASE 6 DEFICIENCY
613853 TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 2; DTGA2
613854 TRANSPOSITION OF THE GREAT ARTERIES, DEXTRO-LOOPED 3; DTGA3
613855 EPISODIC ATAXIA, TYPE 5; EA5
613856 ACHROMATOPSIA 4; ACHM4
613860 IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY
613861 RETINITIS PIGMENTOSA 59; RP59
613862 RETINITIS PIGMENTOSA 38; RP38
613863 GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 7; GEFSP7
613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61
613869 MYOPATHY, MYOFIBRILLAR, FATAL INFANTILE HYPERTONIC, ALPHA-B CRYSTALLIN-RELATED
613870 HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION
613873 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 17; CMH17
613874 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 18; CMH18
613875 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 19; CMH19
613876 CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 20; CMH20
613877 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 4; FPLD4
613881 CARDIOMYOPATHY, DILATED, 1HH; CMD1HH
613882 HYPOMAGNESEMIA 6, RENAL; HOMG6
613884 CHROMOSOME 13q14 DELETION SYNDROME
613885 MECKEL SYNDROME, TYPE 8; MKS8
613886 OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY
613887 CATARACT 36; CTRCT36
613908 SPINOCEREBELLAR ATAXIA 35; SCA35
613912 COMPLEMENT FACTOR D DEFICIENCY; CFDD
613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89
613925 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A
613926 MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING,
613943 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 8; ARCI8
613949 OKT4 EPITOPE DEFICIENCY
613950 SCHIZOPHRENIA 15; SCZD15
613951 FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP
613953 CANDIDIASIS, FAMILIAL, 5; CANDF5
613954 AMYOTROPHIC LATERAL SCLEROSIS 14, WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA;
613955 AMYLOIDOSIS, PRIMARY LOCALIZED CUTANEOUS, 2; PLCA2
613956 CANDIDIASIS, FAMILIAL, 6; CANDF6
613957 SPERMATOGENIC FAILURE 8; SPGF8
613958 SPERMATOGENIC FAILURE 9; SPGF9
613959 SCHIZOPHRENIA 16; SCZD16
613960 GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE,
613970 MENTAL RETARDATION, AUTOSOMAL DOMINANT 6; MRD6
613972 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 6; CMM6
613977 CYANOSIS, TRANSIENT NEONATAL; TNCY
613978 HEMOGLOBIN H DISEASE; HBH
613980 ATRIAL FIBRILLATION, FAMILIAL, 9; ATFB9
613981 HYPOTRICHOSIS 3; HYPT3
613982 OSTEOGENESIS IMPERFECTA, TYPE VI; OI6
613983 RETINITIS PIGMENTOSA 60; RP60
613985 BETA-THALASSEMIA
613986 PITUITARY HORMONE DEFICIENCY, COMBINED, 6; CPHD6
613987 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 2; DKCB2
613988 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3; DKCB3
613989 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 2; DKCA2
613990 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 3; DKCA3
614008 NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS
614009 BLEEDING DISORDER, PLATELET-TYPE, 13, SUSCEPTIBILITY TO; BDPLT13
614017 CILIARY DYSKINESIA, PRIMARY, 16; CILD16
614018 EPILEPSY, PROGRESSIVE MYOCLONIC 6; EPM6
614019 LISSENCEPHALY 4; LIS4
614020 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14; MRT14
614022 ATRIAL FIBRILLATION, FAMILIAL, 10; ATFB10
614023 PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD
614024 PROTEIN Z DEFICIENCY
614025 HEPATIC LIPASE DEFICIENCY
614028 HYPERALPHALIPOPROTEINEMIA 2; HALP2
614034 HEME OXYGENASE 1 DEFICIENCY; HMOX1D
614035 DEAFNESS, AUTOSOMAL RECESSIVE 29; DFNB29
614038 LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA
614039 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1; CDCBM1
614042 MOYAMOYA DISEASE 5; MYMY5
614049 ATRIAL FIBRILLATION, FAMILIAL, 11; ATFB11
614050 ATRIAL FIBRILLATION, FAMILIAL, 12; ATFB12
614052 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2;
614053 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 3;
614063 N-ACETYLASPARTATE DEFICIENCY; NACED
614065 MYOPATHY, DISTAL, 4; MPD4
614066 SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47
614067 SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE; SPG52
614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME
614070 PSORIASIS SUSCEPTIBILITY 13; PSORS13
614072 HERMANSKY-PUDLAK SYNDROME 3; HPS3
614073 HERMANSKY-PUDLAK SYNDROME 4; HPS4
614074 HERMANSKY-PUDLAK SYNDROME 5; HPS5
614075 HERMANSKY-PUDLAK SYNDROME 6; HPS6
614076 HERMANSKY-PUDLAK SYNDROME 7; HPS7
614077 HERMANSKY-PUDLAK SYNDROME 8; HPS8
614078 CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE
614079 ASPERGILLOSIS, SUSCEPTIBILITY TO
614080 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1
614081 ANHAPTOGLOBINEMIA; AHP
614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG
614083 FANCONI ANEMIA, COMPLEMENTATION GROUP L; FANCL
614087 FANCONI ANEMIA, COMPLEMENTATION GROUP M; FANCM
614089 ATRIAL SEPTAL DEFECT 3; ASD3
614090 SICK SINUS SYNDROME 3, SUSCEPTIBILITY TO; SSS3
614091 SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7
614096 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 8; COXPD8
614097 ACATALASEMIA
614099 CRANIOECTODERMAL DYSPLASIA 3; CED3
614102 IMMUNOGLOBULIN KAPPA LIGHT CHAIN DEFICIENCY; IGKCD
614104 MENTAL RETARDATION, AUTOSOMAL DOMINANT 7; MRD7
614105 METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY; MMSDHD
614111 PYRUVATE DEHYDROGENASE E1-BETA DEFICIENCY; PDHBD
614113 MENTAL RETARDATION, AUTOSOMAL DOMINANT 2; MRD2
614114 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2
614115 CORTICAL MALFORMATIONS, OCCIPITAL; OCCM
614116 NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E
614120 HYDROLETHALUS SYNDROME 2; HLS2
614122 CHITOTRIOSIDASE DEFICIENCY; CHITD
614128 LACTATE DEHYDROGENASE B DEFICIENCY; LDHBD
614129 PERRAULT SYNDROME 3; PRLTS3
614131 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 6; FSGS6
614134 STICKLER SYNDROME, TYPE IV; STL4
614135 EPIPHYSEAL DYSPLASIA, MULTIPLE, 6; EDM6
614152 DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64
614153 SPINOCEREBELLAR ATAXIA 36; SCA36
614156 HYPERBILIVERDINEMIA; HBLVD
614157 NAIL DISORDER, NONSYNDROMIC CONGENITAL, 10; NDNC10
614160 MUSCLE HYPERTROPHY; MSLHP
614162 CANDIDIASIS, FAMILIAL, 7; CANDF7
614163 DELAYED SLEEP PHASE SYNDROME, SUSCEPTIBILITY TO; DSPS
614165 PARAGANGLIOMAS 5; PGL5
614167 MYOPIA 21, AUTOSOMAL DOMINANT; MYP21
614170 BRITTLE CORNEA SYNDROME 2; BCS2
614171 HERMANSKY-PUDLAK SYNDROME 9; HPS9
614172 IMMUNODEFICIENCY 21; IMD21
614173 JOUBERT SYNDROME 13; JBTS13
614175 MECKEL SYNDROME, TYPE 10; MKS10
614180 RETINITIS PIGMENTOSA 61; RP61
614181 RETINITIS PIGMENTOSA 62; RP62
614185 GELEOPHYSIC DYSPLASIA 2; GPHYSD2
614186 LEBER CONGENITAL AMAUROSIS 16; LCA16
614188 CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA
614190 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 3; PPNAD3
614192 MACROCEPHALY, MACROSOMIA, FACIAL DYSMORPHISM SYNDROME; MMFD
614193 TRANSFERRIN SERUM LEVEL QUANTITATIVE TRAIT LOCUS 2; TFQTL2
614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS
614196 NEPHROTIC SYNDROME, TYPE 6; NPHS6
614198 MYASTHENIC SYNDROME, CONGENITAL, ACETAZOLAMIDE-RESPONSIVE
614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;
614201 BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11
614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15
614203 PARKINSON DISEASE 17; PARK17
614204 PUSTULAR PSORIASIS, GENERALIZED; PSORP
614205 THREE M SYNDROME 3; 3M3
614207 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3
614209 MECKEL SYNDROME, TYPE 9; MKS9
614212 ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4
614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C
614219 ADAMS-OLIVER SYNDROME 2; AOS2
614222 WARBURG MICRO SYNDROME 3; WARBM3
614224 RETINAL ARTERIAL MACROANEURYSM WITH SUPRAVALVULAR PULMONIC STENOSIS;
614225 WARBURG MICRO SYNDROME 2; WARBM2
614226 HOLOPROSENCEPHALY 11; HPE11
614228 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O
614229 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11
614230 CHROMOSOME 8q21.11 DELETION SYNDROME
614231 MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME; MEDS
614249 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18; MRT18
614250 NARCOLEPSY 7; NRCLP7
614251 PARKINSON DISEASE 18; PARK18
614254 MENTAL RETARDATION, AUTOSOMAL DOMINANT 8; MRD8
614255 MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9
614256 MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10
614257 MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11
614261 MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME; MICCAP
614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA
614266 BARRETT ESOPHAGUS
614278 PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY; PAFAD
614279 46,XY SEX REVERSAL 8; SRXY8
614284 STICKLER SYNDROME, TYPE V; STL5
614286 MYELODYSPLASTIC SYNDROME; MDS
614290 TETRASOMY 18p
614291 BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 4; BROVCA4
614292 MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD
614293 HYDATIDIFORM MOLE, RECURRENT, 2; HYDM2
614294 CHROMOSOME 15q25 DELETION SYNDROME
614296 WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL
614298 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4
614299 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2; MMDS2
614300 HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY
614302 EMERY-DREIFUSS MUSCULAR DYSTROPHY 7, AUTOSOMAL DOMINANT; EDMD7
614303 EDICT SYNDROME; EDICT
614305 SCLEROSTEOSIS 2; SOST2
614306 COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT
614307 ALPHA-METHYLACYL-CoA RACEMASE DEFICIENCY; AMACRD
614320 PANCREATIC CANCER, SUSCEPTIBILITY TO, 4; PNCA4
614321 MYOPATHY, DISTAL, TATEYAMA TYPE; MPDT
614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12
614324 OVARIAN DYSGENESIS 3; ODG3
614325 PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2
614326 FEINGOLD SYNDROME 2; FGLDS2
614327 TUMOR PREDISPOSITION SYNDROME; TPDS
614328 INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL; NISBD
614331 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6
614332 CHROMOSOME 2p16.3 DELETION SYNDROME
614335 ARTHROGRYPOSIS, DISTAL, TYPE 1B; DA1B
614337 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4
614340 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27; MRT27
614350 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5; HNPCC5
614369 PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH
614370 SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 5; SMDP5
614371 DENGUE VIRUS, SUSCEPTIBILITY TO
614372 MANNOSE-BINDING PROTEIN DEFICIENCY
614373 AMYOTROPHIC LATERAL SCLEROSIS 16, JUVENILE; ALS16
614374 BLOOD GROUP, CHIDO/RODGERS SYSTEM
614376 SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5
614377 NEPHRONOPHTHISIS 13; NPHP13
614378 CRANIOECTODERMAL DYSPLASIA 4; CED4
614379 COMPLEMENT COMPONENT 4B DEFICIENCY; C4BD
614380 COMPLEMENT COMPONENT 4A DEFICIENCY; C4AD
614381 LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR
614382 BACTEREMIA, SUSCEPTIBILITY TO, 1; BACTS1
614383 BACTEREMIA, SUSCEPTIBILITY TO, 2; BACTS2
614385 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7
614388 ENCEPHALOPATHY, LETHAL, DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL
614389 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 1; RPRGL1
614390 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 2; RPRGL2
614391 PREGNANCY LOSS, RECURRENT, SUSCEPTIBILITY TO, 3; RPRGL3
614395 GRAFT-VERSUS-HOST DISEASE, SUSCEPTIBILITY TO; GVHDS
614399 MYOPATHY, AREFLEXIA, RESPIRATORY DISTRESS, AND DYSPHAGIA, EARLY-ONSET;
614400 GLUCOCORTICOID THERAPY, RESPONSE TO; GCTR
614401 ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO; ACTFS
614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11
614408 MYOPATHY, CENTRONUCLEAR, 3; CNM3
614409 SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46
614411 GLYCEROL QUANTITATIVE TRAIT LOCUS; GLYCQTL
614415 CHILBLAIN LUPUS 2; CHBL2
614416 RADIOHUMERAL FUSIONS WITH OTHER SKELETAL AND CRANIOFACIAL ANOMALIES;
614417 EPILEPSY, FAMILIAL TEMPORAL LOBE, 5; ETL5
614418 FEBRILE SEIZURES, FAMILIAL, 11; FEB11
614419 ASPARTATE AMINOTRANSFERASE, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
614420 SYSTEMIC LUPUS ERYTHEMATOSUS 16; SLEB16
614424 JOUBERT SYNDROME 14; JBTS14
614429 VENTRICULAR SEPTAL DEFECT 1; VSD1
614430 ATRIOVENTRICULAR SEPTAL DEFECT 4; AVSD4
614431 VENTRICULAR SEPTAL DEFECT 2; VSD2
614432 VENTRICULAR SEPTAL DEFECT 3; VSD3
614433 ATRIAL SEPTAL DEFECT 8; ASD8
614434 CUTIS LAXA, AUTOSOMAL DOMINANT 2; ADCL2
614435 HYPOPLASTIC LEFT HEART SYNDROME 2; HLHS2
614436 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P
614437 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB; ARCL1B
614438 CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIB; ARCL3B
614441 HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 2; PHOAR2
614450 HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6
614455 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE E; CMTDIE
614456 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8
614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR
614458 THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY
614462 PYRUVATE DEHYDROGENASE LIPOIC ACID SYNTHETASE DEFICIENCY; PDHLD
614464 JOUBERT SYNDROME 15; JBTS15
614465 JOUBERT SYNDROME 16; JBTS16
614466 CORONARY HEART DISEASE, SUSCEPTIBILITY TO, 6; CHDS6
614468 FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS3
614470 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME, TYPE IV; ALPS4
614473 ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 2; GACI2
614474 ATRIOVENTRICULAR SEPTAL DEFECT 5; AVSD5
614475 ATRIAL SEPTAL DEFECT 9; ASD9
614480 HYPERTRIGLYCERIDEMIA, TRANSIENT INFANTILE; HTGTI
614482 CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND
614483 PORENCEPHALY 2; POREN2
614485 TRIGONOCEPHALY 2; TRIGNO2
614486 THROMBOPHILIA DUE TO THROMBOMODULIN DEFECT; THPH12
614487 SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE; SPAX5
614490 BLOOD GROUP, JUNIOR SYSTEM; JR
614491 PSEUDOHYPOALDOSTERONISM, TYPE IIB; PHA2B
614492 PSEUDOHYPOALDOSTERONISM, TYPE IIC; PHA2C
614493 WISKOTT-ALDRICH SYNDROME 2; WAS2
614495 PSEUDOHYPOALDOSTERONISM, TYPE IID; PHA2D
614496 PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E
614497 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 7; MCOPCB7
614498 RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL
614499 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34; MRT34
614500 CONE-ROD DYSTROPHY 16; CORD16
614501 PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM; 
614504 USHER SYNDROME, TYPE IIIB; USH3B
614507 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ir; CDG1R
614508 MIRROR MOVEMENTS 2; MRMV2
614514 THROMBOPHILIA DUE TO PROTEIN S DEFICIENCY, AUTOSOMAL RECESSIVE; THPH6
614519 HEMORRHAGE, INTRACEREBRAL, SUSCEPTIBILITY TO; ICH
614521 THROMBOCYTHEMIA 3; THCYT3
614524 FIBROCHONDROGENESIS 2; FBCG2
614526 CHROMOSOME 17q12 DUPLICATION SYNDROME
614527 CHROMOSOME 17q12 DELETION SYNDROME
614541 CHROMOSOME 16q22 DELETION SYNDROME
614546 EFAVIRENZ, POOR METABOLISM OF
614557 EHLERS-DANLOS SYNDROME WITH PROGRESSIVE KYPHOSCOLIOSIS, MYOPATHY,
614558 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13; EIEE13
614559 INFANTILE CEREBELLAR-RETINAL DEGENERATION; ICRD
614562 MENTAL RETARDATION, AUTOSOMAL DOMINANT 12; MRD12
614563 MENTAL RETARDATION, AUTOSOMAL DOMINANT 13; MRD13
614564 CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS
614565 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E; CSNB1E
614576 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L
614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9
614583 BARAITSER-WINTER SYNDROME 2; BRWS2
614592 BENT BONE DYSPLASIA SYNDROME; BBDS
614594 PALMOPLANTAR KERATODERMA, MUTILATING, WITH PERIORIFICIAL KERATOTIC
614595 PREECLAMPSIA/ECLAMPSIA 5; PEE5
614602 TRICHOHEPATOENTERIC SYNDROME 2; THES2
614607 MENTAL RETARDATION, AUTOSOMAL DOMINANT 14; MRD14
614608 MENTAL RETARDATION, AUTOSOMAL DOMINANT 15; MRD15
614609 MENTAL RETARDATION, AUTOSOMAL DOMINANT 16; MRD16
614613 ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS2
614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B
614615 JOUBERT SYNDROME 17; JBTS17
614616 DIARRHEA 6; DIAR6
614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86
614618 HYPEREKPLEXIA 3; HKPX3
614619 HYPEREKPLEXIA 2; HKPX2
614621 UV-SENSITIVE SYNDROME 2; UVSS2
614640 UV-SENSITIVE SYNDROME 3; UVSS3
614643 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6
614651 COENZYME Q10 DEFICIENCY, PRIMARY, 2; COQ10D2
614652 COENZYME Q10 DEFICIENCY, PRIMARY, 3; COQ10D3
614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6
614654 COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5
614662 CORTISONE REDUCTASE DEFICIENCY 2; CORTRD2
614665 MECONIUM ILEUS
614669 AURICULOCONDYLAR SYNDROME 2; ARCND2
614671 CHROMOSOME 16p11.2 DUPLICATION SYNDROME
614672 CARDIOMYOPATHY, DILATED, 2B; CMD2B
614673 MICROCEPHALY 8, PRIMARY, AUTOSOMAL RECESSIVE; MCPH8
614674 PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT
614675 BONE MARROW FAILURE SYNDROME 1; BMFS1
614678 PONTOCEREBELLAR HYPOPLASIA, TYPE 1B; PCH1B
614679 CILIARY DYSKINESIA, PRIMARY, 17; CILD17
614680 INFLUENZA, SEVERE, SUSCEPTIBILITY TO
614689 SOLUBLE INTERLEUKIN-6 RECEPTOR, SERUM LEVEL OF, QUANTITATIVE TRAIT
614691 CATARACT 38; CTRCT38
614696 AMYOTROPHIC LATERAL SCLEROSIS 17; ALS17
614699 IMMUNODEFICIENCY, COMMON VARIABLE, 7; CVID7
614700 IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID8
614701 CORNELIA DE LANGE SYNDROME 4; CDLS4
614702 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10; COXPD10
614706 CEROID LIPOFUSCINOSIS, NEURONAL, 11; CLN11
614707 BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2
614723 ADENINE PHOSPHORIBOSYLTRANSFERASE DEFICIENCY; APRTD
614727 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIk; CDG2K
614728 SECKEL SYNDROME 6; SCKL6
614731 PROSTATE CANCER, HEREDITARY, 2; HPC2
614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA
614736 GLUCOCORTICOID DEFICIENCY 4; GCCD4
614739 3-@METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE
614740 BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7; BCC7
614741 MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY; MPYCD
614742 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1;
614743 PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2;
614744 FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3
614745 BLOOD GROUP, JOHN MILTON HAGEN SYSTEM
614748 INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA,
614749 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2
614750 MYASTHENIC SYNDROME, CONGENITAL, WITH TUBULAR AGGREGATES 2; CMSTA2
614751 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE VB; HMN5B
614752 INTERLEUKIN 6, SERUM LEVEL OF, QUANTITATIVE TRAIT LOCUS
614753 SOTOS SYNDROME 2; SOTOS2
614756 CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR
614779 HETEROTAXY, VISCERAL, 6, AUTOSOMAL; HTX6
614782 TREMOR, HEREDITARY ESSENTIAL, 4; ETM4
614800 SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH
614807 MYOPATHY, CENTRONUCLEAR, 4; CNM4
614808 AMYOTROPHIC LATERAL SCLEROSIS 18; ALS18
614809 CFHR5 DEFICIENCY
614810 MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO, 5; MS5
614813 SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS;
614814 ADAMS-OLIVER SYNDROME 3; AOS3
614815 JOUBERT SYNDROME 18; JBTS18
614816 LOEYS-DIETZ SYNDROME 4; LDS4
614817 INTERSTITIAL NEPHRITIS, KARYOMEGALIC; KMIN
614819 WEILL-MARCHESANI SYNDROME 3; WMS3
614820 ALTERNATING HEMIPLEGIA OF CHILDHOOD 2; AHC2
614822 SPERMATOGENIC FAILURE 10; SPGF10
614823 AORTIC VALVE DISEASE 2; AOVD2
614830 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
614831 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13; SCAR13
614832 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA4; AI2A4
614833 POLYMICROGYRIA WITH SEIZURES; PMGYS
614837 HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8
614838 HYPOGONADOTROPIC HYPOGONADISM 9 WITH OR WITHOUT ANOSMIA; HH9
614839 HYPOGONADOTROPIC HYPOGONADISM 10 WITH OR WITHOUT ANOSMIA; HH10
614840 HYPOGONADOTROPIC HYPOGONADISM 11 WITH OR WITHOUT ANOSMIA; HH11
614841 HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA; HH12
614842 HYPOGONADOTROPIC HYPOGONADISM 13 WITH OR WITHOUT ANOSMIA; HH13
614844 NEPHRONOPHTHISIS 14; NPHP14
614845 NEPHRONOPHTHISIS 15; NPHP15
614846 TETRASOMY 15q26
614847 EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12; EIG12
614849 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 3
614850 HERPES SIMPLEX ENCEPHALITIS, SUSCEPTIBILITY TO, 4
614851 SECKEL SYNDROME 7; SCKL7
614852 MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE; MCPH9
614856 OSTEOGENESIS IMPERFECTA, TYPE XIII; OI13
614857 METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblJ TYPE; MAHCJ
614858 HYPOGONADOTROPIC HYPOGONADISM 14 WITH OR WITHOUT ANOSMIA; HH14
614859 PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A
614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98
614862 PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER); PBD4A
614863 PEROXISOME BIOGENESIS DISORDER 4B; PBD4B
614866 PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER); PBD5A
614867 PEROXISOME BIOGENESIS DISORDER 5B; PBD5B
614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITH
614869 USHER SYNDROME, TYPE IJ; USH1J
614870 PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A
614871 PEROXISOME BIOGENESIS DISORDER 6B; PBD6B
614872 PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A
614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B
614874 CILIARY DYSKINESIA, PRIMARY, 18; CILD18
614876 PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A
614877 PEROXISOME BIOGENESIS DISORDER 8B; PBD8B
614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;
614879 PEROXISOME BIOGENESIS DISORDER 9B; PBD9B
614880 HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA; HH15
614881 SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5; DSMA5
614882 PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A
614883 PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER); PBD11A
614885 PEROXISOME BIOGENESIS DISORDER 11B; PBD11B
614886 PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER); PBD12A
614887 PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER); PBD13A
614893 CD11C-POSITIVE/CD1C-POSITIVE DENDRITIC CELL DEFICIENCY, AUTOSOMAL
614894 MONOCYTE AND DENDRITIC CELL DEFICIENCY, AUTOSOMAL RECESSIVE
614895 CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 4F; CMT4F
614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD
614897 HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16
614898 SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE; SPG53
614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93
614900 DIAMOND-BLACKFAN ANEMIA 11; DBA11
614915 LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4
614916 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 4; CPVT4
614920 PEROXISOME BIOGENESIS DISORDER 14B; PEX14B
614921 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE It; CDG1T
614922 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11
614923 BRANCHED-CHAIN KETOACID DEHYDROGENASE KINASE DEFICIENCY; BCKDKD
614924 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12
614926 PERRAULT SYNDROME 2; PRLTS2
614929 ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7
614931 ECTODERMAL DYSPLASIA 9, HAIR/NAIL TYPE; ECTD9
614932 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13
614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70
614935 CILIARY DYSKINESIA, PRIMARY, 19; CILD19
614937 MYOCLONUS, FAMILIAL CORTICAL; FCM
614940 ECTODERMAL DYSPLASIA 11A, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL
614941 ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL
614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B
614945 DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B
614946 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14
614947 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15
614959 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14
614961 PONTOCEREBELLAR HYPOPLASIA, TYPE 8; PCH8
614962 LEPTIN DEFICIENCY; LEPD
614963 LEPTIN RECEPTOR DEFICIENCY
614970 JOUBERT SYNDROME 20; JBTS20
614972 CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3; ICP3
614974 FOCAL FACIAL DERMAL DYSPLASIA 4; FFDD4
614976 CARPENTER SYNDROME 2; CRPT2
614980 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 2; CHTD2
615005 EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5
615006 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15
615007 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4
615008 NEPHROTIC SYNDROME, TYPE 7; NPHS7
615009 MENTAL RETARDATION, AUTOSOMAL DOMINANT 17; MRD17
615010 AICARDI-GOUTIERES SYNDROME 6; AGS6
615011 PHOSPHOHYDROXYLYSINURIA; PHLU
615021 BLOOD GROUP, GLOBOSIDE SYSTEM; GLOB
615023 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 9; ARCI9
615024 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 10; ARCI10
615025 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q
615026 RIBOFLAVIN DEFICIENCY; RBFVD
615028 EPIDERMOLYSIS BULLOSA, NONSPECIFIC, AUTOSOMAL RECESSIVE; EBNS
615030 SPASTIC PARAPLEGIA 56, AUTOSOMAL RECESSIVE; SPG56
615031 SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE; SPG49
615032 AUTISM, SUSCEPTIBILITY TO, 18; AUTS18
615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54
615034 DYSTONIA 24; DYT24
615035 SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55
615040 EPISODIC PAIN SYNDROME, FAMILIAL, 1; FEPS1
615041 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
615042 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U
615043 SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43
615057 BLEPHAROPHIMOSIS-PTOSIS-INTELLECTUAL DISABILITY SYNDROME; BPIDS
615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F
615059 HYPOTRICHOSIS 11; HYPT11
615065 ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D
615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14
615067 CILIARY DYSKINESIA, PRIMARY, 20; CILD20
615071 ALAZAMI SYNDROME; ALAZS
615072 BRACHYDACTYLY, TYPE A1, C; BDA1C
615073 DYSTONIA 25; DYT25
615074 MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18
615075 MENTAL RETARDATION, AUTOSOMAL DOMINANT 19; MRD19
615081 SPERMATOGENIC FAILURE 11; SPGF11
615082 C3HEX, ABILITY TO SMELL
615083 COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12
615084 MITOCHONDRIAL DNA DEPLETION SYNDROME 11; MTDPS11
615085 OSTEOPETROSIS, AUTOSOMAL RECESSIVE 8; OPTB8
615091 AUTISM, SUSCEPTIBILITY TO, 19; AUTS19
615092 LEFT VENTRICULAR NONCOMPACTION 7; LVNC7
615095 MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10
615106 COWDEN SYNDROME 3; CWS3
615107 COWDEN SYNDROME 4; CWS4
615108 COWDEN SYNDROME 5; CWS5
615109 COWDEN SYNDROME 6; CWS6
615112 UROFACIAL SYNDROME 2; UFS2
615113 MICROPHTHALMIA, ISOLATED 8; MCOP8
615119 CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE
615120 MYASTHENIC SYNDROME, CONGENITAL, WITH PRE- AND POSTSYNAPTIC DEFECTS;
615122 LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2
615134 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9
615135 MAPLE SYRUP URINE DISEASE, MILD VARIANT; MSUDMV
615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS
615145 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9
615147 RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS
615156 PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS,
615157 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2
615158 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 3; MC3DN3
615159 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4
615160 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 5; MC3DN5
615179 ALBINISM, OCULOCUTANEOUS, TYPE VII; OCA7
615181 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD
615184 CARDIOMYOPATHY, DILATED, 1II; CMD1II
615185 CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE F; CMTDIF
615188 CATARACT 39, MULTIPLE TYPES; CTRCT39
615190 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 5; DKCB5
615191 LISSENCEPHALY 5; LIS5
615193 BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15
615206 IMMUNODEFICIENCY 11; IMD11
615207 IL21R IMMUNODEFICIENCY
615214 AGAMMAGLOBULINEMIA 7, AUTOSOMAL RECESSIVE; AGM7
615217 ATAXIA-OCULOMOTOR APRAXIA 3; AOA3
615219 HYDROCEPHALUS, NONSYNDROMIC, AUTOSOMAL RECESSIVE 2; HYC2
615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15
615221 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 16; BMND16
615222 SMITH-MCCORT DYSPLASIA 2; SMC2
615224 ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2
615225 CORNEAL INTRAEPITHELIAL DYSKERATOSIS AND ECTODERMAL DYSPLASIA; CIDED
615226 POLYDACTYLY, POSTAXIAL, TYPE A6; PAPA6
615228 MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4;
615232 SCHIZOPHRENIA 18; SCZD18
615233 RETINITIS PIGMENTOSA 66; RP66
615234 ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 2; AHMIO2
615235 CARDIOMYOPATHY, DILATED, 1JJ; CMD1JJ
615237 CONGENITAL SHORT BOWEL SYNDROME; CSBS
615238 LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 5; FPLD5
615244 NEPHROTIC SYNDROME, TYPE 8; NPHS8
615248 CARDIOMYOPATHY, DILATED, 1KK; CMD1KK
615249 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
615264 BLOOD GROUP, VEL SYSTEM; VEL
615266 HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17
615267 HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18
615268 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME
615269 HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19
615270 HYPOGONADOTROPIC HYPOGONADISM 20 WITH OR WITHOUT ANOSMIA; HH20
615271 HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21
615272 FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
615274 CATARACT 15, MULTIPLE TYPES; CTRCT15
615277 CATARACT 19; CTRCT19
615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2
615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3
615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4
615281 HYPOMYELINATION WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LEG
615282 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2
615284 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3
615285 NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5
615286 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36
615287 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
615290 SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2, AUTOSOMAL
615293 MYOFIBROMATOSIS, INFANTILE, 2; IMF2
615294 CILIARY DYSKINESIA, PRIMARY, 21; CILD21
615297 ADAMS-OLIVER SYNDROME 4; AOS4
615298 SYMPHALANGISM, PROXIMAL, 1B; SYM1B
615300 PERRAULT SYNDROME 4; PRLTS4
615311 BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 17; BMND17
615314 CRANIOSYNOSTOSIS 3; CRS3
615325 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2R; LGMD2R
615327 DOWLING-DEGOS DISEASE 2; DDD2
615328 SHAHEEN SYNDROME; SHNS
615330 MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3
615338 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16
615342 PULMONARY HYPERTENSION, PRIMARY, 2; PPH2
615343 PULMONARY HYPERTENSION, PRIMARY, 3; PPH3
615344 PULMONARY HYPERTENSION, PRIMARY, 4; PPH4
615346 PRECOCIOUS PUBERTY, CENTRAL, 2; CPPB2
615348 NEMALINE MYOPATHY 8; NEM8
615349 EHLERS-DANLOS SYNDROME, PROGEROID TYPE, 2; EDSP2
615350 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE
615351 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),
615352 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14
615355 NOONAN SYNDROME 8; NS8
615356 MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2S; LGMD2S
615360 LEBER CONGENITAL AMAUROSIS 17; LCA17
615361 HYPOCALCEMIA, AUTOSOMAL DOMINANT 2; HYPOC2
615362 CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13
615363 ESTROGEN RESISTANCE; ESTRR
615368 LETHAL CONGENITAL CONTRACTURE SYNDROME 5; LCCS5
615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC
615371 PULMONARY HYPERTENSION, NEONATAL, SUSCEPTIBILITY TO; PHN
615373 LEFT VENTRICULAR NONCOMPACTION 8; LVNC8
615374 CONE-ROD DYSTROPHY 18; CORD18
615376 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE C; CMTRIC
615377 ATRIAL FIBRILLATION, FAMILIAL, 13; ATFB13
615378 ATRIAL FIBRILLATION, FAMILIAL, 14; ATFB14
615381 MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY
615382 NEPHRONOPHTHISIS 16; NPHP16
615386 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14; SCAR14
615387 T-CELL RECEPTOR-ALPHA/BETA DEFICIENCY
615395 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 16; COXPD16
615396 LEFT VENTRICULAR NONCOMPACTION 10; LVNC10
615397 MECKEL SYNDROME, TYPE 11; MKS11
615398 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3
615399 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA 2; PNH2
615400 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5
615401 IMMUNODEFICIENCY 8; IMD8
615402 DYSCHROMATOSIS UNIVERSALIS HEREDITARIA 3; DUH3
615411 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3
615412 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4
615413 SPERMATOGENIC FAILURE 12; SPGF12
615414 MICROCEPHALY 11, PRIMARY, AUTOSOMAL RECESSIVE; MCPH11
615415 RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2
615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12
615419 HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC
615420 MYOPIA 22, AUTOSOMAL DOMINANT; MYP22
615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT
615424 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT
615425 EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE 2; EBSB2
615426 AMYOTROPHIC LATERAL SCLEROSIS 20; ALS20
615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88
615431 MYOPIA 23, AUTOSOMAL RECESSIVE; MYP23
615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5
615433 CHROMOSOME 3q13.31 DELETION SYNDROME
615434 RETINITIS PIGMENTOSA WITH OR WITHOUT SITUS INVERSUS
615436 AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
615438 INFANTILE LIVER FAILURE SYNDROME 1; ILFS1
615439 MACULAR DEGENERATION, AGE-RELATED, 13; ARMD13
615440 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17; COXPD17
615441 VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 5, WITH OR
615444 CILIARY DYSKINESIA, PRIMARY, 22; CILD22
615451 CILIARY DYSKINESIA, PRIMARY, 23; CILD23
615453 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 6; MC3DN6
615457 BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 18; BMIQ18
615458 MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT
615465 HARTSFIELD SYNDROME; HRTFDS
615468 IMMUNODEFICIENCY 12; IMD12
615471 MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE);
615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17
615474 PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES; PASNA
615476 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18; EIEE18
615481 CILIARY DYSKINESIA, PRIMARY, 24; CILD24
615482 CILIARY DYSKINESIA, PRIMARY, 25; CILD25
615483 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5
615486 INFANTILE LIVER FAILURE SYNDROME 2; ILFS2
615489 MACULAR DEGENERATION, AGE-RELATED, 14; ARMD14
615490 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R
615491 NEURODEGENERATION WITH OPTIC ATROPHY, CHILDHOOD-ONSET; NDGOA
615493 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37; MRT37
615500 CILIARY DYSKINESIA, PRIMARY, 26; CILD26
615501 MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC
615502 MENTAL RETARDATION, AUTOSOMAL DOMINANT 21; MRD21
615503 SHORT-RIB THORACIC DYSPLASIA 8 WITH OR WITHOUT POLYDACTYLY; SRTD8
615504 CILIARY DYSKINESIA, PRIMARY, 27; CILD27
615505 CILIARY DYSKINESIA, PRIMARY, 28; CILD28
615506 TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 5; HHT5
615508 ERYTHRODERMA, CONGENITAL, WITH PALMOPLANTAR KERATODERMA, HYPOTRICHOSIS,
615510 ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME; AAMR
615511 MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY; MMDD
615512 TRIOSEPHOSPHATE ISOMERASE DEFICIENCY; TPID
615513 IMMUNODEFICIENCY 14; IMD14
615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38
615517 HEMOCHROMATOSIS, TYPE 5; HFE5
615518 IMMUNODEFICIENCY 13; IMD13
615522 COLE DISEASE; COLED
615523 CORNEAL DYSTROPHY, FUCHS ENDOTHELIAL, 8; FECD8
615524 MICROPHTHALMIA, SYNDROMIC 12; MCOPS12
615527 CANDIDIASIS, FAMILIAL, 8; CANDF8
615528 PARKINSON DISEASE 19, JUVENILE-ONSET; PARK19
615529 CRANIOSYNOSTOSIS 5, SUSCEPTIBILITY TO; CRS5
615530 PARKINSON DISEASE 20, EARLY-ONSET; PARK20
615537 RETICULATE ACROPIGMENTATION OF KITAMURA; RAK
615538 CHROMOSOME 22q13 DUPLICATION SYNDROME
615539 EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE 2; EDSMC2
615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76
615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39
615542 TESTICULAR ANOMALIES WITH OR WITHOUT CONGENITAL HEART DISEASE; TACHD
615544 PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6
615545 LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 3; ALL3
615546 VAN MALDERGEM SYNDROME 2; VMLDS2
615547 PRADER-WILLI-LIKE SYNDROME; PWLS
615548 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7
615550 DIAMOND-BLACKFAN ANEMIA 12; DBA12
615551 EPISODIC PAIN SYNDROME, FAMILIAL, 2; FEPS2
615552 EPISODIC PAIN SYNDROME, FAMILIAL, 3; FEPS3
615553 ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES; AMRS
615554 MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB
615555 HYPERPROLACTINEMIA; HPRL
615557 MELIOIDOSIS, SUSCEPTIBILITY TO
615558 HYPOBETALIPOPROTEINEMIA, FAMILIAL, 1; FHBL1
615559 IMMUNODEFICIENCY, COMMON VARIABLE, 9; CVID9
615560 OTOFACIOCERVICAL SYNDROME 2; OFC2
615561 COMPLEMENT FACTOR B DEFICIENCY; CFBD
615565 RETINITIS PIGMENTOSA 67; RP67
615573 NEPHROTIC SYNDROME, TYPE 9; NPHS9
615574 ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD
615575 NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IID; HMN2D
615577 IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10
615578 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18; COXPD18
615582 RIENHOFF SYNDROME; RNHF
615583 VERHEIJ SYNDROME; VRJS
615590 ALZHEIMER DISEASE 18; AD18
615591 MACULAR DEGENERATION, AGE-RELATED, 15; ARMD15
615592 IMMUNODEFICIENCY 15; IMD15
615593 IMMUNODEFICIENCY 16; IMD16
615595 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 19; COXPD19
615596 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W
615597 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X
615598 PALMOPLANTAR KERATODERMA, NAGASHIMA TYPE; PPKN
615599 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40
615602 MEMORY QUANTITATIVE TRAIT LOCUS; MEMRYQTL
615604 L-FERRITIN DEFICIENCY; LFTD
615605 FANCONI RENOTUBULAR SYNDROME 3; FRTS3
615607 IMMUNODEFICIENCY 17; IMD17
615615 IMMUNODEFICIENCY 18; IMD18
615616 ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 13; ARVD13
615617 IMMUNODEFICIENCY 19; IMD19
615625 SPASTIC PARAPLEGIA 72, AUTOSOMAL RECESSIVE; SPG72
615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56
615630 SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10
615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B
615633 SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11
615636 JOUBERT SYNDROME 21; JBTS21
615637 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41
615643 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6
615651 LEUKOENCEPHALOPATHY WITH ATAXIA; LKPAT
615656 CHROMOSOME 15q11.2 DELETION SYNDROME
615658 SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57
615663 WARBURG MICRO SYNDROME 4; WARBM4
615668 CHROMOSOME 5q12 DELETION SYNDROME
615670 SCHWANNOMATOSIS 2; SWNTS2
615673 MYOPATHY WITH EXTRAPYRAMIDAL SIGNS; MPXPS
615683 SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64
615685 SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61
615686 SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63
615688 POLYARTERITIS NODOSA; PAN
615696 DOWLING-DEGOS DISEASE 4; DDD4
615703 MORBID OBESITY AND SPERMATOGENIC FAILURE; MOSPGF
615704 POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY,
615705 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 15; SCAR15
615706 AURICULOCONDYLAR SYNDROME 3; ARCND3
615707 IMMUNODEFICIENCY 20; IMD20
615710 MITCHELL-RILEY SYNDROME; MTCHRS
615711 ALZHEIMER DISEASE 19; AD19
615715 BONE MARROW FAILURE SYNDROME 2; BMFS2
615716 HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4; HPMRS4
615721 RENAL HYPODYSPLASIA/APLASIA 2; RHDA2
615722 BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS
615723 PREMATURE OVARIAN FAILURE 8; POF8
615724 PREMATURE OVARIAN FAILURE 9; POF9
615726 PACHYONYCHIA CONGENITA 3; PC3
615728 PACHYONYCHIA CONGENITA 4; PC4
615731 NEMALINE MYOPATHY 9; NEM9
615735 PALMOPLANTAR KERATODERMA, NONEPIDERMOLYTIC, FOCAL OR DIFFUSE; PPKNEFD
615744 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19
615745 ATRIAL STANDSTILL 2; ATRST2
615749 ECULIZUMAB, POOR RESPONSE TO
615750 MOYAMOYA DISEASE 6 WITH ACHALASIA; MYMY6
615751 CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO; CA5AD
615752 POLYMICROGYRIA, BILATERAL PERISYLVIAN, AUTOSOMAL RECESSIVE; BPPR
615758 IMMUNODEFICIENCY 22; IMD22
615760 MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR
615761 MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23
615763 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5
615770 ATRIAL FIBRILLATION, FAMILIAL, 15; ATFB15
615771 CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6
615774 OOCYTE MATURATION DEFECT; OOMD
615777 DESBUQUOIS DYSPLASIA 2; DBQD2
615779 CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 4; CHTD4
615780 RETINITIS PIGMENTOSA 69; RP69
615785 WHITE SPONGE NEVUS 2; WSN2
615789 SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES
615803 PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10
615807 SECKEL SYNDROME 8; SCKL8
615809 PONTOCEREBELLAR HYPOPLASIA, TYPE 9; PCH9
615812 ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3
615816 IMMUNODEFICIENCY 23; IMD23
615817 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43
615828 MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24
615829 XIA-GIBBS SYNDROME
615830 PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4; PPNAD4
615834 MENTAL RETARDATION, AUTOSOMAL DOMINANT 26; MRD26
615835 ASTHMA AND OBESITY, SUSCEPTIBILITY TO
615838 MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8
615846 AICARDI-GOUTIERES SYNDROME 7; AGS7
615848 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10
615849 PALLISTER-HALL SYNDROME 2; PHS2
615851 PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E
615860 CONE-ROD DYSTROPHY 19; CORD19
615863 DIARRHEA 7; DIAR7
615873 MENTAL RETARDATION, AUTOSOMAL DOMINANT, 28; MRD28
615878 CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4; PFIC4
615879 TATTON-BROWN-RAHMAN SYNDROME; TBRS
615881 PLASMA TRIGLYCERIDE LEVEL QUANTITATIVE TRAIT LOCUS; TGQTL
615883 MYOPATHY, TUBULAR AGGREGATE, 2; TAM2
615885 HYPOTRICHOSIS 12; HYPT12
615887 AMELOGENESIS IMPERFECTA, HYPOMATURATION TYPE, IIA5; AI2A5
615896 HYPOTRICHOSIS 13; HYPT13
615897 IMMUNODEFICIENCY 24; IMD24
100650 ALDEHYDE DEHYDROGENASE 2 FAMILY; ALDH2
102574 ACTININ, ALPHA-3; ACTN3
103600 ALBUMIN; ALB
103720 ALCOHOL DEHYDROGENASE 1B, CLASS I, BETA POLYPEPTIDE; ADH1B
104150 ALPHA-FETOPROTEIN; AFP
104250 ALPHA-2C-ADRENERGIC RECEPTOR; ADRA2C
106150 ANGIOTENSINOGEN; AGT
106180 ANGIOTENSIN I-CONVERTING ENZYME; ACE
107670 APOLIPOPROTEIN A-II; APOA2
107680 APOLIPOPROTEIN A-I; APOA1
107730 APOLIPOPROTEIN B; APOB
107741 APOLIPOPROTEIN E; APOE
109270 SOLUTE CARRIER FAMILY 4 (ANION EXCHANGER), MEMBER 1; SLC4A1
109630 BETA-1-ADRENERGIC RECEPTOR; ADRB1
109690 BETA-2-ADRENERGIC RECEPTOR; ADRB2
110300 ABO GLYCOSYLTRANSFERASE; ABO
110600 ADP-RIBOSYLTRANSFERASE 4; ART4
110750 BLOOD GROUP--GERBICH; Ge
111100 FUCOSYLTRANSFERASE 3; FUT3
111300 BLOOD GROUP--MN LOCUS; MN
111700 RHESUS BLOOD GROUP, CcEe ANTIGENS; RHCE
111740 BLOOD GROUP--Ss LOCUS; Ss
114835 CARBOXYLESTERASE 1; CES1
116790 CATECHOL-O-METHYLTRANSFERASE; COMT
120140 COLLAGEN, TYPE II, ALPHA-1; COL2A1
120150 COLLAGEN, TYPE I, ALPHA-1; COL1A1
122720 CYTOCHROME P450, SUBFAMILY IIA, POLYPEPTIDE 6; CYP2A6
123890 CYTOTOXIC T LYMPHOCYTE-ASSOCIATED 4; CTLA4
124060 CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2; CYP1A2
125860 NAD(P)H DEHYDROGENASE, QUINONE 1; NQO1
126453 DOPAMINE RECEPTOR D5; DRD5
131240 ENDOTHELIN 1; EDN1
132810 EPOXIDE HYDROLASE 1, MICROSOMAL; EPHX1
133430 ESTROGEN RECEPTOR 1; ESR1
134820 FIBRINOGEN, A ALPHA POLYPEPTIDE; FGA
137192 GAMMA-AMINOBUTYRIC ACID RECEPTOR, BETA-3; GABRB3
137241 GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GIPR
138040 GLUCOCORTICOID RECEPTOR; GCCR
138300 GLUTATHIONE REDUCTASE; GSR
139200 GROUP-SPECIFIC COMPONENT; GC
141800 HEMOGLOBIN--ALPHA LOCUS 1; HBA1
141900 HEMOGLOBIN--BETA LOCUS; HBB
142830 MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, B; HLA-B
142910 3-@HYDROXY-3-METHYLGLUTARYL-CoA REDUCTASE; HMGCR
146691 IMP DEHYDROGENASE 2; IMPDH2
147545 INSULIN RECEPTOR SUBSTRATE 1; IRS1
147892 DEIODINASE, IODOTHYRONINE, TYPE I; DIO1
147910 KALLIKREIN 1; KLK1
151430 B-CELL CLL/LYMPHOMA 2; BCL2
152200 APOLIPOPROTEIN(a); LPA
152780 LUTEINIZING HORMONE, BETA POLYPEPTIDE; LHB
153245 LYMPHOID ENHANCER-BINDING FACTOR 1; LEF1
158105 CHEMOKINE, CC MOTIF, LIGAND 2; CCL2
159555 LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A
162080 NEURAL RETINA LEUCINE ZIPPER; NRL
163729 NITRIC OXIDE SYNTHASE 3; NOS3
164761 REARRANGED DURING TRANSFECTION PROTOONCOGENE; RET
168470 PARATHYROID HORMONE-LIKE HORMONE; PTHLH
168820 PARAOXONASE 1; PON1
170998 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA; PPARA
172425 PHOSPHOLIPID TRANSFER PROTEIN; PLTP
173470 INTEGRIN, BETA-3; ITGB3
176730 INSULIN; INS
177400 BUTYRYLCHOLINESTERASE; BCHE
182100 FUCOSYLTRANSFERASE 2; FUT2
182870 SPECTRIN, BETA, ERYTHROCYTIC; SPTB
184757 NUCLEAR RECEPTOR SUBFAMILY 5, GROUP A, MEMBER 1; NR5A1
187270 TELOMERASE REVERSE TRANSCRIPTASE; TERT
187395 TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1
188545 THYROTROPIN-RELEASING HORMONE RECEPTOR; TRHR
192240 VASCULAR ENDOTHELIAL GROWTH FACTOR A; VEGFA
211100 FUCOSYLTRANSFERASE 1; FUT1
222745 2,4-@DIENOYL-CoA REDUCTASE 1, MITOCHONDRIAL; DECR1
309850 MONOAMINE OXIDASE A; MAOA
314200 THYROXINE-BINDING GLOBULIN OF SERUM; TBG
516060 ATP SYNTHASE 6; MTATP6
516070 ATP SYNTHASE 8; MTATP8
600046 ATP-BINDING CASSETTE, SUBFAMILY A, MEMBER 1; ABCA1
600522 PHOSPHOLIPASE A2, GROUP IVA; PLA2G4A
600781 PEPTIDE YY; PYY
601129 CYTOCHROME P450, SUBFAMILY IIC, POLYPEPTIDE 8; CYP2C8
601199 CALCIUM-SENSING RECEPTOR; CASR
601489 INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN, ACID-LABILE SUBUNIT; IGFALS
601728 PHOSPHATASE AND TENSIN HOMOLOG; PTEN
601877 LEFT-RIGHT DETERMINATION FACTOR 2; LEFTY2
601920 JAGGED 1; JAG1
603030 TOLL-LIKE RECEPTOR 4; TLR4
603324 GAP JUNCTION PROTEIN, BETA-3; GJB3
603372 THYROID-STIMULATING HORMONE RECEPTOR; TSHR
603570 VANIN 1; VNN1
604011 UNC119, C. ELEGANS, HOMOLOG OF; UNC119
604373 CHECKPOINT KINASE 2, S. POMBE, HOMOLOG OF; CHEK2
604824 KLOTHO; KL
604867 TASTE RECEPTOR, TYPE 2, MEMBER 16; TAS2R16
604976 PROTEIN KINASE, AMP-ACTIVATED, NONCATALYTIC, GAMMA-3; PRKAG3
607306 STEROID 5-ALPHA-REDUCTASE 2; SRD5A2
608010 NPC1-LIKE 1; NPC1L1
608307 CARBAMOYL PHOSPHATE SYNTHETASE I; CPS1
608508 CYTOCHROME b(-245), ALPHA SUBUNIT; CYBA
608774 ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING 1; ANKK1
608866 FRAGILE SITE, FOLIC ACID-TYPE, RARE, FRA(10)(q23.3), CANDIDATE GENE
609708 LIPOPROTEIN LIPASE; LPL
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT
100675 ACETAMINOPHEN METABOLISM
100700 ACHARD SYNDROME
101120 ACROCEPHALOPOLYSYNDACTYLY TYPE III
101805 ACROFACIAL DYSOSTOSIS, CATANIA TYPE
101840 ACROKERATODERMA, HEREDITARY PAPULOTRANSLUCENT
102000 ACROLEUKOPATHY, SYMMETRIC
102400 ACROOSTEOLYSIS
102520 ACRORENAL SYNDROME
102590 ACYLASE, COBALT-ACTIVATED
102650 ADACTYLIA, UNILATERAL
102660 ADAMANTINOMA OF LONG BONES
102699 ADENO-ASSOCIATED VIRUS INTEGRATION SITE 1; AAVS1
102730 ADENOSINE DEAMINASE, ELEVATED, HEMOLYTIC ANEMIA DUE TO
103920 ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS, FAMILIAL
104100 PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL DOMINANT
104110 ALOPECIA, FAMILIAL FOCAL
104350 AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM
104400 AMELIA AND TERMINAL TRANSVERSE HEMIMELIA
104600 AMENORRHEA-GALACTORRHEA SYNDROME
105300 AMYOTROPHIC DYSTONIC PARAPLEGIA
105563 ANAL SPHINCTER DYSPLASIA; ASDP
105565 ANAL SPHINCTER MYOPATHY, INTERNAL
105570 ANDROSTENONE, ABILITY TO SMELL
105580 ANAL CANAL CARCINOMA
105805 ANEURYSM OF INTERVENTRICULAR SEPTUM
105835 ANGEL-SHAPED PHALANGOEPIPHYSEAL DYSPLASIA; ASPED
106050 ANGIOMA SERPIGINOSUM, AUTOSOMAL DOMINANT
106190 ANHIDROSIS, FAMILIAL GENERALIZED, WITH NORMAL SWEAT GLANDS
106230 ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT
106240 ANISOCORIA
106250 ANKYLOBLEPHARON FILIFORME ADNATUM AND CLEFT PALATE; AFA
106280 ANKYLOGLOSSIA
106400 ANKYLOSING VERTEBRAL HYPEROSTOSIS WITH TYLOSIS
106500 ANNULAR ERYTHEMA
106750 ANONYCHIA WITH FLEXURAL PIGMENTATION
106900 ANONYCHIA-ECTRODACTYLY
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY
107320 ANTIPHOSPHOLIPID SYNDROME, FAMILIAL
107410 SERPIN PEPTIDASE INHIBITOR, CLADE A, MEMBER 2, PSEUDOGENE; SERPINA2P
107500 AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION
107550 AORTIC ARCH INTERRUPTION, FACIAL PALSY, AND RETINAL COLOBOMA
107700 APPENDICITIS, PRONENESS TO
107800 ARCUS CORNEAE
107850 ARM FOLDING PREFERENCE
107920 AROMATIC ALPHA-KETO ACID REDUCTASE
108050 ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS
108110 ARTHROGRYPOSIS MULTIPLEX CONGENITA; AMC
108200 ARTHROGRYPOSIS, DISTAL, TYPE 6; DA6
108320 ARTICHOKE, MODIFICATION OF TASTE BY
108700 ATAXIA WITH FASCICULATIONS
108950 ATRIAL TACHYARRHYTHMIA WITH SHORT PR INTERVAL
109050 AUROCEPHALOSYNDACTYLY
109120 AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE
109130 AXIAL OSTEOMALACIA
109180 BABOON M7 VIRUS INTEGRATION SITE; BEVI
109540 B-CELL GROWTH FACTOR; BCGF
109600 BEETURIA
109670 BETA-ADRENERGIC STIMULATION, RESPONSE TO; BAS
109740 BIFID NOSE, AUTOSOMAL DOMINANT
109820 BLADDER DIVERTICULUM
109900 BLEPHAROCHALASIS AND DOUBLE LIP
110000 BLEPHAROCHALASIS, SUPERIOR
110050 BLEPHARONASOFACIAL MALFORMATION SYNDROME
110150 BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS
110310 BLOOD GROUP--ABH ANTIGEN, TYPE 2
110720 BLOOD GROUP--En
111360 BLOOD GROUP--NEWFOUNDLAND; NFLD
112240 BONE FRAGILITY WITH CRANIOSYNOSTOSIS, OCULAR PROPTOSIS, HYDROCEPHALUS,
112270 BONE PAIN, PERIODIC
112370 BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUS
112430 LONG-THUMB BRACHYDACTYLY SYNDROME
112450 BRACHYDACTYLY, PREAXIAL, WITH HALLUX VARUS AND THUMB ABDUCTION
112910 BRACHYDACTYLY, TYPE A6; BDA6
113301 BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II
113310 BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME
113470 BRACHYMESOMELIA-RENAL SYNDROME
113475 BRACHYMETATARSUS IV
113477 BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME
113600 BRANCHIAL CLEFT ANOMALIES
113610 BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA
113700 BREASTS AND NIPPLES, ABSENCE OF
113960 BUTYRYLESTERASE 1
114030 CAFE-AU-LAIT SPOTS, MULTIPLE
114065 CALCIFIC AORTIC DISEASE WITH IMMUNOLOGIC ABNORMALITIES, FAMILIAL
114450 CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE
114620 CRANIOFACIOFRONTODIGITAL SYNDROME
114650 CAR FACTOR DEFICIENCY
114700 CARABELLI ANOMALY OF MAXILLARY MOLAR TEETH
115000 CARDIAC ARRHYTHMIA
115250 COLLAGENOMA, FAMILIAL CUTANEOUS
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION
116700 CATARACT, TOTAL CONGENITAL
116870 CELIAC ARTERY STENOSIS FROM COMPRESSION BY MEDIAN ARCUATE LIGAMENT
116950 TEMPERATURE-SENSITIVE AF8 COMPLEMENT; AF8T
117600 CEREBRAL SARCOMA
117650 CEREBROCOSTOMANDIBULAR SYNDROME
117850 CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS
117900 CERVICAL RIB
118000 CERVICAL VERTEBRAL BRIDGE
118005 CERVICAL VERTEBRAL DYSPLASIA
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM
118330 CHEILITIS GLANDULARIS
118350 CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS
118430 CHLORPROPAMIDE-ALCOHOL FLUSHING; CPAF
118610 CHONDROCALCINOSIS DUE TO APATITE CRYSTAL DEPOSITION
118650 CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANT
118670 CHONDRONECTIN
118750 CHOREOATHETOSIS, FAMILIAL INVERTED
118865 CHOROIDAL OSTEOMA, BILATERAL
118900 CIRRHOSIS, FAMILIAL
118943 CHYMOSIN PSEUDOGENE; CYMP
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL
119570 CLEFT SOFT PALATE
119650 CLEIDORHIZOMELIC SYNDROME
120000 COARCTATION OF AORTA
120040 COCHLEOSACCULAR DEGENERATION WITH PROGRESSIVE CATARACTS
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY
120440 COLONIC VARICES WITHOUT PORTAL HYPERTENSION
120500 COMMISSURAL LIP PITS
121070 ARTHROGRYPOSIS, DISTAL, TYPE 2E
121270 COPPER DEFICIENCY, FAMILIAL BENIGN
121350 CORACOCLAVICULAR JOINT, ANOMALOUS
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,
122440 CORNEODERMATOOSSEOUS SYNDROME
122455 CORONARY ARTERY DISSECTION, SPONTANEOUS
122550 CORTICOSTERONE SIDE-CHAIN ISOMERASE; CSCI
122580 COSTOCORACOID LIGAMENT, CONGENITALLY SHORT
122780 COXOAURICULAR SYNDROME
122850 CRANIOACROFACIAL SYNDROME
122900 CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA
123050 CRANIORHINY
123270 CREATINE KINASE, BRAIN TYPE, ECTOPIC EXPRESSION OF; CKBE
123540 CRYOFIBRINOGENEMIA, FAMILIAL PRIMARY
123557 CRYPTOTIA, FAMILIAL
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME
123853 CYPRUS FACIAL NEUROMUSCULOSKELETAL SYNDROME
123880 CYSTIC ANGIOMATOSIS OF BONE, DIFFUSE
124100 DANUBIAN ENDEMIC FAMILIAL NEPHROPATHY
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY
124950 DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE
125050 DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA
125230 DEAFNESS-CRANIOFACIAL SYNDROME
125280 DENS EVAGINATUS
125300 DENS IN DENTE AND PALATAL INVAGINATIONS
125320 DEMENTIA/PARKINSONISM WITH NON-ALZHEIMER AMYLOID PLAQUES
125460 DEOXYRIBOSE-5-PHOSPHATE ALDOLASE DEFICIENCY
125530 DERMAL RIDGES, NELSON SYNDROME
125570 DERMATOGLYPHICS--ARCH ON ANY DIGIT
125580 DERMATOGLYPHICS--FINGER RIDGE COUNT
125630 DERMODISTORTIVE URTICARIA; DDU
125635 DERMOGRAPHISM, FAMILIAL
125640 DERMOODONTODYSPLASIA
125890 DIARRHEA, GLUCOSE-STIMULATED SECRETORY, WITH COMMON VARIABLE IMMUNODEFICIENCY
126100 DIMPLES, FACIAL
126190 DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS
126250 DISTAL OSTEOSCLEROSIS
126320 DISTICHIASIS WITH CONGENITAL ANOMALIES OF THE HEART AND PERIPHERAL
126370 DNA, SATELLITE, III; HS3; D1Z1
126390 DNA, LOW-REPETITIVE SEQUENCES OF
126410 DNA, SATELLITE, ALPHA TYPE
126840 DUODENAL ULCER DUE TO ANTRAL G-CELL HYPERFUNCTION
126950 DWARFISM WITH TALL VERTEBRAE
127100 DWARFISM, LEVI TYPE
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES
127800 DYSPLASIA EPIPHYSEALIS HEMIMELICA
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS
128290 EAR ANTITRAGUS, TAG AT BASE OF
128500 EAR FOLDING
128710 EAR PITS, POSTERIOR HELICAL
128800 EAR WITHOUT HELIX
128900 EARLOBE ATTACHMENT, ATTACHED VS UNATTACHED
128950 EARLOBE CREASE
129000 EARRING HOLES, NATURAL
129510 ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE AND
129550 ECTODERMAL DYSPLASIA WITH ADRENAL CYST
129750 ECTOPIA PUPILLAE
129810 ECTRODACTYLY AND ECTODERMAL DYSPLASIA WITHOUT CLEFT LIP/PALATE
129830 ECTRODACTYLY-CLEFT PALATE SYNDROME
129840 EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL
129905 EGASYN
130090 EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED
130100 ELASTOSIS PERFORANS SERPIGINOSA; EPS
130200 ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKE
130300 ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS
130400 ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES
130700 EMPHYSEMA, HEREDITARY PULMONARY
130710 EMPHYSEMA, CONGENITAL LOBAR; CLE
130950 ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD
131375 ENOLASE, SPERM SPECIFIC; ENO4
131430 EOSINOPHILOPENIA
131880 EPIDERMOLYSIS BULLOSA WITH DEFICIENCY OF GALACTOSYLHYDROXYLYSYL GLUCOSYLTRANSFERASE
132090 EPILEPSY, BENIGN OCCIPITAL; BOE
132300 EPILEPSY, READING
132850 EPSTEIN-BARR VIRUS INSERTION SITE 1; EBVS1
132990 ERYTHEMA NODOSUM, FAMILIAL
133180 ERYTHROLEUKEMIA, FAMILIAL
133240 ESOPHAGEAL RING, LOWER
133300 ESTERASE ES-2, REGULATOR FOR
133600 EXOSTOSES OF HEEL
133690 EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICAL
133900 HEMIFACIAL HYPERPLASIA
134400 FACTOR V EXCESS WITH SPONTANEOUS THROMBOSIS
134430 FACTOR VII AND FACTOR VIII, COMBINED DEFICIENCY OF
134500 FACTOR VIII DEFICIENCY
134510 FACTOR VIII AND FACTOR IX, COMBINED DEFICIENCY OF; F8F9D
134520 FACTORS VIII, IX AND XI, COMBINED DEFICIENCY OF
134540 FACTOR IX AND FACTOR XI, COMBINED DEFICIENCY OF
134700 FAVISM, SUSCEPTIBILITY TO
134720 FECUNDITY GENE, BOOROOLA, OF SHEEP, HOMOLOG OF
134750 FELTY SYNDROME
134780 FEMORAL-FACIAL SYNDROME; FFS
134900 FIBRINOLYTIC DEFECT
135580 FIBROMUSCULAR DYSPLASIA OF ARTERIES
135950 FINGER LOCKING, RECURRENT, WITH INTRAUTERINE GROWTH RETARDATION AND
136100 FINGERS, RELATIVE LENGTH OF
136150 FLOOD FACTOR DEFICIENCY
136400 FOCAL EPITHELIAL HYPERPLASIA OF THE ORAL MUCOSA
136480 FOURTH CRANIAL NERVE PALSY, FAMILIAL CONGENITAL
136600 FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURAL
136830 FUCOSIDASE REGULATOR
137000 FUTCHER LINE
137040 GALLBLADDER, AGENESIS OF
137050 GAMMA-A-GLOBULIN, DEFECT IN ASSEMBLY OF
137130 GASTRIC SNEEZING
137210 GASTRIC VOLVULUS, INTRATHORACIC
137220 GASTRIC JUICE PEPTIDES
137245 GASTRIC LYMPHOMA, PRIMARY
137270 GASTROCUTANEOUS SYNDROME
137280 GASTRITIS, FAMILIAL GIANT HYPERTROPHIC
137370 GENU VALGUM, ST. HELENA FAMILIAL
137400 GEOGRAPHIC TONGUE AND FISSURED TONGUE
137560 GIANT PLATELET SYNDROME WITH THROMBOCYTOPENIA
137700 GLAUCOMA WITH ELEVATED EPISCLERAL VENOUS PRESSURE
137763 GLAUCOMA AND SLEEP APNEA
137900 GLOBULIN ANOMALY INVOLVING BETA (2A)-GLOBULIN
137940 GLOMERULONEPHRITIS WITH SPARSE HAIR AND TELANGIECTASES
138060 GLUCOCORTICOID RECEPTOR-LIKE 1; GRLL1
138070 GLUCOGLYCINURIA
138110 GLUCOSE-6-PHOSPHATE DEHYDROGENASE-LIKE; G6PDL
138277 GLUTAMIC ACID DECARBOXYLASE, BRAIN, MEMBRANE FORM
138340 GLUTATHIONE TRANSFERASE ACTIVITY TOWARD TRANS-STILBENE OXIDE
138770 GMS SYNDROME
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES
138930 GRANT SYNDROME
139000 GRANULOSIS RUBRA NASI
139280 GUANYLATE KINASE 2; GUK2
139290 GUANYLATE KINASE 3; GUK3
139400 HAIR WHORL
139500 HAIRY EARS
139630 HAIRY NOSE TIP
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES
139800 HAND CLASPING PATTERN
140450 HEART-HAND SYNDROME, SPANISH TYPE
140500 HEART, MALFORMATION OF
140850 HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE
140900 HEMANGIOMAS OF SMALL INTESTINE
141000 HEMANGIOMA-THROMBOCYTOPENIA SYNDROME
141405 HEMIFACIAL SPASM, FAMILIAL
141700 HEMOLYTIC POIKILOCYTIC ANEMIA DUE TO REDUCED ANKYRIN BINDING SITES
142350 HERNIA, DOUBLE INGUINAL
142500 HETEROCHROMIA IRIDIS
142625 HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION
142630 HISTIOCYTOSIS, PROGRESSIVE MUCINOUS
142660 HEXOSAMINIDASE C; HEXC
142730 HISTIOCYTIC DERMATOARTHRITIS
142770 HLA MODIFIER
143020 HPA I RECOGNITION POLYMORPHISM, BETA-GLOBIN-RELATED; HPA1
143050 HUMERORADIAL SYNOSTOSIS
143460 5-@HYDROXYTRYPTAMINE OXYGENASE REGULATOR; HTOR
144020 HYPERCHOLESTEROLEMIA SUPPRESSOR
144050 HYPERHEPARINEMIA
144100 HYPERHIDROSIS, GUSTATORY; HYPRG
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROME
144190 HYPERKERATOSIS-HYPERPIGMENTATION SYNDROME
144300 HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS
144600 HYPERLIPOPROTEINEMIA, TYPE IV
144800 HYPEROSTOSIS FRONTALIS INTERNA
145200 HYPERPIGMENTATION OF FULDAUER AND KUIJPERS
145270 HYPERPROGLUCAGONEMIA
145290 HYPERREFLEXIA; HRX
145295 HYPERSECRETION OF ADRENAL ANDROGENS, FAMILIAL
145300 HYPERSENSITIVITY PNEUMONITIS, FAMILIAL
145350 HYPERTAURINURIC CARDIOMYOPATHY
146160 HYPOMELIA WITH MULLERIAN DUCT ANOMALIES
146400 HYPOPLASIA OF TEETH ROOTS
146600 ICHTHYOSIS HYSTRIX GRAVIOR
146720 ICHTHYOSIS--CHEEK--EYEBROW SYNDROME
146750 ICHTHYOSIS, LAMELLAR, AUTOSOMAL DOMINANT
146810 IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRPHEGAL; IPHEG
146820 IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGAT; IGAT
146830 IMMUNE DEFICIENCY, FAMILIAL VARIABLE
146840 IMMUNODEFICIENCY WITH DEFECTIVE LEUKOCYTE AND LYMPHOCYTE FUNCTION
146850 IMMUNE SUPPRESSION; IS
146950 IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRHGAL; IHG
146990 IMMUNOGLOBULIN HEAVY CHAIN DIVERSITY REGION 2; IGHDY2
147080 IMMUNE RESPONSE TO SYNTHETIC POLYPEPTIDE--IRGLPHE 1; IGLP1
147260 IMMUNOGLOBULIN SWITCH SEQUENCES
147320 INSULIN RECEPTORS, FAMILIAL INCREASE IN
147530 INSENSITIVITY TO PAIN WITH HYPERPLASTIC MYELINOPATHY
147540 INSECT STINGS, HYPERSENSITIVITY TO
147560 INTERFERON ANTIVIRAL DEPRESSOR
147610 IRIS PIGMENT LAYER, CLEAVAGE OF
147630 ISLET CELL ADENOMATOSIS
147710 INTUSSUSCEPTION
147820 INTERNAL CAROTID ARTERY, SPONTANEOUS DISSECTION OF
148360 KERATODERMA, PALMOPLANTAR, WITH NAIL DYSTROPHY AND HEREDITARY MOTOR-SENSORY
148390 KERATOSIS, FAMILIAL ACTINIC
148520 KERATOSIS PALMARIS ET PLANTARIS WITH CLINODACTYLY
148800 KLEEBLATTSCHAEDEL
149500 KYRLE DISEASE
149700 LACRIMAL DUCT DEFECT
150170 LACTIC ACIDOSIS, CHRONIC ADULT FORM
150280 LARYNGOMALACIA
150300 LARYNX, CONGENITAL PARTIAL ATRESIA OF
150360 LARYNGEAL WEB, FAMILIAL
150500 LATTICE DEGENERATION OF RETINA LEADING TO RETINAL DETACHMENT
150550 LAZY LEUKOCYTE SYNDROME
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET
150700 LEIOMYOMA OF VULVA AND ESOPHAGUS
150900 LENTIGINES
151000 LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC
151380 LEUKEMIA, ACUTE MONOCYTIC
151500 LEUKOCYTE NUCLEAR APPENDAGES, HEREDITARY PREVALENCE OF
151590 LICHEN SCLEROSUS ET ATROPHICUS; LSA
151610 LEVATOR-MEDIAL RECTUS SYNKINESIS
151620 LICHEN PLANUS, FAMILIAL
151800 LIPOMATOSIS, MULTIPLE SYMMETRIC; MSL
152420 LITHIUM TRANSPORT
152450 LOW DENSITY LIPOPROTEIN, VARIATION IN MOLECULAR WEIGHT OF
152550 LUMBAR STENOSIS, FAMILIAL
152900 LYMPHEDEMA AND CEREBRAL ARTERIOVENOUS ANOMALY
153470 MACROCEPHALY, BENIGN FAMILIAL
153890 MACULAR DYSTROPHY, FENESTRATED SHEEN TYPE
154000 MACULES, HEREDITARY CONGENITAL HYPOPIGMENTED AND HYPERPIGMENTED
154300 MALOCCLUSION DUE TO PROTUBERANT UPPER FRONT TEETH
154370 MAMMASTATIN
154600 MARCUS GUNN PHENOMENON
154750 MARFANOID HYPERMOBILITY SYNDROME
154800 MAST CELL DISEASE
154850 MASTICATORY MUSCLES, HYPERTROPHY OF
155140 MECKEL DIVERTICULUM
155150 MEDIAN-ULNAR NERVE COMMUNICATIONS
155200 MEDIOSTERNAL DEPIGMENTATION LINE
155500 MEGALODACTYLY
155700 MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR
155770 MELANOMA TUMOR ANTIGEN GP90
156000 MENIERE DISEASE
156190 MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA
156220 MERALGIA PARAESTHETICA, FAMILIAL
156300 METACHROMASIA OF FIBROBLASTS
156310 METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASE
156620 MICROCEPHALY-DEAFNESS SYNDROME
156700 MICROCORNEA, GLAUCOMA, AND ABSENT FRONTAL SINUSES
156810 MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD
156830 MICROMELIC BONE DYSPLASIA WITH CLOVERLEAF SKULL
157150 MICROSPHEROPHAKIA WITH HERNIA
157151 MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA
157200 MIDPHALANGEAL HAIR
157800 MITRAL REGURGITATION, CONDUCTIVE DEAFNESS, AND FUSION OF CERVICAL
157960 MOLONEY LEUKEMIA VIRUS INTEGRATION SITE 2, MOUSE, HOMOLOG OF; MLVI2
157980 MOMO SYNDROME
158030 ANTIGEN DEFINED BY MONOCLONAL ANTIBODY AJ9
158250 NONDISJUNCTION
158280 MOTION SICKNESS
158345 MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS
158650 MUSCULAR ATROPHY, MALIGNANT NEUROGENIC
159100 MUSCULAR HYPOPLASIA, CONGENITAL UNIVERSAL, OF KRABBE
159400 MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE
159410 MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS
159420 MYDRIASIS, CONGENITAL
159550 MYELOCEREBELLAR DISORDER
159580 MYELOPATHY, HTLV-1-ASSOCIATED; HAM
159700 MYOCLONUS AND ATAXIA
159800 MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS
160570 MYOPATHY WITH STORAGE OF GLYCOPROTEINS AND GLYCOSAMINOGLYCANS
160990 MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS
161070 NAIL HIGH-SULFUR PROTEIN
161470 NASAL ALAR COLLAPSE, BILATERAL
161480 NASAL BONES, ABSENCE OF
161530 NASAL HYPERPIGMENTATION, FAMILIAL TRANSVERSE
161600 NAVICULAR BONE, ACCESSORY
161700 NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT
162020 NERVE GROWTH FACTOR, ALPHA SUBUNIT; NGFA
162260 NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL; NF3A
162380 NEUROPATHY, HEREDITARY SENSORIMOTOR, WITH UPPER MOTOR NEURON, VISUAL
162600 NEUROPATHY, WITH PARAPROTEIN IN SERUM, CEREBROSPINAL FLUID AND URINE
163600 NIPPLES INVERTED
163850 NODULI CUTANEI, MULTIPLE, WITH URINARY TRACT ABNORMALITIES
164000 NOSE, ANOMALOUS SHAPE OF
164180 OCULOCEREBROCUTANEOUS SYNDROME
164185 OCULAR CICATRICIAL PEMPHIGOID; OCP
164190 OCULAR DOMINANCE
164330 ODONTOMA-DYSPHAGIA SYNDROME
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V
164891 ONCOGENE YUASA
165098 OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION
165150 OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY
165199 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS
165210 ONCOGENE BMYC; BMYC
165510 OPTIC ATROPHY WITH NEGATIVE ELECTRORETINOGRAMS
165590 OROFACIODIGITAL SYNDROME X; OFD10
165670 OSSIFIED EAR CARTILAGES
165680 OSSICULAR MALFORMATIONS, FAMILIAL
166230 OSTEOGENESIS IMPERFECTA WITH OPALESCENT TEETH, BLUE SCLERAE AND WORMIAN
166450 OSTEOMESOPYKNOSIS
166705 OSTEOPOIKILOSIS AND DACRYOCYSTITIS
166740 OSTEOSCLEROSIS WITH ICHTHYOSIS AND FRACTURES
166900 OVALOCYTOSIS, HEREDITARY HEMOLYTIC
166910 OVALOCYTOSIS, HEREDITARY HEMOLYTIC, WITH DEFECTIVE ERYTHROPOIESIS
166950 TERATOMA, OVARIAN
166970 OVARIAN FIBROMATA
166990 OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,
167220 PACMAN DYSPLASIA
167250 PAGET DISEASE OF BONE 1; PDB1
167300 PAGET DISEASE, EXTRAMAMMARY
167700 PALMOMENTAL REFLEX
167750 PANCREAS, ANNULAR
167755 PANCREAS, DORSAL, AGENESIS OF
167950 PAPILLOMATOSIS, FLORID, OF NIPPLE
167959 HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 1; HPV18I1
167960 HUMAN PAPILLOMAVIRUS TYPE 18 INTEGRATION SITE 2; HPV18I2
168100 PARALYSIS AGITANS, JUVENILE, OF HUNT
168710 PAROTID PROLINE-RICH SALIVARY PROTEIN Pc
168830 PASSOVOY FACTOR DEFECT
168850 PATELLA APLASIA, COXA VARA, AND TARSAL SYNOSTOSIS
168885 PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA
169170 PATTERSON PSEUDOLEPRECHAUNISM SYNDROME
169200 PECHET FACTOR DEFICIENCY
169300 PECTUS EXCAVATUM
169550 PELVIS-SHOULDER DYSPLASIA
169610 PEMPHIGUS VULGARIS, FAMILIAL
169710 PEPSINOGEN 3, GROUP I; PGA3
170600 NORMOKALEMIC PERIODIC PARALYSIS
170700 PERIPHERAL DYSOSTOSIS
170900 PERNICIOUS ANEMIA
170980 PERONEAL NERVE, ACCESSORY DEEP
170990 PEROXIDASE, SALIVARY; SAPX
171420 PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA
171660 PHOSPHATASE, ACID, OF TISSUES
172290 PHOSPHOGLYCOPROTEIN 1; PGP1
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRAL
172850 PIEBALD TRAIT WITH NEUROLOGIC DEFECTS
172880 PIERRE ROBIN SYNDROME AND OLIGODACTYLY
173000 PILONIDAL SINUS
173395 PLATELET ADENYLATE CYCLASE ACTIVITY
173400 PLATELET AGGREGATION, SPONTANEOUS
173420 PLATELET DISORDER, UNDEFINED
173450 PLATELET FACTOR 3 DEFICIENCY
173560 PLATELET MEMBRANE FLUIDITY; PMF
173580 PLATELET RESPONSIVENESS TO ADRENALINE, DEPRESSED
173590 PLATELET SIGNAL PROCESSING DEFECT
173700 POIKILODERMA, HEREDITARY SCLEROSING
174310 POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA
174750 POLYKARYOCYTOSIS INDUCER; FUSE
175400 POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE
175450 POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES
175505 POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI
175510 POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL
175750 POPLITEAL CYST
176090 PORPHYRIA CUTANEA TARDA, TYPE I
176240 POSTAXIAL OLIGODACTYLY, TETRAMELIC
176250 POSTERIOR COLUMN ATAXIA
176600 PRESENILE DEMENTIA, KRAEPELIN TYPE
176620 PRIAPISM, FAMILIAL IDIOPATHIC
176630 PRIMARY RELEASE DISORDER OF PLATELETS
176690 PROGEROID SHORT STATURE WITH PIGMENTED NEVI
176770 PROLINE-NEGATIVE AUXOTROPH OF HAMSTER, COMPLEMENTATION OF; PROA
176800 PRONATION-SUPINATION OF THE FOREARM, IMPAIRMENT OF
176900 PROTEOLYTIC CAPACITY OF PLASMA
177100 PRURITUS, HEREDITARY LOCALIZED
177350 PSEUDOATROPHODERMA COLLI
177600 PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF
177800 PSEUDOPAPILLEDEMA
177990 PTERYGIUM COLLI, ISOLATED
178000 PTERYGIUM OF CONJUNCTIVA AND CORNEA
178330 PTOSIS, STRABISMUS, AND ECTOPIC PUPILS
178370 PULMONARY ATRESIA WITH VENTRICULAR SEPTAL DEFECT
178400 PULMONARY EDEMA OF MOUNTAINEERS
178550 PULMONARY HEMOSIDEROSIS
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL
178650 PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHIC
178651 PULMONIC STENOSIS AND DEAFNESS
178995 PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY; PUPPP
179000 PURPURA SIMPLEX
179250 RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARY
179270 RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA
179280 RADIAL-RENAL SYNDROME
179300 RADIOULNAR SYNOSTOSIS
179400 RADIUS, APLASIA OF, WITH CLEFT LIP/PALATE
179450 RAGWEED SENSITIVITY
179500 RAINDROP HYPOPIGMENTATION
179830 RENAL TUBULAR ACIDOSIS, PROXIMAL
179840 RETICULAR DYSTROPHY OF RETINAL PIGMENT EPITHELIUM
180070 RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT
180080 RETINAL VENOUS BEADING
180210 RETINOPATHY, PERICENTRAL PIGMENTARY, DOMINANT
180270 RETINOSCHISIS, AUTOSOMAL DOMINANT
180350 RHEUMATOID NODULOSIS
180360 RHINY
180730 ROMBO SYNDROME
180870 RUVALCABA SYNDROME
181010 SALIVARY DUCT CALCULI
181180 SAY SYNDROME
181200 SC(1) TRAIT OF SALIVA
181250 SCALP DEFECTS AND POSTAXIAL POLYDACTYLY
181700 SCLEROCORNEA, AUTOSOMAL DOMINANT
182150 SIMOSA CRANIOFACIAL SYNDROME
182170 ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT
182190 SINUS NODE DISEASE AND MYOPIA
182200 SELLA TURCICA, BRIDGED
182210 SHPRINTZEN OMPHALOCELE SYNDROME
182220 SISTER CHROMATID EXCHANGE, FREQUENCY OF
182260 SLIPPED FEMORAL CAPITAL EPIPHYSES
182269 SMALL PROLINE-RICH PROTEIN 2C; SPRR2C
182270 KETONE COMPOUNDS, ABILITY TO SMELL
182400 SOMATOMEDIN, EMBRYONIC
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR
182690 SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND
182800 SPASTIC PARAPLEGIA WITH ASSOCIATED EXTRAPYRAMIDAL SIGNS
182815 SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA
182820 SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY
182830 SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND DEMENTIA
182875 SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, AND
182882 SPERM PROTAMINE P4; PRM4
182990 SPINAL INTRADURAL ARACHNOID CYSTS
183300 SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA
183350 SPLENOMEGALY SYNDROME WITH SPLENIC GERMINAL CENTER HYPOPLASIA AND
183700 SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATIC
183849 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH HYPOTRICHOSIS
183850 SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS
184200 SPONDYLOLISTHESIS
184253 SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE
184260 SPONDYLOMETAPHYSEAL DYSPLASIA WITH DENTINOGENESIS IMPERFECTA
184300 SPONDYLOSIS, CERVICAL
184510 STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH
184705 STEINFELD SYNDROME
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF
185020 PSEUDOHYPERKALEMIA CARDIFF
185120 STRATTON-PARKER SYNDROME
185460 SULFHEMOGLOBINEMIA, CONGENITAL
185480 SUPRABULBAR PARESIS, CONGENITAL
185540 SURFACE ANTIGEN, GLYCOPROTEIN 75
185600 SYMPHALANGISM OF TOES
185610 SURFACE POLYPEPTIDES, ANONYMOUS
185650 SYMPHALANGISM, C. S. LEWIS TYPE
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET
186575 SYNOVIAL CHONDROMATOSIS, FAMILIAL, WITH DWARFISM
186600 SYRINGOMAS, MULTIPLE
186750 TALONAVICULAR COALITION
186950 T-CELL SUBGROUPS, NON-HLA-LINKED
187050 TEETH PRESENT AT BIRTH
187100 TEETH, SUPERNUMERARY
187310 TEMPERATURE SENSITIVITY COMPLEMENTATION, CELL CYCLE SPECIFIC, K12
187350 TELECANTHUS
187360 TEMPORAL ARTERITIS
187390 TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF
187400 TESTICULAR TORSION
187501 TETRALOGY OF FALLOT AND GLAUCOMA
187510 TETRAMELIC MONODACTYLY
187550 THALASSEMIA, BETA+, SILENT ALLELE
187750 THORACIC DYSOSTOSIS, ISOLATED
187760 THORACOLARYNGOPELVIC DYSPLASIA; TLPD
187770 THORACOPELVIC DYSOSTOSIS
187940 THROMBOCYTE B; THB
188020 THROMBOCYTOPENIA, CYCLIC
188030 THROMBOCYTOPENIC PURPURA, AUTOIMMUNE; AITP
188100 THUMB DEFORMITY
188150 THUMB DEFORMITY AND ALOPECIA
188201 THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY
188455 THYROGLOSSAL DUCT CYST, FAMILIAL
188560 THYROID HORMONE PLASMA MEMBRANE TRANSPORT DEFECT
188700 BLOUNT DISEASE, INFANTILE
188740 TIBIA, ABSENCE OF, WITH POLYDACTYLY
188850 TL ANTIGEN
189100 TOE, MISSHAPEN
189200 TOES, RELATIVE LENGTH OF FIRST AND SECOND
189300 TONGUE CURLING, FOLDING, OR ROLLING
189490 MALPOSITION OF TEETH WITH OR WITHOUT HYPODONTIA/OLIGODONTIA
189600 TORTICOLLIS
189960 TRACHEOESOPHAGEAL FISTULA WITH OR WITHOUT ESOPHAGEAL ATRESIA
189961 TRACHEOPATHIA OSTEOPLASTICA
190200 TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS
190330 TRICHOMEGALY
190345 TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC
190360 TRICHODYSPLASIA-XERODERMA
190400 TRIGEMINAL NEURALGIA
190410 TRIGGER THUMB
190420 TRIGLYCERIDE STORAGE DISEASE, TYPE I
190430 TRIGLYCERIDE STORAGE DISEASE, TYPE II
190445 TRIIODOTHYRONINE RECEPTOR AUXILIARY PROTEIN; TRAP
191150 TUFTSIN DEFICIENCY
191250 TWINNING DUE TO SUPERFETATION
191270 TYROSINASE-LIKE; TYRL
191400 ULNA AND FIBULA, HYPOPLASIA OF
191420 ULNA METAPHYSEAL DYSPLASIA SYNDROME
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, AND
191540 URATE OXIDASE, PSEUDOGENE; UOX
191600 URETER, CANCER OF
191650 URETEROCELE
191700 UROLITHIASIS, URIC ACID, AUTOSOMAL DOMINANT
191850 URTICARIA, AQUAGENIC
191950 URTICARIA, FAMILIAL LOCALIZED HEAT
192000 UTERINE ANOMALIES
192050 UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL
192200 VARICOSE VEINS
192300 VASCULAR HELIX OF UMBILICAL CORD
192310 VASCULITIS, LYMPHOCYTIC, NODULAR
192400 VEINS, PATTERN OF, ON ANTERIOR THORAX
192445 VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE
192700 VENULAR INSUFFICIENCY, SYSTEMIC
192800 VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS
193005 VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE
193050 VIBRATORY ANGIOEDEMA
193070 VIRUS RD114 RNA COMPLEMENTARITY
193240 VOCAL CORD PARALYSIS AND PTOSIS
193450 VULVOVAGINITIS, ALLERGIC SEMINAL
194000 WIDOW'S PEAK
194320 WORONETS TRAIT
194370 X-RAY SENSITIVITY; XRS
194400 XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD
200130 ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION
200170 ACANTHOSIS NIGRICANS WITH MUSCLE CRAMPS AND ACRAL ENLARGEMENT
200300 ACETOPHENETIDIN SENSITIVITY
200450 ACHALASIA-MICROCEPHALY SYNDROME
200900 SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY
200950 ACID PHOSPHATASE DEFICIENCY
200970 ACKERMAN SYNDROME
200980 ACRORENAL-MANDIBULAR SYNDROME
200995 ACROCEPHALOPOLYDACTYLOUS DYSPLASIA
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV
201050 ACROCRANIOFACIAL DYSOSTOSIS
201180 ACROFRONTOFACIONASAL DYSOSTOSIS 1
201200 ACROGERIA, GOTTRON TYPE
201310 ACRORENAL SYNDROME, AUTOSOMAL RECESSIVE
202150 ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZING
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE
202355 ADRENOCORTICAL UNRESPONSIVENESS TO ACTH WITH POSTRECEPTOR DEFECT
202550 AGANGLIONOSIS, TOTAL INTESTINAL
202660 PAGOD SYNDROME
202900 ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES
203000 FRONTONASAL DYSPLASIA WITH ALAR CLEFTS
203340 ALBINISM-MICROCEPHALY-DIGITAL ANOMALIES SYNDROME
203550 ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN
203760 ALPHA-2-DEFICIENT COLLAGEN DISEASE
204110 AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS
204850 AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION
204900 AMYLOIDOSIS, CUTANEOUS BULLOUS
205250 AMYOTROPHIC LATERAL SCLEROSIS WITH POLYGLUCOSAN BODIES
205700 ANEMIA, AUTOIMMUNE HEMOLYTIC
206000 ANEMIA, SIDEROBLASTIC, PYRIDOXINE-RESPONSIVE, AUTOSOMAL RECESSIVE
206300 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF RED
206400 ANEMIA, NONSPHEROCYTIC HEMOLYTIC, POSSIBLY DUE TO DEFECT IN PORPHYRIN
206550 ANGIOLIPOMATOSIS, FAMILIAL
206600 ANHIDROSIS
206750 ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTOR
207000 ANOSMIA FOR ISOBUTYRIC ACID
207300 ANTITHROMBIN, FAMILIAL HEMORRHAGIC DIATHESIS DUE TO
207500 ANUS, IMPERFORATE
207600 TAKAYASU ARTERITIS
207620 APHALANGY WITH HEMIVERTEBRAE
207720 APNEA, CENTRAL SLEEP
207731 APLASIA CUTIS CONGENITA WITH INTESTINAL LYMPHANGIECTASIA
207740 APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZED
207770 APROSENCEPHALY SYNDROME
207780 AREDYLD
207790 ARACHNOID CYSTS, INTRACRANIAL
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTIC
208155 ILLUM SYNDROME
208158 ARTHROGRYPOSIS WITH HYPERKERATOSIS
208300 ASCITES, CHYLOUS
208600 ASTHMA, SHORT STATURE, AND ELEVATED IgA
208700 ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA
208850 ATAXIA-DEAFNESS-RETARDATION SYNDROME
208870 ATAXIA-MICROCEPHALY-CATARACT SYNDROME
208910 ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY
209010 ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,
209050 ATHROMBIA, ESSENTIAL
209600 ATRIOVENTRICULAR DISSOCIATION
209770 AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION
209800 AUSTRALIA ANTIGEN
209970 BEEMER LETHAL MALFORMATION SYNDROME
210350 BIEMOND SYNDROME II
210400 BIFID NOSE, AUTOSOMAL RECESSIVE
210550 BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY
210700 MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE
210740 BANGSTAD SYNDROME
211000 BLUE DIAPER SYNDROME
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS
211355 BOWING OF LONG BONES, ASYMMETRIC AND SYMMETRIC
211370 BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM
211380 BRACHIOSKELETOGENITAL SYNDROME
211450 BRONCHOMALACIA
211480 BUERGER DISEASE
211770 CAHMR SYNDROME
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1
211920 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA
211965 CAMPTODACTYLY-ICHTHYOSIS SYNDROME
211990 CAMPTOMELIC SYNDROME, LONG-LIMB TYPE
212060 CARBIMAZOLE SENSITIVITY
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIx
212080 CARDIAC LIPIDOSIS, FAMILIAL
212090 CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA
212100 CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE
212360 PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA, AUTOSOMAL RECESSIVE
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME
212710 CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME
212800 CEPHALIN LIPIDOSIS
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA
212850 CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS
212890 CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA
213002 CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS
213010 CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZ
213820 CEREBRAL MALFORMATION, SEIZURES, HYPERTRICHOSIS, AND OVERLAPPING FINGERS
213900 CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE
213950 CEREBROCORTICAL DEGENERATION OF INFANCY
214200 CEROID STORAGE DISEASE
214290 CERVICAL VERTEBRAE, AGENESIS OF
214350 CHANDS
214980 CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE
215030 CHOLESTEROL PNEUMONIA
215050 CHONDRODYSPLASIA CALCIFICANS METAPHYSEALIS
215105 CHONDRODYSPLASIA PUNCTATA SYNDROME
215250 CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME
215450 CHOREA, BENIGN FAMILIAL
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION
215518 CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION
215550 CIRCUMVALLATE PLACENTA SYNDROME
215720 CITRULLINE TRANSPORT DEFECT
215800 CLEFT LARYNX, POSTERIOR
215850 CLEFT-LIMB-HEART MALFORMATION SYNDROME
216100 CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY
216330 CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM
216411 COCKAYNE SYNDROME, TYPE III
216800 COLOBOMA OF MACULA AND SKELETAL ANOMALIES
216820 COLOBOMA, OCULAR
216920 COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT
217085 CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY
217150 CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA
217200 CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET
217520 CORNEAL DEGENERATION, BAND-SHAPED SPHEROID
218010 CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY
218050 CRAMPS, FAMILIAL ADOLESCENT
218090 CRANE-HEISE SYNDROME
218200 CRANIAL NERVES, RECURRENT PARESIS OF
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD
218350 CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE
218450 CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY,
218530 CRANIOSYNOSTOSIS WITH ANOMALIES OF THE CRANIAL BASE AND DIGITS
218550 CRANIOSYNOSTOSIS WITH FIBULAR APLASIA
218649 CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG
218650 CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME
218670 CRANIOTELENCEPHALIC DYSPLASIA
219070 CURVED NAIL OF FOURTH TOE
219095 CUTANEOUS PHOTOSENSITIVITY AND COLITIS, LETHAL
219250 CUTIS MARMORATA TELANGIECTATICA CONGENITA; CMTC
219300 CUTIS VERTICIS GYRATA AND MENTAL RETARDATION; CVG/MR
219400 CYANOSIS AND HEPATIC DISEASE
219550 CYSTEINE PEPTIDURIA
219600 CYSTIC DISEASE OF LUNG
219721 CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC
219730 VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE
220219 DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA,
220220 DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY
220900 DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM
221320 DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES
221400 DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL AND
221500 DEAFNESS, NEURAL, CONGENITAL MODERATE
221700 DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS
221740 DEAFNESS-OLIGODONTIA SYNDROME
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE
221760 DERMATOGLYPHICS--PALMAR TRIRADIUS d, ABSENCE OF
221780 DERMATOGLYPHICS--HYPOTHENAR RADIAL ARCH
221790 DERMATOLEUKODYSTROPHY
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE
221950 DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA
221995 DIABETES INSIPIDUS, NEPHROGENIC, WITH MENTAL RETARDATION AND INTRACEREBRAL
222350 DIAMINOPENTANURIA
222500 DIASTEMATOMYELIA
222730 DICARBOXYLIC AMINOACIDURIA
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY
223320 DIVERTICULOSIS, SMALL-INTESTINAL
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT
223340 DK PHOCOMELIA SYNDROME
223350 DOHLE BODIES AND LEUKEMIA
223380 DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF
223400 DUODENAL ATRESIA
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY
224000 DYSAUTONOMIA-LIKE DISORDER
224250 DYSMYELINATION WITH JAUNDICE
224550 DYSTONIA WITH RINGBINDEN
224700 EBSTEIN ANOMALY
224800 ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS
225040 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESIS
225050 ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARY
225290 ECTRODACTYLY-POLYDACTYLY
225310 EHLERS-DANLOS SYNDROME WITH PLATELET DYSFUNCTION FROM FIBRONECTIN
225450 ELLIPTOCYTOSIS, ATYPICAL
225740 ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY,
225755 ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY,
226000 ENDOCARDIAL FIBROELASTOSIS; EFE
226100 ENDOCARDIAL FIBROELASTOSIS AND COARCTATION OF ABDOMINAL AORTA
226110 ENDOTHELIAL DYSTROPHY, CONGENITAL HEREDITARY, WITH NAIL HYPOPLASIA
226150 ENTEROCOLITIS
226350 EOSINOPHILIC FASCIITIS
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTAL
226735 EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA
226800 EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION
226810 EPILEPSY WITH BILATERAL OCCIPITAL CALCIFICATIONS
226850 EPILEPSY-TELANGIECTASIA
226950 EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS
226985 EPITHELIAL SQUAMOUS DYSPLASIA, KERATINIZING DESQUAMATIVE, OF URINARY
226990 EPSTEIN-BARR VIRUS, SUSCEPTIBILITY TO CHRONIC INFECTION BY
227000 ERYTHEMA OF ACRAL REGIONS
227010 ERMINE PHENOTYPE
227200 EUNUCHOIDISM, FAMILIAL HYPOGONADOTROPIC
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION
227255 FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS
227280 FACIOCARDIORENAL SYNDROME
227310 FACTOR V AND FACTOR VIII, COMBINED DEFICIENCY OF, WITH NORMAL PROTEIN
227320 FACIOTHORACOGENITAL SYNDROME
227850 FANCONI-LIKE SYNDROME
228020 FASCIAL DYSTROPHY, CONGENITAL
228200 FEMUR-FIBULA-ULNA SYNDROME
228355 FETAL IODINE DEFICIENCY DISORDER; FIDD
228400 FEVER, FAMILIAL LIFELONG PERSISTENT
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES
228800 FIBROSCLEROSIS, MULTIFOCAL
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES
229045 FOCAL EPITHELIAL HYPERPLASIA, ORAL
229230 FRASER-LIKE SYNDROME
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA
229650 FRUCTOSE UTILIZATION
230300 GALACTORRHEA
230750 GASTROSCHISIS
231060 GENITOPALATOCARDIAC SYNDROME
231080 GERMAN SYNDROME
231100 HEMOCHROMATOSIS, NEONATAL
231630 MONOSODIUM GLUTAMATE SENSITIVITY
231950 GLUTATHIONURIA
231970 GLUTEAL MUSCLES, ABSENCE OF
232900 GLYCOPROTEIN STORAGE DISEASE
233270 GOMBO SYNDROME
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES
233450 GOODPASTURE SYNDROME
233500 GORLIN-CHAUDHRY-MOSS SYNDROME
233600 GRANULOCYTOPENIA WITH IMMUNOGLOBULIN ABNORMALITY
233670 GRANULOMATOUS DISEASE WITH DEFECT IN NEUTROPHIL CHEMOTAXIS
233800 GROUPED PIGMENTATION OF THE RETINA
233805 GROWTH FACTORS, COMBINED DEFECT OF
233810 GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA
234030 HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME
234280 HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY
234300 HALO NEVI
234350 HALOTHANE HEPATITIS
234580 HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS
234700 HEART BLOCK, CONGENITAL
234750 HEART, MALFORMATION OF
234820 HEMANGIOPERICYTOMA, MALIGNANT
235370 HEMOLYTIC ANEMIA WITH THERMAL SENSITIVITY OF RED CELLS
235500 HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN
235740 HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS
235750 HIRSCHSPRUNG DISEASE WITH ULNAR POLYDACTYLY, POLYSYNDACTYLY OF BIG
235760 HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIAL
236110 HOLZGREVE SYNDROME
236130 HOMOCARNOSINOSIS
236300 HOOFT DISEASE
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME
236635 HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS
236660 HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS
237000 HYDROXYPROLINEMIA
237400 HYPER-BETA-ALANINEMIA
237550 HYPERBILIRUBINEMIA, CONJUGATED, TYPE III
238350 HYPERLEXIA
238710 HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA
238750 HYPERLYSINURIA WITH HYPERAMMONEMIA
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA
239199 HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA
239350 HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2
239711 HYPERTELORISM AND TETRALOGY OF FALLOT
239840 HYPERTRICHOSIS, CONGENITAL ANTERIOR CERVICAL, WITH PERIPHERAL SENSORY
239900 HYPERTROPHIC NEUROPATHY AND CATARACT
240000 HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINE
240150 HYPERVITAMINOSIS A, SUSCEPTIBILITY TO
240400 HYPOASCORBEMIA
240950 HYPOGONADISM-CATARACT SYNDROME
241000 HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY
241100 HYPOGONADISM, MALE
241120 HYPOHIDROSIS WITH ABNORMAL PALMAR DERMAL RIDGES
241519 HYPOPHOSPHATEMIA, RENAL, WITH INTRACEREBRAL CALCIFICATIONS
241540 HYPOPITUITARISM, CONGENITAL, WITH CENTRAL DIABETES INSIPIDUS
241800 HYPOTHALAMIC HAMARTOMAS
242050 HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY
242150 ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS
242510 ICHTHYOSIS WITH ALOPECIA, ECLABIUM, ECTROPION, AND MENTAL RETARDATION
242520 ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION
242530 ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT
242550 ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA
242680 CILIARY DYSKINESIA WITH EXCESSIVELY LONG CILIA
242850 IMMUNE DEFICIENCY DISEASE
242870 IMMUNODEFICIENCY, PARTIAL COMBINED, WITH ABSENCE OF HLA DETERMINANTS
242880 IMMUNOERYTHROMYELOID HYPOPLASIA
242890 IMMUNOGLOBULIN D LEVEL IN PLASMA, LOW
243050 INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION
243080 INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO
243100 INTERNAL CAROTID ARTERIES, HYPOPLASIA OF
243110 IMMUNODEFICIENCY WITH DEFECTIVE T-CELL RESPONSE TO INTERLEUKIN 1
243185 INTESTINAL PSEUDOOBSTRUCTION WITH PATENT DUCTUS ARTERIOSUS AND NATAL
243200 INTRACRANIAL HYPERTENSION, IDIOPATHIC
243320 INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME
243450 ISOVALERIC ACID, INABILITY TO SMELL
243605 JEJUNAL ATRESIA WITH MICROCEPHALY AND OCULAR ANOMALIES
244100 JUMPING FRENCHMAN OF MAINE
244510 KERATOCONUS AND CONGENITAL HIP DYSPLASIA
244600 KERATOCONUS POSTICUS CIRCUMSCRIPTUS; KPC
244850 PALMOPLANTAR KERATODERMA, NORRBOTTEN RECESSIVE TYPE; PPKNR
245130 KETOADIPICACIDURIA
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS
245180 KIFAFA SEIZURE DISORDER
245190 KNIEST-LIKE DYSPLASIA, LETHAL
245450 LACTIC ACIDURIA DUE TO D-LACTIC ACID
245550 LAMBERT SYNDROME
245552 LAMBOTTE SYNDROME
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE
245800 LAURENCE-MOON SYNDROME
246470 LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER
246500 LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS
246555 LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY
246570 FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME
247150 LIP PRINTS
247410 LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME
247430 LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF
247440 LYMPHEDEMA, CONGENITAL RECESSIVE
247450 LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN
247610 LYMPHOID INTERSTITIAL PNEUMONIA; LIP
247630 LYMPHOID SYSTEM DETERIORATION, PROGRESSIVE
247640 LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES; LALL
247650 LYMPHOKINE DEFICIENCY
247950 LYSINE MALABSORPTION SYNDROME
247990 MACDERMOT-WINTER SYNDROME
248010 MACROEPIPHYSEAL DYSPLASIA WITH OSTEOPOROSIS, WRINKLED SKIN, AND AGED
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL
248260 MAGNESIUM, ELEVATED RED CELL
248340 3MC SYNDROME 3; 3MC3
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS
248770 MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL
248910 CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA
248950 MCDONOUGH SYNDROME
249230 MEGAEPIPHYSEAL DWARFISM
249240 MEGALENCEPHALY WITH DYSMYELINATION
249599 MENTAL RETARDATION SYNDROME, BELGIAN TYPE
249600 MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE
249630 MENTAL RETARDATION, BUENOS AIRES TYPE
249660 MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES
249670 MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION
249710 MESOMELIC LIMB SHORTENING AND BOWING
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE
250300 METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE
250400 METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE
250410 METAPHYSEAL CHONDRODYSPLASIA WITH RETINITIS PIGMENTOSA
250500 METAPHYSEAL MODELING ABNORMALITY, SKIN LESIONS, AND SPASTIC PARAPLEGIA
250650 METHANE PRODUCTION
250700 METHEMOGLOBIN REDUCTASE DEFICIENCY
250951 3-@METHYLGLUTACONIC ACIDURIA, TYPE IV; MGCA4
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE
251220 MICROCEPHALY-CARDIOMYOPATHY
251240 MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA
251250 MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES
251280 MICROCEPHALY WITH SPASTIC QUADRIPLEGIA
251400 MICROCOLON
251505 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4; MCOPCB4
251900 MITOCHONDRIAL MYOPATHY
251945 MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT
251950 MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS
252250 MONOCYTE CHEMOTACTIC DISORDER
252300 MORQUIO SYNDROME C
252320 MOTOR NEUROPATHY, PERIPHERAL, WITH DYSAUTONOMIA
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPIC
253590 MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY
254000 MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM
254100 MUSCULAR DYSTROPHY, CONGENITAL, WITH RAPID PROGRESSION
254120 MUSCULAR HYPERTONIA, LETHAL
254190 MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS
254200 MYASTHENIA GRAVIS; MG
254400 MYCOSIS FUNGOIDES
254700 MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE
254940 MYOPATHY, CONGENITAL NONPROGRESSIVE, WITH MOEBIUS SEQUENCE AND ROBIN
254950 MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA
254960 MYOPATHY DUE TO MALATE-ASPARTATE SHUTTLE DEFECT
255100 MYOPATHY WITH ABNORMAL LIPID METABOLISM
255140 MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA
255710 MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION
255990 NATHALIE SYNDROME
256020 NAIL-PATELLA-LIKE RENAL DISEASE
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM
256150 NEPHROSIALIDOSIS
256200 NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS
256690 NEUROFACIODIGITORENAL SYNDROME
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY
256860 NEUROPATHY, HEREDITARY SENSORY, ATYPICAL
256870 NEUROPATHY, PAINFUL
257100 NEUTROPENIA, LETHAL CONGENITAL, WITH EOSINOPHILIA
257350 NUCHAL BLEB, FAMILIAL
257500 OBESITY-HYPOVENTILATION SYNDROME
257790 OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS
257960 OCULOTRICHODYSPLASIA; OTD
258040 OEIS COMPLEX
258200 OLIVER SYNDROME
258320 OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL
258470 OPHTHALMOPLEGIC NEUROMUSCULAR DISORDER WITH ABNORMAL MITOCHONDRIA
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMAL
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS
259050 OSSIFIED EAR CARTILAGES WITH MENTAL DEFICIENCY, MUSCLE WASTING, AND
259200 BLOUNT DISEASE, ADOLESCENT
259550 OSTEOID OSTEOMA
259610 OSTEOLYSIS SYNDROME, RECESSIVE
259650 OSTEOMA OF MIDDLE EAR
259680 CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS; CRMO
259690 OSTEOPENIA AND SPARSE HAIR
259750 OSTEOPOROSIS, JUVENILE
260100 PA POLYMORPHISM OF ALPHA-2-GLOBULIN
260130 PACHYONYCHIA CONGENITA, AUTOSOMAL RECESSIVE
260150 PALANT CLEFT PALATE SYNDROME
260450 PANCREATIC INSUFFICIENCY, COMBINED EXOCRINE
260470 PANENCEPHALITIS, SUBACUTE SCLEROSING
260480 PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX
260530 PARANA HARD-SKIN SYNDROME
260555 PARTINGTON-ANDERSON SYNDROME
260570 PELGER-HUET-LIKE ANOMALY AND EPISODIC FEVER WITH ABDOMINAL PAIN
260650 PELLAGRA-LIKE SYNDROME
260900 PERICARDIAL EFFUSION, CHRONIC
260910 PERIFOLLICULITIS CAPITIS ABSCEDENS ET SUFFODIENS, FAMILIAL
260950 PERIODONTITIS, CHRONIC
260970 PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND
261400 PERONEUS TERTIUS MUSCLE, ABSENCE OF
261560 PFEIFFER-PALM-TELLER SYNDROME
261575 PHAVER SYNDROME
261590 PHENFORMIN 4-HYDROXYLATION
261680 PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC
261990 PILI TORTI AND DEVELOPMENTAL DELAY
262020 PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS
262710 PITUITARY DWARFISM WITH LARGE SELLA TURCICA
262875 PLATELET PROSTACYCLIN RECEPTOR DEFECT
262900 PLEOCONIAL MYOPATHY WITH SALT CRAVING
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES
263600 POLYSACCHARIDE, STORAGE OF UNUSUAL
263610 POLYHYDRAMNIOS, CHRONIC IDIOPATHIC
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY
264050 PRENATAL BOWING
264060 PREPAPILLARY VASCULAR LOOPS
264080 PROGESTERONE RESISTANCE
264110 PROLACTIN DEFICIENCY, ISOLATED
264120 PROLACTIN DEFICIENCY WITH OBESITY AND ENLARGED TESTES
264140 PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, AND
264180 PSEUDODIASTROPHIC DYSPLASIA
264420 FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HAND
264480 PSEUDOTRISOMY 13 SYNDROME
264500 PSEUDOURIDINURIA AND MENTAL DEFECT
265140 PULMONARY ARTERIOVENOUS FISTULAS
265150 PULMONARY ATRESIA WITH INTACT VENTRICULAR SEPTUM
265200 PULMONARY BULLAE CAUSING PNEUMOTHORAX
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE
265430 LUNG AGENESIS
265500 PULMONIC STENOSIS
265600 PULMONIC STENOSIS AND CONGENITAL NEPHROSIS
265880 PYKNOACHONDROGENESIS
266255 RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATION
266270 RAMON SYNDROME
266400 REESE RETINAL DYSPLASIA
266810 RENAL AND MULLERIAN DUCT HYPOPLASIA
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME
267200 RENAL TUBULAR ACIDOSIS III
267400 RENAL, GENITAL, AND MIDDLE EAR ANOMALIES
267480 RESPIRATORY UNDERRESPONSIVENESS TO HYPOXIA AND HYPERCAPNIA
267740 RETINAL DEGENERATION AND EPILEPSY
267760 RETINAL DEGENERATION WITH NANOPHTHALMOS, CYSTIC MACULAR DEGENERATION,
267800 RETINAL DYSTROPHY, RETICULAR PIGMENTARY, OF POSTERIOR POLE
267900 RETINAL TELANGIECTASIA AND HYPOGAMMAGLOBULINEMIA
268010 RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS
268020 RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM
268025 RETINITIS PIGMENTOSA, LATE-ADULT ONSET
268040 RETINOHEPATOENDOCRINOLOGIC SYNDROME
268050 RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION
268060 RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE
268240 RHEUMATIC FEVER-RELATED ANTIGEN
268250 RHIZOMELIC SYNDROME
268315 ROD-CONE DYSTROPHY, SENSORINEURAL DEAFNESS, AND FANCONI-TYPE RENAL
268320 RODRIGUES BLINDNESS
268500 ROWLEY-ROSENBERG SYNDROME
268650 RUDIGER SYNDROME
269300 SCHWARTZ-LELEK SYNDROME
269400 SCLEROCORNEA, AUTOSOMAL RECESSIVE
269630 SECOND METATARSAL-METACARPAL SYNDROME
269650 SECRETORY COMPONENT DEFICIENCY
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE
269800 SENILE PLAQUE FORMATION
269870 SHORT STATURE-OBESITY SYNDROME; SSOS
270220 SJOGREN-LARSSON-LIKE ICHTHYOSIS WITHOUT CNS OR EYE INVOLVEMENT
270350 SKUNK N-BUTYLMERCAPTAN, INABILITY TO SMELL
270425 SODIUM-POTASSIUM-ATPase ACTIVITY OF RED CELL
270460 SONODA SYNDROME
270500 ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC
270805 SPASTIC PARAPLEGIA WITH MYOCLONIC EPILEPSY
270850 SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION
270950 SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION
271109 SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION
271110 SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY
271200 SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE
271220 SPINAL MUSCULAR ATROPHY, SCAPULOPERONEAL
271225 SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES
271270 SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM
271310 SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY
271320 SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITAL
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM
271520 SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES
271620 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION
271950 SUBAORTIC STENOSIS, MEMBRANOUS
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME
272000 SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION
272150 SUGARMAN BRACHYDACTYLY
272350 SUMMITT SYNDROME
272450 SYNDESMODYSPLASIC DWARFISM
272620 TARDIVE DYSKINESIA
272700 TAURODONTISM
272950 TEEBI-SHALTOUT SYNDROME
272980 TEETH, CONGENITAL ABSENCE OF, WITH TAURODONTIA AND SPARSE HAIR
273050 TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM
273120 TERATOMA, PINEAL
273150 TESTES, RUDIMENTARY
273390 TETRAAMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES
273400 TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, AND
273490 THALAMIC DEGENERATION, SYMMETRIC INFANTILE
273680 THANATOPHORIC DYSPLASIA, GLASGOW VARIANT
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME
273740 THORACOMELIC DYSPLASIA
273770 THREONINEMIA
274200 THUMB, DISTAL HYPEREXTENSIBILITY OF
274205 THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,
274230 THYMOMA, FAMILIAL
274265 THYMIC-RENAL-ANAL-LUNG DYSPLASIA
275220 TIBIAL HEMIMELIA
275240 TINEA IMBRICATA, SUSCEPTIBILITY TO
275300 TRACHEOBRONCHOMEGALY
275450 TRICHOODONTOONYCHIAL DYSPLASIA WITH BONE DEFICIENCY
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIES
276200 T-SUBSTANCE ANOMALY
276410 TWINNING, MONOZYGOTIC
276821 ULNAR HYPOPLASIA WITH MENTAL RETARDATION
276822 ULNAR AGENESIS AND ENDOCARDIAL FIBROELASTOSIS
277175 VASCULAR HYALINOSIS
277200 RIGHT VENTRICULAR HYPOPLASIA, ISOLATED
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION
277740 WHITE FORELOCK WITH MALFORMATIONS
277970 WISKOTT-ALDRICH SYNDROME
277990 WOLFF MENTAL RETARDATION SYNDROME
278100 WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS
278200 WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS
278900 XYLOSIDASE DEFICIENCY
300042 ALOPECIA, CONGENITAL
300054 BODY LENGTH, MOUSE, HUMAN HOMOLOG
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM
300073 FETAL AKINESIA SYNDROME, X-LINKED
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED
300113 X-LINKED B CELL SURFACE ANTIGEN, MOUSE, HOMOLOG-LIKE 1; XLRL
300129 HEMATOPOIETIC STEM CELL KINETICS, CONTROL OF
300184 HYPOTONIA, CONGENITAL NYSTAGMUS, ATAXIA, AND ABNORMAL AUDITORY BRAINSTEM
300216 COATS DISEASE
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION
300233 RADIOULNAR SYNOSTOSIS, RADIAL RAY ABNORMALITIES, AND SEVERE MALFORMATIONS
300259 MYCOBACTERIUM TUBERCULOSIS, SUSCEPTIBILITY TO, X-LINKED
300270 ADRENOMYODYSTROPHY
300274 ANDROGEN INSENSITIVITY SYNDROME DUE TO COACTIVATOR DEFICIENCY
300280 URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME
300431 ATKIN-FLAITZ SYNDROME
300602 CLARK-BARAITSER SYNDROME
300650 ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS; OASD
300813 SARCOMA, SYNOVIAL
300864 CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED
301410 NEURAL TUBE DEFECTS, X-LINKED
301790 SPINOCEREBELLAR ATAXIA, X-LINKED 3
301800 ANUS, IMPERFORATE
301815 ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL
301840 SPINOCEREBELLAR ATAXIA, X-LINKED 4
301940 BRACHYDACTYLY, MONONEN TYPE
301950 BRANCHIAL ARCH SYNDROME, X-LINKED
302030 CALVARIAL HYPEROSTOSIS
302600 SPINOCEREBELLAR ATAXIA, X-LINKED 2
302700 CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE
302803 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED, WITH APLASIA
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,
303650 COLONIC ATRESIA
304030 CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN
304200 CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION
304300 CYANIDE, INABILITY TO SMELL
304350 DEAFNESS-HYPOGONADISM SYNDROME; DHS
304900 DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2
305550 FINGERPRINT BODY MYOPATHY
305690 GENITOURINARY TRACT ANOMALIES
305700 SPERMATOGENIC FAILURE, X-LINKED, 1; SPGFX1
305800 MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED
305920 GLUTAMYL RIBOSE-5-PHOSPHATE STORAGE DISEASE
306300 GRANULOMAS, CONGENITAL CEREBRAL
306500 GYNECOMASTIA, FAMILIAL
306930 HEMOPOIETIC PROLIFERATION
306950 HERNIA, ANTERIOR DIAPHRAGMATIC
306980 HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY
306990 HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE
306995 HOMOSEXUALITY 1; HMS1
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS
307300 HYPOGONADISM, MALE
307830 HYPOURICEMIA, FAMILIAL RENAL, DUE TO TUBULAR HYPERSECRETION
308200 ICHTHYOSIS AND MALE HYPOGONADISM
308220 IMMUNODEFICIENCY, X-LINKED, WITH DEFICIENCY OF 115,000 DALTON SURFACE
308290 IMPRINTING GENE RELATED TO RETINOBLASTOMA
308750 KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA
308830 KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY
308850 LARYNGEAL ABDUCTOR PARALYSIS
308960 LEUKEMIA, ACUTE, ?X-LINKED
309050 LUTHERAN SUPPRESSOR, X-LINKED; XS
309120 SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2
309480 MENTAL RETARDATION AND PSORIASIS
309840 MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS
309930 MUSCULAR DYSTROPHY, CARDIAC TYPE
309950 MUSCULAR DYSTROPHY, HEMIZYGOUS LETHAL TYPE
310000 MUSCULAR DYSTROPHY, MABRY TYPE
310095 MUSCULAR DYSTROPHY, PROGRESSIVE PECTORODORSAL
310350 MYELOLYMPHATIC INSUFFICIENCY
310370 MYOCLONIC EPILEPSY, PROGRESSIVE
310465 N SYNDROME; NSX
310470 NEUROPATHY, HEREDITARY SENSORY, X-LINKED
310650 NUCLEAR RIBONUCLEIC ACID; nRNA
310980 OMPHALOCELE, X-LINKED
311100 OPTIC ATROPHY--SPASTIC PARAPLEGIA SYNDROME
311350 OUABAIN RESISTANCE; OUBR
311400 PAINE SYNDROME
311450 PALLISTER W SYNDROME
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES
312100 PSEUDOHERMAPHRODITISM, INCOMPLETE MALE, TYPE I
312190 RADIAL APLASIA, X-LINKED
312210 RADIATION SENSITIVITY OF NATURAL KILLER ACTIVITY
312550 RETINAL DYSPLASIA, PRIMARY; PRD
312780 RUSSELL-SILVER SYNDROME, X-LINKED
312830 SCARF SYNDROME
312840 SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME
312910 SPASTIC PARAPARESIS AND DEAFNESS
313480 TaqI POLYMORPHISM; TAQ1
313490 TAURODONTISM, MICRODONTIA, AND DENS INVAGINATUS
314000 THROMBOCYTOPENIA WITH ELEVATED SERUM IgA AND RENAL DISEASE
314100 THUMBS, CONGENITAL CLASPED
314240 TOOTH SIZE
314320 TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY
314360 ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET
314550 VESICOURETERAL REFLUX, X-LINKED; VURX
314560 VON WILLEBRAND DISEASE, X-LINKED FORM
314570 WIDOW'S PEAK SYNDROME
314600 WILDERVANCK SYNDROME
314700 BLOOD GROUP, XG SYSTEM; XG
314800 XH ANTIGEN
425500 HAIRY EARS, Y-LINKED
489000 UBIQUITIN-ACTIVATING ENZYME, Y-LINKED
600000 SPONDYLOCAMPTODACTYLY
600080 MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC
600084 MACROCYTOSIS, FAMILIAL
600089 PANCREATIC BETA CELL AGENESIS WITH NEONATAL DIABETES MELLITUS
600092 CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME
600093 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES
600096 PUERTO RICAN INFANT HYPOTONIA SYNDROME
600117 DYSPHASIA, FAMILIAL DEVELOPMENTAL
600122 MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL AND
600146 SPASTIC PARAPLEGIA 5B, AUTOSOMAL RECESSIVE; SPG5B
600148 GLYCEROL KINASE, TESTICULAR, TYPE A
600149 GLYCEROL KINASE, TESTICULAR, TYPE B
600159 PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES
600166 HYPERPARATHYROIDISM, PRIMARY, CAUSED BY WATER CLEAR CELL HYPERPLASIA
600171 GONADAL AGENESIS
600252 LOWRY-MACLEAN SYNDROME
600269 SHORT TARSUS WITH ABSENCE OF LOWER EYELASHES; STALE
600302 FRYNS MACROCEPHALY
600329 OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY
600331 PARC SYNDROME
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA
600335 SUCCINIC ACIDEMIA
600347 BREVICAN; BCAN
600348 BAND HETEROTOPIA OF BRAIN
600351 ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY
600356 PACHYDERMODACTYLY, FAMILIAL
600373 CODAS SYNDROME
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL
600419 ANGIOKERATOMA CORPORIS DIFFUSUM WITH ARTERIOVENOUS FISTULAS
600457 HYPERTRICHOSIS, ANTERIOR CERVICAL
600458 ADENOMYOSIS
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY
600461 HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND
600546 INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY
600559 HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS
600561 SPONDYLOEPIPHYSEAL DYSPLASIA WITH ATLANTOAXIAL INSTABILITY
600598 SETTING-SUN PHENOMENON, FAMILIAL BENIGN
600627 HYPERTRYPTOPHANEMIA, FAMILIAL
600628 LOOSE ANAGEN HAIR SYNDROME
600643 CAROLI DISEASE, ISOLATED
600666 POLYCYSTIC KIDNEY DISEASE 3, AUTOSOMAL DOMINANT; PKD3
600679 DERMOID CYSTS, FAMILIAL FRONTONASAL
600705 SATOYOSHI SYNDROME
600706 PROXIMAL MYOPATHY WITH FOCAL DEPLETION OF MITOCHONDRIA
600736 VELOFACIOSKELETAL SYNDROME
600776 FRYNS MICROPHTHALMIA SYNDROME
600801 ISOPROTERENOL-MEDIATED VASODILATATION
600841 EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA-1-LIKE 14; EEF1A1L14
600851 MITOCHONDRIAL IMPORT-STIMULATING FACTOR
600906 ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY
600907 ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS
600908 AGONADISM, 46,XY, WITH MENTAL RETARDATION, SHORT STATURE, RETARDED
600931 PROTOCADHERIN 3
600952 TRANSSEXUALITY
600987 CARDIAC MALFORMATION, CLEFT LIP/PALATE, MICROCEPHALY AND DIGITAL ANOMALIES
600989 INFUNDIBULOPELVIC DYSGENESIS
600991 HYDROCEPHALUS, SPRENGEL ANOMALY, AND COSTOVERTEBRAL DYSPLASIA
601004 PORTAL VEIN, CAVERNOUS TRANSFORMATION OF
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM
601027 TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR
601039 ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES
601075 APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION
601083 CD4/CD8 T-CELL RATIO
601088 CATARACTS, CONGENITAL, WITH SENSORINEURAL DEAFNESS, DOWN SYNDROME-LIKE
601095 HARROD SYNDROME
601096 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC
601127 FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION
601138 GUANYLATE CYCLASE 2E; GUCY2E
601160 LISSENCEPHALY TYPE III AND BONE DYSPLASIA
601161 TRISOMY 18-LIKE SYNDROME
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,
601170 MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM
601187 GURRIERI SYNDROME
601195 IRON OVERLOAD IN AFRICA
601216 PLATYSPONDYLY WITH AMELOGENESIS IMPERFECTA
601217 ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPIC
601220 OSTEOPOROSIS AND OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME; OOCH
601221 TISSUE-SPECIFIC EXTINGUISHER 3
601223 NEURONAL INTESTINAL DYSPLASIA, TYPE B
601230 DERMATITIS HERPETIFORMIS, FAMILIAL
601315 EPITHELIAL BASOLATERAL CHLORIDE CONDUCTANCE REGULATOR, RABBIT, HOMOLOG
601319 ODONTOMICRONYCHIAL DYSPLASIA
601322 PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS
601338 CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL
601341 ATROPHIA MACULOSA VARIOLIFORMIS CUTIS, FAMILIAL; AMVC
601344 SPINAL DYSPLASIA, ANHALT TYPE
601345 ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE
601347 MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,
601348 ECTRODACTYLY OF LOWER LIMBS, CONGENITAL HEART DEFECT, AND MICROGNATHIA
601350 SHORT STATURE SYNDROME, BRUSSELS TYPE
601351 GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL
601352 MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE
601353 BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION
601355 MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,
601360 AMELIA, AUTOSOMAL RECESSIVE
601370 HOLOPROSENCEPHALY, SEMILOBAR, WITH CRANIOSYNOSTOSIS
601371 CATARACT, AGE-RELATED NUCLEAR
601372 CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT
601374 APROSENCEPHALY AND CEREBELLAR DYSGENESIS
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE
601376 CHONDRODYSPLASIA, LETHAL, WITH LONG BONE ANGULATION AND MIXED BONE
601379 HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME
601389 CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION
601420 MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE
601427 ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM,
601438 RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE
601449 DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERS
601453 TRICHODENTAL DYSPLASIA
601466 PATENT DUCTUS VENOSUS; PDV
601477 RIBBING DISEASE
601560 MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE
601561 DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA
601563 HORNS IN SHEEP
601608 SPASTIC PARAPLEGIA AND EVANS SYNDROME
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD
601696 NOVELTY SEEKING PERSONALITY TRAIT
601701 ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA
601706 YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME
601707 CRANIOFACIAL MALFORMATIONS, ASYMMETRIC, WITH POLYSYNDACTYLY AND ABNORMAL
601708 SUPERIOR TRANSVERSE SCAPULAR LIGAMENT, CALCIFICATION OF, FAMILIAL
601759 PREAXIAL HALLUCAL POLYDACTYLY
601775 FOLATE LEVEL IN ERYTHROCYTES
601809 SPONDYLOSPINAL THORACIC DYSOSTOSIS
601811 PREMATURE AGING SYNDROME, OKAMOTO TYPE
601812 PREMATURE AGING SYNDROME, PENTTINEN TYPE
601829 ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE
601853 CEREBELLOTRIGEMINAL DERMAL DYSPLASIA
601876 SPERM-SPECIFIC ANTIGEN 1; SSFA1
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME
601979 HYPERZINCEMIA WITH FUNCTIONAL ZINC DEPLETION
602068 LEISHMANIASIS, TEGUMENTARY, SUSCEPTIBILITY TO
602107 NEUROPATHY, HEREDITARY THERMOSENSITIVE
602114 NEPHROPATHY, PROGRESSIVE TUBULOINTERSTITIAL, WITH CHOLESTATIC LIVER
602152 RHYNS SYNDROME
602197 CEREBELLAR DEGENERATION-RELATED AUTOANTIGEN 3
602249 PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES
602252 MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TIM12, YEAST, HOMOLOG OF
602271 SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL
602340 SENSORINEURAL HEARING LOSS, RETINAL PIGMENT EPITHELIUM LESIONS, DISCOLORED
602418 WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME
602455 REGENERATION-ASSOCIATED SERPIN-1
602472 CREASES, INFRA-AURICULAR CUTANEOUS, WITH TALL STATURE AND ADVANCED
602484 PELVIC HYPOPLASIA WITH LOWER-LIMB ARTHROGRYPOSIS
602497 CHONDRODYSPLASIA PUNCTATA, BRACHYTELEPHALANGIC, AUTOSOMAL
602511 PSEUDOACROMEGALY WITH SEVERE INSULIN RESISTANCE
602531 ARTERIAL OCCLUSIVE DISEASE, PROGRESSIVE, WITH HYPERTENSION, HEART
602551 JEJUNAL ATRESIA WITH RENAL ADYSPLASIA
602553 ANAL ATRESIA, HYPOSPADIAS, AND PENOSCROTAL INVERSION
602554 TORSION DYSTONIA WITH ONSET IN INFANCY
602555 MICROCEPHALY, MACROTIA, AND MENTAL RETARDATION
602556 FACIAL DYSMORPHISM, CLEFT PALATE, HEARING LOSS, AND CAMPTODACTYLY
602557 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE
602558 CRANIOMICROMELIC SYNDROME
602561 BRACHYDACTYLY, INTRAVENTRICULAR SEPTAL DEFECT, AND DEAFNESS
602562 MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA
602564 EMPHYSEMA, CONGENITAL, WITH DEAFNESS, PENOSCROTAL WEB, AND MENTAL
602586 ACYL-CoA THIOESTER HYDROLASE, LONG-CHAIN, 1
602596 PANCREATIC LYMPHOMA, FAMILIAL
602611 SPONDYLOEPIPHYSEAL DYSPLASIA WITH CORONAL CRANIOSYNOSTOSIS, CATARACTS,
602612 CAMPTODACTYLY, MYOPIA, AND FIBROSIS OF THE MEDIAL RECTUS MUSCLE OF
602613 SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION,
602994 LEUKOREGULIN
603117 SPASTIC PARAPLEGIA, OPTIC ATROPHY, MICROCEPHALY, AND XY SEX REVERSAL
603119 APRAXIA OF EYELID OPENING
603133 DISLOCATED ELBOWS, BOWED TIBIAS, SCOLIOSIS, DEAFNESS, CATARACT, MICROCEPHALY,
603174 HOMOCYSTEINEMIA
603209 CYTIDINE MONOPHOSPHO-N-ACETYLNEURAMINIC ACID HYDROXYLASE, PSEUDOGENE;
603282 ZINC FINGER PROTEIN 204; ZNF204
603323 MUSCULAR DYSTROPHY, CONGENITAL, WITH CEREBELLAR ATROPHY
603376 LONG CHAIN FATTY ACIDS, DEFECT IN TRANSPORT OF
603389 OSEBOLD SKELETAL DYSPLASIA/OSTEOLYSIS SYNDROME
603393 OSTEOSCLEROTIC CHONDRODYSPLASIA, LETHAL, WITH INTRACELLULAR INCLUSIONS
603394 MICROCEPHALY, SEVERE, WITH SKELETAL ANOMALIES INCLUDING POSTERIOR
603396 TONOKI SYNDROME
603416 ACTIVATOR OF LIVER FUNCTION 1; ALFN1
603438 RADIOULNAR SYNOSTOSIS WITH MICROCEPHALY, SHORT STATURE, SCOLIOSIS,
603439 EXPANSILE BONE LESIONS
603446 OROACRAL SYNDROME, VERLOES-KOULISCHER TYPE
603457 ARHINIA, CHOANAL ATRESIA, AND MICROPHTHALMIA
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARING
603472 NEURONAL INTRANUCLEAR INCLUSION DISEASE
603523 CHYLOTHORAX, CONGENITAL
603529 DYSERYTHROPOIESIS, CONGENITAL, WITH ULTRASTRUCTURALLY NORMAL ERYTHROBLAST
603530 LIGHT FIXATION SEIZURE SYNDROME
603569 TRACHEOBRONCHIAL STENOSIS, CONGENITAL
603572 MICROCEPHALY, FACIAL ABNORMALITIES, MICROMELIA, AND MENTAL RETARDATION
603587 FOLLICULAR ATROPHODERMA, PERIORAL PIGMENTED, WITH MILIA AND EPIDERMOID
603588 PAROTITIS, JUVENILE RECURRENT
603589 FACIAL DYSMORPHISM, SELECTIVE TOOTH AGENESIS, AND CHOROID CALCIFICATION
603595 CRANIOSYNOSTOSIS WITH ECTOPIA LENTIS
603600 OSTEOMA OF CRANIAL VAULT, FAMILIAL
603641 NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING
603642 ATRIAL SEPTAL DEFECT, SECUNDUM, WITH VARIOUS CARDIAC AND NONCARDIAC
603643 SITUS INVERSUS TOTALIS WITH CYSTIC DYSPLASIA OF KIDNEYS AND PANCREAS
603656 EXOSTOSIS, DUPUYTREN SUBUNGUAL
603664 MENTAL HEALTH WELLNESS 2
603669 ECCRINE SYRINGOFIBROADENOMATOSIS WITH EYELID ABNORMALITIES
603670 BLUE NEVI, FAMILIAL MULTIPLE
603737 OVARIAN GERM CELL CANCER
603740 ACRODYSPLASIA WITH OSSIFICATION ABNORMALITIES, SHORT STATURE, AND
603744 PAPILLARY THYROID MICROCARCINOMA
603794 HYDROA VACCINIFORME, FAMILIAL
603806 URINARY TRACT INFECTIONS, RECURRENT, SUSCEPTIBILITY TO
603828 BRITTLE BONE DISORDER
604093 KERATOSIS PILARIS
604154 ALZHEIMER DISEASE WITHOUT NEUROFIBRILLARY TANGLES
604172 CARONTE
604183 CHOLESTEATOMA, CONGENITAL
604211 HIRSCHSPRUNG DISEASE WITH HEART DEFECTS, LARYNGEAL ANOMALIES, AND
604257 CAMERA-MARUGO-COHEN SYNDROME
604287 CARNEY TRIAD
604291 ASCARIS LUMBRICOIDES INFECTION, SUSCEPTIBILITY TO
604315 ANEMIA, CONGENITAL HYPOPLASTIC, WITH MULTIPLE CONGENITAL ANOMALIES/MENTAL
604324 ACNE, ADULT
604335 REFLEX SYMPATHETIC DYSTROPHY
604363 MYOCLONIC EPILEPSY, CONGENITAL DEAFNESS, MACULAR DYSTROPHY, AND PSYCHIATRIC
604380 ULNAR RAY DYSGENESIS WITH POSTAXIAL POLYDACTYLY AND RENAL CYSTIC DYSPLASIA
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES
604382 LISSENCEPHALY, FAMILIAL, WITH CLEFT PALATE AND CEREBELLAR HYPOPLASIA
604451 BASAL CELL CARCINOMA, INFUNDIBULOCYSTIC
604474 HUMAN HERPESVIRUS TYPE 6, INTEGRATED
604690 GROWTH AND DEVELOPMENTAL RETARDATION, OCULAR PTOSIS, CARDIAC DEFECT,
604771 POLYCYSTIC BONE DISEASE
604830 MANDIBULOFACIAL DYSOSTOSIS SYNDROME, BAURU TYPE
604855 HYALURONAN METABOLISM, DEFECT IN
604856 LANGERHANS CELL HISTIOCYTOSIS
604916 HYDRONEPHROSIS, CONGENITAL, WITH CLEFT PALATE, CHARACTERISTIC FACIES,
604919 BECKER NEVUS SYNDROME
604922 CORTICAL DEFECTS, WORMIAN BONES, AND DENTINOGENESIS IMPERFECTA
605026 DIABETES MELLITUS, CONGENITAL AUTOIMMUNE
605028 LOW DENSITY LIPOPROTEIN CHOLESTEROL, MILD ELEVATION OF
605040 CLAVICULAR HYPOPLASIA, ZYGOMATIC ARCH HYPOPLASIA, AND MICROGNATHIA
605067 TRICUSPID ATRESIA
605105 EARLY RESPONSE TO NEURAL INDUCTION GENE
605274 MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE
605275 NOONAN SYNDROME 2; NS2
605321 FRONTOOCULAR SYNDROME
605400 FIBROMATOSIS, GINGIVAL, WITH HYPERTRICHOSIS AND MENTAL RETARDATION
605463 RADIATION SENSITIVITY/CHROMOSOME INSTABILITY SYNDROME, AUTOSOMAL DOMINANT
605618 TETRALOGY OF FALLOT SYNDROME, AUTOSOMAL RECESSIVE
605672 CEREBELLAR ATAXIA AND HYPERGONADOTROPIC HYPOGONADISM
605685 CUTIS VERTICIS GYRATA, RETINITIS PIGMENTOSA, AND SENSORINEURAL DEAFNESS
605756 OVARIAN DYSGENESIS, HYPERGONADOTROPIC, WITH SHORT STATURE AND RECURRENT
605808 BIRDSHOT CHORIORETINOPATHY
605822 SPONDYLOOCULAR SYNDROME, AUTOSOMAL RECESSIVE
605838 BABY RATTLE PELVIS DYSPLASIA
605935 ARTHROPATHY, EROSIVE
605944 LIVER FIBROCYSTIC DISEASE AND POLYDACTYLY
605945 CRUMPLED HELICES AND SMALL MOUTH
606155 FRYNS-AFTIMOS SYNDROME
606156 SENER SYNDROME
606174 BACULUM, CONGENITAL ABSENCE OF
606175 CARNITINE ACETYLTRANSFERASE DEFICIENCY
606177 PARS PLANITIS
606179 ANEURYSMAL BONE CYSTS
606183 LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY
606190 MENINGIOMA, RADIATION-INDUCED
606220 MENTAL RETARDATION, SHORT STATURE, FACIAL ANOMALIES, AND JOINT DISLOCATIONS
606349 GAMBLING, PATHOLOGIC
606369 MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY
606519 PHACE ASSOCIATION
606527 MEGARBANE SYNDROME
606529 CRANIOSYNOSTOSIS SYNDROME, AUTOSOMAL RECESSIVE
606632 ODOR, MALE, WOMEN'S CHOICE OF
606752 ACUTE HEMORRHAGIC LEUKOENCEPHALITIS
606773 HEMIFACIAL MYOHYPERPLASIA; HMH
606851 CREE MENTAL RETARDATION SYNDROME
606893 VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS
606894 DUODENOJEJUNAL ATRESIA WITH VOLVULUS, ABSENT DORSAL MESENTERY, AND
606895 SYMPHALANGISM, DISTAL, WITH MICRODONTIA, DENTAL PULP STONES, AND NARROWED
607044 T-BOX 24
607132 LARYNGEAL ATRESIA, ENCEPHALOCELE, AND LIMB DEFORMITIES
607161 MULTIPLE CONGENITAL ANOMALIES SYNDROME WITH CLOVERLEAF SKULL
607197 DEAFNESS, AUTOSOMAL RECESSIVE
607214 ANONYCHIA, TOTAL, WITH MICROCEPHALY
607278 OSTEOFIBROUS DYSPLASIA
607395 STREPTOCOCCUS, GROUP A, SEVERITY OF INFECTION BY
607413 ALZHEIMER DISEASE NEURONAL THREAD PROTEIN
607504 HEADACHE ASSOCIATED WITH SEXUAL ACTIVITY; HSA
607540 SECRETORY DIARRHEA, MYOPATHY, AND DEAFNESS
607543 SPONDYLOMETAPHYSEAL DYSPLASIA WITH BOWED FOREARMS AND FACIAL DYSMORPHISM
607552 MINICORE MYOPATHY, ANTENATAL ONSET, WITH ARTHROGRYPOSIS
607565 SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION
607569 MYOPATHY, DISTAL, WITH EARLY RESPIRATORY FAILURE, AUTOSOMAL DOMINANT
607578 BREATH-HOLDING SPELLS
607597 MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES
607665 TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU
607731 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H
607859 ANGIOMA, TUFTED
608028 THAI SYMPHALANGISM SYNDROME
608063 BILE AND PANCREATIC DUCTS, COMPLETE ABSENCE OF
608184 IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 4; HIGM4
608223 ASPIRIN RESISTANCE
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRAL
608257 MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGE
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS
608281 SCIMITAR ANOMALY, MULTIPLE CARDIAC MALFORMATIONS, AND CRANIOFACIAL
608406 VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM
608484 CONGENITAL CORNEAL OPACITIES, CORNEA GUTTATA, AND CORECTOPIA
608509 ALOPECIA UNIVERSALIS CONGENITA, XY GONADAL DYSGENESIS, AND LARYNGOMALACIA
608518 OROFACIODIGITAL SYNDROME VII; OFD7
608571 ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY
608580 MYOSIN, HEAVY CHAIN 16, SKELETAL MUSCLE, PSEUDOGENE; MYH16
608624 MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA
608670 ROBIN SEQUENCE WITH DISTINCTIVE FACIAL APPEARANCE AND BRACHYDACTYLY
608720 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, ADULT-ONSET, WITH ANOSMIA
608763 EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE
608809 LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA;
608811 METAPHYSEAL UNDERMODELING, SPONDYLAR DYSPLASIA, AND OVERGROWTH
608814 LATERAL SEMICIRCULAR CANAL MALFORMATION, FAMILIAL, WITH EXTERNAL AND
608885 CRYOHYDROCYTOSIS, STOMATIN-DEFICIENT, WITH MENTAL RETARDATION, SEIZURES,
609008 MARFANOID HABITUS WITH SITUS INVERSUS
609037 MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY,
609047 SKELETAL DYSPLASIA, RHIZOMELIC, WITH RETINITIS PIGMENTOSA
609250 HYPOTRICHOSIS, PROGRESSIVE PATTERNED SCALP, WITH WIRY HAIR, ONYCHOLYSIS,
609289 SYNCOPE, FAMILIAL VASOVAGAL; VVS
609345 CEREBRORENODIGITAL SYNDROME WITH LIMB MALFORMATIONS AND TRIRADIATE
609363 COLLOID CYSTS OF THIRD VENTRICLE
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIAL
609442 VALPROATE EMBRYOPATHY, SUSCEPTIBILITY TO
609465 AL-GAZALI SYNDROME
609466 CLEFT PALATE, MIDFACIAL HYPOPLASIA, TRIANGULAR FACIES, AND SENSORINEURAL
609515 IRIDOGONIODYSGENESIS AND SKELETAL ANOMALIES
609537 LIPOMYELOMENINGOCELE
609545 OMPHALOCELE, DIAPHRAGMATIC HERNIA, AND RADIAL RAY DEFECTS
609612 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, WITH SYNERGISTIC DIVERGENCE
609616 SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATE
609654 SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS
609655 TALO-PATELLO-SCAPHOID OSTEOLYSIS, SYNOVITIS, AND SHORT FOURTH METACARPALS
609808 HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS
609943 HYPERTRICHOSIS, HYPERKERATOSIS, MENTAL RETARDATION, AND DISTINCTIVE
609944 ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA
610001 ARTHROGRYPOSIS MULTIPLEX WITH DEAFNESS, INGUINAL HERNIAS, AND EARLY
610023 BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS
610136 DEVRIENDT SYNDROME
610157 HEAT-SHOCK RNA 1
610204 PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA
610338 RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL
610442 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS
610797 EPIPHYSEAL DYSPLASIA, BAUMANN TYPE
610830 POLYOSTEOLYSIS-HYPEROSTOSIS SYNDROME
610871 SAKODA COMPLEX
611426 TENTED EYEBROWS
611555 RENAL TUBULAR ACIDOSIS, DISTAL, WITH NEPHROCALCINOSIS, SHORT STATURE,
611650 PERIPAPILLARY ATROPHY, BETA TYPE; PPAB
611702 SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE
611733 DAUWERSE-PETERS SYNDROME
611808 TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS;
611886 MESOMELIC DYSPLASIA, CAMERA TYPE
611961 STEVENSON-CAREY SYNDROME
612289 PROGEROID SYNDROME, CONGENITAL, PETTY TYPE
612396 ALLANTOICASE; ALLC
612445 SCOLIOSIS, ARACHNODACTYLY, AND BLINDNESS
612777 HYPOTONIA, SEIZURES, AND PRECOCIOUS PUBERTY
612785 MEGARBANE-JALKH SYNDROME
612867 CORNEAL DYSTROPHY, SUBEPITHELIAL MUCINOUS; SMCD
612875 GONADOTROPIN-RELEASING HORMONE RECEPTOR 2; GNRHR2
612916 ZECHI-CEIDE SYNDROME
612917 GIACHETI SYNDROME
612947 MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,
613005 SANTOS SYNDROME
613089 CAPILLARY MALFORMATION OF THE LOWER LIP, LYMPHATIC MALFORMATION OF
613124 HYDROPS FETALIS, NONIMMUNE, WITH GRACILE BONES AND DYSMORPHIC FEATURES
613241 PSEUDOPILI ANNULATI
613320 CHONDRODYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE
613328 ROIFMAN-CHITAYAT SYNDROME
613342 MSELENI JOINT DISEASE
613600 TORSADE DE POINTES, SHORT-COUPLED VARIANT
613601 EARLY REPOLARIZATION ASSOCIATED WITH VENTRICULAR FIBRILLATION
613623 AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,
614033 HYDROXYACYL GLUTATHIONE HYDROLASE DEFICIENCY
614036 ALPHA-2-MACROGLOBULIN DEFICIENCY; A2MD
614037 LEUKOTRIENE C4 SYNTHASE DEFICIENCY
614044 TRYPSINOGEN DEFICIENCY
614055 ACETYL-CoA ACETYLTRANSFERASE-2 DEFICIENCY; ACAT2D
614098 KEPPEN-LUBINSKY SYNDROME; KPLBS
614158 BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG
614520 ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL
614687 ALAR CLEFT, ISOLATED
614688 PONTINE TEGMENTAL CAP DYSPLASIA; PTCD
615174 L-THREONINE DEHYDROGENASE, PSEUDOGENE; TDH
615236 WOODS SYNDROME
615619 CHOLANGIOCARCINOMA, SUSCEPTIBILITY TO
